data_2kqb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kqb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 69.8 t . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -89.36 91.85 8.91 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 38.5 mtm-85 -60.03 153.98 20.24 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.315 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.1 t -81.01 138.39 36.04 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -52.8 151.87 4.23 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 121.117 -0.989 . . . . 0.0 109.434 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.4 t -75.79 156.96 34.04 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.088 -1.008 . . . . 0.0 110.898 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 45.7 mtm -57.77 -26.17 61.51 Favored 'General case' 0 N--CA 1.516 2.83 0 O-C-N 121.197 -0.94 . . . . 0.0 110.516 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.408 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 39.9 m-85 -89.58 -19.3 25.13 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.975 -1.078 . . . . 0.0 110.926 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.58 -91.06 0.1 OUTLIER Glycine 0 N--CA 1.493 2.444 0 O-C-N 120.674 -1.266 . . . . 0.0 109.994 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.68 -3.1 24.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.401 -1.058 . . . . 0.0 112.251 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -113.8 20.02 16.18 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.557 -1.339 . . . . 0.0 112.225 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.408 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 28.7 t -50.26 139.68 14.44 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 120.588 -1.32 . . . . 0.0 110.479 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 36.8 p90 -115.89 -36.4 4.17 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.418 -0.801 . . . . 0.0 111.9 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.6 ptt180 -75.64 160.38 30.15 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.0 109.567 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.78 104.31 2.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.171 -0.955 . . . . 0.0 111.116 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -118.69 165.92 15.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 109.798 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.86 -26.16 19.22 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.246 1.129 . . . . 0.0 110.387 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.36 -20.95 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.951 -1.093 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -65.91 -38.21 88.09 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 120.678 -1.264 . . . . 0.0 110.028 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -58.48 -26.41 63.37 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.231 -0.918 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.68 -29.42 36.56 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.167 -0.958 . . . . 0.0 110.897 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -87.34 -35.59 18.31 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.872 -1.143 . . . . 0.0 111.597 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 65.0 m-85 -122.24 137.64 54.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.918 -1.114 . . . . 0.0 110.576 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.24 169.18 11.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -144.06 157.73 56.79 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.651 -0.656 . . . . 0.0 109.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 37.2 Cg_endo -60.74 138.53 80.13 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.55 -1.7 53.16 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.177 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.29 150.39 31.05 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.383 1.592 . . . . 0.0 108.494 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.8 t -61.06 -23.55 65.54 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.32 4.58 46.49 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 120.523 -1.361 . . . . 0.0 112.851 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 29.2 t80 . . . . . 0 N--CA 1.51 2.572 0 O-C-N 120.417 -1.427 . . . . 0.0 109.457 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.95 88.43 7.7 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.256 -0.903 . . . . 0.0 109.722 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -51.12 148.72 4.25 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.226 -0.921 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -77.62 131.85 37.98 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 t -49.98 154.27 1.15 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 120.983 -1.073 . . . . 0.0 110.469 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 3.0 t -79.55 159.28 26.93 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.8 mtm -60.05 -26.25 65.99 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.724 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -88.06 -19.75 26.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.956 -1.09 . . . . 0.0 111.166 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 65.88 -89.02 0.12 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.57 2.84 26.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.307 -1.113 . . . . 0.0 112.599 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.0 m-80 -121.21 22.83 10.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.432 -1.417 . . . . 0.0 112.596 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.5 t -58.92 80.26 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 120.792 -1.193 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 384' ' ' ASN . 42.8 p90 -53.97 -30.54 47.39 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 121.109 -0.994 . . . . 0.0 112.26 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 162.74 27.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.928 -1.107 . . . . 0.0 109.411 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -153.72 93.93 1.72 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.241 -0.912 . . . . 0.0 111.195 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -116.66 153.14 49.05 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.0 -72.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.326 1.172 . . . . 0.0 110.749 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.6 t -47.21 -29.18 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 O-C-N 120.76 -1.212 . . . . 0.0 111.118 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -66.02 -35.99 82.06 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.794 -1.191 . . . . 0.0 109.341 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.92 -24.6 67.07 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.276 -0.89 . . . . 0.0 109.876 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -26.78 35.56 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.009 -1.057 . . . . 0.0 111.068 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -91.27 -38.64 12.54 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.876 -1.14 . . . . 0.0 111.579 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 396' ' ' PHE . 56.2 m-85 -114.23 135.33 54.17 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.958 -1.089 . . . . 0.0 110.612 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.38 165.6 13.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.23 -0.919 . . . . 0.0 110.713 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -142.14 159.57 58.22 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.699 -0.626 . . . . 0.0 109.722 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.7 Cg_endo -60.36 140.36 91.36 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.31 64.72 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.422 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.23 146.83 29.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 119.508 1.654 . . . . 0.0 108.469 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.4 m -55.55 -24.6 33.26 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.901 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.55 11.26 28.85 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.547 -1.345 . . . . 0.0 113.115 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 33.1 t80 . . . . . 0 N--CA 1.512 2.654 0 O-C-N 120.38 -1.45 . . . . 0.0 109.519 179.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.7 0.286 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -84.78 82.71 8.31 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.369 -0.832 . . . . 0.0 109.34 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.488 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -60.19 152.68 23.99 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.7 t -72.95 141.89 47.81 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.182 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.53 157.93 2.7 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.796 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 15.4 t -79.42 156.37 27.93 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.857 -1.152 . . . . 0.0 110.5 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.6 mtm -57.32 -27.21 62.0 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.137 -0.977 . . . . 0.0 110.84 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 88.8 m-85 -83.31 -23.93 32.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.9 -1.125 . . . . 0.0 110.782 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 68.98 -89.95 0.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 7.87 29.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.262 -1.14 . . . . 0.0 112.769 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 386' ' ' TYR . 68.5 m-80 -132.31 30.8 4.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.333 -1.479 . . . . 0.0 112.408 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 38.5 t -58.28 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 O-C-N 120.999 -1.063 . . . . 0.0 111.091 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 387' ' ' ARG . 33.2 p90 -57.03 -29.46 63.39 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.005 -1.06 . . . . 0.0 111.787 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -92.22 152.36 19.88 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.906 -1.121 . . . . 0.0 110.451 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -150.4 129.49 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.343 -0.848 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -129.76 168.23 17.33 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.184 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.12 -34.83 9.65 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.47 1.247 . . . . 0.0 110.489 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.95 -22.12 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.151 -0.968 . . . . 0.0 111.333 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.49 -38.33 90.73 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.657 -1.277 . . . . 0.0 109.62 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.92 -27.35 51.79 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.35 -29.42 28.27 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.059 -1.026 . . . . 0.0 110.609 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -80.59 -32.95 36.34 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.999 -1.063 . . . . 0.0 111.951 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -131.56 141.46 49.7 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.87 -1.143 . . . . 0.0 111.011 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.488 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 73.8 m -86.47 168.76 13.46 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.283 -0.886 . . . . 0.0 110.092 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -143.09 158.88 57.79 Favored Pre-proline 0 N--CA 1.484 1.232 0 O-C-N 121.672 -0.643 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.408 ' HA ' ' CG ' ' A' ' 404' ' ' TYR . 39.5 Cg_endo -62.2 139.15 76.4 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.11 56.06 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.965 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -115.91 156.97 25.23 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.594 1.697 . . . . 0.0 108.272 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.3 m -63.58 -29.34 70.61 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.281 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.12 -2.74 58.85 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.827 -1.171 . . . . 0.0 113.105 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.408 ' CG ' ' HA ' ' A' ' 399' ' ' PRO . 30.6 t80 . . . . . 0 N--CA 1.515 2.793 0 CA-C-N 120.514 1.506 . . . . 0.0 110.122 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.653 0.263 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.27 94.49 9.56 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.442 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -65.43 173.38 2.68 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.449 -0.782 . . . . 0.0 110.741 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.6 t -90.12 141.44 28.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.388 -0.82 . . . . 0.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' SER . . . . . 0.497 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.8 t -64.68 120.55 12.64 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.07 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -34.94 148.69 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 35.1 mtm -50.09 -30.84 11.82 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.39 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -85.54 -23.17 27.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.151 -0.968 . . . . 0.0 111.301 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.03 -87.43 0.11 Allowed Glycine 0 N--CA 1.491 2.334 0 O-C-N 120.459 -1.401 . . . . 0.0 110.11 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.33 1.25 27.78 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.294 -1.121 . . . . 0.0 112.61 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -121.85 22.64 10.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.475 -1.39 . . . . 0.0 112.297 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.4 t -47.22 140.23 5.48 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 120.696 -1.253 . . . . 0.0 111.002 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.465 ' OH ' ' NH1' ' A' ' 387' ' ' ARG . 27.2 p90 -113.43 -37.61 4.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.347 -0.845 . . . . 0.0 111.68 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.465 ' NH1' ' OH ' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.98 154.16 28.41 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.77 -1.206 . . . . 0.0 109.497 179.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 100.0 3.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 110.52 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -115.04 167.0 10.55 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.243 -0.91 . . . . 0.0 110.101 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.69 -30.08 12.17 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.425 1.224 . . . . 0.0 110.754 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.9 -23.4 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 121.134 -0.979 . . . . 0.0 111.481 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -60.9 -39.23 88.51 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 120.599 -1.313 . . . . 0.0 109.572 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -55.54 -29.16 58.43 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.094 -1.004 . . . . 0.0 109.578 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.08 39.46 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.587 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -77.7 -33.36 53.22 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.987 -1.07 . . . . 0.0 111.481 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -132.4 137.82 47.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.896 -1.127 . . . . 0.0 110.793 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 73.8 m -79.38 168.23 19.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.278 -0.889 . . . . 0.0 109.085 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.3 159.19 59.16 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.89 137.36 62.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.602 -1.345 . . . . 0.0 108.602 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.24 -0.78 58.75 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.535 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.05 151.63 39.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.208 1.504 . . . . 0.0 108.554 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 40.4 t -58.46 -31.72 68.06 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.237 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -73.14 -14.77 61.44 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.944 -1.098 . . . . 0.0 113.237 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.497 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 . . . . . 0 N--CA 1.52 3.065 0 CA-C-N 120.192 1.36 . . . . 0.0 111.06 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -85.93 91.96 8.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.299 -0.876 . . . . 0.0 108.997 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -63.27 151.44 40.59 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -71.57 149.61 45.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 28.5 t -62.22 161.83 10.64 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.845 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.06 165.94 23.95 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.01 -1.056 . . . . 0.0 109.466 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -36.5 74.72 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.135 -0.978 . . . . 0.0 110.089 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.79 -24.22 28.83 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.276 -0.89 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 69.42 -83.82 0.26 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.49 -1.63 32.62 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.265 -1.138 . . . . 0.0 113.188 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 386' ' ' TYR . 59.2 m-80 -122.4 14.41 10.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.318 -1.489 . . . . 0.0 113.343 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 45.8 t -45.56 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.393 0 CA-C-N 120.072 1.306 . . . . 0.0 112.668 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 384' ' ' ASN . 48.3 p90 -50.9 -34.9 30.25 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.887 -1.133 . . . . 0.0 111.895 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.431 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.4 OUTLIER -73.95 163.92 27.29 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.019 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -155.86 83.9 1.02 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.253 -0.905 . . . . 0.0 111.015 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -116.41 156.77 46.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.98 -72.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.274 1.144 . . . . 0.0 110.864 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.6 t -45.18 -30.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 120.644 -1.285 . . . . 0.0 111.226 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -65.31 -36.37 83.86 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.882 -1.136 . . . . 0.0 109.25 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -58.28 -28.13 64.69 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.171 -0.956 . . . . 0.0 109.544 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -27.07 46.74 Favored 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.677 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -82.25 -37.23 26.24 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.094 -1.004 . . . . 0.0 110.818 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 49.0 m-85 -129.87 144.54 51.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.05 -1.031 . . . . 0.0 110.077 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 2.5 m -95.41 167.9 11.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 111.151 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -140.72 157.72 67.13 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.73 -0.607 . . . . 0.0 109.911 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.406 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 36.5 Cg_endo -60.62 137.28 72.43 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 N-CA-C 108.544 -1.368 . . . . 0.0 108.544 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.52 -0.63 58.28 Favored Glycine 0 CA--C 1.551 2.321 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.315 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.22 139.16 46.84 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.337 1.568 . . . . 0.0 108.159 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.4 t -50.07 -26.46 4.44 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.012 -1.055 . . . . 0.0 112.045 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -96.87 3.1 52.35 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.575 -1.328 . . . . 0.0 113.411 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.4 t80 . . . . . 0 N--CA 1.518 2.938 0 CA-C-N 120.355 1.434 . . . . 0.0 110.52 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.759 0.314 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.94 93.04 9.46 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.272 -0.893 . . . . 0.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -56.07 152.65 10.16 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.385 -0.822 . . . . 0.0 110.755 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -82.28 133.33 35.24 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 63.4 p -50.76 153.75 1.62 Allowed 'General case' 0 N--CA 1.515 2.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.135 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.9 t -78.15 155.72 30.29 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.126 -0.984 . . . . 0.0 110.845 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.5 mtm -60.15 -30.01 69.03 Favored 'General case' 0 N--CA 1.51 2.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.26 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -84.39 -24.19 29.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.048 -1.032 . . . . 0.0 110.64 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.22 -86.84 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.24 -4.5 20.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -1.143 . . . . 0.0 112.337 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -112.4 16.57 19.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.457 -1.402 . . . . 0.0 112.858 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 14.5 t -46.73 137.31 7.14 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 120.6 -1.312 . . . . 0.0 110.513 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 39.6 p90 -116.91 -39.07 3.3 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.228 -0.92 . . . . 0.0 112.517 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.4 ptp85 -51.95 161.79 0.53 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.646 -1.284 . . . . 0.0 110.82 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -128.31 55.37 1.68 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 0.0 110.492 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.21 140.55 21.25 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.276 -0.89 . . . . 0.0 109.965 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.11 -72.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.258 1.136 . . . . 0.0 110.154 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.2 t -40.12 -28.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 O-C-N 120.864 -1.147 . . . . 0.0 112.497 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.452 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 25.0 t60 -64.22 -37.83 88.87 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 120.492 -1.38 . . . . 0.0 108.568 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -59.79 -30.82 69.16 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.2 -0.938 . . . . 0.0 109.592 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -26.48 53.78 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.186 -0.946 . . . . 0.0 110.85 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -91.69 -38.09 12.63 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.905 -1.122 . . . . 0.0 110.516 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 76.0 m-85 -113.11 138.51 49.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.0 110.49 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.66 168.5 11.44 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 111.224 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -141.48 159.64 59.83 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.77 -0.581 . . . . 0.0 109.66 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.51 139.92 84.44 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.48 -2.55 60.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -107.66 144.66 34.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.592 -1.534 . . . . 0.0 108.215 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 3.0 t -55.18 -24.3 26.24 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.206 -0.934 . . . . 0.0 111.801 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -105.15 7.54 33.78 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.521 -1.362 . . . . 0.0 113.066 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.523 3.184 0 CA-C-N 120.513 1.506 . . . . 0.0 110.876 -179.319 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.634 0.254 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.06 89.88 3.59 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.851 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -57.94 174.18 0.28 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.61 -0.682 . . . . 0.0 111.016 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.6 m -88.45 134.28 33.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 82.9 p -62.92 121.09 12.66 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.539 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 145.69 0.59 Allowed 'General case' 0 N--CA 1.513 2.679 0 O-C-N 121.368 -0.832 . . . . 0.0 112.173 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -46.72 -35.27 5.92 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.627 -0.67 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -78.07 -29.52 49.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.078 -1.014 . . . . 0.0 111.204 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 64.49 -86.19 0.07 OUTLIER Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.24 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -100.82 1.57 40.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.212 -1.169 . . . . 0.0 113.054 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 386' ' ' TYR . 37.3 m-80 -128.76 21.77 5.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.49 -1.381 . . . . 0.0 112.896 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.5 t -55.87 85.79 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 CA-C-N 119.915 1.234 . . . . 0.0 110.704 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 384' ' ' ASN . 28.9 p90 -61.02 -26.75 67.83 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.044 -1.035 . . . . 0.0 111.795 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 149.8 21.17 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.37 127.55 12.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -128.62 166.5 24.22 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.11 -33.79 11.15 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.322 1.17 . . . . 0.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.77 -23.28 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.263 -0.898 . . . . 0.0 111.5 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -62.57 -36.34 82.38 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.689 -1.257 . . . . 0.0 110.229 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.1 -26.36 66.16 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.106 -0.996 . . . . 0.0 109.518 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.1 -30.48 55.37 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.142 -0.974 . . . . 0.0 110.447 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.41 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 19.5 m170 -81.79 -35.4 29.59 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 51.1 m-85 -128.68 139.38 52.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.001 -1.062 . . . . 0.0 111.255 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.13 169.14 16.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.408 -0.808 . . . . 0.0 109.38 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -144.75 153.74 54.79 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.434 -0.791 . . . . 0.0 109.369 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.404 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.3 Cg_endo -61.14 137.46 71.46 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 N-CA-C 108.405 -1.421 . . . . 0.0 108.405 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.34 -1.16 53.83 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.748 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.92 171.69 7.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.649 1.725 . . . . 0.0 108.546 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -24.2 53.11 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.066 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -99.0 1.78 45.74 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.637 -1.289 . . . . 0.0 113.605 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 24.5 t80 . . . . . 0 N--CA 1.522 3.164 0 CA-C-N 120.362 1.437 . . . . 0.0 110.89 -179.552 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -87.05 91.03 8.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.29 151.58 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.372 -0.83 . . . . 0.0 110.25 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.3 t -81.13 136.7 35.93 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.784 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -51.72 149.04 4.92 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 121.155 -0.966 . . . . 0.0 109.964 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.4 t -71.13 163.42 27.64 Favored 'General case' 0 N--CA 1.512 2.627 0 O-C-N 120.944 -1.098 . . . . 0.0 110.495 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 63.7 mtm -62.91 -31.08 72.07 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.227 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -84.41 -23.48 30.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.201 -0.937 . . . . 0.0 110.45 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 70.33 -86.06 0.33 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.55 -4.26 18.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -1.136 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -111.53 16.46 20.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.486 -1.384 . . . . 0.0 112.874 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -47.62 141.0 5.61 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 120.086 1.312 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.2 p90 -121.72 -39.94 2.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 112.285 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.426 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -59.24 149.45 28.49 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.619 -1.301 . . . . 0.0 109.512 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.6 74.73 1.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.159 -0.963 . . . . 0.0 111.111 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.41 148.25 38.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.91 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.34 1.179 . . . . 0.0 110.764 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -42.25 -27.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 O-C-N 120.7 -1.25 . . . . 0.0 112.422 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -66.45 -35.63 80.76 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.456 -1.403 . . . . 0.0 109.238 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.97 -28.82 70.35 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -26.63 57.0 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.224 -0.922 . . . . 0.0 111.297 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 395' ' ' HIS . 18.4 m170 -92.08 -35.52 13.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.852 -1.155 . . . . 0.0 111.238 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -117.55 144.99 44.57 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.064 -1.022 . . . . 0.0 110.521 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.74 168.77 10.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.956 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -140.5 158.3 66.37 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.702 -0.624 . . . . 0.0 110.538 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.42 139.23 75.61 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 107.99 -1.581 . . . . 0.0 107.99 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.73 -3.13 60.73 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.878 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.3 138.1 46.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.627 -1.513 . . . . 0.0 108.466 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -25.67 0.94 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.201 -0.937 . . . . 0.0 113.267 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -106.06 12.96 29.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.512 -1.368 . . . . 0.0 113.192 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.517 2.91 0 O-C-N 120.457 -1.402 . . . . 0.0 109.951 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.74 0.305 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -84.39 82.89 8.19 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.452 ' O ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -56.56 152.35 12.02 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.186 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -72.34 137.27 46.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 p -49.29 160.2 0.25 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.6 t -83.32 157.76 22.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.201 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.7 ptp -61.59 -36.38 80.51 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.011 -1.055 . . . . 0.0 110.181 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -77.81 -32.99 52.63 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.171 -0.956 . . . . 0.0 110.29 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.95 -89.15 0.87 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.52 -4.42 19.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -1.056 . . . . 0.0 112.244 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.77 16.65 19.5 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.353 -1.467 . . . . 0.0 112.584 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 7.3 t -45.86 140.09 3.82 Favored 'General case' 0 N--CA 1.524 3.247 0 O-C-N 120.633 -1.292 . . . . 0.0 110.988 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.8 p90 -116.93 -39.05 3.3 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.381 -0.824 . . . . 0.0 112.279 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.439 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 6.8 ptp85 -55.19 158.75 2.86 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.651 -1.281 . . . . 0.0 110.564 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -128.12 62.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.248 -0.908 . . . . 0.0 110.517 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.35 145.16 33.14 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.23 -59.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.234 1.123 . . . . 0.0 110.901 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 12.2 p -43.61 -33.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 O-C-N 121.084 -1.01 . . . . 0.0 111.708 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.424 ' CG ' ' HD2' ' A' ' 387' ' ' ARG . 34.4 t60 -66.54 -36.33 82.42 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.91 -29.68 70.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.069 -1.019 . . . . 0.0 109.257 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.428 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 1.3 mp0 -77.23 -29.22 54.0 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.233 -0.917 . . . . 0.0 110.749 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -86.09 -32.99 21.07 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.19 -0.944 . . . . 0.0 111.377 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -124.11 143.41 50.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.791 -1.193 . . . . 0.0 110.592 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -89.19 170.03 10.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -0.901 . . . . 0.0 111.354 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -143.02 153.06 59.94 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 38.4 Cg_endo -63.04 140.57 79.52 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 N-CA-C 108.018 -1.57 . . . . 0.0 108.018 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.92 -0.16 62.43 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.454 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.0 144.39 41.42 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.643 1.722 . . . . 0.0 108.071 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 61.4 m -52.09 -26.27 10.68 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.98 -1.075 . . . . 0.0 112.4 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -103.36 10.45 37.43 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.504 -1.372 . . . . 0.0 113.315 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 21.5 t80 . . . . . 0 N--CA 1.515 2.822 0 O-C-N 120.398 -1.439 . . . . 0.0 110.367 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 64.8 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 66.9 9.68 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.895 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.427 ' O ' ' OG ' ' A' ' 397' ' ' SER . 12.4 ptt-85 -58.29 156.43 10.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.759 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.3 t -74.91 145.75 42.4 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.654 -0.818 . . . . 0.0 108.879 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.67 169.06 0.07 Allowed 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.323 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 54.1 t -85.44 158.79 20.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.155 -0.966 . . . . 0.0 108.44 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.0 mtm -63.07 -33.59 75.78 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 120.758 -1.214 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -94.7 -20.11 19.82 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.983 -1.073 . . . . 0.0 111.168 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 58.37 -95.59 0.06 OUTLIER Glycine 0 N--CA 1.494 2.536 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -86.89 -21.16 26.5 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.246 -1.149 . . . . 0.0 111.632 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -94.23 6.81 47.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.743 -1.223 . . . . 0.0 112.558 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.3 t -43.0 134.39 3.43 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 120.655 -1.278 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 27.4 p90 -119.95 -35.66 3.44 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.334 -0.854 . . . . 0.0 112.477 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.473 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 4.0 ptm180 -48.72 163.82 0.07 Allowed 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.68 -1.262 . . . . 0.0 110.968 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.9 pttm -129.81 56.83 1.7 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.196 -0.94 . . . . 0.0 110.522 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -109.41 144.16 29.24 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.26 -0.9 . . . . 0.0 110.51 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -73.94 -73.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 O-C-N 123.318 1.167 . . . . 0.0 110.355 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 72.2 t -41.24 -27.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 O-C-N 120.797 -1.19 . . . . 0.0 112.601 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -63.65 -37.43 87.32 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.375 -1.453 . . . . 0.0 108.533 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -60.59 -31.58 70.72 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.084 -1.01 . . . . 0.0 109.527 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.21 -27.21 38.84 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.102 -0.999 . . . . 0.0 110.987 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -84.8 -29.87 25.04 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.843 -1.161 . . . . 0.0 111.803 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -124.41 137.66 54.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.799 -1.188 . . . . 0.0 111.183 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -77.77 153.77 32.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.296 -0.878 . . . . 0.0 111.516 -179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -134.29 157.32 77.78 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.51 136.67 64.67 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 N-CA-C 108.281 -1.469 . . . . 0.0 108.281 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.32 1.99 56.76 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.032 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.52 141.7 45.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.211 1.506 . . . . 0.0 108.71 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 58.2 m -52.78 -25.94 12.81 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.214 -0.928 . . . . 0.0 111.83 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -98.12 -3.45 37.79 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.68 -1.262 . . . . 0.0 113.051 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 26.2 t80 . . . . . 0 N--CA 1.517 2.91 0 CA-C-N 120.202 1.365 . . . . 0.0 111.491 -179.141 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.742 0.306 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -91.35 94.2 9.4 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.327 -0.858 . . . . 0.0 109.452 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.432 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -70.81 174.21 6.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.606 -0.684 . . . . 0.0 110.433 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -94.68 136.04 35.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.37 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.9 t -58.05 122.78 13.87 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.371 -0.83 . . . . 0.0 109.744 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -42.37 148.61 0.2 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -49.98 -29.13 7.92 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.546 -0.721 . . . . 0.0 110.386 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.63 -23.77 29.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.027 -1.046 . . . . 0.0 111.444 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.05 -88.58 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 O-C-N 120.375 -1.453 . . . . 0.0 110.635 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.5 3.76 40.51 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.177 -1.19 . . . . 0.0 113.259 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 386' ' ' TYR . 16.8 m-80 -130.93 26.97 4.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.424 -1.422 . . . . 0.0 112.371 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 52.9 t -57.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.625 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 384' ' ' ASN . 34.9 p90 -63.59 -27.92 69.57 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 121.135 -0.978 . . . . 0.0 112.362 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 162.63 28.95 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 120.72 -1.237 . . . . 0.0 109.086 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.94 91.77 1.14 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.073 -1.017 . . . . 0.0 111.461 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.57 166.83 10.14 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.0 110.045 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.83 -32.28 5.79 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.404 1.213 . . . . 0.0 110.79 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.52 -22.6 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.149 -0.969 . . . . 0.0 111.029 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.56 -37.01 82.24 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.803 -1.186 . . . . 0.0 109.469 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -56.38 -27.55 56.52 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.095 -1.003 . . . . 0.0 109.53 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.72 -30.49 26.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.106 -0.996 . . . . 0.0 110.562 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.0 m170 -76.2 -32.85 59.2 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.908 -1.12 . . . . 0.0 111.785 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 56.0 m-85 -132.57 138.49 47.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 111.077 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.432 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 28.2 m -78.83 165.42 23.56 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -143.04 160.87 51.14 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.249 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.26 137.52 71.29 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.09 -1.87 61.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.642 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.76 149.6 36.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.449 1.624 . . . . 0.0 108.439 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 79.2 p -56.85 -32.07 65.41 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.062 -1.024 . . . . 0.0 111.152 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -80.18 -8.08 59.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.943 -1.098 . . . . 0.0 113.589 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.463 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 8.0 t80 . . . . . 0 N--CA 1.526 3.368 0 CA-C-N 120.524 1.511 . . . . 0.0 111.263 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 87.62 7.0 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.185 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.442 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -61.92 151.02 35.95 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.258 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.0 t -71.66 141.85 49.9 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.503 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.27 157.51 2.68 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.05 154.41 25.64 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.816 -1.178 . . . . 0.0 110.874 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' MET . . . . . 0.415 ' CE ' ' CE2' ' A' ' 381' ' ' TYR . 4.0 ptt? -54.62 -28.84 49.6 Favored 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.437 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 72.0 m-85 -82.64 -29.03 30.33 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.958 -1.089 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 72.19 -93.84 0.61 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -103.41 -0.23 30.32 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -1.182 . . . . 0.0 112.474 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.9 m-80 -121.38 24.26 10.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.347 -1.471 . . . . 0.0 112.504 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 49.2 t -59.38 81.83 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.95 0 O-C-N 120.783 -1.198 . . . . 0.0 110.589 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 384' ' ' ASN . 29.6 p90 -61.92 -25.42 67.56 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.169 -0.957 . . . . 0.0 111.738 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -87.5 157.89 19.07 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.798 -1.188 . . . . 0.0 110.134 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.73 124.04 5.32 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.217 -0.927 . . . . 0.0 110.91 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -126.06 166.93 18.57 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.284 -0.885 . . . . 0.0 109.69 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.09 -33.48 11.64 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.418 1.22 . . . . 0.0 110.263 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.26 -24.67 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.972 . . . . 0.0 111.416 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -60.48 -38.98 86.0 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.577 -1.327 . . . . 0.0 110.006 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -56.5 -28.6 60.25 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.412 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -79.96 -32.23 39.92 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.577 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -78.15 -35.17 49.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.219 -0.925 . . . . 0.0 111.486 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.25 144.34 51.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.952 -1.093 . . . . 0.0 110.726 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 10.0 m -91.42 171.47 9.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -143.48 159.17 55.7 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.11 139.3 83.3 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.73 -1.03 56.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.3 153.85 30.19 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.267 1.533 . . . . 0.0 107.658 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -29.06 70.41 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.135 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -85.91 -1.8 57.65 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.7 t80 . . . . . 0 N--CA 1.527 3.4 0 CA-C-N 120.713 1.597 . . . . 0.0 111.102 -178.596 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.798 0.332 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -79.87 94.49 5.84 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.455 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.6 OUTLIER -68.52 153.77 43.13 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.605 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.1 t -79.05 142.8 36.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.694 -0.629 . . . . 0.0 109.419 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.3 p -56.33 155.25 7.14 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.33 156.34 28.06 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.05 -1.031 . . . . 0.0 110.265 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -58.54 -35.77 72.83 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.16 -0.963 . . . . 0.0 110.635 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -71.89 -39.11 69.81 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.083 -1.01 . . . . 0.0 110.114 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.51 -86.92 1.31 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.07 -0.73 28.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.144 -1.209 . . . . 0.0 112.33 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.27 13.57 9.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.556 -1.34 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.8 t -49.39 152.57 1.25 Allowed 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.462 -1.398 . . . . 0.0 111.3 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 18.3 p90 -101.93 -29.62 11.71 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.446 -0.784 . . . . 0.0 111.525 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER 23.61 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.16 -2.88 25.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.983 -1.073 . . . . 0.0 111.462 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -130.35 157.57 76.94 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.582 -1.324 . . . . 0.0 109.267 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.23 -44.3 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.312 1.164 . . . . 0.0 110.061 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.4 t -47.73 -31.51 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 O-C-N 121.131 -0.981 . . . . 0.0 110.591 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -63.65 -31.97 73.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.003 -1.061 . . . . 0.0 109.428 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.429 ' CZ ' ' NH1' ' A' ' 387' ' ' ARG . 27.9 m-85 -63.19 -24.37 67.85 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.009 -1.057 . . . . 0.0 109.269 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.89 -28.94 32.63 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.663 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.8 m170 -83.38 -32.58 26.11 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 121.032 -1.043 . . . . 0.0 111.843 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 73.5 m-85 -130.97 143.54 50.8 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.895 -1.128 . . . . 0.0 110.705 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 68.1 m -86.46 163.65 17.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.402 -0.811 . . . . 0.0 110.993 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -139.85 159.43 64.8 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.704 -0.623 . . . . 0.0 109.868 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.07 136.44 60.82 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 N-CA-C 108.248 -1.482 . . . . 0.0 108.248 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.24 -3.39 51.11 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.27 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -113.42 141.06 47.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.56 -1.553 . . . . 0.0 108.248 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 56.0 m -51.78 -25.96 8.68 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.067 -1.021 . . . . 0.0 112.2 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -93.49 0.21 56.63 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.506 -1.371 . . . . 0.0 113.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 17.7 t80 . . . . . 0 N--CA 1.522 3.163 0 CA-C-N 120.562 1.528 . . . . 0.0 111.09 -179.195 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -80.27 81.68 6.48 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.172 -0.955 . . . . 0.0 109.979 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.56 16.52 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.308 -0.87 . . . . 0.0 110.726 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.0 m -67.09 130.21 42.39 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.14 162.33 0.31 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.16 -0.962 . . . . 0.0 110.523 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.48 156.73 27.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.09 -1.006 . . . . 0.0 109.839 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -62.75 -31.04 71.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.987 -1.071 . . . . 0.0 110.725 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -80.09 -33.07 39.08 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.021 -1.05 . . . . 0.0 110.228 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 79.46 -89.34 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.45 -3.46 18.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.323 -1.104 . . . . 0.0 112.338 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.35 17.15 18.72 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.505 -1.372 . . . . 0.0 112.653 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.7 t -45.32 137.27 4.8 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 120.664 -1.273 . . . . 0.0 110.853 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.7 p90 -117.46 -40.98 3.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.926 . . . . 0.0 111.875 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.464 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -55.99 156.66 5.13 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.731 -1.231 . . . . 0.0 110.168 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.07 68.19 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.743 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.78 143.43 28.62 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 109.628 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.03 -70.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.435 1.229 . . . . 0.0 110.594 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 9.9 p -38.18 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 O-C-N 121.221 -0.925 . . . . 0.0 112.94 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -69.19 -42.07 76.3 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.918 -1.114 . . . . 0.0 109.144 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -55.93 -36.72 68.04 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.247 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -77.47 -26.39 51.33 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.452 -0.78 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -86.66 -34.57 19.72 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.856 -1.152 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -117.85 146.97 43.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.925 -1.109 . . . . 0.0 110.449 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.11 162.87 13.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.239 -0.913 . . . . 0.0 110.961 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -135.08 157.62 76.56 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.728 -0.607 . . . . 0.0 110.507 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.2 141.48 88.28 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 N-CA-C 107.78 -1.661 . . . . 0.0 107.78 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.19 65.28 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.5 140.07 43.72 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.727 -1.455 . . . . 0.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.9 t -50.58 -24.38 3.21 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.045 -1.034 . . . . 0.0 112.858 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.45 15.63 23.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.435 -1.416 . . . . 0.0 113.467 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 20.2 t80 . . . . . 0 N--CA 1.524 3.257 0 CA-C-N 120.363 1.438 . . . . 0.0 110.767 -179.852 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.2 t . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.774 0.321 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -86.63 93.97 9.35 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.371 -0.83 . . . . 0.0 109.437 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 155.82 10.77 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.611 -0.681 . . . . 0.0 110.467 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -83.03 138.75 33.61 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 157.79 0.73 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.13 -0.981 . . . . 0.0 110.602 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.8 t -77.98 158.01 29.46 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -62.24 -30.94 71.46 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 120.878 -1.139 . . . . 0.0 110.473 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -81.04 -31.84 34.34 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.089 -1.007 . . . . 0.0 110.412 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 77.35 -89.05 1.01 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 -1.75 21.09 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.193 -1.18 . . . . 0.0 112.138 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -115.95 18.2 15.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.497 -1.377 . . . . 0.0 112.69 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.4 t -46.3 137.63 6.16 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 120.612 -1.305 . . . . 0.0 110.517 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.7 p90 -115.14 -40.44 3.47 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.295 -0.878 . . . . 0.0 112.011 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -60.94 149.8 35.36 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.778 -1.202 . . . . 0.0 109.551 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.23 69.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.271 -0.893 . . . . 0.0 110.613 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.11 151.76 42.71 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.24 -68.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.52 1.274 . . . . 0.0 111.027 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 8.2 p -40.52 -32.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 O-C-N 121.155 -0.965 . . . . 0.0 112.782 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.04 -39.07 83.14 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.959 -1.088 . . . . 0.0 109.445 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.55 -32.1 71.18 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.19 -27.01 59.45 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.391 -0.818 . . . . 0.0 111.427 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 395' ' ' HIS . 24.6 m170 -93.45 -34.51 13.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.836 -1.165 . . . . 0.0 111.162 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.23 140.19 48.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.993 -1.067 . . . . 0.0 110.807 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.8 t -91.68 165.15 13.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.391 -0.818 . . . . 0.0 110.637 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.91 157.94 72.3 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.802 -0.561 . . . . 0.0 109.764 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.4 ' HA ' ' CG ' ' A' ' 404' ' ' TYR . 40.2 Cg_endo -62.53 140.55 82.21 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.28 -1.52 62.58 Favored Glycine 0 CA--C 1.552 2.38 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.935 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -110.64 142.5 42.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.442 -1.622 . . . . 0.0 108.403 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.3 t -50.88 -26.78 6.27 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.201 -0.937 . . . . 0.0 112.472 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -102.24 8.94 40.35 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.505 -1.372 . . . . 0.0 113.157 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.4 ' CG ' ' HA ' ' A' ' 399' ' ' PRO . 23.3 t80 . . . . . 0 N--CA 1.52 3.07 0 CA-C-N 120.305 1.412 . . . . 0.0 110.969 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.81 0.338 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -93.01 96.37 10.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.31 -0.869 . . . . 0.0 109.246 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.431 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 3.1 mtt85 -54.61 -179.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.422 -0.799 . . . . 0.0 111.029 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -107.15 128.64 54.58 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' SER . . . . . 0.418 ' HB2' ' CE1' ' A' ' 404' ' ' TYR . 9.5 p -52.5 117.26 2.74 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.241 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.2 t -36.37 151.64 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 10.8 ptp -51.12 -30.02 15.09 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -84.96 -23.7 28.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.152 -0.967 . . . . 0.0 111.318 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.13 -82.95 0.12 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 120.361 -1.462 . . . . 0.0 109.935 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.01 -0.11 21.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.297 -1.119 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -119.5 19.69 12.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.398 -1.439 . . . . 0.0 113.153 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.1 t -47.66 143.25 3.95 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 120.171 1.35 . . . . 0.0 110.552 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.6 p90 -120.14 -39.38 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.324 -0.86 . . . . 0.0 112.222 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.44 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.7 ptp85 -67.66 145.27 54.97 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.719 -1.238 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 73.13 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.977 . . . . 0.0 111.384 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.55 150.8 40.58 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.945 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.31 -73.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.305 1.16 . . . . 0.0 110.477 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.6 t -41.84 -29.5 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 120.885 -1.134 . . . . 0.0 112.082 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.411 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 30.0 t60 -63.19 -35.09 79.16 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.604 -1.31 . . . . 0.0 109.307 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.01 -26.75 67.68 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -31.57 57.47 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.913 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -82.75 -40.48 20.47 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.872 -1.142 . . . . 0.0 110.397 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -110.02 165.36 11.79 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.294 -0.879 . . . . 0.0 109.685 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -112.38 169.16 9.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -143.35 160.21 52.46 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.035 . . . . 0.0 110.304 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.05 137.71 68.57 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 108.778 -1.278 . . . . 0.0 108.778 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.33 62.54 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.364 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.59 139.35 45.93 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.411 1.605 . . . . 0.0 108.427 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 51.1 m -49.18 -26.13 2.66 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.188 -0.945 . . . . 0.0 112.679 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -97.8 2.58 49.59 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.394 -1.441 . . . . 0.0 114.433 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 378' ' ' SER . 4.6 t80 . . . . . 0 N--CA 1.533 3.688 0 CA-C-N 120.683 1.583 . . . . 0.0 111.029 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.808 0.337 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.74 89.91 6.82 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.779 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.419 ' NE ' ' O ' ' A' ' 394' ' ' GLN . 2.5 mmt-85 -62.14 151.85 34.62 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.319 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.3 t -74.0 140.91 45.8 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.9 p -57.18 157.29 6.29 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.316 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -73.15 161.57 30.44 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.044 -1.035 . . . . 0.0 110.232 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -31.83 71.68 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -85.08 -21.53 29.3 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.105 -0.997 . . . . 0.0 110.564 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.4 -86.61 0.11 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.48 -8.7 18.91 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -1.174 . . . . 0.0 112.243 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -106.63 12.96 28.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.48 -1.388 . . . . 0.0 112.975 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.1 t -47.0 142.28 3.63 Favored 'General case' 0 N--CA 1.524 3.235 0 O-C-N 120.534 -1.354 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.4 p90 -121.13 -37.05 3.0 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.275 -0.891 . . . . 0.0 112.67 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.7 ptm180 -55.11 157.13 3.55 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.742 -1.224 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -129.01 64.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.0 110.749 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -111.74 148.31 38.66 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.076 -1.015 . . . . 0.0 109.93 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.66 -69.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.444 1.234 . . . . 0.0 110.493 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.8 t -43.01 -29.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.177 0 O-C-N 120.819 -1.175 . . . . 0.0 111.752 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.24 -36.26 83.6 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.507 -1.371 . . . . 0.0 108.903 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -57.89 -30.03 65.53 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.071 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.419 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -82.42 -28.65 31.24 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.179 -0.951 . . . . 0.0 110.444 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -75.44 -34.26 60.96 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.969 -1.082 . . . . 0.0 110.873 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -134.65 149.18 50.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.004 -1.06 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.0 t -93.85 164.91 12.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.772 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.15 159.16 70.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.35 138.94 74.35 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.54 -2.08 60.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -110.07 138.9 45.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 119.14 1.47 . . . . 0.0 107.657 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.3 -23.24 5.47 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.13 -0.981 . . . . 0.0 112.538 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -103.6 11.97 35.5 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.294 -1.504 . . . . 0.0 113.562 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.523 3.181 0 CA-C-N 120.546 1.521 . . . . 0.0 110.925 -179.529 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.57 0.224 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.25 88.64 7.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.319 -0.863 . . . . 0.0 109.271 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.483 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 3.3 mmt-85 -61.53 152.18 30.98 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.294 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -73.38 143.64 46.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.5 t -57.35 168.7 0.72 Allowed 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.616 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 35.9 t -83.23 158.12 22.41 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.075 -1.016 . . . . 0.0 109.832 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 52.8 mtm -56.26 -31.23 63.38 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 121.007 -1.058 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.54 -21.89 35.19 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.081 -1.012 . . . . 0.0 111.052 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.36 -91.95 0.17 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.88 0.66 28.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.448 -1.031 . . . . 0.0 112.271 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -117.49 22.13 12.6 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.471 -1.393 . . . . 0.0 112.299 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 13.2 t -52.31 147.55 7.74 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 120.446 -1.409 . . . . 0.0 109.819 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 19.4 p90 -125.96 -35.63 2.45 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.328 -0.858 . . . . 0.0 112.993 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.474 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.0 ptp85 -61.99 162.09 9.74 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.549 -1.344 . . . . 0.0 109.819 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 66.9 1.39 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.199 -0.938 . . . . 0.0 110.649 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -107.53 145.95 32.34 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.272 -0.892 . . . . 0.0 110.078 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.58 -69.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.342 1.18 . . . . 0.0 110.38 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 91.5 t -44.76 -30.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.126 0 O-C-N 120.854 -1.154 . . . . 0.0 110.972 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.434 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 45.4 t60 -63.73 -36.0 82.43 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.863 -1.148 . . . . 0.0 109.064 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 -27.54 65.19 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.005 -1.059 . . . . 0.0 109.272 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.05 -31.25 25.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.106 -0.996 . . . . 0.0 110.176 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -73.24 -29.05 62.5 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.978 -1.076 . . . . 0.0 110.83 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' A' ' 379' ' ' CYS . 59.5 m-85 -140.29 145.86 37.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 110.856 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.483 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 45.7 m -90.1 163.13 14.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.473 -0.767 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -139.14 160.89 60.57 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.692 -0.63 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.03 140.12 77.13 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.003 -1.576 . . . . 0.0 108.003 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.8 60.56 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.256 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.27 143.28 45.12 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.367 1.584 . . . . 0.0 107.813 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.9 m -52.81 -30.4 33.06 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.085 -1.009 . . . . 0.0 110.992 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.29 -1.65 57.69 Favored 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.532 3.657 0 CA-C-N 120.861 1.664 . . . . 0.0 110.903 -179.511 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -68.48 82.99 0.26 Allowed 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.469 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt-85 -61.91 152.24 32.53 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.33 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.4 t -71.84 141.52 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.983 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -54.84 161.03 1.71 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.153 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 25.3 t -81.28 155.99 25.78 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.893 -1.129 . . . . 0.0 110.757 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.9 mtm -56.02 -27.53 53.42 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.24 -0.913 . . . . 0.0 110.932 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 87.8 m-85 -84.52 -21.8 30.4 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.05 -1.032 . . . . 0.0 110.723 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.61 -93.55 0.21 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.08 0.18 23.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.291 -1.123 . . . . 0.0 112.182 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -116.65 23.41 12.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.475 -1.391 . . . . 0.0 111.837 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 14.0 t -52.63 144.22 14.31 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 120.533 -1.355 . . . . 0.0 109.962 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 16.3 p90 -122.9 -36.44 2.88 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.603 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.482 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.08 161.52 26.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.592 -1.318 . . . . 0.0 109.265 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -150.41 111.16 4.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.0 111.223 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -120.06 166.87 13.83 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 109.775 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.36 -28.89 14.49 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.312 1.164 . . . . 0.0 110.395 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.79 -22.94 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.014 -1.054 . . . . 0.0 111.676 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -61.75 -38.04 86.52 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.603 -1.31 . . . . 0.0 109.644 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.83 -28.59 61.77 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.149 -0.97 . . . . 0.0 109.43 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.93 -32.43 25.09 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.404 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 15.8 m170 -71.62 -31.04 66.46 Favored 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.021 -1.049 . . . . 0.0 111.64 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 36.9 m-85 -140.71 148.53 40.9 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.802 -1.186 . . . . 0.0 110.857 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.469 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 18.3 m -86.81 169.52 12.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.444 -0.785 . . . . 0.0 110.657 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.37 157.84 58.87 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.592 -0.693 . . . . 0.0 109.782 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 138.96 73.4 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.114 -1.533 . . . . 0.0 108.114 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.04 54.76 Favored Glycine 0 CA--C 1.553 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.042 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.14 147.62 40.02 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.733 -1.451 . . . . 0.0 107.902 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 48.0 t -58.71 -27.05 64.51 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.725 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.62 -0.56 57.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.681 -1.262 . . . . 0.0 113.918 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.3 t80 . . . . . 0 N--CA 1.521 3.095 0 CA-C-N 120.81 1.641 . . . . 0.0 110.789 -179.127 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -89.53 96.02 10.52 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.251 -0.905 . . . . 0.0 109.427 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.89 150.57 39.12 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.344 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 397' ' ' SER . 14.2 t -76.58 -179.66 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.183 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' SER . . . . . 0.419 ' HB2' ' CE1' ' A' ' 404' ' ' TYR . 0.1 OUTLIER -97.16 126.81 42.59 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.004 -1.06 . . . . 0.0 110.82 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -45.07 145.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.614 -0.679 . . . . 0.0 112.333 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 11.3 ptp -49.4 -28.08 4.76 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.469 -0.769 . . . . 0.0 111.031 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -86.81 -22.47 25.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.942 -1.099 . . . . 0.0 111.214 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.65 -84.87 0.04 OUTLIER Glycine 0 N--CA 1.497 2.703 0 O-C-N 120.495 -1.378 . . . . 0.0 110.784 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.11 -9.74 17.6 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.202 -1.175 . . . . 0.0 112.569 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -112.84 18.69 17.99 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.521 -1.362 . . . . 0.0 113.22 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 30.9 t -47.89 139.13 8.04 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.055 1.298 . . . . 0.0 110.239 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 37.5 p90 -116.22 -40.68 3.23 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.461 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -71.35 162.75 28.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.904 -1.122 . . . . 0.0 109.154 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -155.99 104.07 2.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.177 -0.952 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.49 165.3 14.7 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 -24.74 18.58 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.437 1.23 . . . . 0.0 110.588 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.22 -21.73 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.039 -1.038 . . . . 0.0 111.756 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 45.5 t60 -63.84 -38.19 90.18 Favored 'General case' 0 N--CA 1.512 2.663 0 O-C-N 120.517 -1.364 . . . . 0.0 110.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -58.1 -30.61 66.41 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -32.14 44.93 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.876 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -77.82 -37.76 47.88 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.119 -0.988 . . . . 0.0 110.589 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.9 m-85 -125.18 150.52 46.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 377' ' ' THR . 3.1 t -94.7 174.48 7.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.161 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -144.33 156.49 57.36 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.764 . . . . 0.0 109.278 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 404' ' ' TYR . 37.8 Cg_endo -61.14 138.9 80.88 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.61 -2.54 55.95 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.791 -1.195 . . . . 0.0 110.874 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.14 146.87 39.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.699 1.75 . . . . 0.0 108.415 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.8 t -54.48 -28.45 44.82 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.124 -0.985 . . . . 0.0 111.645 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -92.12 1.44 57.21 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 0.0 113.058 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.425 ' CG ' ' HA ' ' A' ' 399' ' ' PRO . 23.3 t80 . . . . . 0 N--CA 1.514 2.76 0 CA-C-N 120.391 1.451 . . . . 0.0 110.253 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.889 0.376 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -83.29 99.22 9.86 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.452 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -72.64 152.99 41.45 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.803 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -73.43 141.8 46.91 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 378' ' ' SER . . . . . 0.427 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 8.2 t -58.18 158.49 6.97 Favored 'General case' 0 N--CA 1.511 2.606 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.503 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.83 151.46 35.88 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.911 -1.118 . . . . 0.0 110.577 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -52.91 -28.59 24.09 Favored 'General case' 0 N--CA 1.514 2.76 0 O-C-N 121.226 -0.921 . . . . 0.0 111.118 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -77.34 -31.95 54.84 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.977 -1.077 . . . . 0.0 110.169 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.94 -90.91 0.89 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.34 4.98 29.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.331 -1.099 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -128.34 25.78 5.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.556 -1.34 . . . . 0.0 112.191 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 34.4 t -50.66 143.77 9.05 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 120.668 -1.27 . . . . 0.0 110.165 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 13.3 p90 -116.4 -36.01 4.12 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.284 -0.885 . . . . 0.0 112.001 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -73.52 149.54 42.16 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.831 -1.168 . . . . 0.0 109.694 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.5 100.89 3.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.062 -1.024 . . . . 0.0 111.171 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.21 164.57 21.84 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 109.848 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.41 -29.93 16.05 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.324 1.171 . . . . 0.0 110.447 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.14 -23.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.12 -0.988 . . . . 0.0 111.304 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -61.7 -37.45 84.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.764 -1.21 . . . . 0.0 109.637 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -57.73 -26.06 61.27 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.47 -30.3 30.05 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.42 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 11.6 m170 -79.32 -34.22 42.49 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.159 -0.963 . . . . 0.0 111.336 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 65.6 m-85 -133.26 142.43 48.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.224 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 56.0 m -85.71 169.27 13.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.401 -0.812 . . . . 0.0 110.167 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -144.39 158.75 53.77 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.6 -0.687 . . . . 0.0 109.923 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.09 137.43 66.63 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 N-CA-C 108.341 -1.446 . . . . 0.0 108.341 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.12 -1.94 56.45 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.698 -178.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.24 150.75 40.89 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.651 -1.499 . . . . 0.0 107.564 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 81.3 p -60.32 -32.07 70.88 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.456 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.8 -11.44 60.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.028 -1.045 . . . . 0.0 112.634 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.427 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 8.8 t80 . . . . . 0 N--CA 1.517 2.886 0 CA-C-N 120.288 1.404 . . . . 0.0 110.214 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.848 0.356 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -88.37 94.53 9.88 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.75 150.25 48.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.456 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.7 t -78.92 172.12 14.23 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.771 -179.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 p -76.99 157.53 31.15 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.076 -1.015 . . . . 0.0 109.272 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.42 160.74 29.91 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.429 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.5 ptp -61.45 -35.31 77.26 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.901 -1.125 . . . . 0.0 109.944 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -77.14 -33.48 56.69 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.484 179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 76.13 -87.64 0.89 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.75 -3.19 20.74 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.261 -1.141 . . . . 0.0 112.469 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -115.44 17.33 16.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.415 -1.428 . . . . 0.0 112.809 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 8.6 t -45.14 139.69 3.19 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-N 120.059 1.3 . . . . 0.0 110.905 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 33.5 p90 -117.22 -39.39 3.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.313 -0.867 . . . . 0.0 112.363 -178.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.446 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.4 ptp85 -57.28 156.58 7.36 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 120.632 -1.293 . . . . 0.0 110.165 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.93 65.56 1.2 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 110.871 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -109.95 144.15 29.41 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.113 -0.992 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.47 -71.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.358 1.189 . . . . 0.0 110.529 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 71.8 t -41.48 -28.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 O-C-N 120.885 -1.134 . . . . 0.0 112.318 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.429 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 27.2 t60 -65.23 -37.6 87.75 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 120.496 -1.378 . . . . 0.0 108.66 177.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -57.37 -31.04 65.38 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.068 -1.02 . . . . 0.0 109.35 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 -26.99 39.95 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.211 -0.931 . . . . 0.0 110.737 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -81.85 -37.88 26.29 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.002 -1.062 . . . . 0.0 110.185 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.5 m-85 -125.15 145.44 49.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 1.8 t -94.22 170.35 9.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.34 158.77 65.75 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.664 -0.647 . . . . 0.0 109.983 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.61 139.74 82.89 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 108.153 -1.518 . . . . 0.0 108.153 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.41 -1.63 60.47 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.807 -176.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -112.62 141.5 46.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.619 -1.518 . . . . 0.0 107.983 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.0 m -51.6 -28.53 14.41 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.149 -0.969 . . . . 0.0 111.752 -178.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.682 -1.261 . . . . 0.0 113.355 -178.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 26.0 t80 . . . . . 0 N--CA 1.522 3.128 0 CA-C-N 120.466 1.485 . . . . 0.0 111.121 -178.989 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -95.49 100.51 12.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.494 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.7 OUTLIER -80.89 161.75 24.24 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.777 -0.577 . . . . 0.0 111.334 -179.219 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 397' ' ' SER . 7.4 t -76.62 174.17 10.71 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.9 t -94.7 129.99 41.37 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.684 -1.26 . . . . 0.0 111.78 -178.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 7.8 t -40.11 148.55 0.08 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.895 -0.503 . . . . 0.0 112.036 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 6.1 ptp -47.64 -37.83 13.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.622 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.411 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 27.9 m-85 -73.58 -35.21 65.39 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.57 -86.62 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.047 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.24 7.06 43.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.26 -1.141 . . . . 0.0 112.847 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -134.87 25.09 3.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.343 -1.473 . . . . 0.0 112.577 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.411 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.2 t -49.63 151.72 1.6 Allowed 'General case' 0 N--CA 1.521 3.076 0 O-C-N 120.514 -1.366 . . . . 0.0 111.113 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.1 p90 -126.3 -33.2 2.63 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.992 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.423 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.1 OUTLIER -55.97 173.81 0.14 Allowed 'General case' 0 N--CA 1.514 2.729 0 O-C-N 120.388 -1.445 . . . . 0.0 110.167 179.936 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -143.7 55.88 1.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 110.532 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -112.05 148.18 38.48 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 109.606 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -73.34 -66.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.396 1.208 . . . . 0.0 110.473 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.3 t -43.01 -29.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 120.888 -1.132 . . . . 0.0 111.999 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.413 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 39.0 t60 -63.87 -38.98 93.09 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.665 -1.272 . . . . 0.0 108.824 178.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -56.13 -29.27 60.48 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 178.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -29.72 45.23 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.159 -0.963 . . . . 0.0 110.501 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.408 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 17.2 m170 -75.33 -35.47 61.19 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.453 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 34.0 m-85 -134.78 138.19 44.07 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.087 -1.008 . . . . 0.0 110.304 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.494 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 1.5 m -81.58 169.48 17.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.518 -0.739 . . . . 0.0 109.23 178.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -141.6 155.22 66.92 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 404' ' ' TYR . 36.9 Cg_endo -59.61 140.07 92.0 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 N-CA-C 108.735 -1.294 . . . . 0.0 108.735 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.57 0.79 64.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.722 -177.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.22 143.81 44.23 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.413 1.606 . . . . 0.0 108.646 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.6 t -50.01 -30.79 11.32 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.09 -1.006 . . . . 0.0 111.839 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.83 -6.15 54.65 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.684 -1.26 . . . . 0.0 113.55 -177.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.402 ' CG ' ' HA ' ' A' ' 399' ' ' PRO . 25.9 t80 . . . . . 0 N--CA 1.525 3.289 0 CA-C-N 120.551 1.523 . . . . 0.0 111.294 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -69.84 91.38 0.64 Allowed 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.487 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -58.04 158.28 6.97 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.697 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.5 t -75.08 145.67 42.1 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.3 t -56.44 163.2 1.81 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.646 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 6.1 t -78.34 162.3 26.57 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.04 -1.038 . . . . 0.0 109.8 178.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 47.9 mtm -58.4 -31.16 67.43 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.403 179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.11 -26.11 25.42 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.144 -0.972 . . . . 0.0 110.768 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.19 -89.75 0.6 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.61 -1.19 26.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.343 -1.092 . . . . 0.0 111.956 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -112.51 16.95 19.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.34 -1.475 . . . . 0.0 112.275 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.4 t -49.19 143.84 5.67 Favored 'General case' 0 N--CA 1.519 2.98 0 O-C-N 120.558 -1.339 . . . . 0.0 110.377 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.5 p90 -120.77 -33.94 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.353 -0.842 . . . . 0.0 112.536 -179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -72.64 174.54 7.42 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.709 -1.245 . . . . 0.0 109.618 179.571 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.6 93.3 1.18 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.899 -1.126 . . . . 0.0 111.096 -179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -115.23 162.43 24.44 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.736 -1.227 . . . . 0.0 110.034 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -26.04 12.73 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 O-C-N 123.514 1.27 . . . . 0.0 110.652 178.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.76 -25.42 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.093 -1.004 . . . . 0.0 111.411 178.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -61.88 -36.02 80.02 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.662 -1.273 . . . . 0.0 109.946 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -58.13 -26.67 62.94 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -31.08 27.86 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.178 -0.951 . . . . 0.0 110.468 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.5 m170 -75.46 -34.3 60.93 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.808 -1.183 . . . . 0.0 111.371 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 48.3 m-85 -137.21 145.66 43.92 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.722 -1.236 . . . . 0.0 110.839 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 66.5 m -91.4 169.97 10.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.222 -0.924 . . . . 0.0 111.503 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -141.64 153.54 65.22 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.109 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.34 140.14 81.04 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 N-CA-C 107.253 -1.864 . . . . 0.0 107.253 178.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.31 1.61 60.79 Favored Glycine 0 CA--C 1.553 2.438 0 C-N-CA 119.041 -1.552 . . . . 0.0 110.825 -178.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.66 156.94 24.97 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.837 1.818 . . . . 0.0 107.778 177.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -29.11 70.24 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.207 -179.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -94.41 6.09 49.8 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 120.533 -1.355 . . . . 0.0 114.0 -177.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.9 t80 . . . . . 0 N--CA 1.519 3.007 0 CA-C-N 120.643 1.565 . . . . 0.0 109.966 179.899 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 86.88 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.47 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -61.2 153.65 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.293 -179.637 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -71.07 142.46 50.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 28.8 t -53.05 165.19 0.33 Allowed 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.686 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 45.2 t -87.51 156.97 19.3 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.974 -1.079 . . . . 0.0 109.682 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 4.1 ptp -55.25 -31.61 61.67 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -93.52 -20.74 19.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.974 -1.079 . . . . 0.0 111.439 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.45 -98.86 0.22 Allowed Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.521 -1.362 . . . . 0.0 110.392 178.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.58 -13.32 32.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.429 -1.042 . . . . 0.0 111.764 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -104.51 16.44 26.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.565 -1.335 . . . . 0.0 112.39 -179.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.9 t -48.92 139.78 9.71 Favored 'General case' 0 N--CA 1.52 3.065 0 O-C-N 120.517 -1.364 . . . . 0.0 111.039 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 17.9 p90 -117.03 -37.16 3.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.438 -0.789 . . . . 0.0 111.765 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.457 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.69 153.66 29.15 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.644 -1.285 . . . . 0.0 109.408 179.184 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 108.29 4.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -0.98 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -118.97 167.47 11.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 0.0 110.209 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.15 -27.67 16.58 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.432 1.227 . . . . 0.0 110.319 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.4 t -98.17 -24.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.084 -1.01 . . . . 0.0 111.92 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -61.94 -38.09 87.17 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.6 -1.313 . . . . 0.0 110.113 -179.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -56.96 -28.81 62.62 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.83 -1.169 . . . . 0.0 109.148 178.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -32.53 30.06 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.238 -0.914 . . . . 0.0 110.275 179.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.408 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 22.1 m170 -71.98 -32.0 66.81 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.07 -1.019 . . . . 0.0 111.408 -179.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.441 ' HB3' ' HA ' ' A' ' 379' ' ' CYS . 42.7 m-85 -140.02 148.08 41.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.952 -1.093 . . . . 0.0 111.43 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 15.9 m -87.61 168.76 12.75 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -0.81 . . . . 0.0 110.997 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -143.7 153.33 57.91 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.15 139.08 76.33 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 177.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.4 -0.81 55.78 Favored Glycine 0 CA--C 1.553 2.446 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.757 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -116.41 158.07 24.09 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.662 1.731 . . . . 0.0 108.229 178.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 59.2 m -64.02 -28.01 69.51 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.708 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.65 2.38 56.51 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.644 -1.285 . . . . 0.0 114.061 -176.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.2 t80 . . . . . 0 N--CA 1.523 3.182 0 CA-C-N 120.741 1.61 . . . . 0.0 110.131 -179.858 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 367' ' ' SER . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.63 -171.34 0.73 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.426 1.224 . . . . 0.0 110.468 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.3 tt 53.01 95.34 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.103 -0.998 . . . . 0.0 110.78 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 87.18 41.11 6.72 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 363' ' ' GLY . 3.1 m -146.26 108.57 4.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.187 -1.184 . . . . 0.0 110.396 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 139.08 84.2 0.1 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.0 p -142.16 48.23 1.59 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.197 -1.178 . . . . 0.0 110.179 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -127.0 70.01 1.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.194 -0.941 . . . . 0.0 110.156 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -139.25 40.76 1.4 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -148.94 -66.85 0.23 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.239 -1.153 . . . . 0.0 110.415 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -137.15 63.71 1.55 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.12 -0.988 . . . . 0.0 110.243 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 69.8 t -144.7 160.53 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.33 -0.856 . . . . 0.0 109.833 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -89.36 91.85 8.91 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 38.5 mtm-85 -60.03 153.98 20.24 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.315 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.1 t -81.01 138.39 36.04 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -52.8 151.87 4.23 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 121.117 -0.989 . . . . 0.0 109.434 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.4 t -75.79 156.96 34.04 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.088 -1.008 . . . . 0.0 110.898 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 45.7 mtm -57.77 -26.17 61.51 Favored 'General case' 0 N--CA 1.516 2.83 0 O-C-N 121.197 -0.94 . . . . 0.0 110.516 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.408 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 39.9 m-85 -89.58 -19.3 25.13 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.975 -1.078 . . . . 0.0 110.926 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.58 -91.06 0.1 OUTLIER Glycine 0 N--CA 1.493 2.444 0 O-C-N 120.674 -1.266 . . . . 0.0 109.994 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.68 -3.1 24.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.401 -1.058 . . . . 0.0 112.251 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -113.8 20.02 16.18 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.557 -1.339 . . . . 0.0 112.225 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.408 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 28.7 t -50.26 139.68 14.44 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 120.588 -1.32 . . . . 0.0 110.479 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 36.8 p90 -115.89 -36.4 4.17 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.418 -0.801 . . . . 0.0 111.9 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.6 ptt180 -75.64 160.38 30.15 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.0 109.567 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.78 104.31 2.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.171 -0.955 . . . . 0.0 111.116 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -118.69 165.92 15.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 109.798 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.86 -26.16 19.22 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.246 1.129 . . . . 0.0 110.387 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.36 -20.95 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.951 -1.093 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -65.91 -38.21 88.09 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 120.678 -1.264 . . . . 0.0 110.028 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -58.48 -26.41 63.37 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.231 -0.918 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.68 -29.42 36.56 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.167 -0.958 . . . . 0.0 110.897 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -87.34 -35.59 18.31 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.872 -1.143 . . . . 0.0 111.597 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 65.0 m-85 -122.24 137.64 54.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.918 -1.114 . . . . 0.0 110.576 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.24 169.18 11.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -144.06 157.73 56.79 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.651 -0.656 . . . . 0.0 109.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 37.2 Cg_endo -60.74 138.53 80.13 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.55 -1.7 53.16 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.177 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.29 150.39 31.05 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.383 1.592 . . . . 0.0 108.494 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.8 t -61.06 -23.55 65.54 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.32 4.58 46.49 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 120.523 -1.361 . . . . 0.0 112.851 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 29.2 t80 -54.86 141.16 34.21 Favored 'General case' 0 N--CA 1.51 2.572 0 O-C-N 120.417 -1.427 . . . . 0.0 109.457 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -158.35 39.77 0.52 Allowed Glycine 0 N--CA 1.499 2.849 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.596 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -97.25 -56.25 1.13 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 87.1 t 44.27 66.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.717 -0.872 . . . . 0.0 111.422 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -105.04 58.05 0.69 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.315 -0.865 . . . . 0.0 109.778 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 43.4 mt 50.67 74.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.966 -1.084 . . . . 0.0 110.718 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.83 72.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.27 -0.894 . . . . 0.0 109.367 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.83 -42.41 1.67 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.417 ' O ' ' OG1' ' A' ' 415' ' ' THR . 1.7 mt-30 53.64 76.96 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.331 -1.1 . . . . 0.0 110.848 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 16.0 t70 50.11 30.51 4.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.266 -0.896 . . . . 0.0 111.681 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 48.99 40.63 17.43 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.957 -1.089 . . . . 0.0 111.673 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 412' ' ' GLN . 0.2 OUTLIER -117.22 66.86 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.154 -0.966 . . . . 0.0 109.991 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.75 45.35 1.59 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.212 -0.93 . . . . 0.0 110.177 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.217 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.73 86.22 1.07 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.407 1.214 . . . . 0.0 110.404 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.43 -176.64 3.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 97.45 -139.69 14.62 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.8 m 52.53 83.2 0.06 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.023 -1.28 . . . . 0.0 110.808 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -90.01 61.87 3.32 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.8 p -132.07 130.62 41.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.226 -1.161 . . . . 0.0 110.223 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -116.1 52.24 0.92 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.234 -0.916 . . . . 0.0 109.978 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -135.58 42.37 1.34 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -145.46 -59.34 0.34 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.196 -1.179 . . . . 0.0 110.425 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -141.3 53.57 1.54 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.316 -0.865 . . . . 0.0 110.034 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t -144.43 161.17 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.971 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.95 88.43 7.7 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.256 -0.903 . . . . 0.0 109.722 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -51.12 148.72 4.25 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.226 -0.921 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -77.62 131.85 37.98 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 t -49.98 154.27 1.15 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 120.983 -1.073 . . . . 0.0 110.469 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 3.0 t -79.55 159.28 26.93 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.8 mtm -60.05 -26.25 65.99 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.724 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -88.06 -19.75 26.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.956 -1.09 . . . . 0.0 111.166 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 65.88 -89.02 0.12 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.57 2.84 26.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.307 -1.113 . . . . 0.0 112.599 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.0 m-80 -121.21 22.83 10.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.432 -1.417 . . . . 0.0 112.596 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.5 t -58.92 80.26 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 120.792 -1.193 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 384' ' ' ASN . 42.8 p90 -53.97 -30.54 47.39 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 121.109 -0.994 . . . . 0.0 112.26 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 162.74 27.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.928 -1.107 . . . . 0.0 109.411 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -153.72 93.93 1.72 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.241 -0.912 . . . . 0.0 111.195 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -116.66 153.14 49.05 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.0 -72.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.326 1.172 . . . . 0.0 110.749 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.6 t -47.21 -29.18 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 O-C-N 120.76 -1.212 . . . . 0.0 111.118 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -66.02 -35.99 82.06 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.794 -1.191 . . . . 0.0 109.341 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.92 -24.6 67.07 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.276 -0.89 . . . . 0.0 109.876 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -26.78 35.56 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.009 -1.057 . . . . 0.0 111.068 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -91.27 -38.64 12.54 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.876 -1.14 . . . . 0.0 111.579 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 396' ' ' PHE . 56.2 m-85 -114.23 135.33 54.17 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.958 -1.089 . . . . 0.0 110.612 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.38 165.6 13.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.23 -0.919 . . . . 0.0 110.713 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -142.14 159.57 58.22 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.699 -0.626 . . . . 0.0 109.722 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.7 Cg_endo -60.36 140.36 91.36 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.31 64.72 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.422 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.23 146.83 29.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 119.508 1.654 . . . . 0.0 108.469 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.4 m -55.55 -24.6 33.26 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.901 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.55 11.26 28.85 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.547 -1.345 . . . . 0.0 113.115 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -54.34 138.4 39.48 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.38 -1.45 . . . . 0.0 109.519 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -156.13 40.76 0.58 Allowed Glycine 0 N--CA 1.5 2.915 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.59 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -93.25 -58.31 1.3 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 48.5 t 32.59 59.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 122.131 -0.629 . . . . 0.0 112.572 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.06 78.54 1.61 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.226 -0.921 . . . . 0.0 111.193 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 79.5 mt -101.61 62.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.156 -0.965 . . . . 0.0 108.832 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.59 76.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 83.48 57.52 2.45 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -48.8 -63.37 1.11 Allowed 'General case' 0 N--CA 1.511 2.62 0 O-C-N 121.461 -1.023 . . . . 0.0 110.846 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -149.54 35.04 0.7 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.231 -0.918 . . . . 0.0 110.692 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 52.09 40.63 28.93 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.979 -1.076 . . . . 0.0 110.815 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.64 66.92 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.034 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.47 87.81 2.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.324 -0.86 . . . . 0.0 110.177 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.209 179.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.77 85.77 1.12 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.422 1.222 . . . . 0.0 110.422 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 35.0 mt -134.07 99.99 4.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.913 . . . . 0.0 110.171 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.22 129.12 4.6 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.06 -65.14 0.52 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -1.128 . . . . 0.0 110.237 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -62.81 87.56 0.05 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 2.2 p -139.24 103.1 4.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.229 -1.16 . . . . 0.0 110.246 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -134.94 -175.8 4.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.263 -0.898 . . . . 0.0 110.319 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 87.23 40.68 6.86 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -148.47 -67.09 0.23 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.169 -1.195 . . . . 0.0 110.581 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -132.17 45.08 2.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.085 -1.009 . . . . 0.0 110.393 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.9 p -142.84 161.26 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.372 -0.83 . . . . 0.0 110.401 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -84.78 82.71 8.31 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.369 -0.832 . . . . 0.0 109.34 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.488 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -60.19 152.68 23.99 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.7 t -72.95 141.89 47.81 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.182 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.53 157.93 2.7 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.796 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 15.4 t -79.42 156.37 27.93 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.857 -1.152 . . . . 0.0 110.5 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.6 mtm -57.32 -27.21 62.0 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.137 -0.977 . . . . 0.0 110.84 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 88.8 m-85 -83.31 -23.93 32.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.9 -1.125 . . . . 0.0 110.782 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 68.98 -89.95 0.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 7.87 29.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.262 -1.14 . . . . 0.0 112.769 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 386' ' ' TYR . 68.5 m-80 -132.31 30.8 4.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.333 -1.479 . . . . 0.0 112.408 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 38.5 t -58.28 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 O-C-N 120.999 -1.063 . . . . 0.0 111.091 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 387' ' ' ARG . 33.2 p90 -57.03 -29.46 63.39 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.005 -1.06 . . . . 0.0 111.787 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -92.22 152.36 19.88 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.906 -1.121 . . . . 0.0 110.451 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -150.4 129.49 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.343 -0.848 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -129.76 168.23 17.33 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.184 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.12 -34.83 9.65 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.47 1.247 . . . . 0.0 110.489 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.95 -22.12 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.151 -0.968 . . . . 0.0 111.333 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.49 -38.33 90.73 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.657 -1.277 . . . . 0.0 109.62 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.92 -27.35 51.79 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.35 -29.42 28.27 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.059 -1.026 . . . . 0.0 110.609 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -80.59 -32.95 36.34 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.999 -1.063 . . . . 0.0 111.951 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -131.56 141.46 49.7 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.87 -1.143 . . . . 0.0 111.011 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.488 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 73.8 m -86.47 168.76 13.46 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.283 -0.886 . . . . 0.0 110.092 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -143.09 158.88 57.79 Favored Pre-proline 0 N--CA 1.484 1.232 0 O-C-N 121.672 -0.643 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.408 ' HA ' ' CG ' ' A' ' 404' ' ' TYR . 39.5 Cg_endo -62.2 139.15 76.4 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.11 56.06 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.965 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -115.91 156.97 25.23 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.594 1.697 . . . . 0.0 108.272 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.3 m -63.58 -29.34 70.61 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.281 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.12 -2.74 58.85 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.827 -1.171 . . . . 0.0 113.105 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.408 ' CG ' ' HA ' ' A' ' 399' ' ' PRO . 30.6 t80 -50.09 127.84 17.65 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 120.514 1.506 . . . . 0.0 110.122 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -145.51 31.41 1.67 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.4 -1.381 . . . . 0.0 111.061 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -91.93 -56.93 1.55 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 84.3 t 44.84 62.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.788 -0.831 . . . . 0.0 111.261 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -87.91 79.38 8.08 Favored 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.853 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 87.6 mt 51.94 69.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.09 -1.006 . . . . 0.0 110.786 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 65.9 t -113.21 69.76 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 99.77 54.24 1.07 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -58.74 -38.98 79.58 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.282 -1.128 . . . . 0.0 110.199 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.82 37.22 2.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.182 -0.949 . . . . 0.0 110.197 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -144.77 40.09 1.27 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.09 -1.006 . . . . 0.0 110.37 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.55 63.36 1.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.24 47.3 1.94 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 3.4 t70 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.208 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.73 127.59 12.5 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.436 1.23 . . . . 0.0 110.416 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.97 92.94 3.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.907 . . . . 0.0 110.132 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -129.16 164.51 22.16 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.7 m -117.33 -65.37 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.165 -1.197 . . . . 0.0 110.229 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -62.85 93.14 0.09 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.66 138.86 53.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.222 -1.164 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -117.52 -173.16 2.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.077 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 76.79 41.18 24.28 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -133.42 -60.95 0.83 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.146 -1.208 . . . . 0.0 109.843 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -136.98 43.15 2.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.0 109.796 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.8 p -144.51 162.27 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.459 -0.776 . . . . 0.0 110.303 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.27 94.49 9.56 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.442 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -65.43 173.38 2.68 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.449 -0.782 . . . . 0.0 110.741 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.6 t -90.12 141.44 28.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.388 -0.82 . . . . 0.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.497 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.8 t -64.68 120.55 12.64 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.07 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -34.94 148.69 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 35.1 mtm -50.09 -30.84 11.82 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.39 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -85.54 -23.17 27.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.151 -0.968 . . . . 0.0 111.301 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.03 -87.43 0.11 Allowed Glycine 0 N--CA 1.491 2.334 0 O-C-N 120.459 -1.401 . . . . 0.0 110.11 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.33 1.25 27.78 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.294 -1.121 . . . . 0.0 112.61 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -121.85 22.64 10.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.475 -1.39 . . . . 0.0 112.297 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.4 t -47.22 140.23 5.48 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 120.696 -1.253 . . . . 0.0 111.002 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.465 ' OH ' ' NH1' ' A' ' 387' ' ' ARG . 27.2 p90 -113.43 -37.61 4.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.347 -0.845 . . . . 0.0 111.68 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.465 ' NH1' ' OH ' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.98 154.16 28.41 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.77 -1.206 . . . . 0.0 109.497 179.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 100.0 3.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 110.52 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -115.04 167.0 10.55 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.243 -0.91 . . . . 0.0 110.101 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.69 -30.08 12.17 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.425 1.224 . . . . 0.0 110.754 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.9 -23.4 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 121.134 -0.979 . . . . 0.0 111.481 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -60.9 -39.23 88.51 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 120.599 -1.313 . . . . 0.0 109.572 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -55.54 -29.16 58.43 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.094 -1.004 . . . . 0.0 109.578 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.08 39.46 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.587 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -77.7 -33.36 53.22 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.987 -1.07 . . . . 0.0 111.481 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -132.4 137.82 47.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.896 -1.127 . . . . 0.0 110.793 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 73.8 m -79.38 168.23 19.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.278 -0.889 . . . . 0.0 109.085 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.3 159.19 59.16 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.89 137.36 62.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.602 -1.345 . . . . 0.0 108.602 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.24 -0.78 58.75 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.535 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.05 151.63 39.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.208 1.504 . . . . 0.0 108.554 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 40.4 t -58.46 -31.72 68.06 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.237 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -73.14 -14.77 61.44 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.944 -1.098 . . . . 0.0 113.237 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.497 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 -40.73 115.63 0.6 Allowed 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 120.192 1.36 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.9 75.95 0.12 Allowed Glycine 0 N--CA 1.501 2.978 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -145.88 -59.41 0.02 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.532 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.7 p -106.78 62.77 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.157 -1.202 . . . . 0.0 110.798 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.401 ' NE2' ' CD2' ' A' ' 404' ' ' TYR . 18.2 mt-30 -134.9 92.95 2.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.288 -0.883 . . . . 0.0 109.929 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 5.0 mp -105.44 67.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.165 -0.959 . . . . 0.0 109.938 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 66.2 t -117.43 67.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.98 52.31 2.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -46.96 -65.12 0.61 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.459 -1.024 . . . . 0.0 111.3 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -152.52 48.96 0.75 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.184 -0.948 . . . . 0.0 110.598 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 52.95 43.7 31.34 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.054 -1.028 . . . . 0.0 110.738 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.59 67.32 0.67 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 110.048 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.16 94.69 4.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.327 -0.858 . . . . 0.0 110.033 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 16.7 t0 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.147 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.67 138.63 29.54 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.404 1.213 . . . . 0.0 110.44 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 12.8 mt -121.45 -62.21 1.45 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 111.73 -42.85 1.85 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.5 m -138.52 -61.35 0.59 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.205 -1.174 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 138.4 -176.32 20.86 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.7 m -127.32 73.62 1.45 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.142 -1.21 . . . . 0.0 110.208 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.48 -176.46 5.4 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.171 -0.956 . . . . 0.0 110.601 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -98.5 -94.28 2.0 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -119.65 64.88 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.169 -1.195 . . . . 0.0 110.121 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 2.1 mptt 52.46 59.14 4.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.939 -1.1 . . . . 0.0 110.622 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p -136.36 161.23 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -85.93 91.96 8.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.299 -0.876 . . . . 0.0 108.997 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -63.27 151.44 40.59 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -71.57 149.61 45.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 28.5 t -62.22 161.83 10.64 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.845 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.06 165.94 23.95 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.01 -1.056 . . . . 0.0 109.466 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -36.5 74.72 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.135 -0.978 . . . . 0.0 110.089 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.79 -24.22 28.83 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.276 -0.89 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 69.42 -83.82 0.26 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.49 -1.63 32.62 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.265 -1.138 . . . . 0.0 113.188 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 386' ' ' TYR . 59.2 m-80 -122.4 14.41 10.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.318 -1.489 . . . . 0.0 113.343 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 45.8 t -45.56 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.393 0 CA-C-N 120.072 1.306 . . . . 0.0 112.668 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 384' ' ' ASN . 48.3 p90 -50.9 -34.9 30.25 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.887 -1.133 . . . . 0.0 111.895 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.431 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.4 OUTLIER -73.95 163.92 27.29 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.019 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -155.86 83.9 1.02 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.253 -0.905 . . . . 0.0 111.015 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -116.41 156.77 46.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.98 -72.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.274 1.144 . . . . 0.0 110.864 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.6 t -45.18 -30.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 120.644 -1.285 . . . . 0.0 111.226 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -65.31 -36.37 83.86 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.882 -1.136 . . . . 0.0 109.25 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -58.28 -28.13 64.69 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.171 -0.956 . . . . 0.0 109.544 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -27.07 46.74 Favored 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.677 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -82.25 -37.23 26.24 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.094 -1.004 . . . . 0.0 110.818 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 49.0 m-85 -129.87 144.54 51.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.05 -1.031 . . . . 0.0 110.077 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 2.5 m -95.41 167.9 11.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 111.151 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -140.72 157.72 67.13 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.73 -0.607 . . . . 0.0 109.911 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.406 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 36.5 Cg_endo -60.62 137.28 72.43 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 N-CA-C 108.544 -1.368 . . . . 0.0 108.544 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.52 -0.63 58.28 Favored Glycine 0 CA--C 1.551 2.321 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.315 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.22 139.16 46.84 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.337 1.568 . . . . 0.0 108.159 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.4 t -50.07 -26.46 4.44 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.012 -1.055 . . . . 0.0 112.045 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -96.87 3.1 52.35 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.575 -1.328 . . . . 0.0 113.411 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -48.78 142.42 6.3 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 120.355 1.434 . . . . 0.0 110.52 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.77 48.81 0.24 Allowed Glycine 0 N--CA 1.5 2.948 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.9 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -172.16 79.45 0.09 OUTLIER Glycine 0 N--CA 1.497 2.717 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.856 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 62.0 t -85.59 81.4 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.395 -1.062 . . . . 0.0 108.99 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -115.87 89.99 3.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -0.822 . . . . 0.0 110.49 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 82.5 mt -118.87 70.55 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 36.4 t -103.54 84.36 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.405 -0.81 . . . . 0.0 108.969 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 74.23 60.19 3.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.425 ' NE2' ' HA ' ' A' ' 412' ' ' GLN . 12.6 mm-40 -57.01 -39.85 75.49 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.226 -1.161 . . . . 0.0 110.243 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.79 37.92 3.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.022 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -137.44 59.91 1.66 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.158 -0.964 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.31 65.62 0.67 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.235 -0.916 . . . . 0.0 109.999 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.33 45.91 2.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.216 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.74 -171.35 0.74 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.408 1.215 . . . . 0.0 110.404 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 22.1 mt -116.45 96.25 5.44 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.194 -0.941 . . . . 0.0 110.196 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 105.03 166.43 24.06 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.7 t -117.6 135.73 53.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -1.151 . . . . 0.0 110.191 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.28 165.81 25.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.89 -59.51 0.75 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.264 -1.139 . . . . 0.0 110.354 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -121.42 84.65 2.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -0.996 . . . . 0.0 110.035 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -136.31 41.17 1.44 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -146.58 -66.19 0.28 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -1.168 . . . . 0.0 110.4 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 74.32 1.04 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.209 -0.932 . . . . 0.0 110.396 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 96.7 t -147.31 161.9 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.229 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.94 93.04 9.46 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.272 -0.893 . . . . 0.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -56.07 152.65 10.16 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.385 -0.822 . . . . 0.0 110.755 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -82.28 133.33 35.24 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 63.4 p -50.76 153.75 1.62 Allowed 'General case' 0 N--CA 1.515 2.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.135 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.9 t -78.15 155.72 30.29 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.126 -0.984 . . . . 0.0 110.845 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.5 mtm -60.15 -30.01 69.03 Favored 'General case' 0 N--CA 1.51 2.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.26 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -84.39 -24.19 29.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.048 -1.032 . . . . 0.0 110.64 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.22 -86.84 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.24 -4.5 20.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -1.143 . . . . 0.0 112.337 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -112.4 16.57 19.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.457 -1.402 . . . . 0.0 112.858 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 14.5 t -46.73 137.31 7.14 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 120.6 -1.312 . . . . 0.0 110.513 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 39.6 p90 -116.91 -39.07 3.3 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.228 -0.92 . . . . 0.0 112.517 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.4 ptp85 -51.95 161.79 0.53 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.646 -1.284 . . . . 0.0 110.82 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -128.31 55.37 1.68 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 0.0 110.492 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.21 140.55 21.25 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.276 -0.89 . . . . 0.0 109.965 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.11 -72.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.258 1.136 . . . . 0.0 110.154 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.2 t -40.12 -28.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 O-C-N 120.864 -1.147 . . . . 0.0 112.497 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.452 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 25.0 t60 -64.22 -37.83 88.87 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 120.492 -1.38 . . . . 0.0 108.568 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -59.79 -30.82 69.16 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.2 -0.938 . . . . 0.0 109.592 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -26.48 53.78 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.186 -0.946 . . . . 0.0 110.85 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -91.69 -38.09 12.63 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.905 -1.122 . . . . 0.0 110.516 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 76.0 m-85 -113.11 138.51 49.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.0 110.49 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.66 168.5 11.44 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 111.224 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -141.48 159.64 59.83 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.77 -0.581 . . . . 0.0 109.66 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.51 139.92 84.44 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.48 -2.55 60.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -107.66 144.66 34.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.592 -1.534 . . . . 0.0 108.215 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 3.0 t -55.18 -24.3 26.24 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.206 -0.934 . . . . 0.0 111.801 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -105.15 7.54 33.78 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.521 -1.362 . . . . 0.0 113.066 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -45.78 120.21 2.55 Favored 'General case' 0 N--CA 1.523 3.184 0 CA-C-N 120.513 1.506 . . . . 0.0 110.876 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.422 ' HA3' ' NE2' ' A' ' 408' ' ' GLN . . . -51.46 -36.29 38.05 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 81.37 52.05 4.39 Favored Glycine 0 N--CA 1.488 2.155 0 O-C-N 121.192 -1.181 . . . . 0.0 111.064 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 90.3 t 52.3 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.225 -1.162 . . . . 0.0 111.043 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.422 ' NE2' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -166.04 79.54 0.27 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.273 -0.892 . . . . 0.0 110.885 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 59.4 mt -99.47 73.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 120.9 -1.125 . . . . 0.0 110.285 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.65 70.07 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 108.927 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 96.85 53.94 1.35 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -49.25 -62.35 1.59 Allowed 'General case' 0 N--CA 1.513 2.703 0 O-C-N 121.488 -1.007 . . . . 0.0 110.543 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -135.77 34.83 2.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 110.33 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -128.18 68.96 1.34 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.034 . . . . 0.0 110.124 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.43 64.57 0.62 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.129 -0.982 . . . . 0.0 109.967 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -115.24 42.5 2.21 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.204 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.72 124.92 10.1 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.415 1.218 . . . . 0.0 110.377 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.03 48.0 1.8 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.206 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -109.83 79.97 0.26 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.0 p -142.71 105.88 4.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.251 -1.147 . . . . 0.0 110.283 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -140.09 127.69 3.62 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.41 96.14 2.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -1.18 . . . . 0.0 110.159 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.84 163.66 32.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.164 -0.96 . . . . 0.0 110.317 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -153.43 47.6 0.54 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -143.92 -67.19 0.34 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.128 -1.219 . . . . 0.0 110.408 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -169.25 76.93 0.1 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.073 -1.017 . . . . 0.0 110.947 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.3 p -144.76 161.92 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 111.0 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.06 89.88 3.59 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.851 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -57.94 174.18 0.28 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.61 -0.682 . . . . 0.0 111.016 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.6 m -88.45 134.28 33.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 406' ' ' GLY . 82.9 p -62.92 121.09 12.66 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.539 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 145.69 0.59 Allowed 'General case' 0 N--CA 1.513 2.679 0 O-C-N 121.368 -0.832 . . . . 0.0 112.173 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -46.72 -35.27 5.92 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.627 -0.67 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -78.07 -29.52 49.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.078 -1.014 . . . . 0.0 111.204 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 64.49 -86.19 0.07 OUTLIER Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.24 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -100.82 1.57 40.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.212 -1.169 . . . . 0.0 113.054 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 386' ' ' TYR . 37.3 m-80 -128.76 21.77 5.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.49 -1.381 . . . . 0.0 112.896 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.5 t -55.87 85.79 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 CA-C-N 119.915 1.234 . . . . 0.0 110.704 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 384' ' ' ASN . 28.9 p90 -61.02 -26.75 67.83 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.044 -1.035 . . . . 0.0 111.795 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 149.8 21.17 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.37 127.55 12.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -128.62 166.5 24.22 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.11 -33.79 11.15 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.322 1.17 . . . . 0.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.77 -23.28 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.263 -0.898 . . . . 0.0 111.5 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -62.57 -36.34 82.38 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.689 -1.257 . . . . 0.0 110.229 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.1 -26.36 66.16 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.106 -0.996 . . . . 0.0 109.518 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.1 -30.48 55.37 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.142 -0.974 . . . . 0.0 110.447 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.41 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 19.5 m170 -81.79 -35.4 29.59 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 51.1 m-85 -128.68 139.38 52.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.001 -1.062 . . . . 0.0 111.255 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.13 169.14 16.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.408 -0.808 . . . . 0.0 109.38 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -144.75 153.74 54.79 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.434 -0.791 . . . . 0.0 109.369 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.404 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.3 Cg_endo -61.14 137.46 71.46 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 N-CA-C 108.405 -1.421 . . . . 0.0 108.405 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.34 -1.16 53.83 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.748 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.92 171.69 7.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.649 1.725 . . . . 0.0 108.546 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -24.2 53.11 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.066 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -99.0 1.78 45.74 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.637 -1.289 . . . . 0.0 113.605 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -47.32 136.85 8.95 Favored 'General case' 0 N--CA 1.522 3.164 0 CA-C-N 120.362 1.437 . . . . 0.0 110.89 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -176.06 72.72 0.08 OUTLIER Glycine 0 N--CA 1.5 2.959 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.765 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.485 ' O ' ' OG ' ' A' ' 378' ' ' SER . . . -170.13 52.57 0.2 Allowed Glycine 0 N--CA 1.499 2.894 0 C-N-CA 119.333 -1.413 . . . . 0.0 112.495 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 78.5 t -72.86 73.76 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 120.762 -1.434 . . . . 0.0 110.129 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.401 ' CG ' ' O ' ' A' ' 408' ' ' GLN . 0.2 OUTLIER -136.49 81.4 1.88 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.148 -0.97 . . . . 0.0 110.572 179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 8.3 mt -107.43 73.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.868 -1.145 . . . . 0.0 109.8 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.9 79.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 108.838 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 78.33 58.97 3.0 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.234 -1.947 . . . . 0.0 108.234 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -48.13 -65.41 0.57 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.435 -1.038 . . . . 0.0 111.074 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -150.76 35.46 0.61 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.119 -0.988 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.75 54.23 1.5 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.103 -0.998 . . . . 0.0 110.101 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.8 t -132.67 62.61 1.65 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -0.911 . . . . 0.0 110.201 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -103.18 39.38 1.58 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.192 -0.943 . . . . 0.0 109.893 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.236 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.8 117.92 5.34 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.504 1.265 . . . . 0.0 110.384 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.8 tp -138.08 45.38 2.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.157 -0.965 . . . . 0.0 110.178 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -104.59 102.9 2.16 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.41 -60.26 0.67 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.237 -1.155 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 124.65 -137.55 10.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.7 t -134.46 119.31 18.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.211 -1.17 . . . . 0.0 110.178 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.44 56.66 1.66 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 0.0 110.069 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -135.65 40.07 1.59 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -146.3 -67.11 0.28 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.16 -1.2 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -140.46 67.38 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.151 -0.968 . . . . 0.0 110.256 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 67.2 t -146.28 160.69 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.975 . . . . 0.0 109.925 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -87.05 91.03 8.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.29 151.58 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.372 -0.83 . . . . 0.0 110.25 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.3 t -81.13 136.7 35.93 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.784 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -51.72 149.04 4.92 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 121.155 -0.966 . . . . 0.0 109.964 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.4 t -71.13 163.42 27.64 Favored 'General case' 0 N--CA 1.512 2.627 0 O-C-N 120.944 -1.098 . . . . 0.0 110.495 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 63.7 mtm -62.91 -31.08 72.07 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.227 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -84.41 -23.48 30.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.201 -0.937 . . . . 0.0 110.45 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 70.33 -86.06 0.33 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.55 -4.26 18.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -1.136 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -111.53 16.46 20.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.486 -1.384 . . . . 0.0 112.874 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -47.62 141.0 5.61 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 120.086 1.312 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.2 p90 -121.72 -39.94 2.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 112.285 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.426 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -59.24 149.45 28.49 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.619 -1.301 . . . . 0.0 109.512 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.6 74.73 1.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.159 -0.963 . . . . 0.0 111.111 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.41 148.25 38.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.91 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.34 1.179 . . . . 0.0 110.764 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -42.25 -27.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 O-C-N 120.7 -1.25 . . . . 0.0 112.422 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -66.45 -35.63 80.76 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.456 -1.403 . . . . 0.0 109.238 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.97 -28.82 70.35 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -26.63 57.0 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.224 -0.922 . . . . 0.0 111.297 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 395' ' ' HIS . 18.4 m170 -92.08 -35.52 13.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.852 -1.155 . . . . 0.0 111.238 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -117.55 144.99 44.57 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.064 -1.022 . . . . 0.0 110.521 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.74 168.77 10.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.956 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -140.5 158.3 66.37 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.702 -0.624 . . . . 0.0 110.538 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.42 139.23 75.61 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 107.99 -1.581 . . . . 0.0 107.99 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.73 -3.13 60.73 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.878 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.3 138.1 46.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.627 -1.513 . . . . 0.0 108.466 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -25.67 0.94 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.201 -0.937 . . . . 0.0 113.267 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -106.06 12.96 29.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.512 -1.368 . . . . 0.0 113.192 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -50.49 135.29 22.78 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 120.457 -1.402 . . . . 0.0 109.951 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.96 -25.81 28.28 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.316 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 116.34 -116.91 3.73 Favored Glycine 0 N--CA 1.473 1.1 0 N-CA-C 107.551 -2.22 . . . . 0.0 107.551 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 59.9 t -146.01 92.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.633 -0.922 . . . . 0.0 111.743 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -155.81 88.15 1.11 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.152 -0.968 . . . . 0.0 110.297 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 44.6 mt -100.21 69.84 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.844 -1.16 . . . . 0.0 110.255 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 58.0 t -119.74 74.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 91.97 56.9 1.55 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -50.37 -63.62 1.06 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.346 -1.09 . . . . 0.0 110.604 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -148.33 34.7 0.8 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.216 -0.928 . . . . 0.0 110.725 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 52.05 56.29 7.99 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.809 -1.182 . . . . 0.0 110.845 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.4 t -126.56 64.42 1.26 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.192 -0.942 . . . . 0.0 110.181 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.15 39.62 1.53 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.224 -0.922 . . . . 0.0 109.942 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.24 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.71 130.66 16.13 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.456 1.24 . . . . 0.0 110.386 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 5.0 mt -140.04 83.86 1.94 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.134 -0.979 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -125.66 148.34 16.91 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.8 p -122.19 39.69 3.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.153 -1.204 . . . . 0.0 110.337 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 61.79 -146.37 48.81 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 86.6 p -118.29 122.63 43.4 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.199 -1.177 . . . . 0.0 110.254 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.86 113.39 7.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.206 -0.934 . . . . 0.0 110.126 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -156.75 43.09 0.53 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -132.16 -65.21 0.74 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.227 -1.161 . . . . 0.0 110.402 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.27 71.96 1.03 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.269 -0.895 . . . . 0.0 110.527 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.04 160.2 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.151 -0.968 . . . . 0.0 110.703 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -84.39 82.89 8.19 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.452 ' O ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -56.56 152.35 12.02 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.186 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -72.34 137.27 46.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 p -49.29 160.2 0.25 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.6 t -83.32 157.76 22.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.201 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.7 ptp -61.59 -36.38 80.51 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.011 -1.055 . . . . 0.0 110.181 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -77.81 -32.99 52.63 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.171 -0.956 . . . . 0.0 110.29 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.95 -89.15 0.87 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.52 -4.42 19.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -1.056 . . . . 0.0 112.244 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.77 16.65 19.5 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.353 -1.467 . . . . 0.0 112.584 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 7.3 t -45.86 140.09 3.82 Favored 'General case' 0 N--CA 1.524 3.247 0 O-C-N 120.633 -1.292 . . . . 0.0 110.988 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.8 p90 -116.93 -39.05 3.3 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.381 -0.824 . . . . 0.0 112.279 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.439 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 6.8 ptp85 -55.19 158.75 2.86 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.651 -1.281 . . . . 0.0 110.564 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -128.12 62.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.248 -0.908 . . . . 0.0 110.517 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.35 145.16 33.14 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.23 -59.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.234 1.123 . . . . 0.0 110.901 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 12.2 p -43.61 -33.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 O-C-N 121.084 -1.01 . . . . 0.0 111.708 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.424 ' CG ' ' HD2' ' A' ' 387' ' ' ARG . 34.4 t60 -66.54 -36.33 82.42 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.91 -29.68 70.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.069 -1.019 . . . . 0.0 109.257 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.428 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 1.3 mp0 -77.23 -29.22 54.0 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.233 -0.917 . . . . 0.0 110.749 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -86.09 -32.99 21.07 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.19 -0.944 . . . . 0.0 111.377 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -124.11 143.41 50.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.791 -1.193 . . . . 0.0 110.592 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -89.19 170.03 10.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -0.901 . . . . 0.0 111.354 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -143.02 153.06 59.94 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 38.4 Cg_endo -63.04 140.57 79.52 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 N-CA-C 108.018 -1.57 . . . . 0.0 108.018 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.92 -0.16 62.43 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.454 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.0 144.39 41.42 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.643 1.722 . . . . 0.0 108.071 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 61.4 m -52.09 -26.27 10.68 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.98 -1.075 . . . . 0.0 112.4 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -103.36 10.45 37.43 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.504 -1.372 . . . . 0.0 113.315 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 21.5 t80 -50.89 137.23 21.19 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 120.398 -1.439 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -140.05 23.06 2.76 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.662 -1.256 . . . . 0.0 112.008 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.403 ' HA2' ' NE2' ' A' ' 408' ' ' GLN . . . -77.77 -29.49 54.71 Favored Glycine 0 N--CA 1.494 2.503 0 CA-C-N 119.57 1.685 . . . . 0.0 110.041 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 13.5 p -73.63 67.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.517 -0.99 . . . . 0.0 111.242 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.403 ' NE2' ' HA2' ' A' ' 406' ' ' GLY . 4.1 mp0 -92.19 60.72 3.78 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.781 -1.199 . . . . 0.0 109.322 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 19.7 mt 51.62 70.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.902 -1.124 . . . . 0.0 110.4 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.63 61.53 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.424 -0.797 . . . . 0.0 109.459 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 134.81 -43.15 1.28 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 53.85 44.78 29.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -1.077 . . . . 0.0 110.669 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.1 t0 53.56 38.26 27.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.371 -0.83 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -128.53 41.06 3.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.199 -0.938 . . . . 0.0 110.171 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.24 66.36 0.71 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.275 -0.891 . . . . 0.0 110.042 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.33 85.83 2.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.249 -0.907 . . . . 0.0 110.211 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.209 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.8 148.19 45.82 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.34 1.179 . . . . 0.0 110.416 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.75 170.35 16.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 110.195 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -72.22 125.66 10.95 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.6 p -129.57 -65.58 0.84 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.196 -1.179 . . . . 0.0 110.162 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -69.27 128.99 22.72 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 4.8 m -133.1 126.72 32.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.139 -1.213 . . . . 0.0 110.142 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -139.02 62.26 1.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.066 -1.021 . . . . 0.0 110.163 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -146.04 39.17 1.14 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -125.52 -58.63 1.41 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.324 -1.104 . . . . 0.0 109.61 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.81 59.54 1.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 64.8 t -144.48 147.43 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.002 -1.062 . . . . 0.0 110.117 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 66.9 9.68 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.895 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.427 ' O ' ' OG ' ' A' ' 397' ' ' SER . 12.4 ptt-85 -58.29 156.43 10.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.759 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.3 t -74.91 145.75 42.4 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.654 -0.818 . . . . 0.0 108.879 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.67 169.06 0.07 Allowed 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.323 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 54.1 t -85.44 158.79 20.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.155 -0.966 . . . . 0.0 108.44 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.0 mtm -63.07 -33.59 75.78 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 120.758 -1.214 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -94.7 -20.11 19.82 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.983 -1.073 . . . . 0.0 111.168 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 58.37 -95.59 0.06 OUTLIER Glycine 0 N--CA 1.494 2.536 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -86.89 -21.16 26.5 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.246 -1.149 . . . . 0.0 111.632 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -94.23 6.81 47.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.743 -1.223 . . . . 0.0 112.558 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.3 t -43.0 134.39 3.43 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 120.655 -1.278 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 27.4 p90 -119.95 -35.66 3.44 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.334 -0.854 . . . . 0.0 112.477 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.473 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 4.0 ptm180 -48.72 163.82 0.07 Allowed 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.68 -1.262 . . . . 0.0 110.968 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.9 pttm -129.81 56.83 1.7 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.196 -0.94 . . . . 0.0 110.522 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -109.41 144.16 29.24 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.26 -0.9 . . . . 0.0 110.51 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -73.94 -73.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 O-C-N 123.318 1.167 . . . . 0.0 110.355 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 72.2 t -41.24 -27.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 O-C-N 120.797 -1.19 . . . . 0.0 112.601 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -63.65 -37.43 87.32 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.375 -1.453 . . . . 0.0 108.533 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -60.59 -31.58 70.72 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.084 -1.01 . . . . 0.0 109.527 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.21 -27.21 38.84 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.102 -0.999 . . . . 0.0 110.987 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -84.8 -29.87 25.04 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.843 -1.161 . . . . 0.0 111.803 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -124.41 137.66 54.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.799 -1.188 . . . . 0.0 111.183 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -77.77 153.77 32.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.296 -0.878 . . . . 0.0 111.516 -179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -134.29 157.32 77.78 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.51 136.67 64.67 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 N-CA-C 108.281 -1.469 . . . . 0.0 108.281 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.32 1.99 56.76 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.032 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.52 141.7 45.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.211 1.506 . . . . 0.0 108.71 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 58.2 m -52.78 -25.94 12.81 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.214 -0.928 . . . . 0.0 111.83 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -98.12 -3.45 37.79 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.68 -1.262 . . . . 0.0 113.051 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -45.17 141.85 2.23 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 120.202 1.365 . . . . 0.0 111.491 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -172.75 54.23 0.16 Allowed Glycine 0 N--CA 1.502 3.07 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.592 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -110.17 -65.15 0.54 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 85.2 t 45.62 61.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.704 -0.88 . . . . 0.0 111.491 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -101.69 92.29 4.79 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.281 -0.887 . . . . 0.0 110.426 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 92.8 mt -111.28 71.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.104 -0.997 . . . . 0.0 109.768 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.6 t -115.4 77.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.321 -0.862 . . . . 0.0 108.944 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 87.59 57.55 1.95 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -49.94 -62.82 1.35 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.275 -1.132 . . . . 0.0 110.508 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -148.28 34.43 0.8 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.331 -0.855 . . . . 0.0 110.502 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -140.01 53.98 1.66 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.122 -0.986 . . . . 0.0 110.172 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.52 66.38 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.071 -1.018 . . . . 0.0 109.93 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.84 42.78 2.25 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.251 -0.906 . . . . 0.0 110.182 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.259 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.75 140.26 32.02 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.388 1.204 . . . . 0.0 110.381 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 5.4 tp 52.77 80.58 0.1 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.053 -1.03 . . . . 0.0 110.778 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.67 142.42 13.31 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 32.1 t -142.78 46.42 1.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.17 -1.194 . . . . 0.0 110.274 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 75.68 103.47 0.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 7.8 t -122.91 84.68 2.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.233 -1.157 . . . . 0.0 110.334 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -139.58 43.98 1.97 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.243 -0.911 . . . . 0.0 110.118 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -147.51 40.48 0.98 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -128.35 -59.99 1.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -1.176 . . . . 0.0 109.956 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -133.59 48.11 2.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.227 -0.921 . . . . 0.0 110.105 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.37 161.5 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.267 -0.895 . . . . 0.0 110.326 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -91.35 94.2 9.4 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.327 -0.858 . . . . 0.0 109.452 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.432 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -70.81 174.21 6.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.606 -0.684 . . . . 0.0 110.433 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -94.68 136.04 35.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.37 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.9 t -58.05 122.78 13.87 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.371 -0.83 . . . . 0.0 109.744 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -42.37 148.61 0.2 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -49.98 -29.13 7.92 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.546 -0.721 . . . . 0.0 110.386 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -84.63 -23.77 29.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.027 -1.046 . . . . 0.0 111.444 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.05 -88.58 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 O-C-N 120.375 -1.453 . . . . 0.0 110.635 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.5 3.76 40.51 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.177 -1.19 . . . . 0.0 113.259 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 386' ' ' TYR . 16.8 m-80 -130.93 26.97 4.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.424 -1.422 . . . . 0.0 112.371 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 52.9 t -57.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.625 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 384' ' ' ASN . 34.9 p90 -63.59 -27.92 69.57 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 121.135 -0.978 . . . . 0.0 112.362 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 162.63 28.95 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 120.72 -1.237 . . . . 0.0 109.086 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.94 91.77 1.14 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.073 -1.017 . . . . 0.0 111.461 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.57 166.83 10.14 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.0 110.045 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.83 -32.28 5.79 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.404 1.213 . . . . 0.0 110.79 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.52 -22.6 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.149 -0.969 . . . . 0.0 111.029 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.56 -37.01 82.24 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.803 -1.186 . . . . 0.0 109.469 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -56.38 -27.55 56.52 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.095 -1.003 . . . . 0.0 109.53 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.72 -30.49 26.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.106 -0.996 . . . . 0.0 110.562 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.0 m170 -76.2 -32.85 59.2 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.908 -1.12 . . . . 0.0 111.785 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 56.0 m-85 -132.57 138.49 47.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 111.077 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.432 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 28.2 m -78.83 165.42 23.56 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -143.04 160.87 51.14 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.249 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.26 137.52 71.29 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.09 -1.87 61.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.642 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.76 149.6 36.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.449 1.624 . . . . 0.0 108.439 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 79.2 p -56.85 -32.07 65.41 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.062 -1.024 . . . . 0.0 111.152 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -80.18 -8.08 59.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.943 -1.098 . . . . 0.0 113.589 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.463 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 8.0 t80 -40.42 113.82 0.4 Allowed 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 120.524 1.511 . . . . 0.0 111.263 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -165.2 77.89 0.14 Allowed Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.91 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -155.84 -62.47 0.01 OUTLIER Glycine 0 N--CA 1.5 2.939 0 C-N-CA 119.399 -1.382 . . . . 0.0 112.024 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.26 70.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.752 1.276 . . . . 0.0 111.544 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.441 ' NE2' ' CE2' ' A' ' 404' ' ' TYR . 7.7 mt-30 -131.54 86.11 2.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 0.0 109.593 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 71.0 mt -106.44 67.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.238 -0.914 . . . . 0.0 110.092 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.82 66.12 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.315 -0.866 . . . . 0.0 108.823 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 102.17 54.78 0.89 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.403 ' HA ' ' NE2' ' A' ' 412' ' ' GLN . 13.5 mm-40 -56.96 -39.14 74.01 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.277 -1.131 . . . . 0.0 110.173 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.23 37.34 2.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.237 -0.914 . . . . 0.0 110.054 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -148.93 49.41 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.108 -0.995 . . . . 0.0 110.455 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 66.46 0.65 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.227 -0.921 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -143.18 40.34 1.48 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.231 -0.918 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 25.2 t70 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.228 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.74 94.54 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.414 1.218 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.53 93.46 3.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.224 -0.923 . . . . 0.0 110.203 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -110.41 154.38 16.62 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 67.0 m -143.28 83.13 1.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.236 -1.155 . . . . 0.0 110.331 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 110.82 99.38 2.53 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.1 t -141.85 105.5 4.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.177 -1.19 . . . . 0.0 110.204 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -141.61 -172.13 3.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 89.29 41.41 5.82 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -135.4 -64.81 0.63 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.179 -1.189 . . . . 0.0 110.054 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.07 47.71 1.81 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.124 -0.985 . . . . 0.0 109.93 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.74 161.65 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.369 -0.832 . . . . 0.0 110.059 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 87.62 7.0 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.185 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.442 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -61.92 151.02 35.95 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.258 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.0 t -71.66 141.85 49.9 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.503 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.27 157.51 2.68 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.05 154.41 25.64 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.816 -1.178 . . . . 0.0 110.874 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.415 ' CE ' ' CE2' ' A' ' 381' ' ' TYR . 4.0 ptt? -54.62 -28.84 49.6 Favored 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.437 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 72.0 m-85 -82.64 -29.03 30.33 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.958 -1.089 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 72.19 -93.84 0.61 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -103.41 -0.23 30.32 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -1.182 . . . . 0.0 112.474 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.9 m-80 -121.38 24.26 10.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.347 -1.471 . . . . 0.0 112.504 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 49.2 t -59.38 81.83 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.95 0 O-C-N 120.783 -1.198 . . . . 0.0 110.589 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 384' ' ' ASN . 29.6 p90 -61.92 -25.42 67.56 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.169 -0.957 . . . . 0.0 111.738 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -87.5 157.89 19.07 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.798 -1.188 . . . . 0.0 110.134 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.73 124.04 5.32 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.217 -0.927 . . . . 0.0 110.91 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -126.06 166.93 18.57 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.284 -0.885 . . . . 0.0 109.69 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.09 -33.48 11.64 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.418 1.22 . . . . 0.0 110.263 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.26 -24.67 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.972 . . . . 0.0 111.416 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -60.48 -38.98 86.0 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.577 -1.327 . . . . 0.0 110.006 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -56.5 -28.6 60.25 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.412 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -79.96 -32.23 39.92 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.577 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -78.15 -35.17 49.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.219 -0.925 . . . . 0.0 111.486 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.25 144.34 51.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.952 -1.093 . . . . 0.0 110.726 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 10.0 m -91.42 171.47 9.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -143.48 159.17 55.7 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.11 139.3 83.3 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.73 -1.03 56.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.3 153.85 30.19 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.267 1.533 . . . . 0.0 107.658 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -29.06 70.41 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.135 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -85.91 -1.8 57.65 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.408 ' OH ' HG22 ' A' ' 407' ' ' VAL . 23.7 t80 -41.3 112.81 0.34 Allowed 'General case' 0 N--CA 1.527 3.4 0 CA-C-N 120.713 1.597 . . . . 0.0 111.102 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -57.31 -49.25 74.18 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.246 -0.909 . . . . 0.0 111.819 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 126.1 58.16 0.15 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.673 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.408 HG22 ' OH ' ' A' ' 404' ' ' TYR . 80.1 t 44.76 89.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.549 -0.971 . . . . 0.0 113.046 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.42 91.49 2.2 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.174 -0.954 . . . . 0.0 110.715 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 60.8 mt -111.21 74.25 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.944 -1.098 . . . . 0.0 109.826 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.69 74.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.221 -0.924 . . . . 0.0 109.465 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 112.39 -41.62 2.18 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 54.54 37.45 27.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.277 -1.131 . . . . 0.0 110.724 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.1 t70 51.41 38.15 21.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.11 -0.994 . . . . 0.0 110.96 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.11 42.07 3.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.124 -0.985 . . . . 0.0 110.35 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 65.25 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 110.044 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.3 t70 52.74 39.12 28.04 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.031 -1.043 . . . . 0.0 110.754 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.159 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.8 165.33 33.06 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.408 1.215 . . . . 0.0 110.396 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.2 tp -140.71 -59.94 0.51 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 125.02 129.58 3.39 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.2 p -142.7 125.95 16.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.141 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 70.5 157.41 2.11 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.24 39.14 1.59 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.236 -1.155 . . . . 0.0 110.394 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.43 -172.1 4.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.179 -0.951 . . . . 0.0 110.384 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -66.84 -86.77 0.08 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -129.29 64.23 1.48 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.211 -1.17 . . . . 0.0 110.046 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.83 66.32 1.26 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.953 -1.092 . . . . 0.0 110.371 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.14 161.56 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.239 -0.913 . . . . 0.0 110.609 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -79.87 94.49 5.84 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.455 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.6 OUTLIER -68.52 153.77 43.13 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.605 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.1 t -79.05 142.8 36.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.694 -0.629 . . . . 0.0 109.419 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.3 p -56.33 155.25 7.14 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.33 156.34 28.06 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.05 -1.031 . . . . 0.0 110.265 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -58.54 -35.77 72.83 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.16 -0.963 . . . . 0.0 110.635 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -71.89 -39.11 69.81 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.083 -1.01 . . . . 0.0 110.114 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.51 -86.92 1.31 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.07 -0.73 28.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.144 -1.209 . . . . 0.0 112.33 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.27 13.57 9.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.556 -1.34 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.8 t -49.39 152.57 1.25 Allowed 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.462 -1.398 . . . . 0.0 111.3 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 18.3 p90 -101.93 -29.62 11.71 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.446 -0.784 . . . . 0.0 111.525 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER 23.61 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.16 -2.88 25.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.983 -1.073 . . . . 0.0 111.462 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -130.35 157.57 76.94 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.582 -1.324 . . . . 0.0 109.267 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.23 -44.3 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.312 1.164 . . . . 0.0 110.061 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.4 t -47.73 -31.51 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 O-C-N 121.131 -0.981 . . . . 0.0 110.591 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -63.65 -31.97 73.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.003 -1.061 . . . . 0.0 109.428 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.429 ' CZ ' ' NH1' ' A' ' 387' ' ' ARG . 27.9 m-85 -63.19 -24.37 67.85 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.009 -1.057 . . . . 0.0 109.269 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.89 -28.94 32.63 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.663 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.8 m170 -83.38 -32.58 26.11 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 121.032 -1.043 . . . . 0.0 111.843 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 73.5 m-85 -130.97 143.54 50.8 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.895 -1.128 . . . . 0.0 110.705 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 68.1 m -86.46 163.65 17.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.402 -0.811 . . . . 0.0 110.993 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -139.85 159.43 64.8 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.704 -0.623 . . . . 0.0 109.868 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.07 136.44 60.82 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 N-CA-C 108.248 -1.482 . . . . 0.0 108.248 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.24 -3.39 51.11 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.27 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -113.42 141.06 47.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.56 -1.553 . . . . 0.0 108.248 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 56.0 m -51.78 -25.96 8.68 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.067 -1.021 . . . . 0.0 112.2 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -93.49 0.21 56.63 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.506 -1.371 . . . . 0.0 113.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -46.11 131.99 9.81 Favored 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 120.562 1.528 . . . . 0.0 111.09 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -82.8 -25.03 51.42 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.512 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 116.14 -120.04 4.75 Favored Glycine 0 C--O 1.217 -0.961 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 58.7 t -137.53 96.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.747 -0.855 . . . . 0.0 110.367 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -116.5 88.95 3.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.234 -0.916 . . . . 0.0 110.066 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 79.0 mt -108.5 77.15 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.09 -1.007 . . . . 0.0 110.118 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.83 78.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.327 -0.858 . . . . 0.0 108.824 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 77.53 55.51 4.23 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -47.62 -63.35 1.08 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.39 -1.065 . . . . 0.0 110.994 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -135.83 37.61 2.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -0.897 . . . . 0.0 110.364 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 52.9 54.95 9.66 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.901 -1.125 . . . . 0.0 110.864 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.41 66.46 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.211 -0.931 . . . . 0.0 109.944 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -122.15 41.19 3.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 11.3 t0 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.18 -179.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.79 81.13 1.66 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.435 1.229 . . . . 0.0 110.379 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 5.8 tp -137.53 141.67 41.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.172 -0.955 . . . . 0.0 110.224 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 113.06 -132.75 10.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.1 p -140.96 90.96 2.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.213 -1.169 . . . . 0.0 110.204 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -116.93 104.36 1.2 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 2.7 m -137.17 135.16 37.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.171 -1.194 . . . . 0.0 110.171 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -129.16 -174.63 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.197 -0.939 . . . . 0.0 110.286 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 98.93 48.07 1.81 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -147.78 -66.64 0.25 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.162 -1.199 . . . . 0.0 110.421 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -129.35 47.95 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.183 -0.948 . . . . 0.0 110.191 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 66.4 t -146.16 158.41 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.88 . . . . 0.0 109.893 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -80.27 81.68 6.48 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.172 -0.955 . . . . 0.0 109.979 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.56 16.52 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.308 -0.87 . . . . 0.0 110.726 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.0 m -67.09 130.21 42.39 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.427 ' OG ' ' NE2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER -51.14 162.33 0.31 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.16 -0.962 . . . . 0.0 110.523 -178.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.48 156.73 27.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.09 -1.006 . . . . 0.0 109.839 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -62.75 -31.04 71.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.987 -1.071 . . . . 0.0 110.725 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -80.09 -33.07 39.08 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.021 -1.05 . . . . 0.0 110.228 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 79.46 -89.34 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.45 -3.46 18.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.323 -1.104 . . . . 0.0 112.338 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.35 17.15 18.72 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.505 -1.372 . . . . 0.0 112.653 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.7 t -45.32 137.27 4.8 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 120.664 -1.273 . . . . 0.0 110.853 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.7 p90 -117.46 -40.98 3.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.926 . . . . 0.0 111.875 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.464 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -55.99 156.66 5.13 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.731 -1.231 . . . . 0.0 110.168 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.07 68.19 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.743 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.78 143.43 28.62 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 109.628 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.03 -70.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.435 1.229 . . . . 0.0 110.594 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 9.9 p -38.18 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 O-C-N 121.221 -0.925 . . . . 0.0 112.94 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -69.19 -42.07 76.3 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.918 -1.114 . . . . 0.0 109.144 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -55.93 -36.72 68.04 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.247 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -77.47 -26.39 51.33 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.452 -0.78 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -86.66 -34.57 19.72 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.856 -1.152 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -117.85 146.97 43.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.925 -1.109 . . . . 0.0 110.449 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.11 162.87 13.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.239 -0.913 . . . . 0.0 110.961 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -135.08 157.62 76.56 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.728 -0.607 . . . . 0.0 110.507 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.2 141.48 88.28 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 N-CA-C 107.78 -1.661 . . . . 0.0 107.78 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.19 65.28 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.5 140.07 43.72 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.727 -1.455 . . . . 0.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.9 t -50.58 -24.38 3.21 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.045 -1.034 . . . . 0.0 112.858 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.45 15.63 23.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.435 -1.416 . . . . 0.0 113.467 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.406 ' CZ ' ' O ' ' A' ' 406' ' ' GLY . 20.2 t80 -47.34 123.23 5.35 Favored 'General case' 0 N--CA 1.524 3.257 0 CA-C-N 120.363 1.438 . . . . 0.0 110.767 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -61.67 -38.01 95.18 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.406 ' O ' ' CZ ' ' A' ' 404' ' ' TYR . . . 127.31 -130.93 7.0 Favored Glycine 0 C--O 1.216 -0.989 0 N-CA-C 107.671 -2.172 . . . . 0.0 107.671 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.5 93.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 121.687 -0.89 . . . . 0.0 110.324 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.427 ' NE2' ' OG ' ' A' ' 378' ' ' SER . 0.7 OUTLIER -112.95 89.85 3.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.245 -0.909 . . . . 0.0 109.986 179.504 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 11.1 mt -107.23 82.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.127 -0.983 . . . . 0.0 110.174 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.55 57.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.0 109.472 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 412' ' ' GLN . . . 126.81 -46.18 1.1 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 10.7 mt-30 65.3 -65.96 0.15 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.832 -0.804 . . . . 0.0 111.214 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.12 39.01 0.99 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.041 -1.037 . . . . 0.0 110.596 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -116.66 40.75 2.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.119 -0.988 . . . . 0.0 110.215 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.03 65.35 0.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 110.021 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.8 43.14 3.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.174 -0.954 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.1 t0 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.197 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.79 134.01 21.14 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.339 1.179 . . . . 0.0 110.407 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 7.4 tp -133.59 130.76 38.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -0.974 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 137.36 165.97 10.59 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.65 102.44 4.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.247 -1.149 . . . . 0.0 110.273 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 72.82 74.29 0.8 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.1 m -144.1 86.87 1.86 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.251 -1.147 . . . . 0.0 110.326 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -126.79 100.31 6.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.194 -0.941 . . . . 0.0 110.043 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -140.56 41.69 1.26 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -146.93 -67.63 0.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.13 -1.218 . . . . 0.0 110.522 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -156.8 74.86 0.82 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.105 -0.997 . . . . 0.0 110.582 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.2 t -145.23 161.01 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.141 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -86.63 93.97 9.35 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.371 -0.83 . . . . 0.0 109.437 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 155.82 10.77 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.611 -0.681 . . . . 0.0 110.467 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -83.03 138.75 33.61 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 157.79 0.73 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.13 -0.981 . . . . 0.0 110.602 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.8 t -77.98 158.01 29.46 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -62.24 -30.94 71.46 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 120.878 -1.139 . . . . 0.0 110.473 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -81.04 -31.84 34.34 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.089 -1.007 . . . . 0.0 110.412 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 77.35 -89.05 1.01 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 -1.75 21.09 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.193 -1.18 . . . . 0.0 112.138 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -115.95 18.2 15.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.497 -1.377 . . . . 0.0 112.69 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.4 t -46.3 137.63 6.16 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 120.612 -1.305 . . . . 0.0 110.517 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.7 p90 -115.14 -40.44 3.47 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.295 -0.878 . . . . 0.0 112.011 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -60.94 149.8 35.36 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.778 -1.202 . . . . 0.0 109.551 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.23 69.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.271 -0.893 . . . . 0.0 110.613 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.11 151.76 42.71 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.24 -68.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.52 1.274 . . . . 0.0 111.027 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 8.2 p -40.52 -32.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 O-C-N 121.155 -0.965 . . . . 0.0 112.782 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.04 -39.07 83.14 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.959 -1.088 . . . . 0.0 109.445 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.55 -32.1 71.18 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.19 -27.01 59.45 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.391 -0.818 . . . . 0.0 111.427 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 395' ' ' HIS . 24.6 m170 -93.45 -34.51 13.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.836 -1.165 . . . . 0.0 111.162 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.23 140.19 48.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.993 -1.067 . . . . 0.0 110.807 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.8 t -91.68 165.15 13.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.391 -0.818 . . . . 0.0 110.637 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.91 157.94 72.3 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.802 -0.561 . . . . 0.0 109.764 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.4 ' HA ' ' CG ' ' A' ' 404' ' ' TYR . 40.2 Cg_endo -62.53 140.55 82.21 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.28 -1.52 62.58 Favored Glycine 0 CA--C 1.552 2.38 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.935 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -110.64 142.5 42.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.442 -1.622 . . . . 0.0 108.403 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.3 t -50.88 -26.78 6.27 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.201 -0.937 . . . . 0.0 112.472 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -102.24 8.94 40.35 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.505 -1.372 . . . . 0.0 113.157 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.418 ' CE2' ' HA2' ' A' ' 406' ' ' GLY . 23.3 t80 -47.07 125.37 7.57 Favored 'General case' 0 N--CA 1.52 3.07 0 CA-C-N 120.305 1.412 . . . . 0.0 110.969 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -76.65 -29.67 57.38 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.09 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 404' ' ' TYR . . . 116.04 -118.05 4.11 Favored Glycine 0 C--O 1.217 -0.944 0 N-CA-C 106.879 -2.488 . . . . 0.0 106.879 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.76 92.78 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.705 -0.88 . . . . 0.0 110.724 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -131.72 89.28 2.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.258 -0.901 . . . . 0.0 109.666 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.462 ' HA ' ' NE2' ' A' ' 412' ' ' GLN . 73.3 mt -103.65 70.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.149 -0.969 . . . . 0.0 109.932 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.59 80.06 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 108.855 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 412' ' ' GLN . . . 107.95 -67.18 0.23 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 409' ' ' ILE . 12.3 mm-40 77.34 -60.65 0.44 Allowed 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 123.407 0.683 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -103.76 38.67 1.76 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.035 -1.041 . . . . 0.0 110.075 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -142.53 52.4 1.43 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.248 -0.908 . . . . 0.0 110.222 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 66.29 0.66 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.247 -0.908 . . . . 0.0 110.048 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.71 84.83 2.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 110.212 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.3 t0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.172 -179.944 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.76 139.42 30.63 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.455 1.239 . . . . 0.0 110.436 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.2 tp -137.88 41.55 2.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.219 -0.925 . . . . 0.0 110.185 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -131.52 51.98 0.84 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.6 t -133.28 81.83 1.96 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.257 -1.143 . . . . 0.0 110.231 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -123.7 -90.98 0.95 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 12.1 p -120.73 121.86 39.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -1.157 . . . . 0.0 110.198 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -131.91 77.46 1.76 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.153 -0.967 . . . . 0.0 110.024 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -138.53 40.73 1.43 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -145.28 -67.33 0.31 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.126 -1.22 . . . . 0.0 110.407 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -137.91 60.71 1.62 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.083 -1.01 . . . . 0.0 110.298 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 67.8 t -145.24 161.01 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.105 -0.997 . . . . 0.0 110.295 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -93.01 96.37 10.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.31 -0.869 . . . . 0.0 109.246 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.431 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 3.1 mtt85 -54.61 -179.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.422 -0.799 . . . . 0.0 111.029 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -107.15 128.64 54.58 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.452 ' HB3' ' N ' ' A' ' 406' ' ' GLY . 9.5 p -52.5 117.26 2.74 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.241 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.2 t -36.37 151.64 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 10.8 ptp -51.12 -30.02 15.09 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -84.96 -23.7 28.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.152 -0.967 . . . . 0.0 111.318 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.13 -82.95 0.12 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 120.361 -1.462 . . . . 0.0 109.935 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.01 -0.11 21.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.297 -1.119 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -119.5 19.69 12.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.398 -1.439 . . . . 0.0 113.153 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.1 t -47.66 143.25 3.95 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 120.171 1.35 . . . . 0.0 110.552 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.6 p90 -120.14 -39.38 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.324 -0.86 . . . . 0.0 112.222 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.44 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.7 ptp85 -67.66 145.27 54.97 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.719 -1.238 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 73.13 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.977 . . . . 0.0 111.384 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.55 150.8 40.58 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.945 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.31 -73.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.305 1.16 . . . . 0.0 110.477 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.6 t -41.84 -29.5 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 120.885 -1.134 . . . . 0.0 112.082 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.411 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 30.0 t60 -63.19 -35.09 79.16 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.604 -1.31 . . . . 0.0 109.307 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.01 -26.75 67.68 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -31.57 57.47 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.913 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -82.75 -40.48 20.47 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.872 -1.142 . . . . 0.0 110.397 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -110.02 165.36 11.79 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.294 -0.879 . . . . 0.0 109.685 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -112.38 169.16 9.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -143.35 160.21 52.46 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.035 . . . . 0.0 110.304 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.05 137.71 68.57 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 108.778 -1.278 . . . . 0.0 108.778 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.33 62.54 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.364 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.59 139.35 45.93 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.411 1.605 . . . . 0.0 108.427 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 51.1 m -49.18 -26.13 2.66 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.188 -0.945 . . . . 0.0 112.679 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -97.8 2.58 49.59 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.394 -1.441 . . . . 0.0 114.433 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.423 ' CD2' ' NE2' ' A' ' 408' ' ' GLN . 4.6 t80 -39.79 124.5 1.73 Allowed 'General case' 0 N--CA 1.533 3.688 0 CA-C-N 120.683 1.583 . . . . 0.0 111.029 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.99 77.4 0.11 Allowed Glycine 0 N--CA 1.5 2.961 0 C-N-CA 119.224 -1.465 . . . . 0.0 111.27 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.452 ' N ' ' HB3' ' A' ' 378' ' ' SER . . . -151.71 -58.37 0.01 OUTLIER Glycine 0 N--CA 1.497 2.759 0 C-N-CA 119.622 -1.275 . . . . 0.0 111.513 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.96 69.31 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 118.65 1.225 . . . . 0.0 112.266 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.423 ' NE2' ' CD2' ' A' ' 404' ' ' TYR . 5.0 mt-30 -126.89 93.34 3.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.013 -1.054 . . . . 0.0 109.366 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.77 68.67 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 121.185 -0.947 . . . . 0.0 109.778 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 63.7 t -123.13 66.89 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 95.21 51.41 1.89 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -48.39 -61.9 1.77 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.49 -1.006 . . . . 0.0 110.903 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -126.15 37.25 4.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.377 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -126.86 40.35 3.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 110.16 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.6 t -139.02 59.21 1.62 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 0.0 110.089 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -102.6 38.92 1.61 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.275 -0.89 . . . . 0.0 109.969 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.233 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.7 108.26 2.51 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.382 1.201 . . . . 0.0 110.49 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 13.8 tp -133.93 134.97 43.24 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.278 -0.888 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -99.12 142.34 16.0 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 21.8 t -142.25 128.55 19.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.14 -1.212 . . . . 0.0 110.246 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.15 108.94 0.65 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 15.6 m -127.36 103.22 7.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -1.187 . . . . 0.0 110.213 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -138.42 -172.9 3.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.907 . . . . 0.0 110.065 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -86.19 -110.98 0.81 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -126.73 73.56 1.41 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -1.137 . . . . 0.0 109.917 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 4.7 mptt 53.53 60.73 3.51 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.977 -1.077 . . . . 0.0 110.465 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.27 161.75 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.224 -0.923 . . . . 0.0 110.678 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.74 89.91 6.82 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.779 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.419 ' NE ' ' O ' ' A' ' 394' ' ' GLN . 2.5 mmt-85 -62.14 151.85 34.62 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.319 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.3 t -74.0 140.91 45.8 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.408 ' OG ' ' NE2' ' A' ' 408' ' ' GLN . 10.9 p -57.18 157.29 6.29 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.316 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -73.15 161.57 30.44 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.044 -1.035 . . . . 0.0 110.232 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -31.83 71.68 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -85.08 -21.53 29.3 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.105 -0.997 . . . . 0.0 110.564 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.4 -86.61 0.11 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.48 -8.7 18.91 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -1.174 . . . . 0.0 112.243 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -106.63 12.96 28.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.48 -1.388 . . . . 0.0 112.975 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.1 t -47.0 142.28 3.63 Favored 'General case' 0 N--CA 1.524 3.235 0 O-C-N 120.534 -1.354 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.4 p90 -121.13 -37.05 3.0 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.275 -0.891 . . . . 0.0 112.67 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.7 ptm180 -55.11 157.13 3.55 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.742 -1.224 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -129.01 64.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.0 110.749 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -111.74 148.31 38.66 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.076 -1.015 . . . . 0.0 109.93 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.66 -69.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.444 1.234 . . . . 0.0 110.493 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.8 t -43.01 -29.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.177 0 O-C-N 120.819 -1.175 . . . . 0.0 111.752 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.24 -36.26 83.6 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.507 -1.371 . . . . 0.0 108.903 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -57.89 -30.03 65.53 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.071 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.419 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -82.42 -28.65 31.24 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.179 -0.951 . . . . 0.0 110.444 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -75.44 -34.26 60.96 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.969 -1.082 . . . . 0.0 110.873 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -134.65 149.18 50.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.004 -1.06 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.0 t -93.85 164.91 12.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.772 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.15 159.16 70.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.35 138.94 74.35 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.54 -2.08 60.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -110.07 138.9 45.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 119.14 1.47 . . . . 0.0 107.657 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.3 -23.24 5.47 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.13 -0.981 . . . . 0.0 112.538 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -103.6 11.97 35.5 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.294 -1.504 . . . . 0.0 113.562 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -47.07 128.67 11.66 Favored 'General case' 0 N--CA 1.523 3.181 0 CA-C-N 120.546 1.521 . . . . 0.0 110.925 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -66.22 -36.83 92.32 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.697 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 125.15 -130.16 7.24 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 73.9 t -131.38 97.76 3.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.697 -0.884 . . . . 0.0 110.452 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.408 ' NE2' ' OG ' ' A' ' 378' ' ' SER . 0.1 OUTLIER -138.1 83.17 1.96 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 179.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 10.8 mt -103.94 75.34 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.754 -1.216 . . . . 0.0 110.245 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.92 78.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.291 -0.88 . . . . 0.0 108.678 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 80.42 58.62 2.69 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -48.51 -65.0 0.64 Allowed 'General case' 0 N--CA 1.513 2.719 0 O-C-N 121.413 -1.051 . . . . 0.0 110.951 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -153.38 37.04 0.47 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.167 -0.958 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -117.04 51.69 0.99 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.072 -1.017 . . . . 0.0 110.311 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.39 66.13 0.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.174 -0.954 . . . . 0.0 109.93 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 52.77 40.09 29.9 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.189 -0.944 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.292 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.9 123.65 9.08 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.462 1.243 . . . . 0.0 110.405 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.3 mp -132.86 -61.98 0.82 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.258 -0.902 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -114.52 68.73 0.25 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.1 m -141.2 47.27 1.71 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.233 -1.157 . . . . 0.0 110.26 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 117.86 134.89 5.23 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 52.2 m -141.93 39.55 1.64 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -1.188 . . . . 0.0 110.37 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -149.13 163.96 36.1 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.168 -0.958 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -91.4 -61.89 1.23 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -145.96 63.84 1.23 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.156 -1.203 . . . . 0.0 110.399 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 52.96 63.76 2.12 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.022 -1.049 . . . . 0.0 110.741 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.34 160.35 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.25 88.64 7.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.319 -0.863 . . . . 0.0 109.271 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.483 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 3.3 mmt-85 -61.53 152.18 30.98 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.294 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -73.38 143.64 46.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.453 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 8.5 t -57.35 168.7 0.72 Allowed 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.616 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 35.9 t -83.23 158.12 22.41 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.075 -1.016 . . . . 0.0 109.832 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 52.8 mtm -56.26 -31.23 63.38 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 121.007 -1.058 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.54 -21.89 35.19 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.081 -1.012 . . . . 0.0 111.052 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.36 -91.95 0.17 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.88 0.66 28.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.448 -1.031 . . . . 0.0 112.271 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -117.49 22.13 12.6 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.471 -1.393 . . . . 0.0 112.299 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 13.2 t -52.31 147.55 7.74 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 120.446 -1.409 . . . . 0.0 109.819 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 19.4 p90 -125.96 -35.63 2.45 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.328 -0.858 . . . . 0.0 112.993 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.474 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.0 ptp85 -61.99 162.09 9.74 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.549 -1.344 . . . . 0.0 109.819 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 66.9 1.39 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.199 -0.938 . . . . 0.0 110.649 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -107.53 145.95 32.34 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.272 -0.892 . . . . 0.0 110.078 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.58 -69.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.342 1.18 . . . . 0.0 110.38 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 91.5 t -44.76 -30.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.126 0 O-C-N 120.854 -1.154 . . . . 0.0 110.972 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.434 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 45.4 t60 -63.73 -36.0 82.43 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.863 -1.148 . . . . 0.0 109.064 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 -27.54 65.19 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.005 -1.059 . . . . 0.0 109.272 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.05 -31.25 25.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.106 -0.996 . . . . 0.0 110.176 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -73.24 -29.05 62.5 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.978 -1.076 . . . . 0.0 110.83 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' A' ' 379' ' ' CYS . 59.5 m-85 -140.29 145.86 37.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 110.856 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.483 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 45.7 m -90.1 163.13 14.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.473 -0.767 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -139.14 160.89 60.57 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.692 -0.63 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.03 140.12 77.13 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.003 -1.576 . . . . 0.0 108.003 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.8 60.56 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.256 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.27 143.28 45.12 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.367 1.584 . . . . 0.0 107.813 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.9 m -52.81 -30.4 33.06 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.085 -1.009 . . . . 0.0 110.992 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.29 -1.65 57.69 Favored 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.467 ' CE2' ' NE2' ' A' ' 408' ' ' GLN . 8.0 t80 -40.85 116.73 0.75 Allowed 'General case' 0 N--CA 1.532 3.657 0 CA-C-N 120.861 1.664 . . . . 0.0 110.903 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -162.59 79.36 0.15 Allowed Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.437 -1.364 . . . . 0.0 111.221 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -154.35 -56.87 0.01 OUTLIER Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.487 -1.339 . . . . 0.0 111.372 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.72 75.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.068 -1.254 . . . . 0.0 112.247 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.467 ' NE2' ' CE2' ' A' ' 404' ' ' TYR . 14.0 mt-30 -137.68 85.15 2.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.017 -1.052 . . . . 0.0 109.791 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 11.5 mt -101.13 67.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.205 -0.934 . . . . 0.0 109.853 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.2 t -114.14 78.21 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.357 -0.84 . . . . 0.0 108.794 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 79.54 57.82 3.03 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -48.57 -63.75 1.0 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.384 -1.068 . . . . 0.0 110.868 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.76 36.94 0.96 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.208 -0.932 . . . . 0.0 110.429 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 53.14 40.98 32.11 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.976 -1.077 . . . . 0.0 110.686 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.1 t -132.54 61.73 1.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.31 39.1 1.63 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.156 -0.965 . . . . 0.0 109.919 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.224 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.89 110.31 3.0 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.435 1.229 . . . . 0.0 110.37 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.7 mt -117.93 150.28 39.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.186 -0.946 . . . . 0.0 110.301 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 112.69 -135.14 12.45 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.7 p -119.22 128.38 54.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.224 -1.162 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -91.66 -147.35 19.99 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.9 m -117.07 -57.12 2.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.5 -178.83 3.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.178 -0.951 . . . . 0.0 110.111 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -62.84 -68.09 1.81 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -149.04 59.42 1.04 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.207 -1.172 . . . . 0.0 110.483 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 7.5 tptt 53.27 64.89 1.69 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.897 -1.127 . . . . 0.0 110.453 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.62 159.52 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.251 -0.906 . . . . 0.0 110.307 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -68.48 82.99 0.26 Allowed 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.469 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt-85 -61.91 152.24 32.53 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.33 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.4 t -71.84 141.52 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.983 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -54.84 161.03 1.71 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.153 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 25.3 t -81.28 155.99 25.78 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.893 -1.129 . . . . 0.0 110.757 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.9 mtm -56.02 -27.53 53.42 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.24 -0.913 . . . . 0.0 110.932 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 87.8 m-85 -84.52 -21.8 30.4 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.05 -1.032 . . . . 0.0 110.723 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.61 -93.55 0.21 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.08 0.18 23.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.291 -1.123 . . . . 0.0 112.182 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -116.65 23.41 12.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.475 -1.391 . . . . 0.0 111.837 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 14.0 t -52.63 144.22 14.31 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 120.533 -1.355 . . . . 0.0 109.962 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 16.3 p90 -122.9 -36.44 2.88 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.603 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.482 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.08 161.52 26.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.592 -1.318 . . . . 0.0 109.265 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -150.41 111.16 4.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.0 111.223 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -120.06 166.87 13.83 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 109.775 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.36 -28.89 14.49 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.312 1.164 . . . . 0.0 110.395 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.79 -22.94 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.014 -1.054 . . . . 0.0 111.676 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -61.75 -38.04 86.52 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.603 -1.31 . . . . 0.0 109.644 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.83 -28.59 61.77 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.149 -0.97 . . . . 0.0 109.43 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.93 -32.43 25.09 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.404 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 15.8 m170 -71.62 -31.04 66.46 Favored 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.021 -1.049 . . . . 0.0 111.64 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 36.9 m-85 -140.71 148.53 40.9 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.802 -1.186 . . . . 0.0 110.857 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.469 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 18.3 m -86.81 169.52 12.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.444 -0.785 . . . . 0.0 110.657 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.37 157.84 58.87 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.592 -0.693 . . . . 0.0 109.782 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 138.96 73.4 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.114 -1.533 . . . . 0.0 108.114 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.04 54.76 Favored Glycine 0 CA--C 1.553 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.042 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.14 147.62 40.02 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.733 -1.451 . . . . 0.0 107.902 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 48.0 t -58.71 -27.05 64.51 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.725 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.62 -0.56 57.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.681 -1.262 . . . . 0.0 113.918 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -45.37 125.23 5.43 Favored 'General case' 0 N--CA 1.521 3.095 0 CA-C-N 120.81 1.641 . . . . 0.0 110.789 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -71.86 -32.22 63.97 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 121.37 -127.16 6.82 Favored Glycine 0 C--O 1.218 -0.893 0 N-CA-C 106.62 -2.592 . . . . 0.0 106.62 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 64.9 t -138.27 97.95 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.663 -0.904 . . . . 0.0 110.667 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.63 85.86 1.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.179 -0.951 . . . . 0.0 110.982 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.66 72.56 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.974 -1.079 . . . . 0.0 109.827 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 50.7 t -113.27 79.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 73.94 53.67 6.96 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -47.05 -57.27 5.22 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.365 -1.079 . . . . 0.0 111.192 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -143.42 39.32 1.41 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.296 -0.878 . . . . 0.0 110.335 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.11 65.02 1.13 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.13 -0.981 . . . . 0.0 110.144 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.98 65.22 0.64 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.179 -0.95 . . . . 0.0 109.918 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -115.28 41.57 2.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.317 -0.864 . . . . 0.0 110.264 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.214 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.72 79.83 1.85 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.453 1.238 . . . . 0.0 110.408 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 3.4 mt -136.8 114.96 11.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.969 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 130.97 60.58 0.09 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 t -142.74 79.71 1.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.143 -1.21 . . . . 0.0 110.248 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.18 -121.93 2.01 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 10.4 p -121.73 85.66 2.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -1.196 . . . . 0.0 110.345 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -127.36 77.43 1.74 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.929 . . . . 0.0 110.087 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.48 41.26 1.11 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -135.61 -61.16 0.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.151 -1.205 . . . . 0.0 109.943 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.81 59.54 1.69 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.04 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.6 t -145.88 161.46 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.991 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -89.53 96.02 10.52 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.251 -0.905 . . . . 0.0 109.427 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.89 150.57 39.12 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.344 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 397' ' ' SER . 14.2 t -76.58 -179.66 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.183 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.419 ' HB2' ' CE1' ' A' ' 404' ' ' TYR . 0.1 OUTLIER -97.16 126.81 42.59 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.004 -1.06 . . . . 0.0 110.82 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -45.07 145.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.614 -0.679 . . . . 0.0 112.333 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 11.3 ptp -49.4 -28.08 4.76 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.469 -0.769 . . . . 0.0 111.031 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -86.81 -22.47 25.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.942 -1.099 . . . . 0.0 111.214 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.65 -84.87 0.04 OUTLIER Glycine 0 N--CA 1.497 2.703 0 O-C-N 120.495 -1.378 . . . . 0.0 110.784 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.11 -9.74 17.6 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.202 -1.175 . . . . 0.0 112.569 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -112.84 18.69 17.99 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.521 -1.362 . . . . 0.0 113.22 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 30.9 t -47.89 139.13 8.04 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.055 1.298 . . . . 0.0 110.239 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 37.5 p90 -116.22 -40.68 3.23 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.461 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -71.35 162.75 28.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.904 -1.122 . . . . 0.0 109.154 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -155.99 104.07 2.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.177 -0.952 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.49 165.3 14.7 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 -24.74 18.58 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.437 1.23 . . . . 0.0 110.588 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.22 -21.73 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.039 -1.038 . . . . 0.0 111.756 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 45.5 t60 -63.84 -38.19 90.18 Favored 'General case' 0 N--CA 1.512 2.663 0 O-C-N 120.517 -1.364 . . . . 0.0 110.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -58.1 -30.61 66.41 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -32.14 44.93 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.876 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -77.82 -37.76 47.88 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.119 -0.988 . . . . 0.0 110.589 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.9 m-85 -125.18 150.52 46.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 377' ' ' THR . 3.1 t -94.7 174.48 7.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.161 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -144.33 156.49 57.36 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.764 . . . . 0.0 109.278 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 404' ' ' TYR . 37.8 Cg_endo -61.14 138.9 80.88 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.61 -2.54 55.95 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.791 -1.195 . . . . 0.0 110.874 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.14 146.87 39.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.699 1.75 . . . . 0.0 108.415 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.8 t -54.48 -28.45 44.82 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.124 -0.985 . . . . 0.0 111.645 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -92.12 1.44 57.21 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 0.0 113.058 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.425 ' CG ' ' HA ' ' A' ' 399' ' ' PRO . 23.3 t80 -48.58 132.61 17.28 Favored 'General case' 0 N--CA 1.514 2.76 0 CA-C-N 120.391 1.451 . . . . 0.0 110.253 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -126.17 16.09 6.8 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.636 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.67 48.59 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-N 119.942 1.871 . . . . 0.0 111.042 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.9 67.77 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.443 -1.034 . . . . 0.0 109.494 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -66.46 78.92 0.1 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.291 -0.88 . . . . 0.0 109.48 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 13.5 mt 51.33 67.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.07 -1.019 . . . . 0.0 110.42 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.56 65.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.73 51.48 1.96 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -49.07 -61.86 1.84 Allowed 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.441 -1.035 . . . . 0.0 110.702 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -122.34 36.97 4.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.325 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -140.99 54.29 1.57 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.194 -0.941 . . . . 0.0 110.098 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 66.43 0.64 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.191 -0.943 . . . . 0.0 110.079 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -116.3 83.8 2.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.332 -0.855 . . . . 0.0 110.225 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.168 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.81 129.53 14.55 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.445 1.234 . . . . 0.0 110.372 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 12.3 tp -142.87 115.73 8.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -79.3 130.81 10.13 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.7 t -132.11 81.52 1.97 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.223 -1.163 . . . . 0.0 110.302 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 97.63 149.7 25.56 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.41 124.46 43.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -1.168 . . . . 0.0 110.147 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.87 171.05 15.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.168 -0.958 . . . . 0.0 110.417 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -95.88 -43.59 3.29 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -146.07 53.67 1.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.166 -1.196 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 10.0 mttt 52.97 61.88 2.96 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.01 -1.057 . . . . 0.0 110.754 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.7 p -138.52 161.52 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 110.831 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -83.29 99.22 9.86 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.452 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -72.64 152.99 41.45 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.803 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -73.43 141.8 46.91 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.427 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 8.2 t -58.18 158.49 6.97 Favored 'General case' 0 N--CA 1.511 2.606 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.503 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.83 151.46 35.88 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.911 -1.118 . . . . 0.0 110.577 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -52.91 -28.59 24.09 Favored 'General case' 0 N--CA 1.514 2.76 0 O-C-N 121.226 -0.921 . . . . 0.0 111.118 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -77.34 -31.95 54.84 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.977 -1.077 . . . . 0.0 110.169 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.94 -90.91 0.89 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.34 4.98 29.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.331 -1.099 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -128.34 25.78 5.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.556 -1.34 . . . . 0.0 112.191 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 34.4 t -50.66 143.77 9.05 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 120.668 -1.27 . . . . 0.0 110.165 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 13.3 p90 -116.4 -36.01 4.12 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.284 -0.885 . . . . 0.0 112.001 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -73.52 149.54 42.16 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.831 -1.168 . . . . 0.0 109.694 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.5 100.89 3.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.062 -1.024 . . . . 0.0 111.171 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.21 164.57 21.84 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 109.848 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.41 -29.93 16.05 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.324 1.171 . . . . 0.0 110.447 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.14 -23.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.12 -0.988 . . . . 0.0 111.304 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -61.7 -37.45 84.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.764 -1.21 . . . . 0.0 109.637 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -57.73 -26.06 61.27 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.47 -30.3 30.05 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.42 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 11.6 m170 -79.32 -34.22 42.49 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.159 -0.963 . . . . 0.0 111.336 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 65.6 m-85 -133.26 142.43 48.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.224 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 56.0 m -85.71 169.27 13.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.401 -0.812 . . . . 0.0 110.167 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -144.39 158.75 53.77 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.6 -0.687 . . . . 0.0 109.923 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.09 137.43 66.63 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 N-CA-C 108.341 -1.446 . . . . 0.0 108.341 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.12 -1.94 56.45 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.698 -178.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.24 150.75 40.89 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.651 -1.499 . . . . 0.0 107.564 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 81.3 p -60.32 -32.07 70.88 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.456 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.8 -11.44 60.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.028 -1.045 . . . . 0.0 112.634 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.431 ' CD2' ' NE2' ' A' ' 408' ' ' GLN . 8.8 t80 -45.49 113.49 0.6 Allowed 'General case' 0 N--CA 1.517 2.886 0 CA-C-N 120.288 1.404 . . . . 0.0 110.214 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -163.82 78.93 0.14 Allowed Glycine 0 N--CA 1.499 2.875 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.6 -178.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -150.95 -55.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.865 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.93 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.5 p -111.21 61.85 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.118 -1.225 . . . . 0.0 110.509 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.431 ' NE2' ' CD2' ' A' ' 404' ' ' TYR . 12.6 mt-30 -132.17 92.13 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.425 -0.797 . . . . 0.0 109.91 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 68.7 mt -96.66 66.77 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.304 -0.873 . . . . 0.0 109.716 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 67.2 t -117.48 69.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 91.7 53.87 2.03 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -48.34 -62.99 1.2 Allowed 'General case' 0 N--CA 1.511 2.613 0 O-C-N 121.433 -1.039 . . . . 0.0 110.959 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -139.85 38.48 1.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.095 -1.003 . . . . 0.0 110.24 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -116.99 47.88 1.41 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.212 -0.93 . . . . 0.0 110.21 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.55 66.57 0.66 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.129 -0.982 . . . . 0.0 110.076 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -121.89 40.5 3.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.238 -0.914 . . . . 0.0 110.231 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.213 -179.952 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.78 168.14 25.36 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.419 1.22 . . . . 0.0 110.372 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 86.5 mt -133.37 177.14 7.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 104.99 58.16 0.67 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.0 t -143.24 96.08 2.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.121 -1.223 . . . . 0.0 110.386 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 96.51 125.4 4.89 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.1 m -145.67 60.31 1.27 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.201 -1.176 . . . . 0.0 110.447 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -142.62 44.1 1.61 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.045 -1.034 . . . . 0.0 110.21 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -147.33 40.11 1.01 Allowed Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -126.96 -59.11 1.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.248 -1.148 . . . . 0.0 110.079 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -137.75 50.55 1.93 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.298 -0.876 . . . . 0.0 110.258 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.28 160.22 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.055 -1.028 . . . . 0.0 110.634 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -88.37 94.53 9.88 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.75 150.25 48.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.456 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.7 t -78.92 172.12 14.23 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.771 -179.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 p -76.99 157.53 31.15 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.076 -1.015 . . . . 0.0 109.272 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.42 160.74 29.91 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.429 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.5 ptp -61.45 -35.31 77.26 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.901 -1.125 . . . . 0.0 109.944 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -77.14 -33.48 56.69 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.484 179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 76.13 -87.64 0.89 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.75 -3.19 20.74 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.261 -1.141 . . . . 0.0 112.469 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -115.44 17.33 16.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.415 -1.428 . . . . 0.0 112.809 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 8.6 t -45.14 139.69 3.19 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-N 120.059 1.3 . . . . 0.0 110.905 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 33.5 p90 -117.22 -39.39 3.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.313 -0.867 . . . . 0.0 112.363 -178.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.446 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.4 ptp85 -57.28 156.58 7.36 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 120.632 -1.293 . . . . 0.0 110.165 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.93 65.56 1.2 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 110.871 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -109.95 144.15 29.41 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.113 -0.992 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.47 -71.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.358 1.189 . . . . 0.0 110.529 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 71.8 t -41.48 -28.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 O-C-N 120.885 -1.134 . . . . 0.0 112.318 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.429 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 27.2 t60 -65.23 -37.6 87.75 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 120.496 -1.378 . . . . 0.0 108.66 177.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -57.37 -31.04 65.38 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.068 -1.02 . . . . 0.0 109.35 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 -26.99 39.95 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.211 -0.931 . . . . 0.0 110.737 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -81.85 -37.88 26.29 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.002 -1.062 . . . . 0.0 110.185 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.5 m-85 -125.15 145.44 49.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 1.8 t -94.22 170.35 9.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.34 158.77 65.75 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.664 -0.647 . . . . 0.0 109.983 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.61 139.74 82.89 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 108.153 -1.518 . . . . 0.0 108.153 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.41 -1.63 60.47 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.807 -176.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -112.62 141.5 46.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.619 -1.518 . . . . 0.0 107.983 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.0 m -51.6 -28.53 14.41 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.149 -0.969 . . . . 0.0 111.752 -178.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.682 -1.261 . . . . 0.0 113.355 -178.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.431 ' CE2' ' HA2' ' A' ' 406' ' ' GLY . 26.0 t80 -43.79 126.45 4.67 Favored 'General case' 0 N--CA 1.522 3.128 0 CA-C-N 120.466 1.485 . . . . 0.0 111.121 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.6 -24.08 44.16 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.227 -178.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 404' ' ' TYR . . . 115.99 -119.98 4.74 Favored Glycine 0 C--O 1.218 -0.866 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 -179.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 64.1 t -138.7 97.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.821 -0.811 . . . . 0.0 110.526 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -157.43 87.11 0.95 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.335 -0.853 . . . . 0.0 110.444 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 74.9 mt -88.37 71.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.908 -1.12 . . . . 0.0 110.056 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.5 t -126.62 67.62 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 95.88 51.31 1.81 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -178.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -48.85 -56.04 9.9 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 121.379 -1.071 . . . . 0.0 110.565 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -119.57 32.69 5.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.302 -0.874 . . . . 0.0 110.564 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.97 62.65 1.07 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.071 -1.018 . . . . 0.0 109.776 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.25 65.82 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.26 -0.9 . . . . 0.0 110.067 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.55 87.02 2.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.294 -0.879 . . . . 0.0 109.996 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.226 179.959 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.79 169.82 21.1 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.428 1.225 . . . . 0.0 110.481 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 6.5 mt -131.97 103.98 6.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 110.264 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 94.25 43.63 3.71 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.6 m -131.87 -65.33 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.203 -1.175 . . . . 0.0 110.224 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.7 -119.41 5.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.41 128.66 55.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.215 -1.168 . . . . 0.0 110.025 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -127.68 69.1 1.31 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -148.02 38.81 1.03 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -126.38 -60.07 1.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.136 -1.214 . . . . 0.0 109.664 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -133.97 48.13 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.878 . . . . 0.0 109.636 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.48 160.75 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.116 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -95.49 100.51 12.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.494 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.7 OUTLIER -80.89 161.75 24.24 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.777 -0.577 . . . . 0.0 111.334 -179.219 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 397' ' ' SER . 7.4 t -76.62 174.17 10.71 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.9 t -94.7 129.99 41.37 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.684 -1.26 . . . . 0.0 111.78 -178.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 7.8 t -40.11 148.55 0.08 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.895 -0.503 . . . . 0.0 112.036 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 6.1 ptp -47.64 -37.83 13.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.622 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.411 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 27.9 m-85 -73.58 -35.21 65.39 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.57 -86.62 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.047 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.24 7.06 43.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.26 -1.141 . . . . 0.0 112.847 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -134.87 25.09 3.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.343 -1.473 . . . . 0.0 112.577 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.411 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.2 t -49.63 151.72 1.6 Allowed 'General case' 0 N--CA 1.521 3.076 0 O-C-N 120.514 -1.366 . . . . 0.0 111.113 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.1 p90 -126.3 -33.2 2.63 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.992 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.423 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.1 OUTLIER -55.97 173.81 0.14 Allowed 'General case' 0 N--CA 1.514 2.729 0 O-C-N 120.388 -1.445 . . . . 0.0 110.167 179.936 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -143.7 55.88 1.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 110.532 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -112.05 148.18 38.48 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 109.606 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -73.34 -66.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.396 1.208 . . . . 0.0 110.473 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.3 t -43.01 -29.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 120.888 -1.132 . . . . 0.0 111.999 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.413 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 39.0 t60 -63.87 -38.98 93.09 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.665 -1.272 . . . . 0.0 108.824 178.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -56.13 -29.27 60.48 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 178.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -29.72 45.23 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.159 -0.963 . . . . 0.0 110.501 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.408 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 17.2 m170 -75.33 -35.47 61.19 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.453 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 34.0 m-85 -134.78 138.19 44.07 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.087 -1.008 . . . . 0.0 110.304 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.494 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 1.5 m -81.58 169.48 17.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.518 -0.739 . . . . 0.0 109.23 178.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -141.6 155.22 66.92 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 404' ' ' TYR . 36.9 Cg_endo -59.61 140.07 92.0 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 N-CA-C 108.735 -1.294 . . . . 0.0 108.735 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.57 0.79 64.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.722 -177.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.22 143.81 44.23 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.413 1.606 . . . . 0.0 108.646 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.6 t -50.01 -30.79 11.32 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.09 -1.006 . . . . 0.0 111.839 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.83 -6.15 54.65 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.684 -1.26 . . . . 0.0 113.55 -177.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.402 ' CG ' ' HA ' ' A' ' 399' ' ' PRO . 25.9 t80 -39.47 129.55 1.84 Allowed 'General case' 0 N--CA 1.525 3.289 0 CA-C-N 120.551 1.523 . . . . 0.0 111.294 -179.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -173.91 70.62 0.1 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.609 -178.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -137.91 -63.02 0.05 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.128 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 96.1 t 41.67 63.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.695 -0.885 . . . . 0.0 111.333 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -113.86 96.54 5.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.28 -0.888 . . . . 0.0 110.518 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 78.7 mt -108.87 71.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.345 -0.847 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.9 67.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.241 -0.912 . . . . 0.0 108.783 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 92.24 51.4 2.4 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 -178.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -47.81 -62.45 1.45 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 121.432 -1.04 . . . . 0.0 111.058 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.05 39.61 3.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 0.0 110.313 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -123.86 49.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.167 -0.958 . . . . 0.0 110.21 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.4 t -131.41 62.74 1.62 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.161 -0.962 . . . . 0.0 110.111 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.38 39.29 1.61 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.216 -0.928 . . . . 0.0 109.844 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.256 179.934 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.14 -43.68 0.69 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.4 1.211 . . . . 0.0 110.34 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 2.0 tt -127.9 87.88 2.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.141 -0.974 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 106.22 149.2 16.93 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 24.4 p -122.21 136.96 54.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.213 -1.169 . . . . 0.0 110.238 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 130.5 106.98 1.17 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.9 134.85 53.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.22 -1.165 . . . . 0.0 110.221 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.01 167.54 22.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.217 -0.927 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -62.51 -72.0 0.73 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -139.5 57.77 1.63 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.142 -1.211 . . . . 0.0 110.295 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 5.0 mptt 52.31 58.06 5.79 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.955 -1.091 . . . . 0.0 110.76 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.66 152.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 110.062 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -69.84 91.38 0.64 Allowed 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.487 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -58.04 158.28 6.97 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.697 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.5 t -75.08 145.67 42.1 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.415 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 1.3 t -56.44 163.2 1.81 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.646 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 6.1 t -78.34 162.3 26.57 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.04 -1.038 . . . . 0.0 109.8 178.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 47.9 mtm -58.4 -31.16 67.43 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.403 179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.11 -26.11 25.42 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.144 -0.972 . . . . 0.0 110.768 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.19 -89.75 0.6 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.61 -1.19 26.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.343 -1.092 . . . . 0.0 111.956 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -112.51 16.95 19.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.34 -1.475 . . . . 0.0 112.275 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.4 t -49.19 143.84 5.67 Favored 'General case' 0 N--CA 1.519 2.98 0 O-C-N 120.558 -1.339 . . . . 0.0 110.377 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.5 p90 -120.77 -33.94 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.353 -0.842 . . . . 0.0 112.536 -179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -72.64 174.54 7.42 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.709 -1.245 . . . . 0.0 109.618 179.571 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.6 93.3 1.18 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.899 -1.126 . . . . 0.0 111.096 -179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -115.23 162.43 24.44 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.736 -1.227 . . . . 0.0 110.034 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -26.04 12.73 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 O-C-N 123.514 1.27 . . . . 0.0 110.652 178.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.76 -25.42 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.093 -1.004 . . . . 0.0 111.411 178.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -61.88 -36.02 80.02 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.662 -1.273 . . . . 0.0 109.946 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -58.13 -26.67 62.94 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -31.08 27.86 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.178 -0.951 . . . . 0.0 110.468 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.5 m170 -75.46 -34.3 60.93 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.808 -1.183 . . . . 0.0 111.371 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 48.3 m-85 -137.21 145.66 43.92 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.722 -1.236 . . . . 0.0 110.839 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 66.5 m -91.4 169.97 10.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.222 -0.924 . . . . 0.0 111.503 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -141.64 153.54 65.22 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.109 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.34 140.14 81.04 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 N-CA-C 107.253 -1.864 . . . . 0.0 107.253 178.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.31 1.61 60.79 Favored Glycine 0 CA--C 1.553 2.438 0 C-N-CA 119.041 -1.552 . . . . 0.0 110.825 -178.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.66 156.94 24.97 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.837 1.818 . . . . 0.0 107.778 177.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -29.11 70.24 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.207 -179.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -94.41 6.09 49.8 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 120.533 -1.355 . . . . 0.0 114.0 -177.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -48.62 134.62 15.64 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-N 120.643 1.565 . . . . 0.0 109.966 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -155.43 45.04 0.54 Allowed Glycine 0 N--CA 1.497 2.7 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.278 -178.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -109.32 -56.05 0.55 Allowed Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 98.5 t 41.95 69.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.862 -0.787 . . . . 0.0 111.639 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -102.04 53.7 0.81 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.259 -0.9 . . . . 0.0 109.792 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 13.7 mt 50.01 68.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.284 -0.885 . . . . 0.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 62.2 t -107.64 65.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 98.18 51.99 1.41 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 -178.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' A' ' 412' ' ' GLN . 12.5 mm-40 -59.42 -49.77 76.54 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.244 -1.151 . . . . 0.0 109.833 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.75 37.42 2.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.241 -0.912 . . . . 0.0 109.827 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -135.64 62.62 1.62 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.966 . . . . 0.0 110.231 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.0 65.1 0.66 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.014 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -130.37 83.34 2.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.303 -179.999 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.77 130.72 16.12 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.332 1.175 . . . . 0.0 110.38 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.49 -174.18 2.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.263 -0.898 . . . . 0.0 110.249 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -112.81 -58.04 0.43 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 367' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 367' ' ' SER . 9.5 t -132.95 48.62 2.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.171 -1.194 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -126.16 142.98 14.08 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.3 p -122.67 -65.77 1.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.249 -1.148 . . . . 0.0 110.055 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -143.97 75.28 1.46 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -0.97 . . . . 0.0 110.237 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -156.91 39.46 0.56 Allowed Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -126.21 -59.62 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.166 -1.197 . . . . 0.0 110.052 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -139.14 52.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.981 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.1 t -142.83 157.24 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 109.931 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 86.88 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.47 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -61.2 153.65 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.293 -179.637 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -71.07 142.46 50.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.417 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 28.8 t -53.05 165.19 0.33 Allowed 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.686 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 45.2 t -87.51 156.97 19.3 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.974 -1.079 . . . . 0.0 109.682 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 4.1 ptp -55.25 -31.61 61.67 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -93.52 -20.74 19.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.974 -1.079 . . . . 0.0 111.439 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.45 -98.86 0.22 Allowed Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.521 -1.362 . . . . 0.0 110.392 178.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.58 -13.32 32.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.429 -1.042 . . . . 0.0 111.764 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -104.51 16.44 26.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.565 -1.335 . . . . 0.0 112.39 -179.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.9 t -48.92 139.78 9.71 Favored 'General case' 0 N--CA 1.52 3.065 0 O-C-N 120.517 -1.364 . . . . 0.0 111.039 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 17.9 p90 -117.03 -37.16 3.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.438 -0.789 . . . . 0.0 111.765 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.457 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.69 153.66 29.15 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.644 -1.285 . . . . 0.0 109.408 179.184 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 108.29 4.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -0.98 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -118.97 167.47 11.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 0.0 110.209 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.15 -27.67 16.58 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.432 1.227 . . . . 0.0 110.319 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.4 t -98.17 -24.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.084 -1.01 . . . . 0.0 111.92 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -61.94 -38.09 87.17 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.6 -1.313 . . . . 0.0 110.113 -179.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -56.96 -28.81 62.62 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.83 -1.169 . . . . 0.0 109.148 178.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -32.53 30.06 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.238 -0.914 . . . . 0.0 110.275 179.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.408 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 22.1 m170 -71.98 -32.0 66.81 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.07 -1.019 . . . . 0.0 111.408 -179.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.441 ' HB3' ' HA ' ' A' ' 379' ' ' CYS . 42.7 m-85 -140.02 148.08 41.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.952 -1.093 . . . . 0.0 111.43 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 15.9 m -87.61 168.76 12.75 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -0.81 . . . . 0.0 110.997 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -143.7 153.33 57.91 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.15 139.08 76.33 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 177.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.4 -0.81 55.78 Favored Glycine 0 CA--C 1.553 2.446 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.757 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -116.41 158.07 24.09 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.662 1.731 . . . . 0.0 108.229 178.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 59.2 m -64.02 -28.01 69.51 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.708 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.65 2.38 56.51 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.644 -1.285 . . . . 0.0 114.061 -176.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -48.14 130.58 15.87 Favored 'General case' 0 N--CA 1.523 3.182 0 CA-C-N 120.741 1.61 . . . . 0.0 110.131 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -170.54 76.78 0.1 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.759 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -178.32 56.24 0.09 OUTLIER Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.086 -1.53 . . . . 0.0 112.55 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 99.2 t -75.21 77.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.241 -1.152 . . . . 0.0 109.498 179.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.58 94.87 2.7 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.339 -0.85 . . . . 0.0 109.975 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 5.3 mp -110.96 72.54 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.002 -1.061 . . . . 0.0 110.653 -179.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.07 67.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.259 -0.901 . . . . 0.0 108.677 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.21 52.76 2.81 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -178.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -47.5 -65.31 0.59 Allowed 'General case' 0 N--CA 1.513 2.69 0 O-C-N 121.539 -0.977 . . . . 0.0 111.321 -178.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -155.55 39.4 0.39 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.164 -0.96 . . . . 0.0 110.655 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -115.57 45.93 1.59 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.164 -0.96 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.83 66.5 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 0.0 110.005 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.08 42.39 3.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.219 -0.926 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.259 179.915 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 69.8 t . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -89.36 91.85 8.91 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 394' ' ' GLN . 38.5 mtm-85 -60.03 153.98 20.24 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.315 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.1 t -81.01 138.39 36.04 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -52.8 151.87 4.23 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 121.117 -0.989 . . . . 0.0 109.434 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.4 t -75.79 156.96 34.04 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.088 -1.008 . . . . 0.0 110.898 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 45.7 mtm -57.77 -26.17 61.51 Favored 'General case' 0 N--CA 1.516 2.83 0 O-C-N 121.197 -0.94 . . . . 0.0 110.516 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.437 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 39.9 m-85 -89.58 -19.3 25.13 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.975 -1.078 . . . . 0.0 110.926 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.58 -91.06 0.1 OUTLIER Glycine 0 N--CA 1.493 2.444 0 O-C-N 120.674 -1.266 . . . . 0.0 109.994 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.68 -3.1 24.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.401 -1.058 . . . . 0.0 112.251 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -113.8 20.02 16.18 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.557 -1.339 . . . . 0.0 112.225 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 28.7 t -50.26 139.68 14.44 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 120.588 -1.32 . . . . 0.0 110.479 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 36.8 p90 -115.89 -36.4 4.17 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.418 -0.801 . . . . 0.0 111.9 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.6 ptt180 -75.64 160.38 30.15 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.0 109.567 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.78 104.31 2.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.171 -0.955 . . . . 0.0 111.116 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -118.69 165.92 15.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 109.798 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.86 -26.16 19.22 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.246 1.129 . . . . 0.0 110.387 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.36 -20.95 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.951 -1.093 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -65.91 -38.21 88.09 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 120.678 -1.264 . . . . 0.0 110.028 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -58.48 -26.41 63.37 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.231 -0.918 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -80.68 -29.42 36.56 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.167 -0.958 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.34 -35.59 18.31 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.872 -1.143 . . . . 0.0 111.597 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 65.0 m-85 -122.24 137.64 54.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.918 -1.114 . . . . 0.0 110.576 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.24 169.18 11.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -144.06 157.73 56.79 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.651 -0.656 . . . . 0.0 109.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.74 138.53 80.13 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.55 -1.7 53.16 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.177 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.29 150.39 31.05 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.383 1.592 . . . . 0.0 108.494 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.8 t -61.06 -23.55 65.54 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.32 4.58 46.49 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 120.523 -1.361 . . . . 0.0 112.851 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 29.2 t80 . . . . . 0 N--CA 1.51 2.572 0 O-C-N 120.417 -1.427 . . . . 0.0 109.457 179.624 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.95 88.43 7.7 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.256 -0.903 . . . . 0.0 109.722 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -51.12 148.72 4.25 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.226 -0.921 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -77.62 131.85 37.98 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 t -49.98 154.27 1.15 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 120.983 -1.073 . . . . 0.0 110.469 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 3.0 t -79.55 159.28 26.93 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.8 mtm -60.05 -26.25 65.99 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.724 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -88.06 -19.75 26.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.956 -1.09 . . . . 0.0 111.166 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 65.88 -89.02 0.12 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.57 2.84 26.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.307 -1.113 . . . . 0.0 112.599 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.0 m-80 -121.21 22.83 10.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.432 -1.417 . . . . 0.0 112.596 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.5 t -58.92 80.26 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 120.792 -1.193 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 384' ' ' ASN . 42.8 p90 -53.97 -30.54 47.39 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 121.109 -0.994 . . . . 0.0 112.26 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 162.74 27.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.928 -1.107 . . . . 0.0 109.411 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -153.72 93.93 1.72 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.241 -0.912 . . . . 0.0 111.195 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -116.66 153.14 49.05 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.0 -72.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.326 1.172 . . . . 0.0 110.749 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.6 t -47.21 -29.18 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 O-C-N 120.76 -1.212 . . . . 0.0 111.118 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -66.02 -35.99 82.06 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.794 -1.191 . . . . 0.0 109.341 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.92 -24.6 67.07 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.276 -0.89 . . . . 0.0 109.876 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -26.78 35.56 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.009 -1.057 . . . . 0.0 111.068 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -91.27 -38.64 12.54 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.876 -1.14 . . . . 0.0 111.579 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 56.2 m-85 -114.23 135.33 54.17 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.958 -1.089 . . . . 0.0 110.612 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.38 165.6 13.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.23 -0.919 . . . . 0.0 110.713 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -142.14 159.57 58.22 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.699 -0.626 . . . . 0.0 109.722 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.7 Cg_endo -60.36 140.36 91.36 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.31 64.72 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.422 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.23 146.83 29.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 119.508 1.654 . . . . 0.0 108.469 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.4 m -55.55 -24.6 33.26 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.901 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.55 11.26 28.85 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.547 -1.345 . . . . 0.0 113.115 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 33.1 t80 . . . . . 0 N--CA 1.512 2.654 0 O-C-N 120.38 -1.45 . . . . 0.0 109.519 179.69 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.7 0.286 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -84.78 82.71 8.31 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.369 -0.832 . . . . 0.0 109.34 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.488 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -60.19 152.68 23.99 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.445 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.7 t -72.95 141.89 47.81 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.182 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.53 157.93 2.7 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.796 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 15.4 t -79.42 156.37 27.93 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.857 -1.152 . . . . 0.0 110.5 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.6 mtm -57.32 -27.21 62.0 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.137 -0.977 . . . . 0.0 110.84 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 88.8 m-85 -83.31 -23.93 32.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.9 -1.125 . . . . 0.0 110.782 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 68.98 -89.95 0.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 7.87 29.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.262 -1.14 . . . . 0.0 112.769 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 386' ' ' TYR . 68.5 m-80 -132.31 30.8 4.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.333 -1.479 . . . . 0.0 112.408 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 38.5 t -58.28 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 O-C-N 120.999 -1.063 . . . . 0.0 111.091 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 387' ' ' ARG . 33.2 p90 -57.03 -29.46 63.39 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.005 -1.06 . . . . 0.0 111.787 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HB3' ' CE1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -92.22 152.36 19.88 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.906 -1.121 . . . . 0.0 110.451 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -150.4 129.49 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.343 -0.848 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -129.76 168.23 17.33 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.184 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.12 -34.83 9.65 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.47 1.247 . . . . 0.0 110.489 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.95 -22.12 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.151 -0.968 . . . . 0.0 111.333 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.49 -38.33 90.73 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.657 -1.277 . . . . 0.0 109.62 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.92 -27.35 51.79 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.35 -29.42 28.27 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.059 -1.026 . . . . 0.0 110.609 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -80.59 -32.95 36.34 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.999 -1.063 . . . . 0.0 111.951 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -131.56 141.46 49.7 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.87 -1.143 . . . . 0.0 111.011 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.488 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 73.8 m -86.47 168.76 13.46 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.283 -0.886 . . . . 0.0 110.092 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -143.09 158.88 57.79 Favored Pre-proline 0 N--CA 1.484 1.232 0 O-C-N 121.672 -0.643 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 39.5 Cg_endo -62.2 139.15 76.4 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.11 56.06 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.965 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -115.91 156.97 25.23 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.594 1.697 . . . . 0.0 108.272 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.3 m -63.58 -29.34 70.61 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.281 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.12 -2.74 58.85 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.827 -1.171 . . . . 0.0 113.105 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.6 t80 . . . . . 0 N--CA 1.515 2.793 0 CA-C-N 120.514 1.506 . . . . 0.0 110.122 -179.534 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.653 0.263 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.27 94.49 9.56 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.46 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -65.43 173.38 2.68 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.449 -0.782 . . . . 0.0 110.741 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.6 t -90.12 141.44 28.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.388 -0.82 . . . . 0.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.8 t -64.68 120.55 12.64 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.07 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -34.94 148.69 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 35.1 mtm -50.09 -30.84 11.82 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.39 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -85.54 -23.17 27.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.151 -0.968 . . . . 0.0 111.301 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.03 -87.43 0.11 Allowed Glycine 0 N--CA 1.491 2.334 0 O-C-N 120.459 -1.401 . . . . 0.0 110.11 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.33 1.25 27.78 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.294 -1.121 . . . . 0.0 112.61 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -121.85 22.64 10.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.475 -1.39 . . . . 0.0 112.297 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.4 t -47.22 140.23 5.48 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 120.696 -1.253 . . . . 0.0 111.002 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.465 ' OH ' ' NH1' ' A' ' 387' ' ' ARG . 27.2 p90 -113.43 -37.61 4.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.347 -0.845 . . . . 0.0 111.68 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.465 ' NH1' ' OH ' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.98 154.16 28.41 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.77 -1.206 . . . . 0.0 109.497 179.357 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 100.0 3.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 110.52 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -115.04 167.0 10.55 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.243 -0.91 . . . . 0.0 110.101 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.69 -30.08 12.17 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.425 1.224 . . . . 0.0 110.754 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.9 -23.4 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 121.134 -0.979 . . . . 0.0 111.481 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -60.9 -39.23 88.51 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 120.599 -1.313 . . . . 0.0 109.572 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -55.54 -29.16 58.43 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.094 -1.004 . . . . 0.0 109.578 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.08 39.46 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.587 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -77.7 -33.36 53.22 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.987 -1.07 . . . . 0.0 111.481 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -132.4 137.82 47.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.896 -1.127 . . . . 0.0 110.793 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 73.8 m -79.38 168.23 19.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.278 -0.889 . . . . 0.0 109.085 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.3 159.19 59.16 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.89 137.36 62.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.602 -1.345 . . . . 0.0 108.602 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.24 -0.78 58.75 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.535 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.05 151.63 39.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.208 1.504 . . . . 0.0 108.554 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 40.4 t -58.46 -31.72 68.06 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.237 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.416 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 69.4 m-20 -73.14 -14.77 61.44 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.944 -1.098 . . . . 0.0 113.237 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.481 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 . . . . . 0 N--CA 1.52 3.065 0 CA-C-N 120.192 1.36 . . . . 0.0 111.06 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -85.93 91.96 8.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.299 -0.876 . . . . 0.0 108.997 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -63.27 151.44 40.59 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -71.57 149.61 45.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 28.5 t -62.22 161.83 10.64 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.845 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.06 165.94 23.95 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.01 -1.056 . . . . 0.0 109.466 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -36.5 74.72 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.135 -0.978 . . . . 0.0 110.089 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.79 -24.22 28.83 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.276 -0.89 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 69.42 -83.82 0.26 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.49 -1.63 32.62 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.265 -1.138 . . . . 0.0 113.188 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 386' ' ' TYR . 59.2 m-80 -122.4 14.41 10.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.318 -1.489 . . . . 0.0 113.343 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 45.8 t -45.56 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.393 0 CA-C-N 120.072 1.306 . . . . 0.0 112.668 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 384' ' ' ASN . 48.3 p90 -50.9 -34.9 30.25 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.887 -1.133 . . . . 0.0 111.895 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.431 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.4 OUTLIER -73.95 163.92 27.29 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.019 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -155.86 83.9 1.02 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.253 -0.905 . . . . 0.0 111.015 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -116.41 156.77 46.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.98 -72.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.274 1.144 . . . . 0.0 110.864 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.6 t -45.18 -30.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 120.644 -1.285 . . . . 0.0 111.226 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -65.31 -36.37 83.86 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.882 -1.136 . . . . 0.0 109.25 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -58.28 -28.13 64.69 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.171 -0.956 . . . . 0.0 109.544 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -27.07 46.74 Favored 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.677 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.25 -37.23 26.24 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.094 -1.004 . . . . 0.0 110.818 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 49.0 m-85 -129.87 144.54 51.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.05 -1.031 . . . . 0.0 110.077 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 404' ' ' TYR . 2.5 m -95.41 167.9 11.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 111.151 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -140.72 157.72 67.13 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.73 -0.607 . . . . 0.0 109.911 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.406 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 36.5 Cg_endo -60.62 137.28 72.43 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 N-CA-C 108.544 -1.368 . . . . 0.0 108.544 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.52 -0.63 58.28 Favored Glycine 0 CA--C 1.551 2.321 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.315 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.22 139.16 46.84 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.337 1.568 . . . . 0.0 108.159 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.4 t -50.07 -26.46 4.44 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.012 -1.055 . . . . 0.0 112.045 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -96.87 3.1 52.35 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.575 -1.328 . . . . 0.0 113.411 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.415 ' HA ' ' HB3' ' A' ' 397' ' ' SER . 23.4 t80 . . . . . 0 N--CA 1.518 2.938 0 CA-C-N 120.355 1.434 . . . . 0.0 110.52 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.759 0.314 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.94 93.04 9.46 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.272 -0.893 . . . . 0.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 394' ' ' GLN . 13.0 mtt180 -56.07 152.65 10.16 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.385 -0.822 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -82.28 133.33 35.24 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 63.4 p -50.76 153.75 1.62 Allowed 'General case' 0 N--CA 1.515 2.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.135 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.9 t -78.15 155.72 30.29 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.126 -0.984 . . . . 0.0 110.845 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.5 mtm -60.15 -30.01 69.03 Favored 'General case' 0 N--CA 1.51 2.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.26 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.426 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 34.5 m-85 -84.39 -24.19 29.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.048 -1.032 . . . . 0.0 110.64 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.22 -86.84 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.24 -4.5 20.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -1.143 . . . . 0.0 112.337 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -112.4 16.57 19.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.457 -1.402 . . . . 0.0 112.858 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.426 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 14.5 t -46.73 137.31 7.14 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 120.6 -1.312 . . . . 0.0 110.513 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 39.6 p90 -116.91 -39.07 3.3 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.228 -0.92 . . . . 0.0 112.517 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.4 ptp85 -51.95 161.79 0.53 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.646 -1.284 . . . . 0.0 110.82 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -128.31 55.37 1.68 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 0.0 110.492 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.21 140.55 21.25 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.276 -0.89 . . . . 0.0 109.965 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.11 -72.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.258 1.136 . . . . 0.0 110.154 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.2 t -40.12 -28.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 O-C-N 120.864 -1.147 . . . . 0.0 112.497 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.452 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 25.0 t60 -64.22 -37.83 88.87 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 120.492 -1.38 . . . . 0.0 108.568 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -59.79 -30.82 69.16 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.2 -0.938 . . . . 0.0 109.592 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.41 ' HA ' ' NE ' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -77.02 -26.48 53.78 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.186 -0.946 . . . . 0.0 110.85 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.69 -38.09 12.63 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.905 -1.122 . . . . 0.0 110.516 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 76.0 m-85 -113.11 138.51 49.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.0 110.49 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.66 168.5 11.44 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 111.224 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -141.48 159.64 59.83 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.77 -0.581 . . . . 0.0 109.66 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.51 139.92 84.44 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.48 -2.55 60.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -107.66 144.66 34.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.592 -1.534 . . . . 0.0 108.215 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 3.0 t -55.18 -24.3 26.24 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.206 -0.934 . . . . 0.0 111.801 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -105.15 7.54 33.78 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.521 -1.362 . . . . 0.0 113.066 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.523 3.184 0 CA-C-N 120.513 1.506 . . . . 0.0 110.876 -179.319 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.634 0.254 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.06 89.88 3.59 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.851 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -57.94 174.18 0.28 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.61 -0.682 . . . . 0.0 111.016 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.6 m -88.45 134.28 33.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 82.9 p -62.92 121.09 12.66 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.539 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 145.69 0.59 Allowed 'General case' 0 N--CA 1.513 2.679 0 O-C-N 121.368 -0.832 . . . . 0.0 112.173 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -46.72 -35.27 5.92 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.627 -0.67 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -78.07 -29.52 49.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.078 -1.014 . . . . 0.0 111.204 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 64.49 -86.19 0.07 OUTLIER Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.24 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -100.82 1.57 40.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.212 -1.169 . . . . 0.0 113.054 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 386' ' ' TYR . 37.3 m-80 -128.76 21.77 5.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.49 -1.381 . . . . 0.0 112.896 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.5 t -55.87 85.79 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 CA-C-N 119.915 1.234 . . . . 0.0 110.704 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 384' ' ' ASN . 28.9 p90 -61.02 -26.75 67.83 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.044 -1.035 . . . . 0.0 111.795 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 149.8 21.17 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.37 127.55 12.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 392' ' ' HIS . 1.5 m-20 -128.62 166.5 24.22 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.11 -33.79 11.15 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.322 1.17 . . . . 0.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.77 -23.28 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.263 -0.898 . . . . 0.0 111.5 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 389' ' ' ASN . 48.9 t60 -62.57 -36.34 82.38 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.689 -1.257 . . . . 0.0 110.229 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.1 -26.36 66.16 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.106 -0.996 . . . . 0.0 109.518 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.1 -30.48 55.37 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.142 -0.974 . . . . 0.0 110.447 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.433 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 0.3 OUTLIER -81.79 -35.4 29.59 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 51.1 m-85 -128.68 139.38 52.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.001 -1.062 . . . . 0.0 111.255 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.13 169.14 16.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.408 -0.808 . . . . 0.0 109.38 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -144.75 153.74 54.79 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.434 -0.791 . . . . 0.0 109.369 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.404 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.3 Cg_endo -61.14 137.46 71.46 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 N-CA-C 108.405 -1.421 . . . . 0.0 108.405 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.34 -1.16 53.83 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.748 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.92 171.69 7.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.649 1.725 . . . . 0.0 108.546 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -24.2 53.11 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.066 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -99.0 1.78 45.74 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.637 -1.289 . . . . 0.0 113.605 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 24.5 t80 . . . . . 0 N--CA 1.522 3.164 0 CA-C-N 120.362 1.437 . . . . 0.0 110.89 -179.552 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -87.05 91.03 8.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.29 151.58 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.372 -0.83 . . . . 0.0 110.25 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.3 t -81.13 136.7 35.93 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.784 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -51.72 149.04 4.92 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 121.155 -0.966 . . . . 0.0 109.964 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.4 t -71.13 163.42 27.64 Favored 'General case' 0 N--CA 1.512 2.627 0 O-C-N 120.944 -1.098 . . . . 0.0 110.495 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 63.7 mtm -62.91 -31.08 72.07 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.227 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -84.41 -23.48 30.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.201 -0.937 . . . . 0.0 110.45 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 70.33 -86.06 0.33 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.55 -4.26 18.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -1.136 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -111.53 16.46 20.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.486 -1.384 . . . . 0.0 112.874 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -47.62 141.0 5.61 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 120.086 1.312 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.2 p90 -121.72 -39.94 2.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 112.285 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.426 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -59.24 149.45 28.49 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.619 -1.301 . . . . 0.0 109.512 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.6 74.73 1.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.159 -0.963 . . . . 0.0 111.111 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.41 148.25 38.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.91 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.34 1.179 . . . . 0.0 110.764 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -42.25 -27.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 O-C-N 120.7 -1.25 . . . . 0.0 112.422 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -66.45 -35.63 80.76 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.456 -1.403 . . . . 0.0 109.238 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.97 -28.82 70.35 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -26.63 57.0 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.224 -0.922 . . . . 0.0 111.297 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.08 -35.52 13.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.852 -1.155 . . . . 0.0 111.238 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -117.55 144.99 44.57 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.064 -1.022 . . . . 0.0 110.521 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.74 168.77 10.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.956 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -140.5 158.3 66.37 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.702 -0.624 . . . . 0.0 110.538 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.42 139.23 75.61 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 107.99 -1.581 . . . . 0.0 107.99 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.73 -3.13 60.73 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.878 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.3 138.1 46.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.627 -1.513 . . . . 0.0 108.466 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -25.67 0.94 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.201 -0.937 . . . . 0.0 113.267 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -106.06 12.96 29.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.512 -1.368 . . . . 0.0 113.192 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.517 2.91 0 O-C-N 120.457 -1.402 . . . . 0.0 109.951 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.74 0.305 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -84.39 82.89 8.19 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -56.56 152.35 12.02 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.186 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -72.34 137.27 46.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 p -49.29 160.2 0.25 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.6 t -83.32 157.76 22.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.201 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.7 ptp -61.59 -36.38 80.51 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.011 -1.055 . . . . 0.0 110.181 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.416 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 16.0 m-85 -77.81 -32.99 52.63 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.171 -0.956 . . . . 0.0 110.29 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.95 -89.15 0.87 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.52 -4.42 19.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -1.056 . . . . 0.0 112.244 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.77 16.65 19.5 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.353 -1.467 . . . . 0.0 112.584 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.416 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 7.3 t -45.86 140.09 3.82 Favored 'General case' 0 N--CA 1.524 3.247 0 O-C-N 120.633 -1.292 . . . . 0.0 110.988 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.8 p90 -116.93 -39.05 3.3 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.381 -0.824 . . . . 0.0 112.279 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.45 ' HD2' ' CG ' ' A' ' 392' ' ' HIS . 6.8 ptp85 -55.19 158.75 2.86 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.651 -1.281 . . . . 0.0 110.564 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -128.12 62.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.248 -0.908 . . . . 0.0 110.517 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.35 145.16 33.14 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.23 -59.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.234 1.123 . . . . 0.0 110.901 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 12.2 p -43.61 -33.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 O-C-N 121.084 -1.01 . . . . 0.0 111.708 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.45 ' CG ' ' HD2' ' A' ' 387' ' ' ARG . 34.4 t60 -66.54 -36.33 82.42 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.91 -29.68 70.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.069 -1.019 . . . . 0.0 109.257 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.432 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 1.3 mp0 -77.23 -29.22 54.0 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.233 -0.917 . . . . 0.0 110.749 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.09 -32.99 21.07 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.19 -0.944 . . . . 0.0 111.377 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -124.11 143.41 50.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.791 -1.193 . . . . 0.0 110.592 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 404' ' ' TYR . 0.0 OUTLIER -89.19 170.03 10.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -0.901 . . . . 0.0 111.354 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -143.02 153.06 59.94 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.04 140.57 79.52 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 N-CA-C 108.018 -1.57 . . . . 0.0 108.018 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.92 -0.16 62.43 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.454 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.0 144.39 41.42 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.643 1.722 . . . . 0.0 108.071 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 61.4 m -52.09 -26.27 10.68 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.98 -1.075 . . . . 0.0 112.4 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -103.36 10.45 37.43 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.504 -1.372 . . . . 0.0 113.315 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 397' ' ' SER . 21.5 t80 . . . . . 0 N--CA 1.515 2.822 0 O-C-N 120.398 -1.439 . . . . 0.0 110.367 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 64.8 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 66.9 9.68 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.895 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -58.29 156.43 10.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.759 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.3 t -74.91 145.75 42.4 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.654 -0.818 . . . . 0.0 108.879 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.67 169.06 0.07 Allowed 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.323 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 54.1 t -85.44 158.79 20.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.155 -0.966 . . . . 0.0 108.44 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.0 mtm -63.07 -33.59 75.78 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 120.758 -1.214 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -94.7 -20.11 19.82 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.983 -1.073 . . . . 0.0 111.168 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 58.37 -95.59 0.06 OUTLIER Glycine 0 N--CA 1.494 2.536 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -86.89 -21.16 26.5 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.246 -1.149 . . . . 0.0 111.632 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -94.23 6.81 47.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.743 -1.223 . . . . 0.0 112.558 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.3 t -43.0 134.39 3.43 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 120.655 -1.278 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 27.4 p90 -119.95 -35.66 3.44 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.334 -0.854 . . . . 0.0 112.477 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.473 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 4.0 ptm180 -48.72 163.82 0.07 Allowed 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.68 -1.262 . . . . 0.0 110.968 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.9 pttm -129.81 56.83 1.7 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.196 -0.94 . . . . 0.0 110.522 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -109.41 144.16 29.24 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.26 -0.9 . . . . 0.0 110.51 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -73.94 -73.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 O-C-N 123.318 1.167 . . . . 0.0 110.355 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 72.2 t -41.24 -27.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 O-C-N 120.797 -1.19 . . . . 0.0 112.601 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -63.65 -37.43 87.32 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.375 -1.453 . . . . 0.0 108.533 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -60.59 -31.58 70.72 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.084 -1.01 . . . . 0.0 109.527 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.21 -27.21 38.84 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.102 -0.999 . . . . 0.0 110.987 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -84.8 -29.87 25.04 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.843 -1.161 . . . . 0.0 111.803 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -124.41 137.66 54.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.799 -1.188 . . . . 0.0 111.183 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.77 153.77 32.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.296 -0.878 . . . . 0.0 111.516 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -134.29 157.32 77.78 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.51 136.67 64.67 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 N-CA-C 108.281 -1.469 . . . . 0.0 108.281 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.32 1.99 56.76 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.032 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.52 141.7 45.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.211 1.506 . . . . 0.0 108.71 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 58.2 m -52.78 -25.94 12.81 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.214 -0.928 . . . . 0.0 111.83 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -98.12 -3.45 37.79 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.68 -1.262 . . . . 0.0 113.051 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 26.2 t80 . . . . . 0 N--CA 1.517 2.91 0 CA-C-N 120.202 1.365 . . . . 0.0 111.491 -179.141 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.742 0.306 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -91.35 94.2 9.4 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.327 -0.858 . . . . 0.0 109.452 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.45 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -70.81 174.21 6.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.606 -0.684 . . . . 0.0 110.433 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -94.68 136.04 35.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.37 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.9 t -58.05 122.78 13.87 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.371 -0.83 . . . . 0.0 109.744 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -42.37 148.61 0.2 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -49.98 -29.13 7.92 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.546 -0.721 . . . . 0.0 110.386 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 9.3 m-85 -84.63 -23.77 29.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.027 -1.046 . . . . 0.0 111.444 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.05 -88.58 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 O-C-N 120.375 -1.453 . . . . 0.0 110.635 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.5 3.76 40.51 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.177 -1.19 . . . . 0.0 113.259 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 386' ' ' TYR . 16.8 m-80 -130.93 26.97 4.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.424 -1.422 . . . . 0.0 112.371 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.413 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 52.9 t -57.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.625 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 384' ' ' ASN . 34.9 p90 -63.59 -27.92 69.57 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 121.135 -0.978 . . . . 0.0 112.362 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 162.63 28.95 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 120.72 -1.237 . . . . 0.0 109.086 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.94 91.77 1.14 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.073 -1.017 . . . . 0.0 111.461 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.57 166.83 10.14 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.0 110.045 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.83 -32.28 5.79 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.404 1.213 . . . . 0.0 110.79 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.52 -22.6 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.149 -0.969 . . . . 0.0 111.029 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.56 -37.01 82.24 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.803 -1.186 . . . . 0.0 109.469 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -56.38 -27.55 56.52 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.095 -1.003 . . . . 0.0 109.53 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.72 -30.49 26.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.106 -0.996 . . . . 0.0 110.562 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.0 m170 -76.2 -32.85 59.2 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.908 -1.12 . . . . 0.0 111.785 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 56.0 m-85 -132.57 138.49 47.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 111.077 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 28.2 m -78.83 165.42 23.56 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -143.04 160.87 51.14 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.249 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.26 137.52 71.29 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.09 -1.87 61.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.642 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.76 149.6 36.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.449 1.624 . . . . 0.0 108.439 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 79.2 p -56.85 -32.07 65.41 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.062 -1.024 . . . . 0.0 111.152 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -80.18 -8.08 59.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.943 -1.098 . . . . 0.0 113.589 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.457 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 8.0 t80 . . . . . 0 N--CA 1.526 3.368 0 CA-C-N 120.524 1.511 . . . . 0.0 111.263 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 87.62 7.0 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.185 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -61.92 151.02 35.95 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.258 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.0 t -71.66 141.85 49.9 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.503 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.27 157.51 2.68 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.05 154.41 25.64 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.816 -1.178 . . . . 0.0 110.874 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' MET . . . . . 0.415 ' CE ' ' CE2' ' A' ' 381' ' ' TYR . 4.0 ptt? -54.62 -28.84 49.6 Favored 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.437 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.445 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 72.0 m-85 -82.64 -29.03 30.33 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.958 -1.089 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 72.19 -93.84 0.61 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -103.41 -0.23 30.32 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -1.182 . . . . 0.0 112.474 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.9 m-80 -121.38 24.26 10.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.347 -1.471 . . . . 0.0 112.504 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 49.2 t -59.38 81.83 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.95 0 O-C-N 120.783 -1.198 . . . . 0.0 110.589 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 384' ' ' ASN . 29.6 p90 -61.92 -25.42 67.56 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.169 -0.957 . . . . 0.0 111.738 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -87.5 157.89 19.07 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.798 -1.188 . . . . 0.0 110.134 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.73 124.04 5.32 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.217 -0.927 . . . . 0.0 110.91 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 392' ' ' HIS . 6.8 m-20 -126.06 166.93 18.57 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.284 -0.885 . . . . 0.0 109.69 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.09 -33.48 11.64 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.418 1.22 . . . . 0.0 110.263 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.26 -24.67 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.972 . . . . 0.0 111.416 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.404 ' CB ' ' HB2' ' A' ' 389' ' ' ASN . 47.9 t60 -60.48 -38.98 86.0 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.577 -1.327 . . . . 0.0 110.006 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -56.5 -28.6 60.25 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.408 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -79.96 -32.23 39.92 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.577 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -78.15 -35.17 49.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.219 -0.925 . . . . 0.0 111.486 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.25 144.34 51.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.952 -1.093 . . . . 0.0 110.726 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 10.0 m -91.42 171.47 9.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -143.48 159.17 55.7 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.11 139.3 83.3 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.73 -1.03 56.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.3 153.85 30.19 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.267 1.533 . . . . 0.0 107.658 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -29.06 70.41 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.135 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -85.91 -1.8 57.65 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.7 t80 . . . . . 0 N--CA 1.527 3.4 0 CA-C-N 120.713 1.597 . . . . 0.0 111.102 -178.596 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.798 0.332 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -79.87 94.49 5.84 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.455 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.6 OUTLIER -68.52 153.77 43.13 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.605 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.1 t -79.05 142.8 36.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.694 -0.629 . . . . 0.0 109.419 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.3 p -56.33 155.25 7.14 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.33 156.34 28.06 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.05 -1.031 . . . . 0.0 110.265 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -58.54 -35.77 72.83 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.16 -0.963 . . . . 0.0 110.635 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -71.89 -39.11 69.81 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.083 -1.01 . . . . 0.0 110.114 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.51 -86.92 1.31 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.07 -0.73 28.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.144 -1.209 . . . . 0.0 112.33 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.27 13.57 9.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.556 -1.34 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.8 t -49.39 152.57 1.25 Allowed 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.462 -1.398 . . . . 0.0 111.3 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 18.3 p90 -101.93 -29.62 11.71 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.446 -0.784 . . . . 0.0 111.525 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER 23.61 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.16 -2.88 25.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.983 -1.073 . . . . 0.0 111.462 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -130.35 157.57 76.94 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.582 -1.324 . . . . 0.0 109.267 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.23 -44.3 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.312 1.164 . . . . 0.0 110.061 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.4 t -47.73 -31.51 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 O-C-N 121.131 -0.981 . . . . 0.0 110.591 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -63.65 -31.97 73.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.003 -1.061 . . . . 0.0 109.428 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.429 ' CZ ' ' NH1' ' A' ' 387' ' ' ARG . 27.9 m-85 -63.19 -24.37 67.85 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.009 -1.057 . . . . 0.0 109.269 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.89 -28.94 32.63 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.663 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.45 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.8 m170 -83.38 -32.58 26.11 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 121.032 -1.043 . . . . 0.0 111.843 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 73.5 m-85 -130.97 143.54 50.8 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.895 -1.128 . . . . 0.0 110.705 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 68.1 m -86.46 163.65 17.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.402 -0.811 . . . . 0.0 110.993 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -139.85 159.43 64.8 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.704 -0.623 . . . . 0.0 109.868 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.07 136.44 60.82 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 N-CA-C 108.248 -1.482 . . . . 0.0 108.248 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.24 -3.39 51.11 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.27 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -113.42 141.06 47.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.56 -1.553 . . . . 0.0 108.248 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 56.0 m -51.78 -25.96 8.68 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.067 -1.021 . . . . 0.0 112.2 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -93.49 0.21 56.63 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.506 -1.371 . . . . 0.0 113.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 17.7 t80 . . . . . 0 N--CA 1.522 3.163 0 CA-C-N 120.562 1.528 . . . . 0.0 111.09 -179.195 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -80.27 81.68 6.48 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.172 -0.955 . . . . 0.0 109.979 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.56 16.52 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.308 -0.87 . . . . 0.0 110.726 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.0 m -67.09 130.21 42.39 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.14 162.33 0.31 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.16 -0.962 . . . . 0.0 110.523 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.48 156.73 27.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.09 -1.006 . . . . 0.0 109.839 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -62.75 -31.04 71.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.987 -1.071 . . . . 0.0 110.725 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -80.09 -33.07 39.08 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.021 -1.05 . . . . 0.0 110.228 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 79.46 -89.34 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.45 -3.46 18.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.323 -1.104 . . . . 0.0 112.338 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.35 17.15 18.72 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.505 -1.372 . . . . 0.0 112.653 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.7 t -45.32 137.27 4.8 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 120.664 -1.273 . . . . 0.0 110.853 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.7 p90 -117.46 -40.98 3.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.926 . . . . 0.0 111.875 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.464 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -55.99 156.66 5.13 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.731 -1.231 . . . . 0.0 110.168 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.07 68.19 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.743 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.78 143.43 28.62 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 109.628 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.03 -70.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.435 1.229 . . . . 0.0 110.594 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 9.9 p -38.18 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 O-C-N 121.221 -0.925 . . . . 0.0 112.94 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -69.19 -42.07 76.3 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.918 -1.114 . . . . 0.0 109.144 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -55.93 -36.72 68.04 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.247 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -77.47 -26.39 51.33 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.452 -0.78 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.66 -34.57 19.72 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.856 -1.152 . . . . 0.0 110.673 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -117.85 146.97 43.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.925 -1.109 . . . . 0.0 110.449 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.11 162.87 13.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.239 -0.913 . . . . 0.0 110.961 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -135.08 157.62 76.56 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.728 -0.607 . . . . 0.0 110.507 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.2 141.48 88.28 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 N-CA-C 107.78 -1.661 . . . . 0.0 107.78 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.19 65.28 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.5 140.07 43.72 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.727 -1.455 . . . . 0.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.9 t -50.58 -24.38 3.21 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.045 -1.034 . . . . 0.0 112.858 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.45 15.63 23.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.435 -1.416 . . . . 0.0 113.467 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 20.2 t80 . . . . . 0 N--CA 1.524 3.257 0 CA-C-N 120.363 1.438 . . . . 0.0 110.767 -179.852 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.2 t . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.774 0.321 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -86.63 93.97 9.35 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.371 -0.83 . . . . 0.0 109.437 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 155.82 10.77 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.611 -0.681 . . . . 0.0 110.467 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -83.03 138.75 33.61 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 157.79 0.73 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.13 -0.981 . . . . 0.0 110.602 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.8 t -77.98 158.01 29.46 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -62.24 -30.94 71.46 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 120.878 -1.139 . . . . 0.0 110.473 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.401 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 14.2 m-85 -81.04 -31.84 34.34 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.089 -1.007 . . . . 0.0 110.412 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 77.35 -89.05 1.01 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 -1.75 21.09 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.193 -1.18 . . . . 0.0 112.138 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -115.95 18.2 15.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.497 -1.377 . . . . 0.0 112.69 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.401 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.4 t -46.3 137.63 6.16 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 120.612 -1.305 . . . . 0.0 110.517 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.7 p90 -115.14 -40.44 3.47 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.295 -0.878 . . . . 0.0 112.011 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -60.94 149.8 35.36 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.778 -1.202 . . . . 0.0 109.551 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.23 69.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.271 -0.893 . . . . 0.0 110.613 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.11 151.76 42.71 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.24 -68.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.52 1.274 . . . . 0.0 111.027 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 8.2 p -40.52 -32.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 O-C-N 121.155 -0.965 . . . . 0.0 112.782 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.04 -39.07 83.14 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.959 -1.088 . . . . 0.0 109.445 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.55 -32.1 71.18 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -27.01 59.45 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.391 -0.818 . . . . 0.0 111.427 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -93.45 -34.51 13.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.836 -1.165 . . . . 0.0 111.162 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.23 140.19 48.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.993 -1.067 . . . . 0.0 110.807 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.8 t -91.68 165.15 13.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.391 -0.818 . . . . 0.0 110.637 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.91 157.94 72.3 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.802 -0.561 . . . . 0.0 109.764 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.53 140.55 82.21 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.28 -1.52 62.58 Favored Glycine 0 CA--C 1.552 2.38 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.935 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -110.64 142.5 42.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.442 -1.622 . . . . 0.0 108.403 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.3 t -50.88 -26.78 6.27 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.201 -0.937 . . . . 0.0 112.472 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -102.24 8.94 40.35 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.505 -1.372 . . . . 0.0 113.157 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.3 t80 . . . . . 0 N--CA 1.52 3.07 0 CA-C-N 120.305 1.412 . . . . 0.0 110.969 -179.315 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.81 0.338 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -93.01 96.37 10.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.31 -0.869 . . . . 0.0 109.246 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.452 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 3.1 mtt85 -54.61 -179.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.422 -0.799 . . . . 0.0 111.029 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -107.15 128.64 54.58 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' SER . . . . . 0.439 ' HB2' ' CE1' ' A' ' 404' ' ' TYR . 9.5 p -52.5 117.26 2.74 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.241 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.2 t -36.37 151.64 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 381' ' ' TYR . 10.8 ptp -51.12 -30.02 15.09 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.403 ' N ' ' HG3' ' A' ' 380' ' ' MET . 53.6 m-85 -84.96 -23.7 28.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.152 -0.967 . . . . 0.0 111.318 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.13 -82.95 0.12 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 120.361 -1.462 . . . . 0.0 109.935 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.01 -0.11 21.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.297 -1.119 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -119.5 19.69 12.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.398 -1.439 . . . . 0.0 113.153 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.1 t -47.66 143.25 3.95 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 120.171 1.35 . . . . 0.0 110.552 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.6 p90 -120.14 -39.38 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.324 -0.86 . . . . 0.0 112.222 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.44 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.7 ptp85 -67.66 145.27 54.97 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.719 -1.238 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 73.13 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.977 . . . . 0.0 111.384 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.55 150.8 40.58 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.945 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.31 -73.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.305 1.16 . . . . 0.0 110.477 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.6 t -41.84 -29.5 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 120.885 -1.134 . . . . 0.0 112.082 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.418 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 30.0 t60 -63.19 -35.09 79.16 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.604 -1.31 . . . . 0.0 109.307 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.01 -26.75 67.68 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -31.57 57.47 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.913 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -82.75 -40.48 20.47 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.872 -1.142 . . . . 0.0 110.397 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -110.02 165.36 11.79 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.294 -0.879 . . . . 0.0 109.685 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -112.38 169.16 9.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.473 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -143.35 160.21 52.46 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.035 . . . . 0.0 110.304 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.05 137.71 68.57 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 108.778 -1.278 . . . . 0.0 108.778 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.33 62.54 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.364 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.59 139.35 45.93 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.411 1.605 . . . . 0.0 108.427 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 51.1 m -49.18 -26.13 2.66 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.188 -0.945 . . . . 0.0 112.679 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -97.8 2.58 49.59 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.394 -1.441 . . . . 0.0 114.433 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 378' ' ' SER . 4.6 t80 . . . . . 0 N--CA 1.533 3.688 0 CA-C-N 120.683 1.583 . . . . 0.0 111.029 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.808 0.337 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.74 89.91 6.82 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.779 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.419 ' NE ' ' O ' ' A' ' 394' ' ' GLN . 2.5 mmt-85 -62.14 151.85 34.62 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.319 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.3 t -74.0 140.91 45.8 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.9 p -57.18 157.29 6.29 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.316 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -73.15 161.57 30.44 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.044 -1.035 . . . . 0.0 110.232 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -31.83 71.68 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -85.08 -21.53 29.3 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.105 -0.997 . . . . 0.0 110.564 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.4 -86.61 0.11 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.48 -8.7 18.91 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -1.174 . . . . 0.0 112.243 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -106.63 12.96 28.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.48 -1.388 . . . . 0.0 112.975 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.1 t -47.0 142.28 3.63 Favored 'General case' 0 N--CA 1.524 3.235 0 O-C-N 120.534 -1.354 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.4 p90 -121.13 -37.05 3.0 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.275 -0.891 . . . . 0.0 112.67 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.7 ptm180 -55.11 157.13 3.55 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.742 -1.224 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -129.01 64.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.0 110.749 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -111.74 148.31 38.66 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.076 -1.015 . . . . 0.0 109.93 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.66 -69.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.444 1.234 . . . . 0.0 110.493 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.8 t -43.01 -29.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.177 0 O-C-N 120.819 -1.175 . . . . 0.0 111.752 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.24 -36.26 83.6 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.507 -1.371 . . . . 0.0 108.903 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -57.89 -30.03 65.53 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.071 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.419 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -82.42 -28.65 31.24 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.179 -0.951 . . . . 0.0 110.444 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -75.44 -34.26 60.96 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.969 -1.082 . . . . 0.0 110.873 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -134.65 149.18 50.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.004 -1.06 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.0 t -93.85 164.91 12.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.772 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.15 159.16 70.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.35 138.94 74.35 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.54 -2.08 60.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -176.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -110.07 138.9 45.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 119.14 1.47 . . . . 0.0 107.657 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.3 -23.24 5.47 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.13 -0.981 . . . . 0.0 112.538 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -103.6 11.97 35.5 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.294 -1.504 . . . . 0.0 113.562 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.523 3.181 0 CA-C-N 120.546 1.521 . . . . 0.0 110.925 -179.529 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.57 0.224 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.25 88.64 7.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.319 -0.863 . . . . 0.0 109.271 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.483 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 3.3 mmt-85 -61.53 152.18 30.98 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.294 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -73.38 143.64 46.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.5 t -57.35 168.7 0.72 Allowed 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.616 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.9 t -83.23 158.12 22.41 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.075 -1.016 . . . . 0.0 109.832 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 52.8 mtm -56.26 -31.23 63.38 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 121.007 -1.058 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.54 -21.89 35.19 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.081 -1.012 . . . . 0.0 111.052 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.36 -91.95 0.17 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.88 0.66 28.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.448 -1.031 . . . . 0.0 112.271 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -117.49 22.13 12.6 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.471 -1.393 . . . . 0.0 112.299 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 13.2 t -52.31 147.55 7.74 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 120.446 -1.409 . . . . 0.0 109.819 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 19.4 p90 -125.96 -35.63 2.45 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.328 -0.858 . . . . 0.0 112.993 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.474 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.0 ptp85 -61.99 162.09 9.74 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.549 -1.344 . . . . 0.0 109.819 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 66.9 1.39 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.199 -0.938 . . . . 0.0 110.649 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -107.53 145.95 32.34 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.272 -0.892 . . . . 0.0 110.078 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.58 -69.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.342 1.18 . . . . 0.0 110.38 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 91.5 t -44.76 -30.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.126 0 O-C-N 120.854 -1.154 . . . . 0.0 110.972 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.434 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 45.4 t60 -63.73 -36.0 82.43 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.863 -1.148 . . . . 0.0 109.064 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 -27.54 65.19 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.005 -1.059 . . . . 0.0 109.272 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.05 -31.25 25.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.106 -0.996 . . . . 0.0 110.176 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.421 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 25.7 m170 -73.24 -29.05 62.5 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.978 -1.076 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 59.5 m-85 -140.29 145.86 37.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 110.856 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.483 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 45.7 m -90.1 163.13 14.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.473 -0.767 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -139.14 160.89 60.57 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.692 -0.63 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.03 140.12 77.13 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.003 -1.576 . . . . 0.0 108.003 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.8 60.56 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.256 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.27 143.28 45.12 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.367 1.584 . . . . 0.0 107.813 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.9 m -52.81 -30.4 33.06 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.085 -1.009 . . . . 0.0 110.992 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.29 -1.65 57.69 Favored 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.532 3.657 0 CA-C-N 120.861 1.664 . . . . 0.0 110.903 -179.511 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -68.48 82.99 0.26 Allowed 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.473 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt-85 -61.91 152.24 32.53 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.33 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.4 t -71.84 141.52 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.983 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -54.84 161.03 1.71 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.153 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 25.3 t -81.28 155.99 25.78 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.893 -1.129 . . . . 0.0 110.757 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.9 mtm -56.02 -27.53 53.42 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.24 -0.913 . . . . 0.0 110.932 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 87.8 m-85 -84.52 -21.8 30.4 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.05 -1.032 . . . . 0.0 110.723 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.61 -93.55 0.21 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.08 0.18 23.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.291 -1.123 . . . . 0.0 112.182 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -116.65 23.41 12.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.475 -1.391 . . . . 0.0 111.837 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 14.0 t -52.63 144.22 14.31 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 120.533 -1.355 . . . . 0.0 109.962 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 16.3 p90 -122.9 -36.44 2.88 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.603 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.482 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.08 161.52 26.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.592 -1.318 . . . . 0.0 109.265 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -150.41 111.16 4.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.0 111.223 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -120.06 166.87 13.83 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 109.775 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.36 -28.89 14.49 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.312 1.164 . . . . 0.0 110.395 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.79 -22.94 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.014 -1.054 . . . . 0.0 111.676 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -61.75 -38.04 86.52 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.603 -1.31 . . . . 0.0 109.644 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.83 -28.59 61.77 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.149 -0.97 . . . . 0.0 109.43 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.93 -32.43 25.09 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.404 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 15.8 m170 -71.62 -31.04 66.46 Favored 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.021 -1.049 . . . . 0.0 111.64 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 36.9 m-85 -140.71 148.53 40.9 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.802 -1.186 . . . . 0.0 110.857 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 376' ' ' ARG . 18.3 m -86.81 169.52 12.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.444 -0.785 . . . . 0.0 110.657 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.37 157.84 58.87 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.592 -0.693 . . . . 0.0 109.782 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 138.96 73.4 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.114 -1.533 . . . . 0.0 108.114 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.04 54.76 Favored Glycine 0 CA--C 1.553 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.042 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.14 147.62 40.02 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.733 -1.451 . . . . 0.0 107.902 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 48.0 t -58.71 -27.05 64.51 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.725 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.62 -0.56 57.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.681 -1.262 . . . . 0.0 113.918 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.3 t80 . . . . . 0 N--CA 1.521 3.095 0 CA-C-N 120.81 1.641 . . . . 0.0 110.789 -179.127 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -89.53 96.02 10.52 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.251 -0.905 . . . . 0.0 109.427 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.89 150.57 39.12 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.344 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.2 t -76.58 -179.66 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.183 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 404' ' ' TYR . 0.1 OUTLIER -97.16 126.81 42.59 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.004 -1.06 . . . . 0.0 110.82 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -45.07 145.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.614 -0.679 . . . . 0.0 112.333 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 11.3 ptp -49.4 -28.08 4.76 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.469 -0.769 . . . . 0.0 111.031 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -86.81 -22.47 25.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.942 -1.099 . . . . 0.0 111.214 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.65 -84.87 0.04 OUTLIER Glycine 0 N--CA 1.497 2.703 0 O-C-N 120.495 -1.378 . . . . 0.0 110.784 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.11 -9.74 17.6 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.202 -1.175 . . . . 0.0 112.569 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -112.84 18.69 17.99 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.521 -1.362 . . . . 0.0 113.22 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 30.9 t -47.89 139.13 8.04 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.055 1.298 . . . . 0.0 110.239 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 37.5 p90 -116.22 -40.68 3.23 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.461 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -71.35 162.75 28.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.904 -1.122 . . . . 0.0 109.154 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -155.99 104.07 2.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.177 -0.952 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.49 165.3 14.7 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 -24.74 18.58 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.437 1.23 . . . . 0.0 110.588 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.22 -21.73 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.039 -1.038 . . . . 0.0 111.756 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.442 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 45.5 t60 -63.84 -38.19 90.18 Favored 'General case' 0 N--CA 1.512 2.663 0 O-C-N 120.517 -1.364 . . . . 0.0 110.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -58.1 -30.61 66.41 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -32.14 44.93 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.876 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -77.82 -37.76 47.88 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.119 -0.988 . . . . 0.0 110.589 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.9 m-85 -125.18 150.52 46.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.1 t -94.7 174.48 7.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.161 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -144.33 156.49 57.36 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.764 . . . . 0.0 109.278 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.14 138.9 80.88 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.61 -2.54 55.95 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.791 -1.195 . . . . 0.0 110.874 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.14 146.87 39.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.699 1.75 . . . . 0.0 108.415 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.8 t -54.48 -28.45 44.82 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.124 -0.985 . . . . 0.0 111.645 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -92.12 1.44 57.21 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 0.0 113.058 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 378' ' ' SER . 23.3 t80 . . . . . 0 N--CA 1.514 2.76 0 CA-C-N 120.391 1.451 . . . . 0.0 110.253 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.889 0.376 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -83.29 99.22 9.86 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.452 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -72.64 152.99 41.45 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.803 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -73.43 141.8 46.91 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.2 t -58.18 158.49 6.97 Favored 'General case' 0 N--CA 1.511 2.606 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.503 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.83 151.46 35.88 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.911 -1.118 . . . . 0.0 110.577 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -52.91 -28.59 24.09 Favored 'General case' 0 N--CA 1.514 2.76 0 O-C-N 121.226 -0.921 . . . . 0.0 111.118 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.412 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 8.8 m-85 -77.34 -31.95 54.84 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.977 -1.077 . . . . 0.0 110.169 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.94 -90.91 0.89 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.34 4.98 29.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.331 -1.099 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -128.34 25.78 5.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.556 -1.34 . . . . 0.0 112.191 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.412 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 34.4 t -50.66 143.77 9.05 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 120.668 -1.27 . . . . 0.0 110.165 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 13.3 p90 -116.4 -36.01 4.12 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.284 -0.885 . . . . 0.0 112.001 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -73.52 149.54 42.16 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.831 -1.168 . . . . 0.0 109.694 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.5 100.89 3.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.062 -1.024 . . . . 0.0 111.171 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.21 164.57 21.84 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 109.848 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.41 -29.93 16.05 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.324 1.171 . . . . 0.0 110.447 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.14 -23.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.12 -0.988 . . . . 0.0 111.304 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -61.7 -37.45 84.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.764 -1.21 . . . . 0.0 109.637 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -57.73 -26.06 61.27 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.47 -30.3 30.05 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 11.6 m170 -79.32 -34.22 42.49 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.159 -0.963 . . . . 0.0 111.336 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 65.6 m-85 -133.26 142.43 48.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.224 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 56.0 m -85.71 169.27 13.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.401 -0.812 . . . . 0.0 110.167 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -144.39 158.75 53.77 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.6 -0.687 . . . . 0.0 109.923 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.09 137.43 66.63 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 N-CA-C 108.341 -1.446 . . . . 0.0 108.341 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.12 -1.94 56.45 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.698 -178.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.24 150.75 40.89 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.651 -1.499 . . . . 0.0 107.564 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 81.3 p -60.32 -32.07 70.88 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.456 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.8 -11.44 60.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.028 -1.045 . . . . 0.0 112.634 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.517 2.886 0 CA-C-N 120.288 1.404 . . . . 0.0 110.214 -179.448 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.848 0.356 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -88.37 94.53 9.88 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -67.75 150.25 48.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.456 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.7 t -78.92 172.12 14.23 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.771 -179.531 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 p -76.99 157.53 31.15 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.076 -1.015 . . . . 0.0 109.272 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.42 160.74 29.91 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.429 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.5 ptp -61.45 -35.31 77.26 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.901 -1.125 . . . . 0.0 109.944 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.409 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 15.4 m-85 -77.14 -33.48 56.69 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.484 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 76.13 -87.64 0.89 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.75 -3.19 20.74 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.261 -1.141 . . . . 0.0 112.469 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -115.44 17.33 16.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.415 -1.428 . . . . 0.0 112.809 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.409 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 8.6 t -45.14 139.69 3.19 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-N 120.059 1.3 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 33.5 p90 -117.22 -39.39 3.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.313 -0.867 . . . . 0.0 112.363 -178.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.446 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.4 ptp85 -57.28 156.58 7.36 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 120.632 -1.293 . . . . 0.0 110.165 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.93 65.56 1.2 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 110.871 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -109.95 144.15 29.41 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.113 -0.992 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.47 -71.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.358 1.189 . . . . 0.0 110.529 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 71.8 t -41.48 -28.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 O-C-N 120.885 -1.134 . . . . 0.0 112.318 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.435 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 27.2 t60 -65.23 -37.6 87.75 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 120.496 -1.378 . . . . 0.0 108.66 177.378 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -57.37 -31.04 65.38 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.068 -1.02 . . . . 0.0 109.35 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 -26.99 39.95 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.211 -0.931 . . . . 0.0 110.737 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -81.85 -37.88 26.29 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.002 -1.062 . . . . 0.0 110.185 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.5 m-85 -125.15 145.44 49.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 1.8 t -94.22 170.35 9.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.34 158.77 65.75 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.664 -0.647 . . . . 0.0 109.983 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.61 139.74 82.89 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 108.153 -1.518 . . . . 0.0 108.153 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.41 -1.63 60.47 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.807 -176.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -112.62 141.5 46.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.619 -1.518 . . . . 0.0 107.983 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.0 m -51.6 -28.53 14.41 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.149 -0.969 . . . . 0.0 111.752 -178.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.682 -1.261 . . . . 0.0 113.355 -178.386 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 26.0 t80 . . . . . 0 N--CA 1.522 3.128 0 CA-C-N 120.466 1.485 . . . . 0.0 111.121 -178.989 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -95.49 100.51 12.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.494 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.7 OUTLIER -80.89 161.75 24.24 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.777 -0.577 . . . . 0.0 111.334 -179.219 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.4 t -76.62 174.17 10.71 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.9 t -94.7 129.99 41.37 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.684 -1.26 . . . . 0.0 111.78 -178.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 7.8 t -40.11 148.55 0.08 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.895 -0.503 . . . . 0.0 112.036 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 6.1 ptp -47.64 -37.83 13.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.622 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.437 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 27.9 m-85 -73.58 -35.21 65.39 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.57 -86.62 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.047 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.24 7.06 43.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.26 -1.141 . . . . 0.0 112.847 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -134.87 25.09 3.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.343 -1.473 . . . . 0.0 112.577 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.2 t -49.63 151.72 1.6 Allowed 'General case' 0 N--CA 1.521 3.076 0 O-C-N 120.514 -1.366 . . . . 0.0 111.113 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.1 p90 -126.3 -33.2 2.63 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.992 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.423 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.1 OUTLIER -55.97 173.81 0.14 Allowed 'General case' 0 N--CA 1.514 2.729 0 O-C-N 120.388 -1.445 . . . . 0.0 110.167 179.936 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -143.7 55.88 1.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 110.532 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -112.05 148.18 38.48 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 109.606 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -73.34 -66.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.396 1.208 . . . . 0.0 110.473 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.3 t -43.01 -29.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 120.888 -1.132 . . . . 0.0 111.999 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.4 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 39.0 t60 -63.87 -38.98 93.09 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.665 -1.272 . . . . 0.0 108.824 178.356 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -56.13 -29.27 60.48 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 178.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -29.72 45.23 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.159 -0.963 . . . . 0.0 110.501 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 17.2 m170 -75.33 -35.47 61.19 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.453 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 34.0 m-85 -134.78 138.19 44.07 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.087 -1.008 . . . . 0.0 110.304 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.494 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 1.5 m -81.58 169.48 17.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.518 -0.739 . . . . 0.0 109.23 178.715 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -141.6 155.22 66.92 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.61 140.07 92.0 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 N-CA-C 108.735 -1.294 . . . . 0.0 108.735 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.57 0.79 64.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.722 -177.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.22 143.81 44.23 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.413 1.606 . . . . 0.0 108.646 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.6 t -50.01 -30.79 11.32 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.09 -1.006 . . . . 0.0 111.839 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.83 -6.15 54.65 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.684 -1.26 . . . . 0.0 113.55 -177.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.9 t80 . . . . . 0 N--CA 1.525 3.289 0 CA-C-N 120.551 1.523 . . . . 0.0 111.294 -179.092 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -69.84 91.38 0.64 Allowed 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.487 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -58.04 158.28 6.97 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.697 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.5 t -75.08 145.67 42.1 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.3 t -56.44 163.2 1.81 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.646 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 6.1 t -78.34 162.3 26.57 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.04 -1.038 . . . . 0.0 109.8 178.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 47.9 mtm -58.4 -31.16 67.43 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.403 179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.11 -26.11 25.42 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.144 -0.972 . . . . 0.0 110.768 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.19 -89.75 0.6 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.61 -1.19 26.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.343 -1.092 . . . . 0.0 111.956 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -112.51 16.95 19.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.34 -1.475 . . . . 0.0 112.275 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.4 t -49.19 143.84 5.67 Favored 'General case' 0 N--CA 1.519 2.98 0 O-C-N 120.558 -1.339 . . . . 0.0 110.377 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.5 p90 -120.77 -33.94 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.353 -0.842 . . . . 0.0 112.536 -179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -72.64 174.54 7.42 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.709 -1.245 . . . . 0.0 109.618 179.571 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.6 93.3 1.18 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.899 -1.126 . . . . 0.0 111.096 -179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -115.23 162.43 24.44 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.736 -1.227 . . . . 0.0 110.034 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -26.04 12.73 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 O-C-N 123.514 1.27 . . . . 0.0 110.652 178.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.76 -25.42 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.093 -1.004 . . . . 0.0 111.411 178.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -61.88 -36.02 80.02 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.662 -1.273 . . . . 0.0 109.946 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -58.13 -26.67 62.94 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -31.08 27.86 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.178 -0.951 . . . . 0.0 110.468 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.5 m170 -75.46 -34.3 60.93 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.808 -1.183 . . . . 0.0 111.371 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 48.3 m-85 -137.21 145.66 43.92 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.722 -1.236 . . . . 0.0 110.839 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 66.5 m -91.4 169.97 10.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.222 -0.924 . . . . 0.0 111.503 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -141.64 153.54 65.22 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.109 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.34 140.14 81.04 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 N-CA-C 107.253 -1.864 . . . . 0.0 107.253 178.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.31 1.61 60.79 Favored Glycine 0 CA--C 1.553 2.438 0 C-N-CA 119.041 -1.552 . . . . 0.0 110.825 -178.175 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.66 156.94 24.97 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.837 1.818 . . . . 0.0 107.778 177.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -29.11 70.24 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.207 -179.047 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -94.41 6.09 49.8 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 120.533 -1.355 . . . . 0.0 114.0 -177.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.9 t80 . . . . . 0 N--CA 1.519 3.007 0 CA-C-N 120.643 1.565 . . . . 0.0 109.966 179.899 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 86.88 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.47 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -61.2 153.65 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.293 -179.637 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -71.07 142.46 50.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 28.8 t -53.05 165.19 0.33 Allowed 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.686 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 45.2 t -87.51 156.97 19.3 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.974 -1.079 . . . . 0.0 109.682 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 4.1 ptp -55.25 -31.61 61.67 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -93.52 -20.74 19.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.974 -1.079 . . . . 0.0 111.439 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.45 -98.86 0.22 Allowed Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.521 -1.362 . . . . 0.0 110.392 178.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.58 -13.32 32.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.429 -1.042 . . . . 0.0 111.764 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -104.51 16.44 26.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.565 -1.335 . . . . 0.0 112.39 -179.404 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.9 t -48.92 139.78 9.71 Favored 'General case' 0 N--CA 1.52 3.065 0 O-C-N 120.517 -1.364 . . . . 0.0 111.039 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 17.9 p90 -117.03 -37.16 3.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.438 -0.789 . . . . 0.0 111.765 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.457 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.69 153.66 29.15 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.644 -1.285 . . . . 0.0 109.408 179.184 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 108.29 4.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -0.98 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -118.97 167.47 11.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 0.0 110.209 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.15 -27.67 16.58 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.432 1.227 . . . . 0.0 110.319 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.4 t -98.17 -24.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.084 -1.01 . . . . 0.0 111.92 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -61.94 -38.09 87.17 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.6 -1.313 . . . . 0.0 110.113 -179.05 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -56.96 -28.81 62.62 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.83 -1.169 . . . . 0.0 109.148 178.118 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -32.53 30.06 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.238 -0.914 . . . . 0.0 110.275 179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.433 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 22.1 m170 -71.98 -32.0 66.81 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.07 -1.019 . . . . 0.0 111.408 -179.481 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 42.7 m-85 -140.02 148.08 41.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.952 -1.093 . . . . 0.0 111.43 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 15.9 m -87.61 168.76 12.75 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -0.81 . . . . 0.0 110.997 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -143.7 153.33 57.91 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.15 139.08 76.33 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 177.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.4 -0.81 55.78 Favored Glycine 0 CA--C 1.553 2.446 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.757 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -116.41 158.07 24.09 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.662 1.731 . . . . 0.0 108.229 178.139 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 59.2 m -64.02 -28.01 69.51 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.708 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.65 2.38 56.51 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.644 -1.285 . . . . 0.0 114.061 -176.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.2 t80 . . . . . 0 N--CA 1.523 3.182 0 CA-C-N 120.741 1.61 . . . . 0.0 110.131 -179.858 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.63 -171.34 0.73 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.426 1.224 . . . . 0.0 110.468 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.3 tt 53.01 95.34 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.103 -0.998 . . . . 0.0 110.78 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 87.18 41.11 6.72 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.1 m -146.26 108.57 4.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.187 -1.184 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 139.08 84.2 0.1 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.0 p -142.16 48.23 1.59 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.197 -1.178 . . . . 0.0 110.179 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -127.0 70.01 1.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.194 -0.941 . . . . 0.0 110.156 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -139.25 40.76 1.4 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -148.94 -66.85 0.23 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.239 -1.153 . . . . 0.0 110.415 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -137.15 63.71 1.55 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.12 -0.988 . . . . 0.0 110.243 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 69.8 t -144.7 160.53 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.33 -0.856 . . . . 0.0 109.833 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -89.36 91.85 8.91 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 394' ' ' GLN . 38.5 mtm-85 -60.03 153.98 20.24 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.315 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.1 t -81.01 138.39 36.04 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -52.8 151.87 4.23 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 121.117 -0.989 . . . . 0.0 109.434 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.4 t -75.79 156.96 34.04 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.088 -1.008 . . . . 0.0 110.898 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 45.7 mtm -57.77 -26.17 61.51 Favored 'General case' 0 N--CA 1.516 2.83 0 O-C-N 121.197 -0.94 . . . . 0.0 110.516 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.437 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 39.9 m-85 -89.58 -19.3 25.13 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.975 -1.078 . . . . 0.0 110.926 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.58 -91.06 0.1 OUTLIER Glycine 0 N--CA 1.493 2.444 0 O-C-N 120.674 -1.266 . . . . 0.0 109.994 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.68 -3.1 24.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.401 -1.058 . . . . 0.0 112.251 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -113.8 20.02 16.18 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.557 -1.339 . . . . 0.0 112.225 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 28.7 t -50.26 139.68 14.44 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 120.588 -1.32 . . . . 0.0 110.479 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 36.8 p90 -115.89 -36.4 4.17 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.418 -0.801 . . . . 0.0 111.9 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.6 ptt180 -75.64 160.38 30.15 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.0 109.567 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.78 104.31 2.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.171 -0.955 . . . . 0.0 111.116 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -118.69 165.92 15.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 109.798 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.86 -26.16 19.22 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.246 1.129 . . . . 0.0 110.387 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.36 -20.95 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.951 -1.093 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -65.91 -38.21 88.09 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 120.678 -1.264 . . . . 0.0 110.028 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -58.48 -26.41 63.37 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.231 -0.918 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -80.68 -29.42 36.56 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.167 -0.958 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -87.34 -35.59 18.31 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.872 -1.143 . . . . 0.0 111.597 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 65.0 m-85 -122.24 137.64 54.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.918 -1.114 . . . . 0.0 110.576 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.24 169.18 11.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -144.06 157.73 56.79 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.651 -0.656 . . . . 0.0 109.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.74 138.53 80.13 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.55 -1.7 53.16 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.177 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.29 150.39 31.05 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.383 1.592 . . . . 0.0 108.494 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.8 t -61.06 -23.55 65.54 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.32 4.58 46.49 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 120.523 -1.361 . . . . 0.0 112.851 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -54.86 141.16 34.21 Favored 'General case' 0 N--CA 1.51 2.572 0 O-C-N 120.417 -1.427 . . . . 0.0 109.457 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -158.35 39.77 0.52 Allowed Glycine 0 N--CA 1.499 2.849 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.596 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -97.25 -56.25 1.13 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 407' ' ' VAL . 87.1 t 44.27 66.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.717 -0.872 . . . . 0.0 111.422 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -105.04 58.05 0.69 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.315 -0.865 . . . . 0.0 109.778 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.515 HG23 ' CD ' ' A' ' 412' ' ' GLN . 43.4 mt 50.67 74.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.966 -1.084 . . . . 0.0 110.718 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.83 72.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.27 -0.894 . . . . 0.0 109.367 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.83 -42.41 1.67 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.515 ' CD ' HG23 ' A' ' 409' ' ' ILE . 1.7 mt-30 53.64 76.96 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.331 -1.1 . . . . 0.0 110.848 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 16.0 t70 50.11 30.51 4.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.266 -0.896 . . . . 0.0 111.681 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 48.99 40.63 17.43 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.957 -1.089 . . . . 0.0 111.673 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 412' ' ' GLN . 0.2 OUTLIER -117.22 66.86 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.154 -0.966 . . . . 0.0 109.991 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.75 45.35 1.59 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.212 -0.93 . . . . 0.0 110.177 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.217 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.73 86.22 1.07 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.407 1.214 . . . . 0.0 110.404 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.43 -176.64 3.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 97.45 -139.69 14.62 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.8 m 52.53 83.2 0.06 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.023 -1.28 . . . . 0.0 110.808 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -90.01 61.87 3.32 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.8 p -132.07 130.62 41.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.226 -1.161 . . . . 0.0 110.223 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -116.1 52.24 0.92 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.234 -0.916 . . . . 0.0 109.978 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -135.58 42.37 1.34 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -145.46 -59.34 0.34 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.196 -1.179 . . . . 0.0 110.425 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -141.3 53.57 1.54 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.316 -0.865 . . . . 0.0 110.034 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t -144.43 161.17 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.971 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.95 88.43 7.7 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.256 -0.903 . . . . 0.0 109.722 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -51.12 148.72 4.25 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.226 -0.921 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -77.62 131.85 37.98 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 t -49.98 154.27 1.15 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 120.983 -1.073 . . . . 0.0 110.469 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 3.0 t -79.55 159.28 26.93 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.8 mtm -60.05 -26.25 65.99 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.724 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -88.06 -19.75 26.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.956 -1.09 . . . . 0.0 111.166 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 65.88 -89.02 0.12 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.57 2.84 26.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.307 -1.113 . . . . 0.0 112.599 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.0 m-80 -121.21 22.83 10.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.432 -1.417 . . . . 0.0 112.596 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.5 t -58.92 80.26 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 120.792 -1.193 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 384' ' ' ASN . 42.8 p90 -53.97 -30.54 47.39 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 121.109 -0.994 . . . . 0.0 112.26 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 162.74 27.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.928 -1.107 . . . . 0.0 109.411 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -153.72 93.93 1.72 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.241 -0.912 . . . . 0.0 111.195 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -116.66 153.14 49.05 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.0 -72.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.326 1.172 . . . . 0.0 110.749 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.6 t -47.21 -29.18 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 O-C-N 120.76 -1.212 . . . . 0.0 111.118 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -66.02 -35.99 82.06 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.794 -1.191 . . . . 0.0 109.341 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.92 -24.6 67.07 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.276 -0.89 . . . . 0.0 109.876 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -26.78 35.56 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.009 -1.057 . . . . 0.0 111.068 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -91.27 -38.64 12.54 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.876 -1.14 . . . . 0.0 111.579 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 56.2 m-85 -114.23 135.33 54.17 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.958 -1.089 . . . . 0.0 110.612 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.38 165.6 13.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.23 -0.919 . . . . 0.0 110.713 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -142.14 159.57 58.22 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.699 -0.626 . . . . 0.0 109.722 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.7 Cg_endo -60.36 140.36 91.36 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.31 64.72 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.422 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.23 146.83 29.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 119.508 1.654 . . . . 0.0 108.469 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.4 m -55.55 -24.6 33.26 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.901 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.55 11.26 28.85 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.547 -1.345 . . . . 0.0 113.115 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -54.34 138.4 39.48 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.38 -1.45 . . . . 0.0 109.519 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -156.13 40.76 0.58 Allowed Glycine 0 N--CA 1.5 2.915 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.59 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -93.25 -58.31 1.3 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 407' ' ' VAL . 48.5 t 32.59 59.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 122.131 -0.629 . . . . 0.0 112.572 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.06 78.54 1.61 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.226 -0.921 . . . . 0.0 111.193 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 409' ' ' ILE . 79.5 mt -101.61 62.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.156 -0.965 . . . . 0.0 108.832 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.59 76.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 83.48 57.52 2.45 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -48.8 -63.37 1.11 Allowed 'General case' 0 N--CA 1.511 2.62 0 O-C-N 121.461 -1.023 . . . . 0.0 110.846 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -149.54 35.04 0.7 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.231 -0.918 . . . . 0.0 110.692 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 52.09 40.63 28.93 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.979 -1.076 . . . . 0.0 110.815 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.64 66.92 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.034 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.47 87.81 2.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.324 -0.86 . . . . 0.0 110.177 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.209 179.953 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.77 85.77 1.12 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.422 1.222 . . . . 0.0 110.422 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 35.0 mt -134.07 99.99 4.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.913 . . . . 0.0 110.171 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.22 129.12 4.6 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.06 -65.14 0.52 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -1.128 . . . . 0.0 110.237 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -62.81 87.56 0.05 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 2.2 p -139.24 103.1 4.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.229 -1.16 . . . . 0.0 110.246 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -134.94 -175.8 4.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.263 -0.898 . . . . 0.0 110.319 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 87.23 40.68 6.86 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -148.47 -67.09 0.23 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.169 -1.195 . . . . 0.0 110.581 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -132.17 45.08 2.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.085 -1.009 . . . . 0.0 110.393 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.9 p -142.84 161.26 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.372 -0.83 . . . . 0.0 110.401 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -84.78 82.71 8.31 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.369 -0.832 . . . . 0.0 109.34 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.488 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -60.19 152.68 23.99 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.445 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.7 t -72.95 141.89 47.81 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.182 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.4 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 1.0 OUTLIER -54.53 157.93 2.7 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.796 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 15.4 t -79.42 156.37 27.93 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.857 -1.152 . . . . 0.0 110.5 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.6 mtm -57.32 -27.21 62.0 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.137 -0.977 . . . . 0.0 110.84 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 88.8 m-85 -83.31 -23.93 32.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.9 -1.125 . . . . 0.0 110.782 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 68.98 -89.95 0.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 7.87 29.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.262 -1.14 . . . . 0.0 112.769 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 386' ' ' TYR . 68.5 m-80 -132.31 30.8 4.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.333 -1.479 . . . . 0.0 112.408 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 38.5 t -58.28 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 O-C-N 120.999 -1.063 . . . . 0.0 111.091 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 387' ' ' ARG . 33.2 p90 -57.03 -29.46 63.39 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.005 -1.06 . . . . 0.0 111.787 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HB3' ' CE1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -92.22 152.36 19.88 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.906 -1.121 . . . . 0.0 110.451 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -150.4 129.49 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.343 -0.848 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -129.76 168.23 17.33 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.184 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.12 -34.83 9.65 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.47 1.247 . . . . 0.0 110.489 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.95 -22.12 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.151 -0.968 . . . . 0.0 111.333 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.49 -38.33 90.73 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.657 -1.277 . . . . 0.0 109.62 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.92 -27.35 51.79 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.35 -29.42 28.27 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.059 -1.026 . . . . 0.0 110.609 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -80.59 -32.95 36.34 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.999 -1.063 . . . . 0.0 111.951 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -131.56 141.46 49.7 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.87 -1.143 . . . . 0.0 111.011 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.488 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 73.8 m -86.47 168.76 13.46 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.283 -0.886 . . . . 0.0 110.092 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -143.09 158.88 57.79 Favored Pre-proline 0 N--CA 1.484 1.232 0 O-C-N 121.672 -0.643 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 39.5 Cg_endo -62.2 139.15 76.4 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.11 56.06 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.965 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -115.91 156.97 25.23 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.594 1.697 . . . . 0.0 108.272 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.3 m -63.58 -29.34 70.61 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.281 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.12 -2.74 58.85 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.827 -1.171 . . . . 0.0 113.105 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -50.09 127.84 17.65 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 120.514 1.506 . . . . 0.0 110.122 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -145.51 31.41 1.67 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.4 -1.381 . . . . 0.0 111.061 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -91.93 -56.93 1.55 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 407' ' ' VAL . 84.3 t 44.84 62.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.788 -0.831 . . . . 0.0 111.261 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -87.91 79.38 8.08 Favored 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.853 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.598 HG23 ' CG ' ' A' ' 412' ' ' GLN . 87.6 mt 51.94 69.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.09 -1.006 . . . . 0.0 110.786 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 65.9 t -113.21 69.76 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 99.77 54.24 1.07 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.598 ' CG ' HG23 ' A' ' 409' ' ' ILE . 12.0 mm100 -58.74 -38.98 79.58 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.282 -1.128 . . . . 0.0 110.199 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.82 37.22 2.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.182 -0.949 . . . . 0.0 110.197 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -144.77 40.09 1.27 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.09 -1.006 . . . . 0.0 110.37 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.55 63.36 1.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.24 47.3 1.94 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 3.4 t70 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.208 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.73 127.59 12.5 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.436 1.23 . . . . 0.0 110.416 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.97 92.94 3.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.907 . . . . 0.0 110.132 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -129.16 164.51 22.16 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.7 m -117.33 -65.37 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.165 -1.197 . . . . 0.0 110.229 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -62.85 93.14 0.09 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.66 138.86 53.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.222 -1.164 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -117.52 -173.16 2.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.077 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 76.79 41.18 24.28 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -133.42 -60.95 0.83 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.146 -1.208 . . . . 0.0 109.843 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -136.98 43.15 2.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.0 109.796 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.8 p -144.51 162.27 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.459 -0.776 . . . . 0.0 110.303 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.27 94.49 9.56 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.46 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -65.43 173.38 2.68 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.449 -0.782 . . . . 0.0 110.741 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.6 t -90.12 141.44 28.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.388 -0.82 . . . . 0.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.8 t -64.68 120.55 12.64 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.07 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -34.94 148.69 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 35.1 mtm -50.09 -30.84 11.82 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.39 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -85.54 -23.17 27.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.151 -0.968 . . . . 0.0 111.301 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.03 -87.43 0.11 Allowed Glycine 0 N--CA 1.491 2.334 0 O-C-N 120.459 -1.401 . . . . 0.0 110.11 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.33 1.25 27.78 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.294 -1.121 . . . . 0.0 112.61 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -121.85 22.64 10.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.475 -1.39 . . . . 0.0 112.297 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.4 t -47.22 140.23 5.48 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 120.696 -1.253 . . . . 0.0 111.002 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.465 ' OH ' ' NH1' ' A' ' 387' ' ' ARG . 27.2 p90 -113.43 -37.61 4.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.347 -0.845 . . . . 0.0 111.68 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.465 ' NH1' ' OH ' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.98 154.16 28.41 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.77 -1.206 . . . . 0.0 109.497 179.357 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 100.0 3.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 110.52 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -115.04 167.0 10.55 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.243 -0.91 . . . . 0.0 110.101 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.69 -30.08 12.17 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.425 1.224 . . . . 0.0 110.754 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.9 -23.4 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 121.134 -0.979 . . . . 0.0 111.481 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -60.9 -39.23 88.51 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 120.599 -1.313 . . . . 0.0 109.572 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -55.54 -29.16 58.43 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.094 -1.004 . . . . 0.0 109.578 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.08 39.46 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.587 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -77.7 -33.36 53.22 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.987 -1.07 . . . . 0.0 111.481 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -132.4 137.82 47.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.896 -1.127 . . . . 0.0 110.793 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 73.8 m -79.38 168.23 19.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.278 -0.889 . . . . 0.0 109.085 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.3 159.19 59.16 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.89 137.36 62.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.602 -1.345 . . . . 0.0 108.602 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.24 -0.78 58.75 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.535 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.05 151.63 39.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.208 1.504 . . . . 0.0 108.554 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 40.4 t -58.46 -31.72 68.06 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.237 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.416 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 69.4 m-20 -73.14 -14.77 61.44 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.944 -1.098 . . . . 0.0 113.237 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.481 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 -40.73 115.63 0.6 Allowed 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 120.192 1.36 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.9 75.95 0.12 Allowed Glycine 0 N--CA 1.501 2.978 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -145.88 -59.41 0.02 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.532 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 407' ' ' VAL . 12.7 p -106.78 62.77 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.157 -1.202 . . . . 0.0 110.798 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -134.9 92.95 2.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.288 -0.883 . . . . 0.0 109.929 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.575 HG23 ' CD ' ' A' ' 412' ' ' GLN . 5.0 mp -105.44 67.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.165 -0.959 . . . . 0.0 109.938 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 410' ' ' VAL . 66.2 t -117.43 67.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.98 52.31 2.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.575 ' CD ' HG23 ' A' ' 409' ' ' ILE . 3.0 mt-30 -46.96 -65.12 0.61 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.459 -1.024 . . . . 0.0 111.3 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -152.52 48.96 0.75 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.184 -0.948 . . . . 0.0 110.598 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 52.95 43.7 31.34 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.054 -1.028 . . . . 0.0 110.738 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.59 67.32 0.67 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 110.048 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.16 94.69 4.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.327 -0.858 . . . . 0.0 110.033 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 16.7 t0 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.147 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.67 138.63 29.54 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.404 1.213 . . . . 0.0 110.44 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 12.8 mt -121.45 -62.21 1.45 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 111.73 -42.85 1.85 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.5 m -138.52 -61.35 0.59 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.205 -1.174 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 138.4 -176.32 20.86 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.7 m -127.32 73.62 1.45 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.142 -1.21 . . . . 0.0 110.208 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.48 -176.46 5.4 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.171 -0.956 . . . . 0.0 110.601 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -98.5 -94.28 2.0 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -119.65 64.88 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.169 -1.195 . . . . 0.0 110.121 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 2.1 mptt 52.46 59.14 4.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.939 -1.1 . . . . 0.0 110.622 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p -136.36 161.23 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -85.93 91.96 8.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.299 -0.876 . . . . 0.0 108.997 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -63.27 151.44 40.59 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -71.57 149.61 45.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 28.5 t -62.22 161.83 10.64 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.845 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.06 165.94 23.95 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.01 -1.056 . . . . 0.0 109.466 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -36.5 74.72 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.135 -0.978 . . . . 0.0 110.089 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.79 -24.22 28.83 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.276 -0.89 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 69.42 -83.82 0.26 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.49 -1.63 32.62 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.265 -1.138 . . . . 0.0 113.188 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 386' ' ' TYR . 59.2 m-80 -122.4 14.41 10.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.318 -1.489 . . . . 0.0 113.343 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 45.8 t -45.56 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.393 0 CA-C-N 120.072 1.306 . . . . 0.0 112.668 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 384' ' ' ASN . 48.3 p90 -50.9 -34.9 30.25 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.887 -1.133 . . . . 0.0 111.895 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.431 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.4 OUTLIER -73.95 163.92 27.29 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.019 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -155.86 83.9 1.02 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.253 -0.905 . . . . 0.0 111.015 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -116.41 156.77 46.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.98 -72.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.274 1.144 . . . . 0.0 110.864 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.6 t -45.18 -30.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 120.644 -1.285 . . . . 0.0 111.226 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -65.31 -36.37 83.86 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.882 -1.136 . . . . 0.0 109.25 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -58.28 -28.13 64.69 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.171 -0.956 . . . . 0.0 109.544 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -27.07 46.74 Favored 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.677 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.25 -37.23 26.24 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.094 -1.004 . . . . 0.0 110.818 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 49.0 m-85 -129.87 144.54 51.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.05 -1.031 . . . . 0.0 110.077 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 404' ' ' TYR . 2.5 m -95.41 167.9 11.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 111.151 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -140.72 157.72 67.13 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.73 -0.607 . . . . 0.0 109.911 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.406 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 36.5 Cg_endo -60.62 137.28 72.43 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 N-CA-C 108.544 -1.368 . . . . 0.0 108.544 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.52 -0.63 58.28 Favored Glycine 0 CA--C 1.551 2.321 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.315 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.22 139.16 46.84 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.337 1.568 . . . . 0.0 108.159 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.4 t -50.07 -26.46 4.44 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.012 -1.055 . . . . 0.0 112.045 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -96.87 3.1 52.35 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.575 -1.328 . . . . 0.0 113.411 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.472 ' CE2' HG22 ' A' ' 407' ' ' VAL . 23.4 t80 -48.78 142.42 6.3 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 120.355 1.434 . . . . 0.0 110.52 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.77 48.81 0.24 Allowed Glycine 0 N--CA 1.5 2.948 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.9 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -172.16 79.45 0.09 OUTLIER Glycine 0 N--CA 1.497 2.717 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.856 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 404' ' ' TYR . 62.0 t -85.59 81.4 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.395 -1.062 . . . . 0.0 108.99 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -115.87 89.99 3.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -0.822 . . . . 0.0 110.49 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.719 HG23 ' CG ' ' A' ' 412' ' ' GLN . 82.5 mt -118.87 70.55 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 36.4 t -103.54 84.36 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.405 -0.81 . . . . 0.0 108.969 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 74.23 60.19 3.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.719 ' CG ' HG23 ' A' ' 409' ' ' ILE . 11.4 mm100 -57.01 -39.85 75.49 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.226 -1.161 . . . . 0.0 110.243 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.79 37.92 3.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.022 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -137.44 59.91 1.66 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.158 -0.964 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.31 65.62 0.67 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.235 -0.916 . . . . 0.0 109.999 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.33 45.91 2.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.216 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.74 -171.35 0.74 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.408 1.215 . . . . 0.0 110.404 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 22.1 mt -116.45 96.25 5.44 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.194 -0.941 . . . . 0.0 110.196 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 105.03 166.43 24.06 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.7 t -117.6 135.73 53.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -1.151 . . . . 0.0 110.191 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.28 165.81 25.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.89 -59.51 0.75 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.264 -1.139 . . . . 0.0 110.354 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.495 ' HG2' HG11 ' A' ' 374' ' ' VAL . 26.7 mt-10 -121.42 84.65 2.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -0.996 . . . . 0.0 110.035 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -136.31 41.17 1.44 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -146.58 -66.19 0.28 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -1.168 . . . . 0.0 110.4 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.437 ' C ' HG23 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -152.94 74.32 1.04 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.209 -0.932 . . . . 0.0 110.396 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 370' ' ' GLU . 96.7 t -147.31 161.9 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.229 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.94 93.04 9.46 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.272 -0.893 . . . . 0.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 394' ' ' GLN . 13.0 mtt180 -56.07 152.65 10.16 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.385 -0.822 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -82.28 133.33 35.24 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 63.4 p -50.76 153.75 1.62 Allowed 'General case' 0 N--CA 1.515 2.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.135 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.9 t -78.15 155.72 30.29 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.126 -0.984 . . . . 0.0 110.845 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.5 mtm -60.15 -30.01 69.03 Favored 'General case' 0 N--CA 1.51 2.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.26 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.426 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 34.5 m-85 -84.39 -24.19 29.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.048 -1.032 . . . . 0.0 110.64 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.22 -86.84 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.24 -4.5 20.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -1.143 . . . . 0.0 112.337 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -112.4 16.57 19.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.457 -1.402 . . . . 0.0 112.858 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.426 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 14.5 t -46.73 137.31 7.14 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 120.6 -1.312 . . . . 0.0 110.513 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 39.6 p90 -116.91 -39.07 3.3 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.228 -0.92 . . . . 0.0 112.517 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.4 ptp85 -51.95 161.79 0.53 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.646 -1.284 . . . . 0.0 110.82 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -128.31 55.37 1.68 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 0.0 110.492 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.21 140.55 21.25 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.276 -0.89 . . . . 0.0 109.965 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.11 -72.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.258 1.136 . . . . 0.0 110.154 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.2 t -40.12 -28.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 O-C-N 120.864 -1.147 . . . . 0.0 112.497 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.452 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 25.0 t60 -64.22 -37.83 88.87 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 120.492 -1.38 . . . . 0.0 108.568 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -59.79 -30.82 69.16 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.2 -0.938 . . . . 0.0 109.592 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.41 ' HA ' ' NE ' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -77.02 -26.48 53.78 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.186 -0.946 . . . . 0.0 110.85 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -91.69 -38.09 12.63 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.905 -1.122 . . . . 0.0 110.516 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 76.0 m-85 -113.11 138.51 49.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.0 110.49 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.66 168.5 11.44 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 111.224 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -141.48 159.64 59.83 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.77 -0.581 . . . . 0.0 109.66 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.51 139.92 84.44 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.48 -2.55 60.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -107.66 144.66 34.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.592 -1.534 . . . . 0.0 108.215 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 3.0 t -55.18 -24.3 26.24 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.206 -0.934 . . . . 0.0 111.801 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -105.15 7.54 33.78 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.521 -1.362 . . . . 0.0 113.066 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -45.78 120.21 2.55 Favored 'General case' 0 N--CA 1.523 3.184 0 CA-C-N 120.513 1.506 . . . . 0.0 110.876 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -51.46 -36.29 38.05 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 81.37 52.05 4.39 Favored Glycine 0 N--CA 1.488 2.155 0 O-C-N 121.192 -1.181 . . . . 0.0 111.064 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 90.3 t 52.3 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.225 -1.162 . . . . 0.0 111.043 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -166.04 79.54 0.27 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.273 -0.892 . . . . 0.0 110.885 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.62 HG23 ' CD ' ' A' ' 412' ' ' GLN . 59.4 mt -99.47 73.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 120.9 -1.125 . . . . 0.0 110.285 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.65 70.07 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 108.927 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 96.85 53.94 1.35 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.62 ' CD ' HG23 ' A' ' 409' ' ' ILE . 6.1 mt-30 -49.25 -62.35 1.59 Allowed 'General case' 0 N--CA 1.513 2.703 0 O-C-N 121.488 -1.007 . . . . 0.0 110.543 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -135.77 34.83 2.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 110.33 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -128.18 68.96 1.34 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.034 . . . . 0.0 110.124 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.43 64.57 0.62 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.129 -0.982 . . . . 0.0 109.967 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -115.24 42.5 2.21 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.204 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.72 124.92 10.1 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.415 1.218 . . . . 0.0 110.377 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.03 48.0 1.8 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.206 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -109.83 79.97 0.26 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.0 p -142.71 105.88 4.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.251 -1.147 . . . . 0.0 110.283 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -140.09 127.69 3.62 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.41 96.14 2.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -1.18 . . . . 0.0 110.159 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.521 ' HG2' HG11 ' A' ' 374' ' ' VAL . 0.9 OUTLIER -142.84 163.66 32.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.164 -0.96 . . . . 0.0 110.317 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -153.43 47.6 0.54 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -143.92 -67.19 0.34 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.128 -1.219 . . . . 0.0 110.408 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -169.25 76.93 0.1 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.073 -1.017 . . . . 0.0 110.947 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.521 HG11 ' HG2' ' A' ' 370' ' ' GLU . 13.3 p -144.76 161.92 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 111.0 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.06 89.88 3.59 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.851 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -57.94 174.18 0.28 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.61 -0.682 . . . . 0.0 111.016 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.6 m -88.45 134.28 33.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 406' ' ' GLY . 82.9 p -62.92 121.09 12.66 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.539 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 145.69 0.59 Allowed 'General case' 0 N--CA 1.513 2.679 0 O-C-N 121.368 -0.832 . . . . 0.0 112.173 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -46.72 -35.27 5.92 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.627 -0.67 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -78.07 -29.52 49.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.078 -1.014 . . . . 0.0 111.204 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 64.49 -86.19 0.07 OUTLIER Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.24 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -100.82 1.57 40.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.212 -1.169 . . . . 0.0 113.054 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 386' ' ' TYR . 37.3 m-80 -128.76 21.77 5.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.49 -1.381 . . . . 0.0 112.896 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.5 t -55.87 85.79 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 CA-C-N 119.915 1.234 . . . . 0.0 110.704 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 384' ' ' ASN . 28.9 p90 -61.02 -26.75 67.83 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.044 -1.035 . . . . 0.0 111.795 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 149.8 21.17 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.37 127.55 12.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 392' ' ' HIS . 1.5 m-20 -128.62 166.5 24.22 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.11 -33.79 11.15 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.322 1.17 . . . . 0.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.77 -23.28 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.263 -0.898 . . . . 0.0 111.5 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 389' ' ' ASN . 48.9 t60 -62.57 -36.34 82.38 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.689 -1.257 . . . . 0.0 110.229 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.1 -26.36 66.16 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.106 -0.996 . . . . 0.0 109.518 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.1 -30.48 55.37 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.142 -0.974 . . . . 0.0 110.447 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.433 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 0.3 OUTLIER -81.79 -35.4 29.59 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 51.1 m-85 -128.68 139.38 52.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.001 -1.062 . . . . 0.0 111.255 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.13 169.14 16.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.408 -0.808 . . . . 0.0 109.38 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -144.75 153.74 54.79 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.434 -0.791 . . . . 0.0 109.369 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.404 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.3 Cg_endo -61.14 137.46 71.46 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 N-CA-C 108.405 -1.421 . . . . 0.0 108.405 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.34 -1.16 53.83 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.748 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.92 171.69 7.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.649 1.725 . . . . 0.0 108.546 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -24.2 53.11 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.066 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -99.0 1.78 45.74 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.637 -1.289 . . . . 0.0 113.605 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -47.32 136.85 8.95 Favored 'General case' 0 N--CA 1.522 3.164 0 CA-C-N 120.362 1.437 . . . . 0.0 110.89 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -176.06 72.72 0.08 OUTLIER Glycine 0 N--CA 1.5 2.959 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.765 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.484 ' O ' ' OG ' ' A' ' 378' ' ' SER . . . -170.13 52.57 0.2 Allowed Glycine 0 N--CA 1.499 2.894 0 C-N-CA 119.333 -1.413 . . . . 0.0 112.495 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 407' ' ' VAL . 78.5 t -72.86 73.76 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 120.762 -1.434 . . . . 0.0 110.129 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 408' ' ' GLN . 0.2 OUTLIER -136.49 81.4 1.88 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.148 -0.97 . . . . 0.0 110.572 179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.519 HG23 ' CD ' ' A' ' 412' ' ' GLN . 8.3 mt -107.43 73.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.868 -1.145 . . . . 0.0 109.8 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.9 79.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 108.838 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 78.33 58.97 3.0 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.234 -1.947 . . . . 0.0 108.234 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.519 ' CD ' HG23 ' A' ' 409' ' ' ILE . 13.4 mt-30 -48.13 -65.41 0.57 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.435 -1.038 . . . . 0.0 111.074 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -150.76 35.46 0.61 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.119 -0.988 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.75 54.23 1.5 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.103 -0.998 . . . . 0.0 110.101 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 415' ' ' THR . 5.8 t -132.67 62.61 1.65 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -0.911 . . . . 0.0 110.201 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -103.18 39.38 1.58 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.192 -0.943 . . . . 0.0 109.893 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.236 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.8 117.92 5.34 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.504 1.265 . . . . 0.0 110.384 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.8 tp -138.08 45.38 2.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.157 -0.965 . . . . 0.0 110.178 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -104.59 102.9 2.16 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.41 -60.26 0.67 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.237 -1.155 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 124.65 -137.55 10.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.7 t -134.46 119.31 18.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.211 -1.17 . . . . 0.0 110.178 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.44 56.66 1.66 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 0.0 110.069 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -135.65 40.07 1.59 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -146.3 -67.11 0.28 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.16 -1.2 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.422 ' C ' HG23 ' A' ' 374' ' ' VAL . 9.8 mttp -140.46 67.38 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.151 -0.968 . . . . 0.0 110.256 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.422 HG23 ' C ' ' A' ' 373' ' ' LYS . 67.2 t -146.28 160.69 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.975 . . . . 0.0 109.925 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -87.05 91.03 8.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.29 151.58 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.372 -0.83 . . . . 0.0 110.25 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.3 t -81.13 136.7 35.93 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.784 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -51.72 149.04 4.92 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 121.155 -0.966 . . . . 0.0 109.964 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.4 t -71.13 163.42 27.64 Favored 'General case' 0 N--CA 1.512 2.627 0 O-C-N 120.944 -1.098 . . . . 0.0 110.495 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.408 ' HA ' ' CD1' ' A' ' 409' ' ' ILE . 63.7 mtm -62.91 -31.08 72.07 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.227 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -84.41 -23.48 30.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.201 -0.937 . . . . 0.0 110.45 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 70.33 -86.06 0.33 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.55 -4.26 18.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -1.136 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -111.53 16.46 20.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.486 -1.384 . . . . 0.0 112.874 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -47.62 141.0 5.61 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 120.086 1.312 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.2 p90 -121.72 -39.94 2.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 112.285 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.426 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -59.24 149.45 28.49 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.619 -1.301 . . . . 0.0 109.512 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.6 74.73 1.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.159 -0.963 . . . . 0.0 111.111 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.41 148.25 38.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.91 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.34 1.179 . . . . 0.0 110.764 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -42.25 -27.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 O-C-N 120.7 -1.25 . . . . 0.0 112.422 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -66.45 -35.63 80.76 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.456 -1.403 . . . . 0.0 109.238 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.97 -28.82 70.35 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -26.63 57.0 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.224 -0.922 . . . . 0.0 111.297 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.08 -35.52 13.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.852 -1.155 . . . . 0.0 111.238 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -117.55 144.99 44.57 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.064 -1.022 . . . . 0.0 110.521 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.74 168.77 10.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.956 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -140.5 158.3 66.37 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.702 -0.624 . . . . 0.0 110.538 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.42 139.23 75.61 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 107.99 -1.581 . . . . 0.0 107.99 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.73 -3.13 60.73 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.878 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.3 138.1 46.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.627 -1.513 . . . . 0.0 108.466 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -25.67 0.94 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.201 -0.937 . . . . 0.0 113.267 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -106.06 12.96 29.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.512 -1.368 . . . . 0.0 113.192 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -50.49 135.29 22.78 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 120.457 -1.402 . . . . 0.0 109.951 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.96 -25.81 28.28 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.316 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.428 ' C ' HG23 ' A' ' 407' ' ' VAL . . . 116.34 -116.91 3.73 Favored Glycine 0 N--CA 1.473 1.1 0 N-CA-C 107.551 -2.22 . . . . 0.0 107.551 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.428 HG23 ' C ' ' A' ' 406' ' ' GLY . 59.9 t -146.01 92.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.633 -0.922 . . . . 0.0 111.743 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -155.81 88.15 1.11 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.152 -0.968 . . . . 0.0 110.297 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.477 HG23 ' CD ' ' A' ' 412' ' ' GLN . 44.6 mt -100.21 69.84 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.844 -1.16 . . . . 0.0 110.255 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 58.0 t -119.74 74.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 91.97 56.9 1.55 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.477 ' CD ' HG23 ' A' ' 409' ' ' ILE . 8.2 mt-30 -50.37 -63.62 1.06 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.346 -1.09 . . . . 0.0 110.604 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -148.33 34.7 0.8 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.216 -0.928 . . . . 0.0 110.725 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 52.05 56.29 7.99 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.809 -1.182 . . . . 0.0 110.845 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 415' ' ' THR . 7.4 t -126.56 64.42 1.26 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.192 -0.942 . . . . 0.0 110.181 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.15 39.62 1.53 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.224 -0.922 . . . . 0.0 109.942 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.24 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.71 130.66 16.13 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.456 1.24 . . . . 0.0 110.386 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 5.0 mt -140.04 83.86 1.94 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.134 -0.979 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -125.66 148.34 16.91 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.8 p -122.19 39.69 3.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.153 -1.204 . . . . 0.0 110.337 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 61.79 -146.37 48.81 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 86.6 p -118.29 122.63 43.4 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.199 -1.177 . . . . 0.0 110.254 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.86 113.39 7.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.206 -0.934 . . . . 0.0 110.126 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -156.75 43.09 0.53 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -132.16 -65.21 0.74 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.227 -1.161 . . . . 0.0 110.402 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.27 71.96 1.03 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.269 -0.895 . . . . 0.0 110.527 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.04 160.2 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.151 -0.968 . . . . 0.0 110.703 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -84.39 82.89 8.19 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -56.56 152.35 12.02 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.186 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -72.34 137.27 46.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.41 ' HB3' ' CA ' ' A' ' 406' ' ' GLY . 2.1 p -49.29 160.2 0.25 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.6 t -83.32 157.76 22.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.201 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.7 ptp -61.59 -36.38 80.51 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.011 -1.055 . . . . 0.0 110.181 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.416 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 16.0 m-85 -77.81 -32.99 52.63 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.171 -0.956 . . . . 0.0 110.29 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.95 -89.15 0.87 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.52 -4.42 19.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -1.056 . . . . 0.0 112.244 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.77 16.65 19.5 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.353 -1.467 . . . . 0.0 112.584 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.416 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 7.3 t -45.86 140.09 3.82 Favored 'General case' 0 N--CA 1.524 3.247 0 O-C-N 120.633 -1.292 . . . . 0.0 110.988 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.8 p90 -116.93 -39.05 3.3 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.381 -0.824 . . . . 0.0 112.279 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.45 ' HD2' ' CG ' ' A' ' 392' ' ' HIS . 6.8 ptp85 -55.19 158.75 2.86 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.651 -1.281 . . . . 0.0 110.564 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -128.12 62.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.248 -0.908 . . . . 0.0 110.517 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.35 145.16 33.14 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.23 -59.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.234 1.123 . . . . 0.0 110.901 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 12.2 p -43.61 -33.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 O-C-N 121.084 -1.01 . . . . 0.0 111.708 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.45 ' CG ' ' HD2' ' A' ' 387' ' ' ARG . 34.4 t60 -66.54 -36.33 82.42 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.91 -29.68 70.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.069 -1.019 . . . . 0.0 109.257 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.432 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 1.3 mp0 -77.23 -29.22 54.0 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.233 -0.917 . . . . 0.0 110.749 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.09 -32.99 21.07 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.19 -0.944 . . . . 0.0 111.377 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -124.11 143.41 50.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.791 -1.193 . . . . 0.0 110.592 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 404' ' ' TYR . 0.0 OUTLIER -89.19 170.03 10.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -0.901 . . . . 0.0 111.354 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -143.02 153.06 59.94 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.04 140.57 79.52 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 N-CA-C 108.018 -1.57 . . . . 0.0 108.018 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.92 -0.16 62.43 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.454 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.0 144.39 41.42 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.643 1.722 . . . . 0.0 108.071 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 61.4 m -52.09 -26.27 10.68 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.98 -1.075 . . . . 0.0 112.4 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -103.36 10.45 37.43 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.504 -1.372 . . . . 0.0 113.315 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 397' ' ' SER . 21.5 t80 -50.89 137.23 21.19 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 120.398 -1.439 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -140.05 23.06 2.76 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.662 -1.256 . . . . 0.0 112.008 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.412 ' HA2' ' NE2' ' A' ' 408' ' ' GLN . . . -77.77 -29.49 54.71 Favored Glycine 0 N--CA 1.494 2.503 0 CA-C-N 119.57 1.685 . . . . 0.0 110.041 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 407' ' ' VAL . 13.5 p -73.63 67.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.517 -0.99 . . . . 0.0 111.242 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.412 ' NE2' ' HA2' ' A' ' 406' ' ' GLY . 4.1 mp0 -92.19 60.72 3.78 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.781 -1.199 . . . . 0.0 109.322 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 409' ' ' ILE . 19.7 mt 51.62 70.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.902 -1.124 . . . . 0.0 110.4 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 410' ' ' VAL . 59.9 t -120.63 61.53 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.424 -0.797 . . . . 0.0 109.459 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 134.81 -43.15 1.28 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 53.85 44.78 29.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -1.077 . . . . 0.0 110.669 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.1 t0 53.56 38.26 27.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.371 -0.83 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -128.53 41.06 3.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.199 -0.938 . . . . 0.0 110.171 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.24 66.36 0.71 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.275 -0.891 . . . . 0.0 110.042 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.33 85.83 2.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.249 -0.907 . . . . 0.0 110.211 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.209 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.8 148.19 45.82 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.34 1.179 . . . . 0.0 110.416 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.75 170.35 16.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 110.195 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -72.22 125.66 10.95 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.6 p -129.57 -65.58 0.84 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.196 -1.179 . . . . 0.0 110.162 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -69.27 128.99 22.72 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 4.8 m -133.1 126.72 32.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.139 -1.213 . . . . 0.0 110.142 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -139.02 62.26 1.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.066 -1.021 . . . . 0.0 110.163 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -146.04 39.17 1.14 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -125.52 -58.63 1.41 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.324 -1.104 . . . . 0.0 109.61 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.81 59.54 1.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 64.8 t -144.48 147.43 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.002 -1.062 . . . . 0.0 110.117 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 66.9 9.68 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.895 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -58.29 156.43 10.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.759 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.3 t -74.91 145.75 42.4 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.654 -0.818 . . . . 0.0 108.879 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 0.8 OUTLIER -51.67 169.06 0.07 Allowed 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.323 -178.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 54.1 t -85.44 158.79 20.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.155 -0.966 . . . . 0.0 108.44 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.0 mtm -63.07 -33.59 75.78 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 120.758 -1.214 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -94.7 -20.11 19.82 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.983 -1.073 . . . . 0.0 111.168 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 58.37 -95.59 0.06 OUTLIER Glycine 0 N--CA 1.494 2.536 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -86.89 -21.16 26.5 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.246 -1.149 . . . . 0.0 111.632 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -94.23 6.81 47.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.743 -1.223 . . . . 0.0 112.558 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.3 t -43.0 134.39 3.43 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 120.655 -1.278 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 27.4 p90 -119.95 -35.66 3.44 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.334 -0.854 . . . . 0.0 112.477 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.473 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 4.0 ptm180 -48.72 163.82 0.07 Allowed 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.68 -1.262 . . . . 0.0 110.968 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.9 pttm -129.81 56.83 1.7 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.196 -0.94 . . . . 0.0 110.522 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -109.41 144.16 29.24 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.26 -0.9 . . . . 0.0 110.51 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -73.94 -73.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 O-C-N 123.318 1.167 . . . . 0.0 110.355 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 72.2 t -41.24 -27.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 O-C-N 120.797 -1.19 . . . . 0.0 112.601 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -63.65 -37.43 87.32 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.375 -1.453 . . . . 0.0 108.533 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -60.59 -31.58 70.72 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.084 -1.01 . . . . 0.0 109.527 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.21 -27.21 38.84 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.102 -0.999 . . . . 0.0 110.987 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -84.8 -29.87 25.04 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.843 -1.161 . . . . 0.0 111.803 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -124.41 137.66 54.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.799 -1.188 . . . . 0.0 111.183 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.77 153.77 32.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.296 -0.878 . . . . 0.0 111.516 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -134.29 157.32 77.78 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.51 136.67 64.67 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 N-CA-C 108.281 -1.469 . . . . 0.0 108.281 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.32 1.99 56.76 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.032 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.52 141.7 45.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.211 1.506 . . . . 0.0 108.71 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 58.2 m -52.78 -25.94 12.81 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.214 -0.928 . . . . 0.0 111.83 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -98.12 -3.45 37.79 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.68 -1.262 . . . . 0.0 113.051 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -45.17 141.85 2.23 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 120.202 1.365 . . . . 0.0 111.491 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -172.75 54.23 0.16 Allowed Glycine 0 N--CA 1.502 3.07 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.592 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -110.17 -65.15 0.54 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 407' ' ' VAL . 85.2 t 45.62 61.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.704 -0.88 . . . . 0.0 111.491 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -101.69 92.29 4.79 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.281 -0.887 . . . . 0.0 110.426 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.571 HG23 ' CD ' ' A' ' 412' ' ' GLN . 92.8 mt -111.28 71.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.104 -0.997 . . . . 0.0 109.768 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.6 t -115.4 77.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.321 -0.862 . . . . 0.0 108.944 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 87.59 57.55 1.95 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.571 ' CD ' HG23 ' A' ' 409' ' ' ILE . 8.3 mt-30 -49.94 -62.82 1.35 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.275 -1.132 . . . . 0.0 110.508 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -148.28 34.43 0.8 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.331 -0.855 . . . . 0.0 110.502 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -140.01 53.98 1.66 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.122 -0.986 . . . . 0.0 110.172 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.52 66.38 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.071 -1.018 . . . . 0.0 109.93 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.84 42.78 2.25 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.251 -0.906 . . . . 0.0 110.182 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.259 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.75 140.26 32.02 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.388 1.204 . . . . 0.0 110.381 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 5.4 tp 52.77 80.58 0.1 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.053 -1.03 . . . . 0.0 110.778 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.67 142.42 13.31 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 32.1 t -142.78 46.42 1.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.17 -1.194 . . . . 0.0 110.274 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 75.68 103.47 0.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 7.8 t -122.91 84.68 2.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.233 -1.157 . . . . 0.0 110.334 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -139.58 43.98 1.97 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.243 -0.911 . . . . 0.0 110.118 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -147.51 40.48 0.98 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -128.35 -59.99 1.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -1.176 . . . . 0.0 109.956 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -133.59 48.11 2.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.227 -0.921 . . . . 0.0 110.105 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.37 161.5 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.267 -0.895 . . . . 0.0 110.326 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -91.35 94.2 9.4 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.327 -0.858 . . . . 0.0 109.452 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.45 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -70.81 174.21 6.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.606 -0.684 . . . . 0.0 110.433 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -94.68 136.04 35.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.37 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.9 t -58.05 122.78 13.87 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.371 -0.83 . . . . 0.0 109.744 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -42.37 148.61 0.2 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -49.98 -29.13 7.92 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.546 -0.721 . . . . 0.0 110.386 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 9.3 m-85 -84.63 -23.77 29.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.027 -1.046 . . . . 0.0 111.444 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.05 -88.58 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 O-C-N 120.375 -1.453 . . . . 0.0 110.635 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.5 3.76 40.51 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.177 -1.19 . . . . 0.0 113.259 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 386' ' ' TYR . 16.8 m-80 -130.93 26.97 4.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.424 -1.422 . . . . 0.0 112.371 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.413 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 52.9 t -57.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.625 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 384' ' ' ASN . 34.9 p90 -63.59 -27.92 69.57 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 121.135 -0.978 . . . . 0.0 112.362 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 162.63 28.95 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 120.72 -1.237 . . . . 0.0 109.086 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.94 91.77 1.14 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.073 -1.017 . . . . 0.0 111.461 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.57 166.83 10.14 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.0 110.045 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.83 -32.28 5.79 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.404 1.213 . . . . 0.0 110.79 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.52 -22.6 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.149 -0.969 . . . . 0.0 111.029 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.56 -37.01 82.24 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.803 -1.186 . . . . 0.0 109.469 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -56.38 -27.55 56.52 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.095 -1.003 . . . . 0.0 109.53 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.72 -30.49 26.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.106 -0.996 . . . . 0.0 110.562 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.0 m170 -76.2 -32.85 59.2 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.908 -1.12 . . . . 0.0 111.785 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 56.0 m-85 -132.57 138.49 47.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 111.077 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 28.2 m -78.83 165.42 23.56 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -143.04 160.87 51.14 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.249 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.26 137.52 71.29 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.09 -1.87 61.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.642 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.76 149.6 36.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.449 1.624 . . . . 0.0 108.439 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 79.2 p -56.85 -32.07 65.41 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.062 -1.024 . . . . 0.0 111.152 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -80.18 -8.08 59.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.943 -1.098 . . . . 0.0 113.589 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.457 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 8.0 t80 -40.42 113.82 0.4 Allowed 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 120.524 1.511 . . . . 0.0 111.263 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -165.2 77.89 0.14 Allowed Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.91 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.446 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -155.84 -62.47 0.01 OUTLIER Glycine 0 N--CA 1.5 2.939 0 C-N-CA 119.399 -1.382 . . . . 0.0 112.024 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 407' ' ' VAL . 12.9 p -109.26 70.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.752 1.276 . . . . 0.0 111.544 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -131.54 86.11 2.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 0.0 109.593 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.491 HG23 ' CG ' ' A' ' 412' ' ' GLN . 71.0 mt -106.44 67.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.238 -0.914 . . . . 0.0 110.092 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 410' ' ' VAL . 12.0 p -113.82 66.12 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.315 -0.866 . . . . 0.0 108.823 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 102.17 54.78 0.89 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.491 ' CG ' HG23 ' A' ' 409' ' ' ILE . 11.7 mm100 -56.96 -39.14 74.01 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.277 -1.131 . . . . 0.0 110.173 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.23 37.34 2.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.237 -0.914 . . . . 0.0 110.054 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -148.93 49.41 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.108 -0.995 . . . . 0.0 110.455 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 66.46 0.65 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.227 -0.921 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -143.18 40.34 1.48 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.231 -0.918 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 25.2 t70 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.228 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.74 94.54 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.414 1.218 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.53 93.46 3.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.224 -0.923 . . . . 0.0 110.203 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -110.41 154.38 16.62 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 67.0 m -143.28 83.13 1.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.236 -1.155 . . . . 0.0 110.331 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 110.82 99.38 2.53 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.1 t -141.85 105.5 4.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.177 -1.19 . . . . 0.0 110.204 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -141.61 -172.13 3.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 89.29 41.41 5.82 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -135.4 -64.81 0.63 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.179 -1.189 . . . . 0.0 110.054 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.07 47.71 1.81 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.124 -0.985 . . . . 0.0 109.93 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.74 161.65 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.369 -0.832 . . . . 0.0 110.059 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 87.62 7.0 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.185 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -61.92 151.02 35.95 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.258 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.0 t -71.66 141.85 49.9 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.503 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.27 157.51 2.68 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.05 154.41 25.64 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.816 -1.178 . . . . 0.0 110.874 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.415 ' CE ' ' CE2' ' A' ' 381' ' ' TYR . 4.0 ptt? -54.62 -28.84 49.6 Favored 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.437 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.445 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 72.0 m-85 -82.64 -29.03 30.33 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.958 -1.089 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 72.19 -93.84 0.61 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -103.41 -0.23 30.32 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -1.182 . . . . 0.0 112.474 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.9 m-80 -121.38 24.26 10.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.347 -1.471 . . . . 0.0 112.504 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 49.2 t -59.38 81.83 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.95 0 O-C-N 120.783 -1.198 . . . . 0.0 110.589 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 384' ' ' ASN . 29.6 p90 -61.92 -25.42 67.56 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.169 -0.957 . . . . 0.0 111.738 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -87.5 157.89 19.07 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.798 -1.188 . . . . 0.0 110.134 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.73 124.04 5.32 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.217 -0.927 . . . . 0.0 110.91 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 392' ' ' HIS . 6.8 m-20 -126.06 166.93 18.57 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.284 -0.885 . . . . 0.0 109.69 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.09 -33.48 11.64 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.418 1.22 . . . . 0.0 110.263 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.26 -24.67 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.972 . . . . 0.0 111.416 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.404 ' CB ' ' HB2' ' A' ' 389' ' ' ASN . 47.9 t60 -60.48 -38.98 86.0 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.577 -1.327 . . . . 0.0 110.006 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -56.5 -28.6 60.25 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.408 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -79.96 -32.23 39.92 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.577 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -78.15 -35.17 49.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.219 -0.925 . . . . 0.0 111.486 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.25 144.34 51.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.952 -1.093 . . . . 0.0 110.726 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 10.0 m -91.42 171.47 9.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -143.48 159.17 55.7 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.11 139.3 83.3 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.73 -1.03 56.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.3 153.85 30.19 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.267 1.533 . . . . 0.0 107.658 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -29.06 70.41 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.135 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -85.91 -1.8 57.65 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -41.3 112.81 0.34 Allowed 'General case' 0 N--CA 1.527 3.4 0 CA-C-N 120.713 1.597 . . . . 0.0 111.102 -178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -57.31 -49.25 74.18 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.246 -0.909 . . . . 0.0 111.819 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 126.1 58.16 0.15 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.673 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 80.1 t 44.76 89.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.549 -0.971 . . . . 0.0 113.046 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.42 91.49 2.2 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.174 -0.954 . . . . 0.0 110.715 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 60.8 mt -111.21 74.25 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.944 -1.098 . . . . 0.0 109.826 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.69 74.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.221 -0.924 . . . . 0.0 109.465 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 112.39 -41.62 2.18 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 54.54 37.45 27.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.277 -1.131 . . . . 0.0 110.724 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.1 t70 51.41 38.15 21.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.11 -0.994 . . . . 0.0 110.96 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.11 42.07 3.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.124 -0.985 . . . . 0.0 110.35 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 65.25 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 110.044 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.3 t70 52.74 39.12 28.04 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.031 -1.043 . . . . 0.0 110.754 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.159 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.8 165.33 33.06 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.408 1.215 . . . . 0.0 110.396 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.2 tp -140.71 -59.94 0.51 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 125.02 129.58 3.39 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.2 p -142.7 125.95 16.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.141 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 70.5 157.41 2.11 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.24 39.14 1.59 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.236 -1.155 . . . . 0.0 110.394 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.43 -172.1 4.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.179 -0.951 . . . . 0.0 110.384 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -66.84 -86.77 0.08 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -129.29 64.23 1.48 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.211 -1.17 . . . . 0.0 110.046 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.83 66.32 1.26 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.953 -1.092 . . . . 0.0 110.371 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.14 161.56 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.239 -0.913 . . . . 0.0 110.609 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -79.87 94.49 5.84 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.455 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.6 OUTLIER -68.52 153.77 43.13 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.605 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.1 t -79.05 142.8 36.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.694 -0.629 . . . . 0.0 109.419 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.3 p -56.33 155.25 7.14 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.33 156.34 28.06 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.05 -1.031 . . . . 0.0 110.265 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -58.54 -35.77 72.83 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.16 -0.963 . . . . 0.0 110.635 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -71.89 -39.11 69.81 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.083 -1.01 . . . . 0.0 110.114 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.51 -86.92 1.31 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.07 -0.73 28.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.144 -1.209 . . . . 0.0 112.33 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.27 13.57 9.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.556 -1.34 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.8 t -49.39 152.57 1.25 Allowed 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.462 -1.398 . . . . 0.0 111.3 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 18.3 p90 -101.93 -29.62 11.71 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.446 -0.784 . . . . 0.0 111.525 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER 23.61 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.16 -2.88 25.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.983 -1.073 . . . . 0.0 111.462 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -130.35 157.57 76.94 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.582 -1.324 . . . . 0.0 109.267 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.23 -44.3 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.312 1.164 . . . . 0.0 110.061 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.4 t -47.73 -31.51 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 O-C-N 121.131 -0.981 . . . . 0.0 110.591 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -63.65 -31.97 73.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.003 -1.061 . . . . 0.0 109.428 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.429 ' CZ ' ' NH1' ' A' ' 387' ' ' ARG . 27.9 m-85 -63.19 -24.37 67.85 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.009 -1.057 . . . . 0.0 109.269 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.89 -28.94 32.63 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.663 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.45 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.8 m170 -83.38 -32.58 26.11 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 121.032 -1.043 . . . . 0.0 111.843 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 73.5 m-85 -130.97 143.54 50.8 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.895 -1.128 . . . . 0.0 110.705 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 68.1 m -86.46 163.65 17.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.402 -0.811 . . . . 0.0 110.993 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -139.85 159.43 64.8 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.704 -0.623 . . . . 0.0 109.868 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.07 136.44 60.82 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 N-CA-C 108.248 -1.482 . . . . 0.0 108.248 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.24 -3.39 51.11 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.27 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -113.42 141.06 47.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.56 -1.553 . . . . 0.0 108.248 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 56.0 m -51.78 -25.96 8.68 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.067 -1.021 . . . . 0.0 112.2 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -93.49 0.21 56.63 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.506 -1.371 . . . . 0.0 113.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -46.11 131.99 9.81 Favored 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 120.562 1.528 . . . . 0.0 111.09 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -82.8 -25.03 51.42 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.512 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 116.14 -120.04 4.75 Favored Glycine 0 C--O 1.217 -0.961 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 58.7 t -137.53 96.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.747 -0.855 . . . . 0.0 110.367 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -116.5 88.95 3.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.234 -0.916 . . . . 0.0 110.066 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.794 HG23 ' CD ' ' A' ' 412' ' ' GLN . 79.0 mt -108.5 77.15 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.09 -1.007 . . . . 0.0 110.118 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.83 78.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.327 -0.858 . . . . 0.0 108.824 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 77.53 55.51 4.23 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.794 ' CD ' HG23 ' A' ' 409' ' ' ILE . 4.4 mt-30 -47.62 -63.35 1.08 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.39 -1.065 . . . . 0.0 110.994 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -135.83 37.61 2.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -0.897 . . . . 0.0 110.364 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 52.9 54.95 9.66 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.901 -1.125 . . . . 0.0 110.864 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.41 66.46 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.211 -0.931 . . . . 0.0 109.944 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -122.15 41.19 3.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 11.3 t0 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.18 -179.963 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.79 81.13 1.66 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.435 1.229 . . . . 0.0 110.379 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 5.8 tp -137.53 141.67 41.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.172 -0.955 . . . . 0.0 110.224 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 113.06 -132.75 10.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.1 p -140.96 90.96 2.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.213 -1.169 . . . . 0.0 110.204 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -116.93 104.36 1.2 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 2.7 m -137.17 135.16 37.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.171 -1.194 . . . . 0.0 110.171 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -129.16 -174.63 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.197 -0.939 . . . . 0.0 110.286 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 98.93 48.07 1.81 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -147.78 -66.64 0.25 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.162 -1.199 . . . . 0.0 110.421 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.408 ' C ' HG23 ' A' ' 374' ' ' VAL . 10.7 mptt -129.35 47.95 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.183 -0.948 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.408 HG23 ' C ' ' A' ' 373' ' ' LYS . 66.4 t -146.16 158.41 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.88 . . . . 0.0 109.893 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -80.27 81.68 6.48 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.172 -0.955 . . . . 0.0 109.979 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.56 16.52 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.308 -0.87 . . . . 0.0 110.726 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.0 m -67.09 130.21 42.39 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.14 162.33 0.31 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.16 -0.962 . . . . 0.0 110.523 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.48 156.73 27.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.09 -1.006 . . . . 0.0 109.839 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -62.75 -31.04 71.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.987 -1.071 . . . . 0.0 110.725 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -80.09 -33.07 39.08 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.021 -1.05 . . . . 0.0 110.228 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 79.46 -89.34 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.45 -3.46 18.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.323 -1.104 . . . . 0.0 112.338 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.35 17.15 18.72 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.505 -1.372 . . . . 0.0 112.653 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.7 t -45.32 137.27 4.8 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 120.664 -1.273 . . . . 0.0 110.853 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.7 p90 -117.46 -40.98 3.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.926 . . . . 0.0 111.875 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.464 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -55.99 156.66 5.13 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.731 -1.231 . . . . 0.0 110.168 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.07 68.19 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.743 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.78 143.43 28.62 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 109.628 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.03 -70.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.435 1.229 . . . . 0.0 110.594 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 9.9 p -38.18 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 O-C-N 121.221 -0.925 . . . . 0.0 112.94 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -69.19 -42.07 76.3 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.918 -1.114 . . . . 0.0 109.144 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -55.93 -36.72 68.04 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.247 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -77.47 -26.39 51.33 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.452 -0.78 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.66 -34.57 19.72 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.856 -1.152 . . . . 0.0 110.673 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -117.85 146.97 43.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.925 -1.109 . . . . 0.0 110.449 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.11 162.87 13.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.239 -0.913 . . . . 0.0 110.961 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -135.08 157.62 76.56 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.728 -0.607 . . . . 0.0 110.507 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.2 141.48 88.28 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 N-CA-C 107.78 -1.661 . . . . 0.0 107.78 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.19 65.28 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.5 140.07 43.72 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.727 -1.455 . . . . 0.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.9 t -50.58 -24.38 3.21 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.045 -1.034 . . . . 0.0 112.858 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.45 15.63 23.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.435 -1.416 . . . . 0.0 113.467 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.406 ' CZ ' ' O ' ' A' ' 406' ' ' GLY . 20.2 t80 -47.34 123.23 5.35 Favored 'General case' 0 N--CA 1.524 3.257 0 CA-C-N 120.363 1.438 . . . . 0.0 110.767 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -61.67 -38.01 95.18 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.406 ' O ' ' CZ ' ' A' ' 404' ' ' TYR . . . 127.31 -130.93 7.0 Favored Glycine 0 C--O 1.216 -0.989 0 N-CA-C 107.671 -2.172 . . . . 0.0 107.671 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.5 93.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 121.687 -0.89 . . . . 0.0 110.324 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -112.95 89.85 3.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.245 -0.909 . . . . 0.0 109.986 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.407 HG23 ' CG ' ' A' ' 412' ' ' GLN . 11.1 mt -107.23 82.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.127 -0.983 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 410' ' ' VAL . 59.1 t -118.55 57.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.0 109.472 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 412' ' ' GLN . . . 126.81 -46.18 1.1 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.407 ' CG ' HG23 ' A' ' 409' ' ' ILE . 10.7 mt-30 65.3 -65.96 0.15 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.832 -0.804 . . . . 0.0 111.214 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.12 39.01 0.99 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.041 -1.037 . . . . 0.0 110.596 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -116.66 40.75 2.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.119 -0.988 . . . . 0.0 110.215 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.03 65.35 0.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 110.021 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.8 43.14 3.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.174 -0.954 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.1 t0 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.197 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.79 134.01 21.14 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.339 1.179 . . . . 0.0 110.407 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 7.4 tp -133.59 130.76 38.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -0.974 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 137.36 165.97 10.59 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.65 102.44 4.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.247 -1.149 . . . . 0.0 110.273 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.496 ' O ' ' CE1' ' A' ' 395' ' ' HIS . . . 72.82 74.29 0.8 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.1 m -144.1 86.87 1.86 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.251 -1.147 . . . . 0.0 110.326 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -126.79 100.31 6.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.194 -0.941 . . . . 0.0 110.043 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -140.56 41.69 1.26 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -146.93 -67.63 0.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.13 -1.218 . . . . 0.0 110.522 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -156.8 74.86 0.82 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.105 -0.997 . . . . 0.0 110.582 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.2 t -145.23 161.01 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.141 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -86.63 93.97 9.35 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.371 -0.83 . . . . 0.0 109.437 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 155.82 10.77 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.611 -0.681 . . . . 0.0 110.467 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -83.03 138.75 33.61 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 157.79 0.73 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.13 -0.981 . . . . 0.0 110.602 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.8 t -77.98 158.01 29.46 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -62.24 -30.94 71.46 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 120.878 -1.139 . . . . 0.0 110.473 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.401 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 14.2 m-85 -81.04 -31.84 34.34 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.089 -1.007 . . . . 0.0 110.412 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 77.35 -89.05 1.01 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 -1.75 21.09 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.193 -1.18 . . . . 0.0 112.138 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -115.95 18.2 15.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.497 -1.377 . . . . 0.0 112.69 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.401 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.4 t -46.3 137.63 6.16 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 120.612 -1.305 . . . . 0.0 110.517 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.7 p90 -115.14 -40.44 3.47 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.295 -0.878 . . . . 0.0 112.011 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -60.94 149.8 35.36 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.778 -1.202 . . . . 0.0 109.551 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.23 69.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.271 -0.893 . . . . 0.0 110.613 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.11 151.76 42.71 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.24 -68.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.52 1.274 . . . . 0.0 111.027 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 8.2 p -40.52 -32.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 O-C-N 121.155 -0.965 . . . . 0.0 112.782 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.04 -39.07 83.14 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.959 -1.088 . . . . 0.0 109.445 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.55 -32.1 71.18 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -27.01 59.45 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.391 -0.818 . . . . 0.0 111.427 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 368' ' ' GLY . 1.2 m-70 -93.45 -34.51 13.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.836 -1.165 . . . . 0.0 111.162 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.23 140.19 48.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.993 -1.067 . . . . 0.0 110.807 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.8 t -91.68 165.15 13.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.391 -0.818 . . . . 0.0 110.637 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.91 157.94 72.3 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.802 -0.561 . . . . 0.0 109.764 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.53 140.55 82.21 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.28 -1.52 62.58 Favored Glycine 0 CA--C 1.552 2.38 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.935 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -110.64 142.5 42.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.442 -1.622 . . . . 0.0 108.403 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.3 t -50.88 -26.78 6.27 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.201 -0.937 . . . . 0.0 112.472 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -102.24 8.94 40.35 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.505 -1.372 . . . . 0.0 113.157 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 406' ' ' GLY . 23.3 t80 -47.07 125.37 7.57 Favored 'General case' 0 N--CA 1.52 3.07 0 CA-C-N 120.305 1.412 . . . . 0.0 110.969 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -76.65 -29.67 57.38 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.09 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 404' ' ' TYR . . . 116.04 -118.05 4.11 Favored Glycine 0 C--O 1.217 -0.944 0 N-CA-C 106.879 -2.488 . . . . 0.0 106.879 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.76 92.78 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.705 -0.88 . . . . 0.0 110.724 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -131.72 89.28 2.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.258 -0.901 . . . . 0.0 109.666 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 73.3 mt -103.65 70.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.149 -0.969 . . . . 0.0 109.932 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.59 80.06 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 108.855 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 412' ' ' GLN . . . 107.95 -67.18 0.23 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 411' ' ' GLY . 11.2 mm100 77.34 -60.65 0.44 Allowed 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 123.407 0.683 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -103.76 38.67 1.76 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.035 -1.041 . . . . 0.0 110.075 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -142.53 52.4 1.43 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.248 -0.908 . . . . 0.0 110.222 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 66.29 0.66 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.247 -0.908 . . . . 0.0 110.048 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.71 84.83 2.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 110.212 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.3 t0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.172 -179.944 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.76 139.42 30.63 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.455 1.239 . . . . 0.0 110.436 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.2 tp -137.88 41.55 2.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.219 -0.925 . . . . 0.0 110.185 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -131.52 51.98 0.84 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.6 t -133.28 81.83 1.96 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.257 -1.143 . . . . 0.0 110.231 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -123.7 -90.98 0.95 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 12.1 p -120.73 121.86 39.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -1.157 . . . . 0.0 110.198 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -131.91 77.46 1.76 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.153 -0.967 . . . . 0.0 110.024 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -138.53 40.73 1.43 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -145.28 -67.33 0.31 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.126 -1.22 . . . . 0.0 110.407 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.401 ' C ' HG23 ' A' ' 374' ' ' VAL . 17.6 mttt -137.91 60.71 1.62 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.083 -1.01 . . . . 0.0 110.298 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 373' ' ' LYS . 67.8 t -145.24 161.01 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.105 -0.997 . . . . 0.0 110.295 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -93.01 96.37 10.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.31 -0.869 . . . . 0.0 109.246 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.452 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 3.1 mtt85 -54.61 -179.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.422 -0.799 . . . . 0.0 111.029 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -107.15 128.64 54.58 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.464 ' HB3' ' N ' ' A' ' 406' ' ' GLY . 9.5 p -52.5 117.26 2.74 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.241 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.2 t -36.37 151.64 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 381' ' ' TYR . 10.8 ptp -51.12 -30.02 15.09 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.403 ' N ' ' HG3' ' A' ' 380' ' ' MET . 53.6 m-85 -84.96 -23.7 28.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.152 -0.967 . . . . 0.0 111.318 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.13 -82.95 0.12 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 120.361 -1.462 . . . . 0.0 109.935 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.01 -0.11 21.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.297 -1.119 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -119.5 19.69 12.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.398 -1.439 . . . . 0.0 113.153 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.1 t -47.66 143.25 3.95 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 120.171 1.35 . . . . 0.0 110.552 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.6 p90 -120.14 -39.38 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.324 -0.86 . . . . 0.0 112.222 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.44 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.7 ptp85 -67.66 145.27 54.97 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.719 -1.238 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 73.13 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.977 . . . . 0.0 111.384 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.55 150.8 40.58 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.945 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.31 -73.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.305 1.16 . . . . 0.0 110.477 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.6 t -41.84 -29.5 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 120.885 -1.134 . . . . 0.0 112.082 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.418 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 30.0 t60 -63.19 -35.09 79.16 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.604 -1.31 . . . . 0.0 109.307 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.01 -26.75 67.68 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -31.57 57.47 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.913 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -82.75 -40.48 20.47 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.872 -1.142 . . . . 0.0 110.397 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -110.02 165.36 11.79 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.294 -0.879 . . . . 0.0 109.685 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -112.38 169.16 9.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -143.35 160.21 52.46 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.035 . . . . 0.0 110.304 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.05 137.71 68.57 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 108.778 -1.278 . . . . 0.0 108.778 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.33 62.54 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.364 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.59 139.35 45.93 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.411 1.605 . . . . 0.0 108.427 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 51.1 m -49.18 -26.13 2.66 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.188 -0.945 . . . . 0.0 112.679 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -97.8 2.58 49.59 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.394 -1.441 . . . . 0.0 114.433 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 378' ' ' SER . 4.6 t80 -39.79 124.5 1.73 Allowed 'General case' 0 N--CA 1.533 3.688 0 CA-C-N 120.683 1.583 . . . . 0.0 111.029 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.99 77.4 0.11 Allowed Glycine 0 N--CA 1.5 2.961 0 C-N-CA 119.224 -1.465 . . . . 0.0 111.27 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.464 ' N ' ' HB3' ' A' ' 378' ' ' SER . . . -151.71 -58.37 0.01 OUTLIER Glycine 0 N--CA 1.497 2.759 0 C-N-CA 119.622 -1.275 . . . . 0.0 111.513 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 407' ' ' VAL . 14.5 p -118.96 69.31 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 118.65 1.225 . . . . 0.0 112.266 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -126.89 93.34 3.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.013 -1.054 . . . . 0.0 109.366 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.592 HG23 ' CD ' ' A' ' 412' ' ' GLN . 64.9 mt -80.77 68.67 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 121.185 -0.947 . . . . 0.0 109.778 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 63.7 t -123.13 66.89 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 95.21 51.41 1.89 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.592 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.7 mt-30 -48.39 -61.9 1.77 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.49 -1.006 . . . . 0.0 110.903 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -126.15 37.25 4.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.377 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -126.86 40.35 3.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 110.16 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.6 t -139.02 59.21 1.62 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 0.0 110.089 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -102.6 38.92 1.61 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.275 -0.89 . . . . 0.0 109.969 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.233 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.7 108.26 2.51 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.382 1.201 . . . . 0.0 110.49 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 13.8 tp -133.93 134.97 43.24 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.278 -0.888 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -99.12 142.34 16.0 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 21.8 t -142.25 128.55 19.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.14 -1.212 . . . . 0.0 110.246 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.15 108.94 0.65 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 15.6 m -127.36 103.22 7.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -1.187 . . . . 0.0 110.213 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -138.42 -172.9 3.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.907 . . . . 0.0 110.065 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -86.19 -110.98 0.81 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -126.73 73.56 1.41 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -1.137 . . . . 0.0 109.917 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 4.7 mptt 53.53 60.73 3.51 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.977 -1.077 . . . . 0.0 110.465 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.27 161.75 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.224 -0.923 . . . . 0.0 110.678 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.74 89.91 6.82 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.779 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.419 ' NE ' ' O ' ' A' ' 394' ' ' GLN . 2.5 mmt-85 -62.14 151.85 34.62 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.319 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.3 t -74.0 140.91 45.8 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.9 p -57.18 157.29 6.29 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.316 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -73.15 161.57 30.44 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.044 -1.035 . . . . 0.0 110.232 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -31.83 71.68 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -85.08 -21.53 29.3 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.105 -0.997 . . . . 0.0 110.564 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.4 -86.61 0.11 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.48 -8.7 18.91 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -1.174 . . . . 0.0 112.243 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -106.63 12.96 28.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.48 -1.388 . . . . 0.0 112.975 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.1 t -47.0 142.28 3.63 Favored 'General case' 0 N--CA 1.524 3.235 0 O-C-N 120.534 -1.354 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.4 p90 -121.13 -37.05 3.0 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.275 -0.891 . . . . 0.0 112.67 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.7 ptm180 -55.11 157.13 3.55 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.742 -1.224 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -129.01 64.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.0 110.749 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -111.74 148.31 38.66 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.076 -1.015 . . . . 0.0 109.93 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.66 -69.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.444 1.234 . . . . 0.0 110.493 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.8 t -43.01 -29.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.177 0 O-C-N 120.819 -1.175 . . . . 0.0 111.752 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.24 -36.26 83.6 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.507 -1.371 . . . . 0.0 108.903 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -57.89 -30.03 65.53 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.071 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.419 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -82.42 -28.65 31.24 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.179 -0.951 . . . . 0.0 110.444 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -75.44 -34.26 60.96 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.969 -1.082 . . . . 0.0 110.873 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -134.65 149.18 50.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.004 -1.06 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.0 t -93.85 164.91 12.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.772 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.15 159.16 70.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.35 138.94 74.35 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.54 -2.08 60.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -176.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -110.07 138.9 45.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 119.14 1.47 . . . . 0.0 107.657 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.3 -23.24 5.47 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.13 -0.981 . . . . 0.0 112.538 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -103.6 11.97 35.5 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.294 -1.504 . . . . 0.0 113.562 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -47.07 128.67 11.66 Favored 'General case' 0 N--CA 1.523 3.181 0 CA-C-N 120.546 1.521 . . . . 0.0 110.925 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -66.22 -36.83 92.32 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.697 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 125.15 -130.16 7.24 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 73.9 t -131.38 97.76 3.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.697 -0.884 . . . . 0.0 110.452 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.402 ' O ' ' CG ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -138.1 83.17 1.96 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 179.495 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.576 HG23 ' CD ' ' A' ' 412' ' ' GLN . 10.8 mt -103.94 75.34 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.754 -1.216 . . . . 0.0 110.245 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.92 78.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.291 -0.88 . . . . 0.0 108.678 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 80.42 58.62 2.69 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.576 ' CD ' HG23 ' A' ' 409' ' ' ILE . 7.9 mt-30 -48.51 -65.0 0.64 Allowed 'General case' 0 N--CA 1.513 2.719 0 O-C-N 121.413 -1.051 . . . . 0.0 110.951 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -153.38 37.04 0.47 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.167 -0.958 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -117.04 51.69 0.99 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.072 -1.017 . . . . 0.0 110.311 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.39 66.13 0.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.174 -0.954 . . . . 0.0 109.93 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 52.77 40.09 29.9 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.189 -0.944 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.292 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.9 123.65 9.08 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.462 1.243 . . . . 0.0 110.405 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.3 mp -132.86 -61.98 0.82 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.258 -0.902 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -114.52 68.73 0.25 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.1 m -141.2 47.27 1.71 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.233 -1.157 . . . . 0.0 110.26 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 117.86 134.89 5.23 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 52.2 m -141.93 39.55 1.64 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -1.188 . . . . 0.0 110.37 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -149.13 163.96 36.1 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.168 -0.958 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -91.4 -61.89 1.23 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -145.96 63.84 1.23 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.156 -1.203 . . . . 0.0 110.399 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 52.96 63.76 2.12 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.022 -1.049 . . . . 0.0 110.741 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.34 160.35 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.25 88.64 7.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.319 -0.863 . . . . 0.0 109.271 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.483 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 3.3 mmt-85 -61.53 152.18 30.98 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.294 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -73.38 143.64 46.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.463 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 8.5 t -57.35 168.7 0.72 Allowed 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.616 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.9 t -83.23 158.12 22.41 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.075 -1.016 . . . . 0.0 109.832 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 52.8 mtm -56.26 -31.23 63.38 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 121.007 -1.058 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.54 -21.89 35.19 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.081 -1.012 . . . . 0.0 111.052 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.36 -91.95 0.17 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.88 0.66 28.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.448 -1.031 . . . . 0.0 112.271 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -117.49 22.13 12.6 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.471 -1.393 . . . . 0.0 112.299 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 13.2 t -52.31 147.55 7.74 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 120.446 -1.409 . . . . 0.0 109.819 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 19.4 p90 -125.96 -35.63 2.45 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.328 -0.858 . . . . 0.0 112.993 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.474 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.0 ptp85 -61.99 162.09 9.74 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.549 -1.344 . . . . 0.0 109.819 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 66.9 1.39 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.199 -0.938 . . . . 0.0 110.649 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -107.53 145.95 32.34 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.272 -0.892 . . . . 0.0 110.078 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.58 -69.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.342 1.18 . . . . 0.0 110.38 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 91.5 t -44.76 -30.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.126 0 O-C-N 120.854 -1.154 . . . . 0.0 110.972 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.434 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 45.4 t60 -63.73 -36.0 82.43 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.863 -1.148 . . . . 0.0 109.064 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 -27.54 65.19 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.005 -1.059 . . . . 0.0 109.272 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.05 -31.25 25.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.106 -0.996 . . . . 0.0 110.176 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.421 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 25.7 m170 -73.24 -29.05 62.5 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.978 -1.076 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 59.5 m-85 -140.29 145.86 37.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 110.856 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.483 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 45.7 m -90.1 163.13 14.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.473 -0.767 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -139.14 160.89 60.57 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.692 -0.63 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.03 140.12 77.13 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.003 -1.576 . . . . 0.0 108.003 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.8 60.56 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.256 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.27 143.28 45.12 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.367 1.584 . . . . 0.0 107.813 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.9 m -52.81 -30.4 33.06 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.085 -1.009 . . . . 0.0 110.992 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.29 -1.65 57.69 Favored 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -40.85 116.73 0.75 Allowed 'General case' 0 N--CA 1.532 3.657 0 CA-C-N 120.861 1.664 . . . . 0.0 110.903 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -162.59 79.36 0.15 Allowed Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.437 -1.364 . . . . 0.0 111.221 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -154.35 -56.87 0.01 OUTLIER Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.487 -1.339 . . . . 0.0 111.372 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 407' ' ' VAL . 15.0 p -120.72 75.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.068 -1.254 . . . . 0.0 112.247 -178.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -137.68 85.15 2.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.017 -1.052 . . . . 0.0 109.791 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.525 HG23 ' CD ' ' A' ' 412' ' ' GLN . 11.5 mt -101.13 67.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.205 -0.934 . . . . 0.0 109.853 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.2 t -114.14 78.21 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.357 -0.84 . . . . 0.0 108.794 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 79.54 57.82 3.03 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.525 ' CD ' HG23 ' A' ' 409' ' ' ILE . 7.0 mt-30 -48.57 -63.75 1.0 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.384 -1.068 . . . . 0.0 110.868 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.76 36.94 0.96 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.208 -0.932 . . . . 0.0 110.429 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 53.14 40.98 32.11 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.976 -1.077 . . . . 0.0 110.686 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 415' ' ' THR . 6.1 t -132.54 61.73 1.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.31 39.1 1.63 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.156 -0.965 . . . . 0.0 109.919 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.224 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.89 110.31 3.0 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.435 1.229 . . . . 0.0 110.37 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.7 mt -117.93 150.28 39.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.186 -0.946 . . . . 0.0 110.301 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 112.69 -135.14 12.45 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.7 p -119.22 128.38 54.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.224 -1.162 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -91.66 -147.35 19.99 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.9 m -117.07 -57.12 2.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.5 -178.83 3.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.178 -0.951 . . . . 0.0 110.111 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -62.84 -68.09 1.81 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -149.04 59.42 1.04 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.207 -1.172 . . . . 0.0 110.483 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 7.5 tptt 53.27 64.89 1.69 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.897 -1.127 . . . . 0.0 110.453 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.62 159.52 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.251 -0.906 . . . . 0.0 110.307 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -68.48 82.99 0.26 Allowed 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.473 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt-85 -61.91 152.24 32.53 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.33 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.4 t -71.84 141.52 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.983 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -54.84 161.03 1.71 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.153 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 25.3 t -81.28 155.99 25.78 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.893 -1.129 . . . . 0.0 110.757 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.9 mtm -56.02 -27.53 53.42 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.24 -0.913 . . . . 0.0 110.932 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 87.8 m-85 -84.52 -21.8 30.4 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.05 -1.032 . . . . 0.0 110.723 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.61 -93.55 0.21 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.08 0.18 23.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.291 -1.123 . . . . 0.0 112.182 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -116.65 23.41 12.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.475 -1.391 . . . . 0.0 111.837 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 14.0 t -52.63 144.22 14.31 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 120.533 -1.355 . . . . 0.0 109.962 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 16.3 p90 -122.9 -36.44 2.88 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.603 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.482 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.08 161.52 26.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.592 -1.318 . . . . 0.0 109.265 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -150.41 111.16 4.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.0 111.223 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -120.06 166.87 13.83 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 109.775 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.36 -28.89 14.49 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.312 1.164 . . . . 0.0 110.395 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.79 -22.94 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.014 -1.054 . . . . 0.0 111.676 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -61.75 -38.04 86.52 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.603 -1.31 . . . . 0.0 109.644 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.83 -28.59 61.77 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.149 -0.97 . . . . 0.0 109.43 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.93 -32.43 25.09 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.404 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 15.8 m170 -71.62 -31.04 66.46 Favored 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.021 -1.049 . . . . 0.0 111.64 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 36.9 m-85 -140.71 148.53 40.9 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.802 -1.186 . . . . 0.0 110.857 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 376' ' ' ARG . 18.3 m -86.81 169.52 12.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.444 -0.785 . . . . 0.0 110.657 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.37 157.84 58.87 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.592 -0.693 . . . . 0.0 109.782 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 138.96 73.4 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.114 -1.533 . . . . 0.0 108.114 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.04 54.76 Favored Glycine 0 CA--C 1.553 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.042 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.14 147.62 40.02 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.733 -1.451 . . . . 0.0 107.902 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 48.0 t -58.71 -27.05 64.51 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.725 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.62 -0.56 57.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.681 -1.262 . . . . 0.0 113.918 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -45.37 125.23 5.43 Favored 'General case' 0 N--CA 1.521 3.095 0 CA-C-N 120.81 1.641 . . . . 0.0 110.789 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -71.86 -32.22 63.97 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 121.37 -127.16 6.82 Favored Glycine 0 C--O 1.218 -0.893 0 N-CA-C 106.62 -2.592 . . . . 0.0 106.62 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 64.9 t -138.27 97.95 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.663 -0.904 . . . . 0.0 110.667 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.63 85.86 1.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.179 -0.951 . . . . 0.0 110.982 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.834 HG23 ' CD ' ' A' ' 412' ' ' GLN . 5.2 mp -111.66 72.56 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.974 -1.079 . . . . 0.0 109.827 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 50.7 t -113.27 79.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 73.94 53.67 6.96 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.834 ' CD ' HG23 ' A' ' 409' ' ' ILE . 3.2 mt-30 -47.05 -57.27 5.22 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.365 -1.079 . . . . 0.0 111.192 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -143.42 39.32 1.41 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.296 -0.878 . . . . 0.0 110.335 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.11 65.02 1.13 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.13 -0.981 . . . . 0.0 110.144 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.98 65.22 0.64 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.179 -0.95 . . . . 0.0 109.918 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -115.28 41.57 2.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.317 -0.864 . . . . 0.0 110.264 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.214 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.72 79.83 1.85 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.453 1.238 . . . . 0.0 110.408 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 3.4 mt -136.8 114.96 11.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.969 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 130.97 60.58 0.09 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 t -142.74 79.71 1.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.143 -1.21 . . . . 0.0 110.248 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.18 -121.93 2.01 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 10.4 p -121.73 85.66 2.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -1.196 . . . . 0.0 110.345 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -127.36 77.43 1.74 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.929 . . . . 0.0 110.087 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.48 41.26 1.11 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -135.61 -61.16 0.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.151 -1.205 . . . . 0.0 109.943 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.81 59.54 1.69 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.04 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.6 t -145.88 161.46 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.991 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -89.53 96.02 10.52 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.251 -0.905 . . . . 0.0 109.427 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.89 150.57 39.12 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.344 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.2 t -76.58 -179.66 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.183 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 404' ' ' TYR . 0.1 OUTLIER -97.16 126.81 42.59 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.004 -1.06 . . . . 0.0 110.82 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -45.07 145.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.614 -0.679 . . . . 0.0 112.333 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 11.3 ptp -49.4 -28.08 4.76 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.469 -0.769 . . . . 0.0 111.031 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -86.81 -22.47 25.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.942 -1.099 . . . . 0.0 111.214 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.65 -84.87 0.04 OUTLIER Glycine 0 N--CA 1.497 2.703 0 O-C-N 120.495 -1.378 . . . . 0.0 110.784 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.11 -9.74 17.6 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.202 -1.175 . . . . 0.0 112.569 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -112.84 18.69 17.99 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.521 -1.362 . . . . 0.0 113.22 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 30.9 t -47.89 139.13 8.04 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.055 1.298 . . . . 0.0 110.239 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 37.5 p90 -116.22 -40.68 3.23 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.461 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -71.35 162.75 28.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.904 -1.122 . . . . 0.0 109.154 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -155.99 104.07 2.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.177 -0.952 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.49 165.3 14.7 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 -24.74 18.58 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.437 1.23 . . . . 0.0 110.588 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.22 -21.73 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.039 -1.038 . . . . 0.0 111.756 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.442 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 45.5 t60 -63.84 -38.19 90.18 Favored 'General case' 0 N--CA 1.512 2.663 0 O-C-N 120.517 -1.364 . . . . 0.0 110.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -58.1 -30.61 66.41 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -32.14 44.93 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.876 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -77.82 -37.76 47.88 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.119 -0.988 . . . . 0.0 110.589 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.9 m-85 -125.18 150.52 46.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.1 t -94.7 174.48 7.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.161 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -144.33 156.49 57.36 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.764 . . . . 0.0 109.278 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.14 138.9 80.88 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.61 -2.54 55.95 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.791 -1.195 . . . . 0.0 110.874 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.14 146.87 39.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.699 1.75 . . . . 0.0 108.415 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.8 t -54.48 -28.45 44.82 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.124 -0.985 . . . . 0.0 111.645 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -92.12 1.44 57.21 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 0.0 113.058 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 378' ' ' SER . 23.3 t80 -48.58 132.61 17.28 Favored 'General case' 0 N--CA 1.514 2.76 0 CA-C-N 120.391 1.451 . . . . 0.0 110.253 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -126.17 16.09 6.8 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.636 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -54.55 -29.67 48.59 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-N 119.942 1.871 . . . . 0.0 111.042 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 407' ' ' VAL . 89.3 t -99.9 67.77 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.443 -1.034 . . . . 0.0 109.494 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -66.46 78.92 0.1 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.291 -0.88 . . . . 0.0 109.48 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.566 HG23 ' CD ' ' A' ' 412' ' ' GLN . 13.5 mt 51.33 67.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.07 -1.019 . . . . 0.0 110.42 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 410' ' ' VAL . 70.4 t -120.56 65.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.73 51.48 1.96 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.566 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.5 mt-30 -49.07 -61.86 1.84 Allowed 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.441 -1.035 . . . . 0.0 110.702 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -122.34 36.97 4.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.325 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -140.99 54.29 1.57 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.194 -0.941 . . . . 0.0 110.098 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 66.43 0.64 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.191 -0.943 . . . . 0.0 110.079 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -116.3 83.8 2.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.332 -0.855 . . . . 0.0 110.225 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.168 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.81 129.53 14.55 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.445 1.234 . . . . 0.0 110.372 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 12.3 tp -142.87 115.73 8.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -79.3 130.81 10.13 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.7 t -132.11 81.52 1.97 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.223 -1.163 . . . . 0.0 110.302 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 97.63 149.7 25.56 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.41 124.46 43.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -1.168 . . . . 0.0 110.147 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.87 171.05 15.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.168 -0.958 . . . . 0.0 110.417 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -95.88 -43.59 3.29 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -146.07 53.67 1.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.166 -1.196 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 10.0 mttt 52.97 61.88 2.96 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.01 -1.057 . . . . 0.0 110.754 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.7 p -138.52 161.52 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 110.831 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -83.29 99.22 9.86 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.452 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -72.64 152.99 41.45 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.803 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -73.43 141.8 46.91 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.439 ' HB2' ' N ' ' A' ' 406' ' ' GLY . 8.2 t -58.18 158.49 6.97 Favored 'General case' 0 N--CA 1.511 2.606 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.503 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.83 151.46 35.88 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.911 -1.118 . . . . 0.0 110.577 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -52.91 -28.59 24.09 Favored 'General case' 0 N--CA 1.514 2.76 0 O-C-N 121.226 -0.921 . . . . 0.0 111.118 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.412 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 8.8 m-85 -77.34 -31.95 54.84 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.977 -1.077 . . . . 0.0 110.169 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.94 -90.91 0.89 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.34 4.98 29.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.331 -1.099 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -128.34 25.78 5.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.556 -1.34 . . . . 0.0 112.191 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.412 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 34.4 t -50.66 143.77 9.05 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 120.668 -1.27 . . . . 0.0 110.165 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 13.3 p90 -116.4 -36.01 4.12 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.284 -0.885 . . . . 0.0 112.001 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -73.52 149.54 42.16 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.831 -1.168 . . . . 0.0 109.694 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.5 100.89 3.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.062 -1.024 . . . . 0.0 111.171 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.21 164.57 21.84 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 109.848 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.41 -29.93 16.05 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.324 1.171 . . . . 0.0 110.447 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.14 -23.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.12 -0.988 . . . . 0.0 111.304 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -61.7 -37.45 84.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.764 -1.21 . . . . 0.0 109.637 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -57.73 -26.06 61.27 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.47 -30.3 30.05 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 11.6 m170 -79.32 -34.22 42.49 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.159 -0.963 . . . . 0.0 111.336 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 65.6 m-85 -133.26 142.43 48.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.224 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 56.0 m -85.71 169.27 13.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.401 -0.812 . . . . 0.0 110.167 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -144.39 158.75 53.77 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.6 -0.687 . . . . 0.0 109.923 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.09 137.43 66.63 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 N-CA-C 108.341 -1.446 . . . . 0.0 108.341 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.12 -1.94 56.45 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.698 -178.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.24 150.75 40.89 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.651 -1.499 . . . . 0.0 107.564 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 81.3 p -60.32 -32.07 70.88 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.456 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.8 -11.44 60.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.028 -1.045 . . . . 0.0 112.634 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -45.49 113.49 0.6 Allowed 'General case' 0 N--CA 1.517 2.886 0 CA-C-N 120.288 1.404 . . . . 0.0 110.214 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -163.82 78.93 0.14 Allowed Glycine 0 N--CA 1.499 2.875 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.6 -178.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.439 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -150.95 -55.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.865 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.93 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 407' ' ' VAL . 12.5 p -111.21 61.85 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.118 -1.225 . . . . 0.0 110.509 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -132.17 92.13 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.425 -0.797 . . . . 0.0 109.91 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.569 HG23 ' CD ' ' A' ' 412' ' ' GLN . 68.7 mt -96.66 66.77 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.304 -0.873 . . . . 0.0 109.716 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 67.2 t -117.48 69.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 91.7 53.87 2.03 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.569 ' CD ' HG23 ' A' ' 409' ' ' ILE . 5.0 mt-30 -48.34 -62.99 1.2 Allowed 'General case' 0 N--CA 1.511 2.613 0 O-C-N 121.433 -1.039 . . . . 0.0 110.959 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -139.85 38.48 1.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.095 -1.003 . . . . 0.0 110.24 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -116.99 47.88 1.41 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.212 -0.93 . . . . 0.0 110.21 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.55 66.57 0.66 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.129 -0.982 . . . . 0.0 110.076 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -121.89 40.5 3.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.238 -0.914 . . . . 0.0 110.231 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.213 -179.952 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.78 168.14 25.36 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.419 1.22 . . . . 0.0 110.372 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 86.5 mt -133.37 177.14 7.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 104.99 58.16 0.67 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.0 t -143.24 96.08 2.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.121 -1.223 . . . . 0.0 110.386 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 96.51 125.4 4.89 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.1 m -145.67 60.31 1.27 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.201 -1.176 . . . . 0.0 110.447 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -142.62 44.1 1.61 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.045 -1.034 . . . . 0.0 110.21 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -147.33 40.11 1.01 Allowed Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -126.96 -59.11 1.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.248 -1.148 . . . . 0.0 110.079 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -137.75 50.55 1.93 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.298 -0.876 . . . . 0.0 110.258 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.28 160.22 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.055 -1.028 . . . . 0.0 110.634 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -88.37 94.53 9.88 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -67.75 150.25 48.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.456 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.7 t -78.92 172.12 14.23 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.771 -179.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 p -76.99 157.53 31.15 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.076 -1.015 . . . . 0.0 109.272 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.42 160.74 29.91 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.429 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.5 ptp -61.45 -35.31 77.26 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.901 -1.125 . . . . 0.0 109.944 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.409 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 15.4 m-85 -77.14 -33.48 56.69 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.484 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 76.13 -87.64 0.89 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.75 -3.19 20.74 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.261 -1.141 . . . . 0.0 112.469 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -115.44 17.33 16.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.415 -1.428 . . . . 0.0 112.809 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.409 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 8.6 t -45.14 139.69 3.19 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-N 120.059 1.3 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 33.5 p90 -117.22 -39.39 3.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.313 -0.867 . . . . 0.0 112.363 -178.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.446 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.4 ptp85 -57.28 156.58 7.36 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 120.632 -1.293 . . . . 0.0 110.165 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.93 65.56 1.2 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 110.871 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -109.95 144.15 29.41 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.113 -0.992 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.47 -71.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.358 1.189 . . . . 0.0 110.529 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 71.8 t -41.48 -28.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 O-C-N 120.885 -1.134 . . . . 0.0 112.318 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.435 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 27.2 t60 -65.23 -37.6 87.75 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 120.496 -1.378 . . . . 0.0 108.66 177.378 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -57.37 -31.04 65.38 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.068 -1.02 . . . . 0.0 109.35 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 -26.99 39.95 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.211 -0.931 . . . . 0.0 110.737 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -81.85 -37.88 26.29 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.002 -1.062 . . . . 0.0 110.185 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.5 m-85 -125.15 145.44 49.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 1.8 t -94.22 170.35 9.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.34 158.77 65.75 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.664 -0.647 . . . . 0.0 109.983 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.61 139.74 82.89 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 108.153 -1.518 . . . . 0.0 108.153 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.41 -1.63 60.47 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.807 -176.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -112.62 141.5 46.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.619 -1.518 . . . . 0.0 107.983 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.0 m -51.6 -28.53 14.41 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.149 -0.969 . . . . 0.0 111.752 -178.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.682 -1.261 . . . . 0.0 113.355 -178.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.426 ' CE2' ' HA2' ' A' ' 406' ' ' GLY . 26.0 t80 -43.79 126.45 4.67 Favored 'General case' 0 N--CA 1.522 3.128 0 CA-C-N 120.466 1.485 . . . . 0.0 111.121 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.6 -24.08 44.16 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.227 -178.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 404' ' ' TYR . . . 115.99 -119.98 4.74 Favored Glycine 0 C--O 1.218 -0.866 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 -179.359 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 64.1 t -138.7 97.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.821 -0.811 . . . . 0.0 110.526 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -157.43 87.11 0.95 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.335 -0.853 . . . . 0.0 110.444 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.535 HG23 ' CD ' ' A' ' 412' ' ' GLN . 74.9 mt -88.37 71.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.908 -1.12 . . . . 0.0 110.056 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.5 t -126.62 67.62 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 95.88 51.31 1.81 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -178.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.535 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.4 mt-30 -48.85 -56.04 9.9 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 121.379 -1.071 . . . . 0.0 110.565 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -119.57 32.69 5.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.302 -0.874 . . . . 0.0 110.564 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.97 62.65 1.07 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.071 -1.018 . . . . 0.0 109.776 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.25 65.82 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.26 -0.9 . . . . 0.0 110.067 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.55 87.02 2.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.294 -0.879 . . . . 0.0 109.996 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.226 179.959 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.79 169.82 21.1 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.428 1.225 . . . . 0.0 110.481 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 6.5 mt -131.97 103.98 6.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 110.264 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 94.25 43.63 3.71 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.6 m -131.87 -65.33 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.203 -1.175 . . . . 0.0 110.224 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.7 -119.41 5.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.41 128.66 55.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.215 -1.168 . . . . 0.0 110.025 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -127.68 69.1 1.31 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -148.02 38.81 1.03 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -126.38 -60.07 1.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.136 -1.214 . . . . 0.0 109.664 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -133.97 48.13 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.878 . . . . 0.0 109.636 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.48 160.75 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.116 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -95.49 100.51 12.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.494 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.7 OUTLIER -80.89 161.75 24.24 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.777 -0.577 . . . . 0.0 111.334 -179.219 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.4 t -76.62 174.17 10.71 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.9 t -94.7 129.99 41.37 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.684 -1.26 . . . . 0.0 111.78 -178.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 7.8 t -40.11 148.55 0.08 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.895 -0.503 . . . . 0.0 112.036 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 6.1 ptp -47.64 -37.83 13.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.622 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.437 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 27.9 m-85 -73.58 -35.21 65.39 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.57 -86.62 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.047 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.24 7.06 43.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.26 -1.141 . . . . 0.0 112.847 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -134.87 25.09 3.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.343 -1.473 . . . . 0.0 112.577 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.2 t -49.63 151.72 1.6 Allowed 'General case' 0 N--CA 1.521 3.076 0 O-C-N 120.514 -1.366 . . . . 0.0 111.113 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.1 p90 -126.3 -33.2 2.63 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.992 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.423 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.1 OUTLIER -55.97 173.81 0.14 Allowed 'General case' 0 N--CA 1.514 2.729 0 O-C-N 120.388 -1.445 . . . . 0.0 110.167 179.936 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -143.7 55.88 1.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 110.532 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -112.05 148.18 38.48 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 109.606 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -73.34 -66.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.396 1.208 . . . . 0.0 110.473 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.3 t -43.01 -29.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 120.888 -1.132 . . . . 0.0 111.999 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.4 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 39.0 t60 -63.87 -38.98 93.09 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.665 -1.272 . . . . 0.0 108.824 178.356 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -56.13 -29.27 60.48 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 178.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -29.72 45.23 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.159 -0.963 . . . . 0.0 110.501 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 17.2 m170 -75.33 -35.47 61.19 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.453 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 34.0 m-85 -134.78 138.19 44.07 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.087 -1.008 . . . . 0.0 110.304 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.494 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 1.5 m -81.58 169.48 17.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.518 -0.739 . . . . 0.0 109.23 178.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -141.6 155.22 66.92 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.61 140.07 92.0 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 N-CA-C 108.735 -1.294 . . . . 0.0 108.735 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.57 0.79 64.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.722 -177.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.22 143.81 44.23 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.413 1.606 . . . . 0.0 108.646 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.6 t -50.01 -30.79 11.32 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.09 -1.006 . . . . 0.0 111.839 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.83 -6.15 54.65 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.684 -1.26 . . . . 0.0 113.55 -177.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -39.47 129.55 1.84 Allowed 'General case' 0 N--CA 1.525 3.289 0 CA-C-N 120.551 1.523 . . . . 0.0 111.294 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -173.91 70.62 0.1 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.609 -178.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -137.91 -63.02 0.05 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.128 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 407' ' ' VAL . 96.1 t 41.67 63.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.695 -0.885 . . . . 0.0 111.333 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -113.86 96.54 5.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.28 -0.888 . . . . 0.0 110.518 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.642 HG23 ' CD ' ' A' ' 412' ' ' GLN . 78.7 mt -108.87 71.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.345 -0.847 . . . . 0.0 109.962 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.9 67.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.241 -0.912 . . . . 0.0 108.783 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 92.24 51.4 2.4 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 -178.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.642 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.8 mt-30 -47.81 -62.45 1.45 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 121.432 -1.04 . . . . 0.0 111.058 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.05 39.61 3.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 0.0 110.313 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -123.86 49.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.167 -0.958 . . . . 0.0 110.21 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 415' ' ' THR . 6.4 t -131.41 62.74 1.62 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.161 -0.962 . . . . 0.0 110.111 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.38 39.29 1.61 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.216 -0.928 . . . . 0.0 109.844 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.256 179.934 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.14 -43.68 0.69 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.4 1.211 . . . . 0.0 110.34 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 2.0 tt -127.9 87.88 2.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.141 -0.974 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 106.22 149.2 16.93 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 24.4 p -122.21 136.96 54.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.213 -1.169 . . . . 0.0 110.238 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 130.5 106.98 1.17 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.9 134.85 53.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.22 -1.165 . . . . 0.0 110.221 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.01 167.54 22.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.217 -0.927 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -62.51 -72.0 0.73 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -139.5 57.77 1.63 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.142 -1.211 . . . . 0.0 110.295 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 5.0 mptt 52.31 58.06 5.79 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.955 -1.091 . . . . 0.0 110.76 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.66 152.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 110.062 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -69.84 91.38 0.64 Allowed 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.487 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -58.04 158.28 6.97 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.697 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.5 t -75.08 145.67 42.1 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.449 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 1.3 t -56.44 163.2 1.81 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.646 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 6.1 t -78.34 162.3 26.57 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.04 -1.038 . . . . 0.0 109.8 178.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 47.9 mtm -58.4 -31.16 67.43 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.403 179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.11 -26.11 25.42 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.144 -0.972 . . . . 0.0 110.768 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.19 -89.75 0.6 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.61 -1.19 26.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.343 -1.092 . . . . 0.0 111.956 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -112.51 16.95 19.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.34 -1.475 . . . . 0.0 112.275 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.4 t -49.19 143.84 5.67 Favored 'General case' 0 N--CA 1.519 2.98 0 O-C-N 120.558 -1.339 . . . . 0.0 110.377 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.5 p90 -120.77 -33.94 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.353 -0.842 . . . . 0.0 112.536 -179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -72.64 174.54 7.42 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.709 -1.245 . . . . 0.0 109.618 179.571 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.6 93.3 1.18 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.899 -1.126 . . . . 0.0 111.096 -179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -115.23 162.43 24.44 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.736 -1.227 . . . . 0.0 110.034 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -26.04 12.73 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 O-C-N 123.514 1.27 . . . . 0.0 110.652 178.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.76 -25.42 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.093 -1.004 . . . . 0.0 111.411 178.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -61.88 -36.02 80.02 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.662 -1.273 . . . . 0.0 109.946 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -58.13 -26.67 62.94 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -31.08 27.86 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.178 -0.951 . . . . 0.0 110.468 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.5 m170 -75.46 -34.3 60.93 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.808 -1.183 . . . . 0.0 111.371 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 48.3 m-85 -137.21 145.66 43.92 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.722 -1.236 . . . . 0.0 110.839 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 66.5 m -91.4 169.97 10.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.222 -0.924 . . . . 0.0 111.503 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -141.64 153.54 65.22 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.109 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.34 140.14 81.04 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 N-CA-C 107.253 -1.864 . . . . 0.0 107.253 178.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.31 1.61 60.79 Favored Glycine 0 CA--C 1.553 2.438 0 C-N-CA 119.041 -1.552 . . . . 0.0 110.825 -178.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.66 156.94 24.97 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.837 1.818 . . . . 0.0 107.778 177.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -29.11 70.24 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.207 -179.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -94.41 6.09 49.8 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 120.533 -1.355 . . . . 0.0 114.0 -177.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -48.62 134.62 15.64 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-N 120.643 1.565 . . . . 0.0 109.966 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -155.43 45.04 0.54 Allowed Glycine 0 N--CA 1.497 2.7 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.278 -178.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -109.32 -56.05 0.55 Allowed Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 407' ' ' VAL . 98.5 t 41.95 69.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.862 -0.787 . . . . 0.0 111.639 179.148 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -102.04 53.7 0.81 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.259 -0.9 . . . . 0.0 109.792 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.545 HG23 ' HG2' ' A' ' 412' ' ' GLN . 13.7 mt 50.01 68.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.284 -0.885 . . . . 0.0 110.807 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 410' ' ' VAL . 62.2 t -107.64 65.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 98.18 51.99 1.41 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 -178.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.545 ' HG2' HG23 ' A' ' 409' ' ' ILE . 11.8 mm100 -59.42 -49.77 76.54 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.244 -1.151 . . . . 0.0 109.833 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.75 37.42 2.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.241 -0.912 . . . . 0.0 109.827 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -135.64 62.62 1.62 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.966 . . . . 0.0 110.231 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.0 65.1 0.66 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.014 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -130.37 83.34 2.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.303 -179.999 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.77 130.72 16.12 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.332 1.175 . . . . 0.0 110.38 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.49 -174.18 2.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.263 -0.898 . . . . 0.0 110.249 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -112.81 -58.04 0.43 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 367' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 367' ' ' SER . 9.5 t -132.95 48.62 2.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.171 -1.194 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -126.16 142.98 14.08 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.3 p -122.67 -65.77 1.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.249 -1.148 . . . . 0.0 110.055 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -143.97 75.28 1.46 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -0.97 . . . . 0.0 110.237 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -156.91 39.46 0.56 Allowed Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -126.21 -59.62 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.166 -1.197 . . . . 0.0 110.052 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -139.14 52.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.981 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.1 t -142.83 157.24 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 109.931 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 86.88 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.47 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -61.2 153.65 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.293 -179.637 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -71.07 142.46 50.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.425 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 28.8 t -53.05 165.19 0.33 Allowed 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.686 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 45.2 t -87.51 156.97 19.3 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.974 -1.079 . . . . 0.0 109.682 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 4.1 ptp -55.25 -31.61 61.67 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -93.52 -20.74 19.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.974 -1.079 . . . . 0.0 111.439 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.45 -98.86 0.22 Allowed Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.521 -1.362 . . . . 0.0 110.392 178.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.58 -13.32 32.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.429 -1.042 . . . . 0.0 111.764 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -104.51 16.44 26.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.565 -1.335 . . . . 0.0 112.39 -179.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.9 t -48.92 139.78 9.71 Favored 'General case' 0 N--CA 1.52 3.065 0 O-C-N 120.517 -1.364 . . . . 0.0 111.039 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 17.9 p90 -117.03 -37.16 3.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.438 -0.789 . . . . 0.0 111.765 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.457 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.69 153.66 29.15 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.644 -1.285 . . . . 0.0 109.408 179.184 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 108.29 4.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -0.98 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -118.97 167.47 11.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 0.0 110.209 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.15 -27.67 16.58 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.432 1.227 . . . . 0.0 110.319 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.4 t -98.17 -24.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.084 -1.01 . . . . 0.0 111.92 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -61.94 -38.09 87.17 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.6 -1.313 . . . . 0.0 110.113 -179.05 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -56.96 -28.81 62.62 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.83 -1.169 . . . . 0.0 109.148 178.118 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -32.53 30.06 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.238 -0.914 . . . . 0.0 110.275 179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.433 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 22.1 m170 -71.98 -32.0 66.81 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.07 -1.019 . . . . 0.0 111.408 -179.481 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 42.7 m-85 -140.02 148.08 41.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.952 -1.093 . . . . 0.0 111.43 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 15.9 m -87.61 168.76 12.75 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -0.81 . . . . 0.0 110.997 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -143.7 153.33 57.91 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.15 139.08 76.33 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 177.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.4 -0.81 55.78 Favored Glycine 0 CA--C 1.553 2.446 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.757 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -116.41 158.07 24.09 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.662 1.731 . . . . 0.0 108.229 178.139 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 59.2 m -64.02 -28.01 69.51 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.708 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.65 2.38 56.51 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.644 -1.285 . . . . 0.0 114.061 -176.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -48.14 130.58 15.87 Favored 'General case' 0 N--CA 1.523 3.182 0 CA-C-N 120.741 1.61 . . . . 0.0 110.131 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -170.54 76.78 0.1 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.759 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -178.32 56.24 0.09 OUTLIER Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.086 -1.53 . . . . 0.0 112.55 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 99.2 t -75.21 77.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.241 -1.152 . . . . 0.0 109.498 179.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.58 94.87 2.7 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.339 -0.85 . . . . 0.0 109.975 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.673 HG23 ' CD ' ' A' ' 412' ' ' GLN . 5.3 mp -110.96 72.54 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.002 -1.061 . . . . 0.0 110.653 -179.379 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.07 67.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.259 -0.901 . . . . 0.0 108.677 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.21 52.76 2.81 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -178.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.673 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.9 mt-30 -47.5 -65.31 0.59 Allowed 'General case' 0 N--CA 1.513 2.69 0 O-C-N 121.539 -0.977 . . . . 0.0 111.321 -178.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -155.55 39.4 0.39 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.164 -0.96 . . . . 0.0 110.655 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -115.57 45.93 1.59 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.164 -0.96 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.83 66.5 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 0.0 110.005 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.08 42.39 3.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.219 -0.926 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.259 179.915 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 69.8 t . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -89.36 91.85 8.91 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 394' ' ' GLN . 38.5 mtm-85 -60.03 153.98 20.24 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.315 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.1 t -81.01 138.39 36.04 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -52.8 151.87 4.23 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 121.117 -0.989 . . . . 0.0 109.434 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.4 t -75.79 156.96 34.04 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.088 -1.008 . . . . 0.0 110.898 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 45.7 mtm -57.77 -26.17 61.51 Favored 'General case' 0 N--CA 1.516 2.83 0 O-C-N 121.197 -0.94 . . . . 0.0 110.516 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.437 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 39.9 m-85 -89.58 -19.3 25.13 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.975 -1.078 . . . . 0.0 110.926 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.58 -91.06 0.1 OUTLIER Glycine 0 N--CA 1.493 2.444 0 O-C-N 120.674 -1.266 . . . . 0.0 109.994 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.68 -3.1 24.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.401 -1.058 . . . . 0.0 112.251 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -113.8 20.02 16.18 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.557 -1.339 . . . . 0.0 112.225 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 28.7 t -50.26 139.68 14.44 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 120.588 -1.32 . . . . 0.0 110.479 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 36.8 p90 -115.89 -36.4 4.17 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.418 -0.801 . . . . 0.0 111.9 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.6 ptt180 -75.64 160.38 30.15 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.0 109.567 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.78 104.31 2.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.171 -0.955 . . . . 0.0 111.116 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -118.69 165.92 15.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 109.798 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.86 -26.16 19.22 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.246 1.129 . . . . 0.0 110.387 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.36 -20.95 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.951 -1.093 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -65.91 -38.21 88.09 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 120.678 -1.264 . . . . 0.0 110.028 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -58.48 -26.41 63.37 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.231 -0.918 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -80.68 -29.42 36.56 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.167 -0.958 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -87.34 -35.59 18.31 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.872 -1.143 . . . . 0.0 111.597 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 65.0 m-85 -122.24 137.64 54.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.918 -1.114 . . . . 0.0 110.576 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.24 169.18 11.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -144.06 157.73 56.79 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.651 -0.656 . . . . 0.0 109.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.74 138.53 80.13 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.55 -1.7 53.16 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.177 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.29 150.39 31.05 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.383 1.592 . . . . 0.0 108.494 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.8 t -61.06 -23.55 65.54 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.32 4.58 46.49 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 120.523 -1.361 . . . . 0.0 112.851 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 29.2 t80 . . . . . 0 N--CA 1.51 2.572 0 O-C-N 120.417 -1.427 . . . . 0.0 109.457 179.624 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.95 88.43 7.7 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.256 -0.903 . . . . 0.0 109.722 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -51.12 148.72 4.25 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.226 -0.921 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -77.62 131.85 37.98 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 t -49.98 154.27 1.15 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 120.983 -1.073 . . . . 0.0 110.469 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 3.0 t -79.55 159.28 26.93 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.8 mtm -60.05 -26.25 65.99 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.724 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -88.06 -19.75 26.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.956 -1.09 . . . . 0.0 111.166 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 65.88 -89.02 0.12 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.57 2.84 26.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.307 -1.113 . . . . 0.0 112.599 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.0 m-80 -121.21 22.83 10.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.432 -1.417 . . . . 0.0 112.596 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.5 t -58.92 80.26 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 120.792 -1.193 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 384' ' ' ASN . 42.8 p90 -53.97 -30.54 47.39 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 121.109 -0.994 . . . . 0.0 112.26 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 162.74 27.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.928 -1.107 . . . . 0.0 109.411 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -153.72 93.93 1.72 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.241 -0.912 . . . . 0.0 111.195 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -116.66 153.14 49.05 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.0 -72.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.326 1.172 . . . . 0.0 110.749 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.6 t -47.21 -29.18 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 O-C-N 120.76 -1.212 . . . . 0.0 111.118 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -66.02 -35.99 82.06 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.794 -1.191 . . . . 0.0 109.341 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.92 -24.6 67.07 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.276 -0.89 . . . . 0.0 109.876 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -26.78 35.56 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.009 -1.057 . . . . 0.0 111.068 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -91.27 -38.64 12.54 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.876 -1.14 . . . . 0.0 111.579 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 396' ' ' PHE . 56.2 m-85 -114.23 135.33 54.17 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.958 -1.089 . . . . 0.0 110.612 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.38 165.6 13.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.23 -0.919 . . . . 0.0 110.713 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -142.14 159.57 58.22 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.699 -0.626 . . . . 0.0 109.722 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.7 Cg_endo -60.36 140.36 91.36 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.31 64.72 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.422 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.23 146.83 29.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 119.508 1.654 . . . . 0.0 108.469 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.4 m -55.55 -24.6 33.26 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.901 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.55 11.26 28.85 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.547 -1.345 . . . . 0.0 113.115 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 33.1 t80 . . . . . 0 N--CA 1.512 2.654 0 O-C-N 120.38 -1.45 . . . . 0.0 109.519 179.69 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.7 0.286 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -84.78 82.71 8.31 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.369 -0.832 . . . . 0.0 109.34 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.488 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -60.19 152.68 23.99 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.7 t -72.95 141.89 47.81 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.182 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.53 157.93 2.7 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.796 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 15.4 t -79.42 156.37 27.93 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.857 -1.152 . . . . 0.0 110.5 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.6 mtm -57.32 -27.21 62.0 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.137 -0.977 . . . . 0.0 110.84 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 88.8 m-85 -83.31 -23.93 32.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.9 -1.125 . . . . 0.0 110.782 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 68.98 -89.95 0.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 7.87 29.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.262 -1.14 . . . . 0.0 112.769 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 386' ' ' TYR . 68.5 m-80 -132.31 30.8 4.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.333 -1.479 . . . . 0.0 112.408 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 38.5 t -58.28 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 O-C-N 120.999 -1.063 . . . . 0.0 111.091 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 387' ' ' ARG . 33.2 p90 -57.03 -29.46 63.39 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.005 -1.06 . . . . 0.0 111.787 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HB3' ' CE1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -92.22 152.36 19.88 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.906 -1.121 . . . . 0.0 110.451 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -150.4 129.49 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.343 -0.848 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -129.76 168.23 17.33 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.184 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.12 -34.83 9.65 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.47 1.247 . . . . 0.0 110.489 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.95 -22.12 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.151 -0.968 . . . . 0.0 111.333 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.49 -38.33 90.73 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.657 -1.277 . . . . 0.0 109.62 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.92 -27.35 51.79 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.35 -29.42 28.27 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.059 -1.026 . . . . 0.0 110.609 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -80.59 -32.95 36.34 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.999 -1.063 . . . . 0.0 111.951 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -131.56 141.46 49.7 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.87 -1.143 . . . . 0.0 111.011 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.488 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 73.8 m -86.47 168.76 13.46 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.283 -0.886 . . . . 0.0 110.092 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -143.09 158.88 57.79 Favored Pre-proline 0 N--CA 1.484 1.232 0 O-C-N 121.672 -0.643 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 39.5 Cg_endo -62.2 139.15 76.4 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.11 56.06 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.965 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -115.91 156.97 25.23 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.594 1.697 . . . . 0.0 108.272 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.3 m -63.58 -29.34 70.61 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.281 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.12 -2.74 58.85 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.827 -1.171 . . . . 0.0 113.105 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.6 t80 . . . . . 0 N--CA 1.515 2.793 0 CA-C-N 120.514 1.506 . . . . 0.0 110.122 -179.534 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.653 0.263 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.27 94.49 9.56 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.46 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -65.43 173.38 2.68 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.449 -0.782 . . . . 0.0 110.741 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.6 t -90.12 141.44 28.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.388 -0.82 . . . . 0.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.8 t -64.68 120.55 12.64 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.07 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -34.94 148.69 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 35.1 mtm -50.09 -30.84 11.82 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.39 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -85.54 -23.17 27.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.151 -0.968 . . . . 0.0 111.301 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.03 -87.43 0.11 Allowed Glycine 0 N--CA 1.491 2.334 0 O-C-N 120.459 -1.401 . . . . 0.0 110.11 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.33 1.25 27.78 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.294 -1.121 . . . . 0.0 112.61 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -121.85 22.64 10.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.475 -1.39 . . . . 0.0 112.297 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.4 t -47.22 140.23 5.48 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 120.696 -1.253 . . . . 0.0 111.002 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.465 ' OH ' ' NH1' ' A' ' 387' ' ' ARG . 27.2 p90 -113.43 -37.61 4.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.347 -0.845 . . . . 0.0 111.68 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.465 ' NH1' ' OH ' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.98 154.16 28.41 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.77 -1.206 . . . . 0.0 109.497 179.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 100.0 3.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 110.52 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -115.04 167.0 10.55 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.243 -0.91 . . . . 0.0 110.101 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.69 -30.08 12.17 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.425 1.224 . . . . 0.0 110.754 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.9 -23.4 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 121.134 -0.979 . . . . 0.0 111.481 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -60.9 -39.23 88.51 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 120.599 -1.313 . . . . 0.0 109.572 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -55.54 -29.16 58.43 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.094 -1.004 . . . . 0.0 109.578 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.08 39.46 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.587 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -77.7 -33.36 53.22 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.987 -1.07 . . . . 0.0 111.481 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -132.4 137.82 47.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.896 -1.127 . . . . 0.0 110.793 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 73.8 m -79.38 168.23 19.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.278 -0.889 . . . . 0.0 109.085 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.3 159.19 59.16 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.89 137.36 62.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.602 -1.345 . . . . 0.0 108.602 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.24 -0.78 58.75 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.535 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.05 151.63 39.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.208 1.504 . . . . 0.0 108.554 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 40.4 t -58.46 -31.72 68.06 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.237 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.416 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 69.4 m-20 -73.14 -14.77 61.44 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.944 -1.098 . . . . 0.0 113.237 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.481 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 . . . . . 0 N--CA 1.52 3.065 0 CA-C-N 120.192 1.36 . . . . 0.0 111.06 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -85.93 91.96 8.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.299 -0.876 . . . . 0.0 108.997 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -63.27 151.44 40.59 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -71.57 149.61 45.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 28.5 t -62.22 161.83 10.64 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.845 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.06 165.94 23.95 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.01 -1.056 . . . . 0.0 109.466 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -36.5 74.72 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.135 -0.978 . . . . 0.0 110.089 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.79 -24.22 28.83 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.276 -0.89 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 69.42 -83.82 0.26 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.49 -1.63 32.62 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.265 -1.138 . . . . 0.0 113.188 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 386' ' ' TYR . 59.2 m-80 -122.4 14.41 10.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.318 -1.489 . . . . 0.0 113.343 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 45.8 t -45.56 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.393 0 CA-C-N 120.072 1.306 . . . . 0.0 112.668 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 384' ' ' ASN . 48.3 p90 -50.9 -34.9 30.25 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.887 -1.133 . . . . 0.0 111.895 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.431 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.4 OUTLIER -73.95 163.92 27.29 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.019 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -155.86 83.9 1.02 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.253 -0.905 . . . . 0.0 111.015 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -116.41 156.77 46.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.98 -72.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.274 1.144 . . . . 0.0 110.864 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.6 t -45.18 -30.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 120.644 -1.285 . . . . 0.0 111.226 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -65.31 -36.37 83.86 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.882 -1.136 . . . . 0.0 109.25 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -58.28 -28.13 64.69 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.171 -0.956 . . . . 0.0 109.544 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -27.07 46.74 Favored 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.677 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -82.25 -37.23 26.24 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.094 -1.004 . . . . 0.0 110.818 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 49.0 m-85 -129.87 144.54 51.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.05 -1.031 . . . . 0.0 110.077 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 404' ' ' TYR . 2.5 m -95.41 167.9 11.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 111.151 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -140.72 157.72 67.13 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.73 -0.607 . . . . 0.0 109.911 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.406 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 36.5 Cg_endo -60.62 137.28 72.43 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 N-CA-C 108.544 -1.368 . . . . 0.0 108.544 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.52 -0.63 58.28 Favored Glycine 0 CA--C 1.551 2.321 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.315 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.22 139.16 46.84 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.337 1.568 . . . . 0.0 108.159 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.4 t -50.07 -26.46 4.44 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.012 -1.055 . . . . 0.0 112.045 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -96.87 3.1 52.35 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.575 -1.328 . . . . 0.0 113.411 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.415 ' HA ' ' HB3' ' A' ' 397' ' ' SER . 23.4 t80 . . . . . 0 N--CA 1.518 2.938 0 CA-C-N 120.355 1.434 . . . . 0.0 110.52 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.759 0.314 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.94 93.04 9.46 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.272 -0.893 . . . . 0.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 394' ' ' GLN . 13.0 mtt180 -56.07 152.65 10.16 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.385 -0.822 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -82.28 133.33 35.24 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 63.4 p -50.76 153.75 1.62 Allowed 'General case' 0 N--CA 1.515 2.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.135 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.9 t -78.15 155.72 30.29 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.126 -0.984 . . . . 0.0 110.845 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.5 mtm -60.15 -30.01 69.03 Favored 'General case' 0 N--CA 1.51 2.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.26 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.426 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 34.5 m-85 -84.39 -24.19 29.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.048 -1.032 . . . . 0.0 110.64 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.22 -86.84 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.24 -4.5 20.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -1.143 . . . . 0.0 112.337 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -112.4 16.57 19.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.457 -1.402 . . . . 0.0 112.858 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.426 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 14.5 t -46.73 137.31 7.14 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 120.6 -1.312 . . . . 0.0 110.513 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 39.6 p90 -116.91 -39.07 3.3 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.228 -0.92 . . . . 0.0 112.517 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.4 ptp85 -51.95 161.79 0.53 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.646 -1.284 . . . . 0.0 110.82 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -128.31 55.37 1.68 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 0.0 110.492 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.21 140.55 21.25 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.276 -0.89 . . . . 0.0 109.965 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.11 -72.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.258 1.136 . . . . 0.0 110.154 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.2 t -40.12 -28.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 O-C-N 120.864 -1.147 . . . . 0.0 112.497 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.452 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 25.0 t60 -64.22 -37.83 88.87 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 120.492 -1.38 . . . . 0.0 108.568 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -59.79 -30.82 69.16 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.2 -0.938 . . . . 0.0 109.592 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.41 ' HA ' ' NE ' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -77.02 -26.48 53.78 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.186 -0.946 . . . . 0.0 110.85 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -91.69 -38.09 12.63 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.905 -1.122 . . . . 0.0 110.516 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 76.0 m-85 -113.11 138.51 49.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.0 110.49 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.66 168.5 11.44 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 111.224 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -141.48 159.64 59.83 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.77 -0.581 . . . . 0.0 109.66 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.51 139.92 84.44 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.48 -2.55 60.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -107.66 144.66 34.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.592 -1.534 . . . . 0.0 108.215 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 3.0 t -55.18 -24.3 26.24 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.206 -0.934 . . . . 0.0 111.801 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -105.15 7.54 33.78 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.521 -1.362 . . . . 0.0 113.066 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.523 3.184 0 CA-C-N 120.513 1.506 . . . . 0.0 110.876 -179.319 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.634 0.254 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.06 89.88 3.59 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.851 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -57.94 174.18 0.28 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.61 -0.682 . . . . 0.0 111.016 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.6 m -88.45 134.28 33.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 82.9 p -62.92 121.09 12.66 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.539 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 145.69 0.59 Allowed 'General case' 0 N--CA 1.513 2.679 0 O-C-N 121.368 -0.832 . . . . 0.0 112.173 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -46.72 -35.27 5.92 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.627 -0.67 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -78.07 -29.52 49.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.078 -1.014 . . . . 0.0 111.204 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 64.49 -86.19 0.07 OUTLIER Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.24 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -100.82 1.57 40.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.212 -1.169 . . . . 0.0 113.054 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 386' ' ' TYR . 37.3 m-80 -128.76 21.77 5.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.49 -1.381 . . . . 0.0 112.896 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.5 t -55.87 85.79 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 CA-C-N 119.915 1.234 . . . . 0.0 110.704 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 384' ' ' ASN . 28.9 p90 -61.02 -26.75 67.83 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.044 -1.035 . . . . 0.0 111.795 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 149.8 21.17 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.37 127.55 12.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 392' ' ' HIS . 1.5 m-20 -128.62 166.5 24.22 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.11 -33.79 11.15 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.322 1.17 . . . . 0.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.77 -23.28 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.263 -0.898 . . . . 0.0 111.5 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 389' ' ' ASN . 48.9 t60 -62.57 -36.34 82.38 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.689 -1.257 . . . . 0.0 110.229 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.1 -26.36 66.16 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.106 -0.996 . . . . 0.0 109.518 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.1 -30.48 55.37 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.142 -0.974 . . . . 0.0 110.447 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.433 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 19.5 m170 -81.79 -35.4 29.59 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 51.1 m-85 -128.68 139.38 52.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.001 -1.062 . . . . 0.0 111.255 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.13 169.14 16.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.408 -0.808 . . . . 0.0 109.38 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -144.75 153.74 54.79 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.434 -0.791 . . . . 0.0 109.369 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.404 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.3 Cg_endo -61.14 137.46 71.46 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 N-CA-C 108.405 -1.421 . . . . 0.0 108.405 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.34 -1.16 53.83 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.748 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.92 171.69 7.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.649 1.725 . . . . 0.0 108.546 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -24.2 53.11 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.066 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -99.0 1.78 45.74 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.637 -1.289 . . . . 0.0 113.605 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 24.5 t80 . . . . . 0 N--CA 1.522 3.164 0 CA-C-N 120.362 1.437 . . . . 0.0 110.89 -179.552 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -87.05 91.03 8.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.29 151.58 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.372 -0.83 . . . . 0.0 110.25 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.3 t -81.13 136.7 35.93 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.784 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -51.72 149.04 4.92 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 121.155 -0.966 . . . . 0.0 109.964 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.4 t -71.13 163.42 27.64 Favored 'General case' 0 N--CA 1.512 2.627 0 O-C-N 120.944 -1.098 . . . . 0.0 110.495 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 63.7 mtm -62.91 -31.08 72.07 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.227 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -84.41 -23.48 30.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.201 -0.937 . . . . 0.0 110.45 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 70.33 -86.06 0.33 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.55 -4.26 18.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -1.136 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -111.53 16.46 20.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.486 -1.384 . . . . 0.0 112.874 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -47.62 141.0 5.61 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 120.086 1.312 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.2 p90 -121.72 -39.94 2.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 112.285 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.426 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -59.24 149.45 28.49 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.619 -1.301 . . . . 0.0 109.512 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.6 74.73 1.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.159 -0.963 . . . . 0.0 111.111 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.41 148.25 38.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.91 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.34 1.179 . . . . 0.0 110.764 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -42.25 -27.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 O-C-N 120.7 -1.25 . . . . 0.0 112.422 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -66.45 -35.63 80.76 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.456 -1.403 . . . . 0.0 109.238 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.97 -28.82 70.35 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -26.63 57.0 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.224 -0.922 . . . . 0.0 111.297 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 395' ' ' HIS . 18.4 m170 -92.08 -35.52 13.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.852 -1.155 . . . . 0.0 111.238 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -117.55 144.99 44.57 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.064 -1.022 . . . . 0.0 110.521 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.74 168.77 10.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.956 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -140.5 158.3 66.37 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.702 -0.624 . . . . 0.0 110.538 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.42 139.23 75.61 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 107.99 -1.581 . . . . 0.0 107.99 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.73 -3.13 60.73 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.878 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.3 138.1 46.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.627 -1.513 . . . . 0.0 108.466 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -25.67 0.94 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.201 -0.937 . . . . 0.0 113.267 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -106.06 12.96 29.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.512 -1.368 . . . . 0.0 113.192 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.517 2.91 0 O-C-N 120.457 -1.402 . . . . 0.0 109.951 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.74 0.305 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -84.39 82.89 8.19 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.433 ' HA ' ' NE ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -56.56 152.35 12.02 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.186 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -72.34 137.27 46.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 p -49.29 160.2 0.25 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.6 t -83.32 157.76 22.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.201 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.7 ptp -61.59 -36.38 80.51 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.011 -1.055 . . . . 0.0 110.181 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.416 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 16.0 m-85 -77.81 -32.99 52.63 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.171 -0.956 . . . . 0.0 110.29 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.95 -89.15 0.87 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.52 -4.42 19.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -1.056 . . . . 0.0 112.244 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.77 16.65 19.5 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.353 -1.467 . . . . 0.0 112.584 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.416 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 7.3 t -45.86 140.09 3.82 Favored 'General case' 0 N--CA 1.524 3.247 0 O-C-N 120.633 -1.292 . . . . 0.0 110.988 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.8 p90 -116.93 -39.05 3.3 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.381 -0.824 . . . . 0.0 112.279 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.45 ' HD2' ' CG ' ' A' ' 392' ' ' HIS . 6.8 ptp85 -55.19 158.75 2.86 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.651 -1.281 . . . . 0.0 110.564 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -128.12 62.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.248 -0.908 . . . . 0.0 110.517 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.35 145.16 33.14 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.23 -59.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.234 1.123 . . . . 0.0 110.901 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 12.2 p -43.61 -33.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 O-C-N 121.084 -1.01 . . . . 0.0 111.708 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.45 ' CG ' ' HD2' ' A' ' 387' ' ' ARG . 34.4 t60 -66.54 -36.33 82.42 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.91 -29.68 70.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.069 -1.019 . . . . 0.0 109.257 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.432 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 1.3 mp0 -77.23 -29.22 54.0 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.233 -0.917 . . . . 0.0 110.749 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -86.09 -32.99 21.07 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.19 -0.944 . . . . 0.0 111.377 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -124.11 143.41 50.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.791 -1.193 . . . . 0.0 110.592 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 404' ' ' TYR . 0.0 OUTLIER -89.19 170.03 10.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -0.901 . . . . 0.0 111.354 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -143.02 153.06 59.94 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.04 140.57 79.52 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 N-CA-C 108.018 -1.57 . . . . 0.0 108.018 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.92 -0.16 62.43 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.454 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.0 144.39 41.42 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.643 1.722 . . . . 0.0 108.071 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 61.4 m -52.09 -26.27 10.68 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.98 -1.075 . . . . 0.0 112.4 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -103.36 10.45 37.43 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.504 -1.372 . . . . 0.0 113.315 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 397' ' ' SER . 21.5 t80 . . . . . 0 N--CA 1.515 2.822 0 O-C-N 120.398 -1.439 . . . . 0.0 110.367 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 64.8 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 66.9 9.68 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.895 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -58.29 156.43 10.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.759 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.3 t -74.91 145.75 42.4 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.654 -0.818 . . . . 0.0 108.879 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.67 169.06 0.07 Allowed 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.323 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 54.1 t -85.44 158.79 20.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.155 -0.966 . . . . 0.0 108.44 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.0 mtm -63.07 -33.59 75.78 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 120.758 -1.214 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -94.7 -20.11 19.82 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.983 -1.073 . . . . 0.0 111.168 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 58.37 -95.59 0.06 OUTLIER Glycine 0 N--CA 1.494 2.536 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -86.89 -21.16 26.5 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.246 -1.149 . . . . 0.0 111.632 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -94.23 6.81 47.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.743 -1.223 . . . . 0.0 112.558 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.3 t -43.0 134.39 3.43 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 120.655 -1.278 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 27.4 p90 -119.95 -35.66 3.44 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.334 -0.854 . . . . 0.0 112.477 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.473 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 4.0 ptm180 -48.72 163.82 0.07 Allowed 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.68 -1.262 . . . . 0.0 110.968 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.9 pttm -129.81 56.83 1.7 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.196 -0.94 . . . . 0.0 110.522 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -109.41 144.16 29.24 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.26 -0.9 . . . . 0.0 110.51 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -73.94 -73.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 O-C-N 123.318 1.167 . . . . 0.0 110.355 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 72.2 t -41.24 -27.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 O-C-N 120.797 -1.19 . . . . 0.0 112.601 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -63.65 -37.43 87.32 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.375 -1.453 . . . . 0.0 108.533 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -60.59 -31.58 70.72 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.084 -1.01 . . . . 0.0 109.527 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.21 -27.21 38.84 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.102 -0.999 . . . . 0.0 110.987 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -84.8 -29.87 25.04 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.843 -1.161 . . . . 0.0 111.803 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -124.41 137.66 54.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.799 -1.188 . . . . 0.0 111.183 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.77 153.77 32.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.296 -0.878 . . . . 0.0 111.516 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -134.29 157.32 77.78 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.51 136.67 64.67 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 N-CA-C 108.281 -1.469 . . . . 0.0 108.281 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.32 1.99 56.76 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.032 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.52 141.7 45.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.211 1.506 . . . . 0.0 108.71 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 58.2 m -52.78 -25.94 12.81 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.214 -0.928 . . . . 0.0 111.83 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -98.12 -3.45 37.79 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.68 -1.262 . . . . 0.0 113.051 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 26.2 t80 . . . . . 0 N--CA 1.517 2.91 0 CA-C-N 120.202 1.365 . . . . 0.0 111.491 -179.141 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.742 0.306 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -91.35 94.2 9.4 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.327 -0.858 . . . . 0.0 109.452 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.45 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -70.81 174.21 6.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.606 -0.684 . . . . 0.0 110.433 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -94.68 136.04 35.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.37 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.9 t -58.05 122.78 13.87 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.371 -0.83 . . . . 0.0 109.744 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -42.37 148.61 0.2 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -49.98 -29.13 7.92 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.546 -0.721 . . . . 0.0 110.386 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 9.3 m-85 -84.63 -23.77 29.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.027 -1.046 . . . . 0.0 111.444 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.05 -88.58 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 O-C-N 120.375 -1.453 . . . . 0.0 110.635 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.5 3.76 40.51 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.177 -1.19 . . . . 0.0 113.259 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 386' ' ' TYR . 16.8 m-80 -130.93 26.97 4.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.424 -1.422 . . . . 0.0 112.371 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.413 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 52.9 t -57.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.625 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 384' ' ' ASN . 34.9 p90 -63.59 -27.92 69.57 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 121.135 -0.978 . . . . 0.0 112.362 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 162.63 28.95 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 120.72 -1.237 . . . . 0.0 109.086 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.94 91.77 1.14 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.073 -1.017 . . . . 0.0 111.461 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.57 166.83 10.14 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.0 110.045 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.83 -32.28 5.79 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.404 1.213 . . . . 0.0 110.79 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.52 -22.6 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.149 -0.969 . . . . 0.0 111.029 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.56 -37.01 82.24 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.803 -1.186 . . . . 0.0 109.469 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -56.38 -27.55 56.52 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.095 -1.003 . . . . 0.0 109.53 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.72 -30.49 26.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.106 -0.996 . . . . 0.0 110.562 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.0 m170 -76.2 -32.85 59.2 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.908 -1.12 . . . . 0.0 111.785 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 56.0 m-85 -132.57 138.49 47.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 111.077 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 28.2 m -78.83 165.42 23.56 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -143.04 160.87 51.14 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.249 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.26 137.52 71.29 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.09 -1.87 61.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.642 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.76 149.6 36.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.449 1.624 . . . . 0.0 108.439 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 79.2 p -56.85 -32.07 65.41 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.062 -1.024 . . . . 0.0 111.152 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -80.18 -8.08 59.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.943 -1.098 . . . . 0.0 113.589 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.457 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 8.0 t80 . . . . . 0 N--CA 1.526 3.368 0 CA-C-N 120.524 1.511 . . . . 0.0 111.263 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 87.62 7.0 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.185 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -61.92 151.02 35.95 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.258 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.0 t -71.66 141.85 49.9 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.503 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.27 157.51 2.68 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.05 154.41 25.64 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.816 -1.178 . . . . 0.0 110.874 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . 0.415 ' CE ' ' CE2' ' A' ' 381' ' ' TYR . 4.0 ptt? -54.62 -28.84 49.6 Favored 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.437 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.445 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 72.0 m-85 -82.64 -29.03 30.33 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.958 -1.089 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 72.19 -93.84 0.61 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -103.41 -0.23 30.32 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -1.182 . . . . 0.0 112.474 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.9 m-80 -121.38 24.26 10.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.347 -1.471 . . . . 0.0 112.504 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 49.2 t -59.38 81.83 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.95 0 O-C-N 120.783 -1.198 . . . . 0.0 110.589 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 384' ' ' ASN . 29.6 p90 -61.92 -25.42 67.56 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.169 -0.957 . . . . 0.0 111.738 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -87.5 157.89 19.07 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.798 -1.188 . . . . 0.0 110.134 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.73 124.04 5.32 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.217 -0.927 . . . . 0.0 110.91 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 392' ' ' HIS . 6.8 m-20 -126.06 166.93 18.57 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.284 -0.885 . . . . 0.0 109.69 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.09 -33.48 11.64 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.418 1.22 . . . . 0.0 110.263 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.26 -24.67 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.972 . . . . 0.0 111.416 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.404 ' CB ' ' HB2' ' A' ' 389' ' ' ASN . 47.9 t60 -60.48 -38.98 86.0 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.577 -1.327 . . . . 0.0 110.006 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -56.5 -28.6 60.25 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.408 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -79.96 -32.23 39.92 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.577 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -78.15 -35.17 49.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.219 -0.925 . . . . 0.0 111.486 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.25 144.34 51.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.952 -1.093 . . . . 0.0 110.726 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 10.0 m -91.42 171.47 9.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -143.48 159.17 55.7 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.11 139.3 83.3 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.73 -1.03 56.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.3 153.85 30.19 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.267 1.533 . . . . 0.0 107.658 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -29.06 70.41 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.135 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -85.91 -1.8 57.65 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.7 t80 . . . . . 0 N--CA 1.527 3.4 0 CA-C-N 120.713 1.597 . . . . 0.0 111.102 -178.596 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.798 0.332 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -79.87 94.49 5.84 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.455 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.6 OUTLIER -68.52 153.77 43.13 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.605 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.1 t -79.05 142.8 36.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.694 -0.629 . . . . 0.0 109.419 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.3 p -56.33 155.25 7.14 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.33 156.34 28.06 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.05 -1.031 . . . . 0.0 110.265 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -58.54 -35.77 72.83 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.16 -0.963 . . . . 0.0 110.635 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -71.89 -39.11 69.81 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.083 -1.01 . . . . 0.0 110.114 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.51 -86.92 1.31 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.07 -0.73 28.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.144 -1.209 . . . . 0.0 112.33 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.27 13.57 9.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.556 -1.34 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.8 t -49.39 152.57 1.25 Allowed 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.462 -1.398 . . . . 0.0 111.3 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 18.3 p90 -101.93 -29.62 11.71 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.446 -0.784 . . . . 0.0 111.525 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER 23.61 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.16 -2.88 25.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.983 -1.073 . . . . 0.0 111.462 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -130.35 157.57 76.94 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.582 -1.324 . . . . 0.0 109.267 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.23 -44.3 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.312 1.164 . . . . 0.0 110.061 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.4 t -47.73 -31.51 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 O-C-N 121.131 -0.981 . . . . 0.0 110.591 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -63.65 -31.97 73.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.003 -1.061 . . . . 0.0 109.428 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.429 ' CZ ' ' NH1' ' A' ' 387' ' ' ARG . 27.9 m-85 -63.19 -24.37 67.85 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.009 -1.057 . . . . 0.0 109.269 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.89 -28.94 32.63 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.663 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.45 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.8 m170 -83.38 -32.58 26.11 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 121.032 -1.043 . . . . 0.0 111.843 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 73.5 m-85 -130.97 143.54 50.8 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.895 -1.128 . . . . 0.0 110.705 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 68.1 m -86.46 163.65 17.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.402 -0.811 . . . . 0.0 110.993 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -139.85 159.43 64.8 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.704 -0.623 . . . . 0.0 109.868 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.07 136.44 60.82 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 N-CA-C 108.248 -1.482 . . . . 0.0 108.248 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.24 -3.39 51.11 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.27 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -113.42 141.06 47.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.56 -1.553 . . . . 0.0 108.248 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 56.0 m -51.78 -25.96 8.68 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.067 -1.021 . . . . 0.0 112.2 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -93.49 0.21 56.63 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.506 -1.371 . . . . 0.0 113.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 17.7 t80 . . . . . 0 N--CA 1.522 3.163 0 CA-C-N 120.562 1.528 . . . . 0.0 111.09 -179.195 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -80.27 81.68 6.48 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.172 -0.955 . . . . 0.0 109.979 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.56 16.52 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.308 -0.87 . . . . 0.0 110.726 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.0 m -67.09 130.21 42.39 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.14 162.33 0.31 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.16 -0.962 . . . . 0.0 110.523 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.48 156.73 27.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.09 -1.006 . . . . 0.0 109.839 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -62.75 -31.04 71.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.987 -1.071 . . . . 0.0 110.725 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -80.09 -33.07 39.08 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.021 -1.05 . . . . 0.0 110.228 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 79.46 -89.34 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.45 -3.46 18.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.323 -1.104 . . . . 0.0 112.338 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.35 17.15 18.72 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.505 -1.372 . . . . 0.0 112.653 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.7 t -45.32 137.27 4.8 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 120.664 -1.273 . . . . 0.0 110.853 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.7 p90 -117.46 -40.98 3.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.926 . . . . 0.0 111.875 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.464 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -55.99 156.66 5.13 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.731 -1.231 . . . . 0.0 110.168 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.07 68.19 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.743 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.78 143.43 28.62 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 109.628 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.03 -70.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.435 1.229 . . . . 0.0 110.594 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 9.9 p -38.18 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 O-C-N 121.221 -0.925 . . . . 0.0 112.94 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -69.19 -42.07 76.3 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.918 -1.114 . . . . 0.0 109.144 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -55.93 -36.72 68.04 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.247 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -77.47 -26.39 51.33 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.452 -0.78 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -86.66 -34.57 19.72 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.856 -1.152 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -117.85 146.97 43.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.925 -1.109 . . . . 0.0 110.449 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.11 162.87 13.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.239 -0.913 . . . . 0.0 110.961 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -135.08 157.62 76.56 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.728 -0.607 . . . . 0.0 110.507 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.2 141.48 88.28 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 N-CA-C 107.78 -1.661 . . . . 0.0 107.78 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.19 65.28 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.5 140.07 43.72 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.727 -1.455 . . . . 0.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.9 t -50.58 -24.38 3.21 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.045 -1.034 . . . . 0.0 112.858 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.45 15.63 23.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.435 -1.416 . . . . 0.0 113.467 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 20.2 t80 . . . . . 0 N--CA 1.524 3.257 0 CA-C-N 120.363 1.438 . . . . 0.0 110.767 -179.852 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.2 t . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.774 0.321 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -86.63 93.97 9.35 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.371 -0.83 . . . . 0.0 109.437 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 155.82 10.77 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.611 -0.681 . . . . 0.0 110.467 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -83.03 138.75 33.61 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 157.79 0.73 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.13 -0.981 . . . . 0.0 110.602 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.8 t -77.98 158.01 29.46 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -62.24 -30.94 71.46 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 120.878 -1.139 . . . . 0.0 110.473 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.401 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 14.2 m-85 -81.04 -31.84 34.34 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.089 -1.007 . . . . 0.0 110.412 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 77.35 -89.05 1.01 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 -1.75 21.09 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.193 -1.18 . . . . 0.0 112.138 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -115.95 18.2 15.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.497 -1.377 . . . . 0.0 112.69 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.401 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.4 t -46.3 137.63 6.16 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 120.612 -1.305 . . . . 0.0 110.517 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.7 p90 -115.14 -40.44 3.47 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.295 -0.878 . . . . 0.0 112.011 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -60.94 149.8 35.36 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.778 -1.202 . . . . 0.0 109.551 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.23 69.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.271 -0.893 . . . . 0.0 110.613 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.11 151.76 42.71 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.24 -68.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.52 1.274 . . . . 0.0 111.027 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 8.2 p -40.52 -32.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 O-C-N 121.155 -0.965 . . . . 0.0 112.782 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.04 -39.07 83.14 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.959 -1.088 . . . . 0.0 109.445 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.55 -32.1 71.18 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.19 -27.01 59.45 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.391 -0.818 . . . . 0.0 111.427 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 395' ' ' HIS . 24.6 m170 -93.45 -34.51 13.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.836 -1.165 . . . . 0.0 111.162 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.23 140.19 48.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.993 -1.067 . . . . 0.0 110.807 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.8 t -91.68 165.15 13.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.391 -0.818 . . . . 0.0 110.637 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.91 157.94 72.3 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.802 -0.561 . . . . 0.0 109.764 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.53 140.55 82.21 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.28 -1.52 62.58 Favored Glycine 0 CA--C 1.552 2.38 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.935 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -110.64 142.5 42.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.442 -1.622 . . . . 0.0 108.403 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.3 t -50.88 -26.78 6.27 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.201 -0.937 . . . . 0.0 112.472 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -102.24 8.94 40.35 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.505 -1.372 . . . . 0.0 113.157 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.3 t80 . . . . . 0 N--CA 1.52 3.07 0 CA-C-N 120.305 1.412 . . . . 0.0 110.969 -179.315 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.81 0.338 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -93.01 96.37 10.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.31 -0.869 . . . . 0.0 109.246 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.452 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 3.1 mtt85 -54.61 -179.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.422 -0.799 . . . . 0.0 111.029 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -107.15 128.64 54.58 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . 0.439 ' HB2' ' CE1' ' A' ' 404' ' ' TYR . 9.5 p -52.5 117.26 2.74 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.241 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.2 t -36.37 151.64 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 381' ' ' TYR . 10.8 ptp -51.12 -30.02 15.09 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.403 ' N ' ' HG3' ' A' ' 380' ' ' MET . 53.6 m-85 -84.96 -23.7 28.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.152 -0.967 . . . . 0.0 111.318 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.13 -82.95 0.12 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 120.361 -1.462 . . . . 0.0 109.935 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.01 -0.11 21.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.297 -1.119 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -119.5 19.69 12.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.398 -1.439 . . . . 0.0 113.153 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.1 t -47.66 143.25 3.95 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 120.171 1.35 . . . . 0.0 110.552 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.6 p90 -120.14 -39.38 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.324 -0.86 . . . . 0.0 112.222 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.44 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.7 ptp85 -67.66 145.27 54.97 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.719 -1.238 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 73.13 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.977 . . . . 0.0 111.384 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.55 150.8 40.58 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.945 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.31 -73.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.305 1.16 . . . . 0.0 110.477 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.6 t -41.84 -29.5 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 120.885 -1.134 . . . . 0.0 112.082 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.418 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 30.0 t60 -63.19 -35.09 79.16 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.604 -1.31 . . . . 0.0 109.307 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.01 -26.75 67.68 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -31.57 57.47 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.913 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -82.75 -40.48 20.47 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.872 -1.142 . . . . 0.0 110.397 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -110.02 165.36 11.79 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.294 -0.879 . . . . 0.0 109.685 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -112.38 169.16 9.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -143.35 160.21 52.46 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.035 . . . . 0.0 110.304 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.05 137.71 68.57 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 108.778 -1.278 . . . . 0.0 108.778 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.33 62.54 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.364 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.59 139.35 45.93 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.411 1.605 . . . . 0.0 108.427 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 51.1 m -49.18 -26.13 2.66 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.188 -0.945 . . . . 0.0 112.679 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -97.8 2.58 49.59 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.394 -1.441 . . . . 0.0 114.433 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 378' ' ' SER . 4.6 t80 . . . . . 0 N--CA 1.533 3.688 0 CA-C-N 120.683 1.583 . . . . 0.0 111.029 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.808 0.337 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.74 89.91 6.82 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.779 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.419 ' NE ' ' O ' ' A' ' 394' ' ' GLN . 2.5 mmt-85 -62.14 151.85 34.62 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.319 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.3 t -74.0 140.91 45.8 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.9 p -57.18 157.29 6.29 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.316 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -73.15 161.57 30.44 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.044 -1.035 . . . . 0.0 110.232 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -31.83 71.68 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -85.08 -21.53 29.3 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.105 -0.997 . . . . 0.0 110.564 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.4 -86.61 0.11 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.48 -8.7 18.91 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -1.174 . . . . 0.0 112.243 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -106.63 12.96 28.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.48 -1.388 . . . . 0.0 112.975 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.1 t -47.0 142.28 3.63 Favored 'General case' 0 N--CA 1.524 3.235 0 O-C-N 120.534 -1.354 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.4 p90 -121.13 -37.05 3.0 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.275 -0.891 . . . . 0.0 112.67 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.7 ptm180 -55.11 157.13 3.55 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.742 -1.224 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -129.01 64.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.0 110.749 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -111.74 148.31 38.66 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.076 -1.015 . . . . 0.0 109.93 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.66 -69.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.444 1.234 . . . . 0.0 110.493 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.8 t -43.01 -29.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.177 0 O-C-N 120.819 -1.175 . . . . 0.0 111.752 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.24 -36.26 83.6 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.507 -1.371 . . . . 0.0 108.903 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -57.89 -30.03 65.53 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.071 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.419 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -82.42 -28.65 31.24 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.179 -0.951 . . . . 0.0 110.444 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -75.44 -34.26 60.96 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.969 -1.082 . . . . 0.0 110.873 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -134.65 149.18 50.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.004 -1.06 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.0 t -93.85 164.91 12.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.772 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.15 159.16 70.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.35 138.94 74.35 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.54 -2.08 60.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -176.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -110.07 138.9 45.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 119.14 1.47 . . . . 0.0 107.657 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.3 -23.24 5.47 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.13 -0.981 . . . . 0.0 112.538 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -103.6 11.97 35.5 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.294 -1.504 . . . . 0.0 113.562 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.523 3.181 0 CA-C-N 120.546 1.521 . . . . 0.0 110.925 -179.529 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.57 0.224 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.25 88.64 7.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.319 -0.863 . . . . 0.0 109.271 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.483 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 3.3 mmt-85 -61.53 152.18 30.98 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.294 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -73.38 143.64 46.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.5 t -57.35 168.7 0.72 Allowed 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.616 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.9 t -83.23 158.12 22.41 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.075 -1.016 . . . . 0.0 109.832 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 52.8 mtm -56.26 -31.23 63.38 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 121.007 -1.058 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.54 -21.89 35.19 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.081 -1.012 . . . . 0.0 111.052 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.36 -91.95 0.17 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.88 0.66 28.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.448 -1.031 . . . . 0.0 112.271 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -117.49 22.13 12.6 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.471 -1.393 . . . . 0.0 112.299 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 13.2 t -52.31 147.55 7.74 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 120.446 -1.409 . . . . 0.0 109.819 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 19.4 p90 -125.96 -35.63 2.45 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.328 -0.858 . . . . 0.0 112.993 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.474 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.0 ptp85 -61.99 162.09 9.74 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.549 -1.344 . . . . 0.0 109.819 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 66.9 1.39 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.199 -0.938 . . . . 0.0 110.649 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -107.53 145.95 32.34 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.272 -0.892 . . . . 0.0 110.078 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.58 -69.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.342 1.18 . . . . 0.0 110.38 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 91.5 t -44.76 -30.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.126 0 O-C-N 120.854 -1.154 . . . . 0.0 110.972 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.434 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 45.4 t60 -63.73 -36.0 82.43 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.863 -1.148 . . . . 0.0 109.064 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 -27.54 65.19 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.005 -1.059 . . . . 0.0 109.272 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.05 -31.25 25.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.106 -0.996 . . . . 0.0 110.176 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.421 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 25.7 m170 -73.24 -29.05 62.5 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.978 -1.076 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 59.5 m-85 -140.29 145.86 37.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 110.856 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.483 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 45.7 m -90.1 163.13 14.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.473 -0.767 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -139.14 160.89 60.57 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.692 -0.63 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.03 140.12 77.13 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.003 -1.576 . . . . 0.0 108.003 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.8 60.56 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.256 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.27 143.28 45.12 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.367 1.584 . . . . 0.0 107.813 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.9 m -52.81 -30.4 33.06 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.085 -1.009 . . . . 0.0 110.992 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.29 -1.65 57.69 Favored 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.532 3.657 0 CA-C-N 120.861 1.664 . . . . 0.0 110.903 -179.511 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -68.48 82.99 0.26 Allowed 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.473 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt-85 -61.91 152.24 32.53 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.33 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.4 t -71.84 141.52 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.983 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -54.84 161.03 1.71 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.153 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 25.3 t -81.28 155.99 25.78 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.893 -1.129 . . . . 0.0 110.757 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.9 mtm -56.02 -27.53 53.42 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.24 -0.913 . . . . 0.0 110.932 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 87.8 m-85 -84.52 -21.8 30.4 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.05 -1.032 . . . . 0.0 110.723 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.61 -93.55 0.21 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.08 0.18 23.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.291 -1.123 . . . . 0.0 112.182 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -116.65 23.41 12.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.475 -1.391 . . . . 0.0 111.837 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 14.0 t -52.63 144.22 14.31 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 120.533 -1.355 . . . . 0.0 109.962 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 16.3 p90 -122.9 -36.44 2.88 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.603 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.482 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.08 161.52 26.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.592 -1.318 . . . . 0.0 109.265 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -150.41 111.16 4.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.0 111.223 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -120.06 166.87 13.83 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 109.775 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.36 -28.89 14.49 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.312 1.164 . . . . 0.0 110.395 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.79 -22.94 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.014 -1.054 . . . . 0.0 111.676 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -61.75 -38.04 86.52 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.603 -1.31 . . . . 0.0 109.644 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.83 -28.59 61.77 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.149 -0.97 . . . . 0.0 109.43 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.93 -32.43 25.09 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.404 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 15.8 m170 -71.62 -31.04 66.46 Favored 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.021 -1.049 . . . . 0.0 111.64 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 36.9 m-85 -140.71 148.53 40.9 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.802 -1.186 . . . . 0.0 110.857 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 376' ' ' ARG . 18.3 m -86.81 169.52 12.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.444 -0.785 . . . . 0.0 110.657 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.37 157.84 58.87 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.592 -0.693 . . . . 0.0 109.782 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 138.96 73.4 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.114 -1.533 . . . . 0.0 108.114 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.04 54.76 Favored Glycine 0 CA--C 1.553 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.042 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.14 147.62 40.02 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.733 -1.451 . . . . 0.0 107.902 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 48.0 t -58.71 -27.05 64.51 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.725 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.62 -0.56 57.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.681 -1.262 . . . . 0.0 113.918 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.3 t80 . . . . . 0 N--CA 1.521 3.095 0 CA-C-N 120.81 1.641 . . . . 0.0 110.789 -179.127 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -89.53 96.02 10.52 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.251 -0.905 . . . . 0.0 109.427 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.89 150.57 39.12 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.344 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.2 t -76.58 -179.66 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.183 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 404' ' ' TYR . 0.1 OUTLIER -97.16 126.81 42.59 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.004 -1.06 . . . . 0.0 110.82 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -45.07 145.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.614 -0.679 . . . . 0.0 112.333 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 11.3 ptp -49.4 -28.08 4.76 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.469 -0.769 . . . . 0.0 111.031 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -86.81 -22.47 25.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.942 -1.099 . . . . 0.0 111.214 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.65 -84.87 0.04 OUTLIER Glycine 0 N--CA 1.497 2.703 0 O-C-N 120.495 -1.378 . . . . 0.0 110.784 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.11 -9.74 17.6 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.202 -1.175 . . . . 0.0 112.569 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -112.84 18.69 17.99 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.521 -1.362 . . . . 0.0 113.22 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 30.9 t -47.89 139.13 8.04 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.055 1.298 . . . . 0.0 110.239 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 37.5 p90 -116.22 -40.68 3.23 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.461 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -71.35 162.75 28.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.904 -1.122 . . . . 0.0 109.154 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -155.99 104.07 2.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.177 -0.952 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.49 165.3 14.7 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 -24.74 18.58 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.437 1.23 . . . . 0.0 110.588 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.22 -21.73 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.039 -1.038 . . . . 0.0 111.756 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.442 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 45.5 t60 -63.84 -38.19 90.18 Favored 'General case' 0 N--CA 1.512 2.663 0 O-C-N 120.517 -1.364 . . . . 0.0 110.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -58.1 -30.61 66.41 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -32.14 44.93 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.876 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -77.82 -37.76 47.88 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.119 -0.988 . . . . 0.0 110.589 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.9 m-85 -125.18 150.52 46.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.1 t -94.7 174.48 7.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.161 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -144.33 156.49 57.36 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.764 . . . . 0.0 109.278 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.14 138.9 80.88 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.61 -2.54 55.95 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.791 -1.195 . . . . 0.0 110.874 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.14 146.87 39.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.699 1.75 . . . . 0.0 108.415 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.8 t -54.48 -28.45 44.82 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.124 -0.985 . . . . 0.0 111.645 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -92.12 1.44 57.21 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 0.0 113.058 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 378' ' ' SER . 23.3 t80 . . . . . 0 N--CA 1.514 2.76 0 CA-C-N 120.391 1.451 . . . . 0.0 110.253 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.889 0.376 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -83.29 99.22 9.86 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.452 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -72.64 152.99 41.45 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.803 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -73.43 141.8 46.91 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.2 t -58.18 158.49 6.97 Favored 'General case' 0 N--CA 1.511 2.606 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.503 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.83 151.46 35.88 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.911 -1.118 . . . . 0.0 110.577 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -52.91 -28.59 24.09 Favored 'General case' 0 N--CA 1.514 2.76 0 O-C-N 121.226 -0.921 . . . . 0.0 111.118 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.412 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 8.8 m-85 -77.34 -31.95 54.84 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.977 -1.077 . . . . 0.0 110.169 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.94 -90.91 0.89 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.34 4.98 29.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.331 -1.099 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -128.34 25.78 5.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.556 -1.34 . . . . 0.0 112.191 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.412 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 34.4 t -50.66 143.77 9.05 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 120.668 -1.27 . . . . 0.0 110.165 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 13.3 p90 -116.4 -36.01 4.12 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.284 -0.885 . . . . 0.0 112.001 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -73.52 149.54 42.16 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.831 -1.168 . . . . 0.0 109.694 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.5 100.89 3.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.062 -1.024 . . . . 0.0 111.171 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.21 164.57 21.84 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 109.848 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.41 -29.93 16.05 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.324 1.171 . . . . 0.0 110.447 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.14 -23.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.12 -0.988 . . . . 0.0 111.304 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -61.7 -37.45 84.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.764 -1.21 . . . . 0.0 109.637 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -57.73 -26.06 61.27 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.47 -30.3 30.05 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 11.6 m170 -79.32 -34.22 42.49 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.159 -0.963 . . . . 0.0 111.336 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 65.6 m-85 -133.26 142.43 48.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.224 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 56.0 m -85.71 169.27 13.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.401 -0.812 . . . . 0.0 110.167 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -144.39 158.75 53.77 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.6 -0.687 . . . . 0.0 109.923 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.09 137.43 66.63 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 N-CA-C 108.341 -1.446 . . . . 0.0 108.341 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.12 -1.94 56.45 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.698 -178.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.24 150.75 40.89 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.651 -1.499 . . . . 0.0 107.564 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 81.3 p -60.32 -32.07 70.88 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.456 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.8 -11.44 60.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.028 -1.045 . . . . 0.0 112.634 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.517 2.886 0 CA-C-N 120.288 1.404 . . . . 0.0 110.214 -179.448 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.848 0.356 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -88.37 94.53 9.88 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -67.75 150.25 48.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.456 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.7 t -78.92 172.12 14.23 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.771 -179.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 p -76.99 157.53 31.15 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.076 -1.015 . . . . 0.0 109.272 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.42 160.74 29.91 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.429 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.5 ptp -61.45 -35.31 77.26 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.901 -1.125 . . . . 0.0 109.944 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.409 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 15.4 m-85 -77.14 -33.48 56.69 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.484 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 76.13 -87.64 0.89 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.75 -3.19 20.74 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.261 -1.141 . . . . 0.0 112.469 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -115.44 17.33 16.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.415 -1.428 . . . . 0.0 112.809 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.409 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 8.6 t -45.14 139.69 3.19 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-N 120.059 1.3 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 33.5 p90 -117.22 -39.39 3.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.313 -0.867 . . . . 0.0 112.363 -178.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.446 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.4 ptp85 -57.28 156.58 7.36 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 120.632 -1.293 . . . . 0.0 110.165 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.93 65.56 1.2 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 110.871 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -109.95 144.15 29.41 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.113 -0.992 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.47 -71.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.358 1.189 . . . . 0.0 110.529 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 71.8 t -41.48 -28.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 O-C-N 120.885 -1.134 . . . . 0.0 112.318 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.435 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 27.2 t60 -65.23 -37.6 87.75 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 120.496 -1.378 . . . . 0.0 108.66 177.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -57.37 -31.04 65.38 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.068 -1.02 . . . . 0.0 109.35 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 -26.99 39.95 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.211 -0.931 . . . . 0.0 110.737 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -81.85 -37.88 26.29 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.002 -1.062 . . . . 0.0 110.185 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.5 m-85 -125.15 145.44 49.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 1.8 t -94.22 170.35 9.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.34 158.77 65.75 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.664 -0.647 . . . . 0.0 109.983 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.61 139.74 82.89 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 108.153 -1.518 . . . . 0.0 108.153 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.41 -1.63 60.47 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.807 -176.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -112.62 141.5 46.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.619 -1.518 . . . . 0.0 107.983 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.0 m -51.6 -28.53 14.41 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.149 -0.969 . . . . 0.0 111.752 -178.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.682 -1.261 . . . . 0.0 113.355 -178.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 26.0 t80 . . . . . 0 N--CA 1.522 3.128 0 CA-C-N 120.466 1.485 . . . . 0.0 111.121 -178.989 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -95.49 100.51 12.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.494 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.7 OUTLIER -80.89 161.75 24.24 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.777 -0.577 . . . . 0.0 111.334 -179.219 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.4 t -76.62 174.17 10.71 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.9 t -94.7 129.99 41.37 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.684 -1.26 . . . . 0.0 111.78 -178.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 7.8 t -40.11 148.55 0.08 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.895 -0.503 . . . . 0.0 112.036 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 6.1 ptp -47.64 -37.83 13.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.622 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.437 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 27.9 m-85 -73.58 -35.21 65.39 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.57 -86.62 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.047 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.24 7.06 43.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.26 -1.141 . . . . 0.0 112.847 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -134.87 25.09 3.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.343 -1.473 . . . . 0.0 112.577 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.2 t -49.63 151.72 1.6 Allowed 'General case' 0 N--CA 1.521 3.076 0 O-C-N 120.514 -1.366 . . . . 0.0 111.113 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.1 p90 -126.3 -33.2 2.63 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.992 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.423 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.1 OUTLIER -55.97 173.81 0.14 Allowed 'General case' 0 N--CA 1.514 2.729 0 O-C-N 120.388 -1.445 . . . . 0.0 110.167 179.936 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -143.7 55.88 1.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 110.532 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -112.05 148.18 38.48 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 109.606 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -73.34 -66.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.396 1.208 . . . . 0.0 110.473 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.3 t -43.01 -29.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 120.888 -1.132 . . . . 0.0 111.999 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.4 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 39.0 t60 -63.87 -38.98 93.09 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.665 -1.272 . . . . 0.0 108.824 178.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -56.13 -29.27 60.48 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 178.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -29.72 45.23 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.159 -0.963 . . . . 0.0 110.501 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 17.2 m170 -75.33 -35.47 61.19 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.453 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 34.0 m-85 -134.78 138.19 44.07 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.087 -1.008 . . . . 0.0 110.304 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.494 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 1.5 m -81.58 169.48 17.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.518 -0.739 . . . . 0.0 109.23 178.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -141.6 155.22 66.92 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.61 140.07 92.0 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 N-CA-C 108.735 -1.294 . . . . 0.0 108.735 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.57 0.79 64.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.722 -177.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.22 143.81 44.23 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.413 1.606 . . . . 0.0 108.646 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.6 t -50.01 -30.79 11.32 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.09 -1.006 . . . . 0.0 111.839 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.83 -6.15 54.65 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.684 -1.26 . . . . 0.0 113.55 -177.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.9 t80 . . . . . 0 N--CA 1.525 3.289 0 CA-C-N 120.551 1.523 . . . . 0.0 111.294 -179.092 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -69.84 91.38 0.64 Allowed 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.487 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -58.04 158.28 6.97 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.697 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.5 t -75.08 145.67 42.1 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.3 t -56.44 163.2 1.81 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.646 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 6.1 t -78.34 162.3 26.57 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.04 -1.038 . . . . 0.0 109.8 178.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 47.9 mtm -58.4 -31.16 67.43 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.403 179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.11 -26.11 25.42 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.144 -0.972 . . . . 0.0 110.768 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.19 -89.75 0.6 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.61 -1.19 26.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.343 -1.092 . . . . 0.0 111.956 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -112.51 16.95 19.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.34 -1.475 . . . . 0.0 112.275 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.4 t -49.19 143.84 5.67 Favored 'General case' 0 N--CA 1.519 2.98 0 O-C-N 120.558 -1.339 . . . . 0.0 110.377 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.5 p90 -120.77 -33.94 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.353 -0.842 . . . . 0.0 112.536 -179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -72.64 174.54 7.42 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.709 -1.245 . . . . 0.0 109.618 179.571 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.6 93.3 1.18 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.899 -1.126 . . . . 0.0 111.096 -179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -115.23 162.43 24.44 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.736 -1.227 . . . . 0.0 110.034 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -26.04 12.73 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 O-C-N 123.514 1.27 . . . . 0.0 110.652 178.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.76 -25.42 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.093 -1.004 . . . . 0.0 111.411 178.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -61.88 -36.02 80.02 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.662 -1.273 . . . . 0.0 109.946 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -58.13 -26.67 62.94 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -31.08 27.86 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.178 -0.951 . . . . 0.0 110.468 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.5 m170 -75.46 -34.3 60.93 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.808 -1.183 . . . . 0.0 111.371 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 48.3 m-85 -137.21 145.66 43.92 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.722 -1.236 . . . . 0.0 110.839 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 66.5 m -91.4 169.97 10.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.222 -0.924 . . . . 0.0 111.503 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -141.64 153.54 65.22 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.109 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.34 140.14 81.04 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 N-CA-C 107.253 -1.864 . . . . 0.0 107.253 178.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.31 1.61 60.79 Favored Glycine 0 CA--C 1.553 2.438 0 C-N-CA 119.041 -1.552 . . . . 0.0 110.825 -178.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.66 156.94 24.97 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.837 1.818 . . . . 0.0 107.778 177.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -29.11 70.24 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.207 -179.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -94.41 6.09 49.8 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 120.533 -1.355 . . . . 0.0 114.0 -177.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.9 t80 . . . . . 0 N--CA 1.519 3.007 0 CA-C-N 120.643 1.565 . . . . 0.0 109.966 179.899 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 86.88 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.47 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -61.2 153.65 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.293 -179.637 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -71.07 142.46 50.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 28.8 t -53.05 165.19 0.33 Allowed 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.686 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 45.2 t -87.51 156.97 19.3 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.974 -1.079 . . . . 0.0 109.682 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 4.1 ptp -55.25 -31.61 61.67 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -93.52 -20.74 19.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.974 -1.079 . . . . 0.0 111.439 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.45 -98.86 0.22 Allowed Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.521 -1.362 . . . . 0.0 110.392 178.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.58 -13.32 32.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.429 -1.042 . . . . 0.0 111.764 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -104.51 16.44 26.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.565 -1.335 . . . . 0.0 112.39 -179.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.9 t -48.92 139.78 9.71 Favored 'General case' 0 N--CA 1.52 3.065 0 O-C-N 120.517 -1.364 . . . . 0.0 111.039 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 17.9 p90 -117.03 -37.16 3.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.438 -0.789 . . . . 0.0 111.765 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.457 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.69 153.66 29.15 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.644 -1.285 . . . . 0.0 109.408 179.184 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 108.29 4.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -0.98 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -118.97 167.47 11.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 0.0 110.209 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.15 -27.67 16.58 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.432 1.227 . . . . 0.0 110.319 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.4 t -98.17 -24.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.084 -1.01 . . . . 0.0 111.92 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -61.94 -38.09 87.17 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.6 -1.313 . . . . 0.0 110.113 -179.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -56.96 -28.81 62.62 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.83 -1.169 . . . . 0.0 109.148 178.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -32.53 30.06 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.238 -0.914 . . . . 0.0 110.275 179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.433 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 22.1 m170 -71.98 -32.0 66.81 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.07 -1.019 . . . . 0.0 111.408 -179.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 42.7 m-85 -140.02 148.08 41.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.952 -1.093 . . . . 0.0 111.43 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 15.9 m -87.61 168.76 12.75 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -0.81 . . . . 0.0 110.997 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -143.7 153.33 57.91 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.15 139.08 76.33 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 177.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.4 -0.81 55.78 Favored Glycine 0 CA--C 1.553 2.446 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.757 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -116.41 158.07 24.09 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.662 1.731 . . . . 0.0 108.229 178.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 59.2 m -64.02 -28.01 69.51 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.708 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.65 2.38 56.51 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.644 -1.285 . . . . 0.0 114.061 -176.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.2 t80 . . . . . 0 N--CA 1.523 3.182 0 CA-C-N 120.741 1.61 . . . . 0.0 110.131 -179.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.63 -171.34 0.73 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.426 1.224 . . . . 0.0 110.468 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.3 tt 53.01 95.34 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.103 -0.998 . . . . 0.0 110.78 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 87.18 41.11 6.72 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.1 m -146.26 108.57 4.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.187 -1.184 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 139.08 84.2 0.1 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.0 p -142.16 48.23 1.59 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.197 -1.178 . . . . 0.0 110.179 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -127.0 70.01 1.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.194 -0.941 . . . . 0.0 110.156 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -139.25 40.76 1.4 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -148.94 -66.85 0.23 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.239 -1.153 . . . . 0.0 110.415 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -137.15 63.71 1.55 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.12 -0.988 . . . . 0.0 110.243 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 69.8 t -144.7 160.53 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.33 -0.856 . . . . 0.0 109.833 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -89.36 91.85 8.91 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 394' ' ' GLN . 38.5 mtm-85 -60.03 153.98 20.24 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.315 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.1 t -81.01 138.39 36.04 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -52.8 151.87 4.23 Favored 'General case' 0 N--CA 1.514 2.729 0 O-C-N 121.117 -0.989 . . . . 0.0 109.434 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.4 t -75.79 156.96 34.04 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.088 -1.008 . . . . 0.0 110.898 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 45.7 mtm -57.77 -26.17 61.51 Favored 'General case' 0 N--CA 1.516 2.83 0 O-C-N 121.197 -0.94 . . . . 0.0 110.516 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.437 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 39.9 m-85 -89.58 -19.3 25.13 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.975 -1.078 . . . . 0.0 110.926 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.58 -91.06 0.1 OUTLIER Glycine 0 N--CA 1.493 2.444 0 O-C-N 120.674 -1.266 . . . . 0.0 109.994 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.68 -3.1 24.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.401 -1.058 . . . . 0.0 112.251 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -113.8 20.02 16.18 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.557 -1.339 . . . . 0.0 112.225 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 28.7 t -50.26 139.68 14.44 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 120.588 -1.32 . . . . 0.0 110.479 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 36.8 p90 -115.89 -36.4 4.17 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.418 -0.801 . . . . 0.0 111.9 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.6 ptt180 -75.64 160.38 30.15 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.745 -1.222 . . . . 0.0 109.567 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.78 104.31 2.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.171 -0.955 . . . . 0.0 111.116 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -118.69 165.92 15.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 109.798 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.86 -26.16 19.22 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.246 1.129 . . . . 0.0 110.387 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.36 -20.95 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.951 -1.093 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -65.91 -38.21 88.09 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 120.678 -1.264 . . . . 0.0 110.028 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -58.48 -26.41 63.37 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.231 -0.918 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -80.68 -29.42 36.56 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.167 -0.958 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -87.34 -35.59 18.31 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.872 -1.143 . . . . 0.0 111.597 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 65.0 m-85 -122.24 137.64 54.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.918 -1.114 . . . . 0.0 110.576 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.24 169.18 11.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -144.06 157.73 56.79 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.651 -0.656 . . . . 0.0 109.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.74 138.53 80.13 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.55 -1.7 53.16 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.177 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.29 150.39 31.05 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.383 1.592 . . . . 0.0 108.494 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.8 t -61.06 -23.55 65.54 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.32 4.58 46.49 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 120.523 -1.361 . . . . 0.0 112.851 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -54.86 141.16 34.21 Favored 'General case' 0 N--CA 1.51 2.572 0 O-C-N 120.417 -1.427 . . . . 0.0 109.457 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -158.35 39.77 0.52 Allowed Glycine 0 N--CA 1.499 2.849 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.596 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -97.25 -56.25 1.13 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 407' ' ' VAL . 87.1 t 44.27 66.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.717 -0.872 . . . . 0.0 111.422 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -105.04 58.05 0.69 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.315 -0.865 . . . . 0.0 109.778 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.515 HG23 ' CD ' ' A' ' 412' ' ' GLN . 43.4 mt 50.67 74.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.966 -1.084 . . . . 0.0 110.718 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.83 72.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.27 -0.894 . . . . 0.0 109.367 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.83 -42.41 1.67 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.515 ' CD ' HG23 ' A' ' 409' ' ' ILE . 1.7 mt-30 53.64 76.96 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.331 -1.1 . . . . 0.0 110.848 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 16.0 t70 50.11 30.51 4.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.266 -0.896 . . . . 0.0 111.681 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 48.99 40.63 17.43 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.957 -1.089 . . . . 0.0 111.673 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 412' ' ' GLN . 0.2 OUTLIER -117.22 66.86 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.154 -0.966 . . . . 0.0 109.991 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.75 45.35 1.59 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.212 -0.93 . . . . 0.0 110.177 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.217 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.73 86.22 1.07 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.407 1.214 . . . . 0.0 110.404 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.43 -176.64 3.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 97.45 -139.69 14.62 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.8 m 52.53 83.2 0.06 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.023 -1.28 . . . . 0.0 110.808 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -90.01 61.87 3.32 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.8 p -132.07 130.62 41.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.226 -1.161 . . . . 0.0 110.223 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -116.1 52.24 0.92 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.234 -0.916 . . . . 0.0 109.978 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -135.58 42.37 1.34 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -145.46 -59.34 0.34 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.196 -1.179 . . . . 0.0 110.425 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -141.3 53.57 1.54 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.316 -0.865 . . . . 0.0 110.034 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t -144.43 161.17 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.971 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.95 88.43 7.7 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.256 -0.903 . . . . 0.0 109.722 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -51.12 148.72 4.25 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.226 -0.921 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -77.62 131.85 37.98 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.1 t -49.98 154.27 1.15 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 120.983 -1.073 . . . . 0.0 110.469 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 3.0 t -79.55 159.28 26.93 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.009 -1.057 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.8 mtm -60.05 -26.25 65.99 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.724 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -88.06 -19.75 26.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.956 -1.09 . . . . 0.0 111.166 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 65.88 -89.02 0.12 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.57 2.84 26.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.307 -1.113 . . . . 0.0 112.599 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.0 m-80 -121.21 22.83 10.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.432 -1.417 . . . . 0.0 112.596 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.5 t -58.92 80.26 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 120.792 -1.193 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 384' ' ' ASN . 42.8 p90 -53.97 -30.54 47.39 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 121.109 -0.994 . . . . 0.0 112.26 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 162.74 27.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.928 -1.107 . . . . 0.0 109.411 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -153.72 93.93 1.72 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.241 -0.912 . . . . 0.0 111.195 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -116.66 153.14 49.05 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.0 -72.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.326 1.172 . . . . 0.0 110.749 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.6 t -47.21 -29.18 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 O-C-N 120.76 -1.212 . . . . 0.0 111.118 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -66.02 -35.99 82.06 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.794 -1.191 . . . . 0.0 109.341 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.92 -24.6 67.07 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.276 -0.89 . . . . 0.0 109.876 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -26.78 35.56 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.009 -1.057 . . . . 0.0 111.068 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -91.27 -38.64 12.54 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.876 -1.14 . . . . 0.0 111.579 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 396' ' ' PHE . 56.2 m-85 -114.23 135.33 54.17 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.958 -1.089 . . . . 0.0 110.612 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.38 165.6 13.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.23 -0.919 . . . . 0.0 110.713 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -142.14 159.57 58.22 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.699 -0.626 . . . . 0.0 109.722 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.7 Cg_endo -60.36 140.36 91.36 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.31 64.72 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.422 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.23 146.83 29.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 119.508 1.654 . . . . 0.0 108.469 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.4 m -55.55 -24.6 33.26 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.901 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.55 11.26 28.85 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.547 -1.345 . . . . 0.0 113.115 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -54.34 138.4 39.48 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.38 -1.45 . . . . 0.0 109.519 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -156.13 40.76 0.58 Allowed Glycine 0 N--CA 1.5 2.915 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.59 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -93.25 -58.31 1.3 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 407' ' ' VAL . 48.5 t 32.59 59.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 122.131 -0.629 . . . . 0.0 112.572 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.06 78.54 1.61 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.226 -0.921 . . . . 0.0 111.193 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 409' ' ' ILE . 79.5 mt -101.61 62.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.156 -0.965 . . . . 0.0 108.832 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.59 76.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 83.48 57.52 2.45 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -48.8 -63.37 1.11 Allowed 'General case' 0 N--CA 1.511 2.62 0 O-C-N 121.461 -1.023 . . . . 0.0 110.846 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -149.54 35.04 0.7 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.231 -0.918 . . . . 0.0 110.692 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 52.09 40.63 28.93 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.979 -1.076 . . . . 0.0 110.815 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.64 66.92 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.034 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.47 87.81 2.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.324 -0.86 . . . . 0.0 110.177 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.209 179.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.77 85.77 1.12 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.422 1.222 . . . . 0.0 110.422 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 35.0 mt -134.07 99.99 4.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.913 . . . . 0.0 110.171 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.22 129.12 4.6 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.06 -65.14 0.52 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -1.128 . . . . 0.0 110.237 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -62.81 87.56 0.05 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 2.2 p -139.24 103.1 4.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.229 -1.16 . . . . 0.0 110.246 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -134.94 -175.8 4.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.263 -0.898 . . . . 0.0 110.319 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 87.23 40.68 6.86 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -148.47 -67.09 0.23 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.169 -1.195 . . . . 0.0 110.581 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -132.17 45.08 2.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.085 -1.009 . . . . 0.0 110.393 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.9 p -142.84 161.26 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.372 -0.83 . . . . 0.0 110.401 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -84.78 82.71 8.31 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.369 -0.832 . . . . 0.0 109.34 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.488 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -60.19 152.68 23.99 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.7 t -72.95 141.89 47.81 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.182 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.4 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 1.0 OUTLIER -54.53 157.93 2.7 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.796 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 15.4 t -79.42 156.37 27.93 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.857 -1.152 . . . . 0.0 110.5 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.6 mtm -57.32 -27.21 62.0 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.137 -0.977 . . . . 0.0 110.84 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 88.8 m-85 -83.31 -23.93 32.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.9 -1.125 . . . . 0.0 110.782 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 68.98 -89.95 0.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 7.87 29.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.262 -1.14 . . . . 0.0 112.769 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 386' ' ' TYR . 68.5 m-80 -132.31 30.8 4.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.333 -1.479 . . . . 0.0 112.408 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 38.5 t -58.28 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 O-C-N 120.999 -1.063 . . . . 0.0 111.091 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 387' ' ' ARG . 33.2 p90 -57.03 -29.46 63.39 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.005 -1.06 . . . . 0.0 111.787 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HB3' ' CE1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -92.22 152.36 19.88 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.906 -1.121 . . . . 0.0 110.451 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -150.4 129.49 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.343 -0.848 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -129.76 168.23 17.33 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.184 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.12 -34.83 9.65 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.47 1.247 . . . . 0.0 110.489 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.95 -22.12 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.151 -0.968 . . . . 0.0 111.333 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.49 -38.33 90.73 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.657 -1.277 . . . . 0.0 109.62 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.92 -27.35 51.79 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.35 -29.42 28.27 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.059 -1.026 . . . . 0.0 110.609 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -80.59 -32.95 36.34 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.999 -1.063 . . . . 0.0 111.951 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -131.56 141.46 49.7 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.87 -1.143 . . . . 0.0 111.011 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.488 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 73.8 m -86.47 168.76 13.46 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.283 -0.886 . . . . 0.0 110.092 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -143.09 158.88 57.79 Favored Pre-proline 0 N--CA 1.484 1.232 0 O-C-N 121.672 -0.643 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 39.5 Cg_endo -62.2 139.15 76.4 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 N-CA-C 108.149 -1.52 . . . . 0.0 108.149 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.11 56.06 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.965 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -115.91 156.97 25.23 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.594 1.697 . . . . 0.0 108.272 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.3 m -63.58 -29.34 70.61 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.281 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.12 -2.74 58.85 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.827 -1.171 . . . . 0.0 113.105 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -50.09 127.84 17.65 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 120.514 1.506 . . . . 0.0 110.122 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -145.51 31.41 1.67 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.4 -1.381 . . . . 0.0 111.061 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -91.93 -56.93 1.55 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 407' ' ' VAL . 84.3 t 44.84 62.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.788 -0.831 . . . . 0.0 111.261 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -87.91 79.38 8.08 Favored 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.853 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.598 HG23 ' CG ' ' A' ' 412' ' ' GLN . 87.6 mt 51.94 69.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.09 -1.006 . . . . 0.0 110.786 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 65.9 t -113.21 69.76 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 99.77 54.24 1.07 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.598 ' CG ' HG23 ' A' ' 409' ' ' ILE . 14.0 mm-40 -58.74 -38.98 79.58 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.282 -1.128 . . . . 0.0 110.199 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.82 37.22 2.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.182 -0.949 . . . . 0.0 110.197 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -144.77 40.09 1.27 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.09 -1.006 . . . . 0.0 110.37 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.55 63.36 1.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.24 47.3 1.94 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 3.4 t70 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.208 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.73 127.59 12.5 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.436 1.23 . . . . 0.0 110.416 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.97 92.94 3.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.907 . . . . 0.0 110.132 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -129.16 164.51 22.16 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.7 m -117.33 -65.37 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.165 -1.197 . . . . 0.0 110.229 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -62.85 93.14 0.09 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.66 138.86 53.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.222 -1.164 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -117.52 -173.16 2.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.077 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 76.79 41.18 24.28 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -133.42 -60.95 0.83 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.146 -1.208 . . . . 0.0 109.843 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -136.98 43.15 2.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.0 109.796 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.8 p -144.51 162.27 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.459 -0.776 . . . . 0.0 110.303 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.27 94.49 9.56 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.46 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -65.43 173.38 2.68 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.449 -0.782 . . . . 0.0 110.741 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.6 t -90.12 141.44 28.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.388 -0.82 . . . . 0.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.8 t -64.68 120.55 12.64 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.07 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -34.94 148.69 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 35.1 mtm -50.09 -30.84 11.82 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.39 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -85.54 -23.17 27.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.151 -0.968 . . . . 0.0 111.301 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.03 -87.43 0.11 Allowed Glycine 0 N--CA 1.491 2.334 0 O-C-N 120.459 -1.401 . . . . 0.0 110.11 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.33 1.25 27.78 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.294 -1.121 . . . . 0.0 112.61 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -121.85 22.64 10.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.475 -1.39 . . . . 0.0 112.297 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.4 t -47.22 140.23 5.48 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 120.696 -1.253 . . . . 0.0 111.002 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.465 ' OH ' ' NH1' ' A' ' 387' ' ' ARG . 27.2 p90 -113.43 -37.61 4.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.347 -0.845 . . . . 0.0 111.68 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.465 ' NH1' ' OH ' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.98 154.16 28.41 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.77 -1.206 . . . . 0.0 109.497 179.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 100.0 3.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 110.52 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -115.04 167.0 10.55 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.243 -0.91 . . . . 0.0 110.101 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.69 -30.08 12.17 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.425 1.224 . . . . 0.0 110.754 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.9 -23.4 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 121.134 -0.979 . . . . 0.0 111.481 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -60.9 -39.23 88.51 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 120.599 -1.313 . . . . 0.0 109.572 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -55.54 -29.16 58.43 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.094 -1.004 . . . . 0.0 109.578 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.08 39.46 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.587 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -77.7 -33.36 53.22 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.987 -1.07 . . . . 0.0 111.481 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -132.4 137.82 47.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.896 -1.127 . . . . 0.0 110.793 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 73.8 m -79.38 168.23 19.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.278 -0.889 . . . . 0.0 109.085 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.3 159.19 59.16 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.89 137.36 62.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.602 -1.345 . . . . 0.0 108.602 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.24 -0.78 58.75 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.535 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.05 151.63 39.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.208 1.504 . . . . 0.0 108.554 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 40.4 t -58.46 -31.72 68.06 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.237 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.416 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 69.4 m-20 -73.14 -14.77 61.44 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.944 -1.098 . . . . 0.0 113.237 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.481 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 -40.73 115.63 0.6 Allowed 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 120.192 1.36 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.9 75.95 0.12 Allowed Glycine 0 N--CA 1.501 2.978 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -145.88 -59.41 0.02 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.532 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 407' ' ' VAL . 12.7 p -106.78 62.77 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.157 -1.202 . . . . 0.0 110.798 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.401 ' NE2' ' CD2' ' A' ' 404' ' ' TYR . 18.2 mt-30 -134.9 92.95 2.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.288 -0.883 . . . . 0.0 109.929 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.575 HG23 ' CD ' ' A' ' 412' ' ' GLN . 5.0 mp -105.44 67.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.165 -0.959 . . . . 0.0 109.938 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 410' ' ' VAL . 66.2 t -117.43 67.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.98 52.31 2.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.575 ' CD ' HG23 ' A' ' 409' ' ' ILE . 3.0 mt-30 -46.96 -65.12 0.61 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.459 -1.024 . . . . 0.0 111.3 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -152.52 48.96 0.75 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.184 -0.948 . . . . 0.0 110.598 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 52.95 43.7 31.34 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.054 -1.028 . . . . 0.0 110.738 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.59 67.32 0.67 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 110.048 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.16 94.69 4.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.327 -0.858 . . . . 0.0 110.033 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 16.7 t0 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.147 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.67 138.63 29.54 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.404 1.213 . . . . 0.0 110.44 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 12.8 mt -121.45 -62.21 1.45 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 111.73 -42.85 1.85 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.5 m -138.52 -61.35 0.59 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.205 -1.174 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 138.4 -176.32 20.86 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.7 m -127.32 73.62 1.45 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.142 -1.21 . . . . 0.0 110.208 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.48 -176.46 5.4 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.171 -0.956 . . . . 0.0 110.601 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -98.5 -94.28 2.0 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -119.65 64.88 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.169 -1.195 . . . . 0.0 110.121 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 2.1 mptt 52.46 59.14 4.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.939 -1.1 . . . . 0.0 110.622 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p -136.36 161.23 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -85.93 91.96 8.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.299 -0.876 . . . . 0.0 108.997 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -63.27 151.44 40.59 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -71.57 149.61 45.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 28.5 t -62.22 161.83 10.64 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.845 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.06 165.94 23.95 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.01 -1.056 . . . . 0.0 109.466 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -36.5 74.72 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.135 -0.978 . . . . 0.0 110.089 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.79 -24.22 28.83 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.276 -0.89 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 69.42 -83.82 0.26 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.49 -1.63 32.62 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.265 -1.138 . . . . 0.0 113.188 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 386' ' ' TYR . 59.2 m-80 -122.4 14.41 10.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.318 -1.489 . . . . 0.0 113.343 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 45.8 t -45.56 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.393 0 CA-C-N 120.072 1.306 . . . . 0.0 112.668 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 384' ' ' ASN . 48.3 p90 -50.9 -34.9 30.25 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.887 -1.133 . . . . 0.0 111.895 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.431 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.4 OUTLIER -73.95 163.92 27.29 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.019 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -155.86 83.9 1.02 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.253 -0.905 . . . . 0.0 111.015 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -116.41 156.77 46.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.98 -72.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.274 1.144 . . . . 0.0 110.864 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.6 t -45.18 -30.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 120.644 -1.285 . . . . 0.0 111.226 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -65.31 -36.37 83.86 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.882 -1.136 . . . . 0.0 109.25 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -58.28 -28.13 64.69 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.171 -0.956 . . . . 0.0 109.544 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -27.07 46.74 Favored 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.677 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -82.25 -37.23 26.24 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.094 -1.004 . . . . 0.0 110.818 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 49.0 m-85 -129.87 144.54 51.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.05 -1.031 . . . . 0.0 110.077 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 404' ' ' TYR . 2.5 m -95.41 167.9 11.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 111.151 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -140.72 157.72 67.13 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.73 -0.607 . . . . 0.0 109.911 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.406 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 36.5 Cg_endo -60.62 137.28 72.43 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 N-CA-C 108.544 -1.368 . . . . 0.0 108.544 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.52 -0.63 58.28 Favored Glycine 0 CA--C 1.551 2.321 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.315 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.22 139.16 46.84 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.337 1.568 . . . . 0.0 108.159 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.4 t -50.07 -26.46 4.44 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.012 -1.055 . . . . 0.0 112.045 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -96.87 3.1 52.35 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.575 -1.328 . . . . 0.0 113.411 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.472 ' CE2' HG22 ' A' ' 407' ' ' VAL . 23.4 t80 -48.78 142.42 6.3 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 120.355 1.434 . . . . 0.0 110.52 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.77 48.81 0.24 Allowed Glycine 0 N--CA 1.5 2.948 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.9 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -172.16 79.45 0.09 OUTLIER Glycine 0 N--CA 1.497 2.717 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.856 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 404' ' ' TYR . 62.0 t -85.59 81.4 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.395 -1.062 . . . . 0.0 108.99 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -115.87 89.99 3.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -0.822 . . . . 0.0 110.49 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.719 HG23 ' CG ' ' A' ' 412' ' ' GLN . 82.5 mt -118.87 70.55 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 36.4 t -103.54 84.36 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.405 -0.81 . . . . 0.0 108.969 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 74.23 60.19 3.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.719 ' CG ' HG23 ' A' ' 409' ' ' ILE . 12.6 mm-40 -57.01 -39.85 75.49 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.226 -1.161 . . . . 0.0 110.243 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.79 37.92 3.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.022 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -137.44 59.91 1.66 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.158 -0.964 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.31 65.62 0.67 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.235 -0.916 . . . . 0.0 109.999 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.33 45.91 2.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.216 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.74 -171.35 0.74 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.408 1.215 . . . . 0.0 110.404 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 22.1 mt -116.45 96.25 5.44 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.194 -0.941 . . . . 0.0 110.196 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 105.03 166.43 24.06 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.7 t -117.6 135.73 53.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -1.151 . . . . 0.0 110.191 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.28 165.81 25.37 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.89 -59.51 0.75 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.264 -1.139 . . . . 0.0 110.354 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.495 ' HG2' HG11 ' A' ' 374' ' ' VAL . 26.7 mt-10 -121.42 84.65 2.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -0.996 . . . . 0.0 110.035 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -136.31 41.17 1.44 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -146.58 -66.19 0.28 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -1.168 . . . . 0.0 110.4 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.437 ' C ' HG23 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -152.94 74.32 1.04 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.209 -0.932 . . . . 0.0 110.396 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 370' ' ' GLU . 96.7 t -147.31 161.9 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.229 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.94 93.04 9.46 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.272 -0.893 . . . . 0.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 394' ' ' GLN . 13.0 mtt180 -56.07 152.65 10.16 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.385 -0.822 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -82.28 133.33 35.24 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 63.4 p -50.76 153.75 1.62 Allowed 'General case' 0 N--CA 1.515 2.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.135 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.9 t -78.15 155.72 30.29 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.126 -0.984 . . . . 0.0 110.845 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 48.5 mtm -60.15 -30.01 69.03 Favored 'General case' 0 N--CA 1.51 2.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.26 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.426 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 34.5 m-85 -84.39 -24.19 29.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.048 -1.032 . . . . 0.0 110.64 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.22 -86.84 0.14 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.24 -4.5 20.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -1.143 . . . . 0.0 112.337 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -112.4 16.57 19.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.457 -1.402 . . . . 0.0 112.858 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.426 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 14.5 t -46.73 137.31 7.14 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 120.6 -1.312 . . . . 0.0 110.513 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 39.6 p90 -116.91 -39.07 3.3 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.228 -0.92 . . . . 0.0 112.517 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.4 ptp85 -51.95 161.79 0.53 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.646 -1.284 . . . . 0.0 110.82 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -128.31 55.37 1.68 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 0.0 110.492 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.21 140.55 21.25 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.276 -0.89 . . . . 0.0 109.965 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.11 -72.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.258 1.136 . . . . 0.0 110.154 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.2 t -40.12 -28.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 O-C-N 120.864 -1.147 . . . . 0.0 112.497 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.452 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 25.0 t60 -64.22 -37.83 88.87 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 120.492 -1.38 . . . . 0.0 108.568 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -59.79 -30.82 69.16 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.2 -0.938 . . . . 0.0 109.592 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.41 ' HA ' ' NE ' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -77.02 -26.48 53.78 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.186 -0.946 . . . . 0.0 110.85 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -91.69 -38.09 12.63 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.905 -1.122 . . . . 0.0 110.516 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 76.0 m-85 -113.11 138.51 49.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.0 110.49 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.66 168.5 11.44 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.278 -0.889 . . . . 0.0 111.224 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -141.48 159.64 59.83 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.77 -0.581 . . . . 0.0 109.66 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.51 139.92 84.44 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.48 -2.55 60.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -107.66 144.66 34.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.592 -1.534 . . . . 0.0 108.215 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 3.0 t -55.18 -24.3 26.24 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.206 -0.934 . . . . 0.0 111.801 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -105.15 7.54 33.78 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.521 -1.362 . . . . 0.0 113.066 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -45.78 120.21 2.55 Favored 'General case' 0 N--CA 1.523 3.184 0 CA-C-N 120.513 1.506 . . . . 0.0 110.876 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.432 ' HA3' ' NE2' ' A' ' 408' ' ' GLN . . . -51.46 -36.29 38.05 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 81.37 52.05 4.39 Favored Glycine 0 N--CA 1.488 2.155 0 O-C-N 121.192 -1.181 . . . . 0.0 111.064 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 90.3 t 52.3 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.225 -1.162 . . . . 0.0 111.043 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.432 ' NE2' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -166.04 79.54 0.27 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.273 -0.892 . . . . 0.0 110.885 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.62 HG23 ' CD ' ' A' ' 412' ' ' GLN . 59.4 mt -99.47 73.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 120.9 -1.125 . . . . 0.0 110.285 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.65 70.07 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 108.927 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 96.85 53.94 1.35 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.62 ' CD ' HG23 ' A' ' 409' ' ' ILE . 6.1 mt-30 -49.25 -62.35 1.59 Allowed 'General case' 0 N--CA 1.513 2.703 0 O-C-N 121.488 -1.007 . . . . 0.0 110.543 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -135.77 34.83 2.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 110.33 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -128.18 68.96 1.34 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.034 . . . . 0.0 110.124 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.43 64.57 0.62 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.129 -0.982 . . . . 0.0 109.967 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -115.24 42.5 2.21 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.204 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.72 124.92 10.1 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.415 1.218 . . . . 0.0 110.377 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.03 48.0 1.8 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.206 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -109.83 79.97 0.26 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.0 p -142.71 105.88 4.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.251 -1.147 . . . . 0.0 110.283 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -140.09 127.69 3.62 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.41 96.14 2.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -1.18 . . . . 0.0 110.159 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.521 ' HG2' HG11 ' A' ' 374' ' ' VAL . 0.9 OUTLIER -142.84 163.66 32.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.164 -0.96 . . . . 0.0 110.317 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -153.43 47.6 0.54 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -143.92 -67.19 0.34 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.128 -1.219 . . . . 0.0 110.408 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -169.25 76.93 0.1 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.073 -1.017 . . . . 0.0 110.947 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.521 HG11 ' HG2' ' A' ' 370' ' ' GLU . 13.3 p -144.76 161.92 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 111.0 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.06 89.88 3.59 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.851 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -57.94 174.18 0.28 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.61 -0.682 . . . . 0.0 111.016 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.6 m -88.45 134.28 33.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 406' ' ' GLY . 82.9 p -62.92 121.09 12.66 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.539 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 145.69 0.59 Allowed 'General case' 0 N--CA 1.513 2.679 0 O-C-N 121.368 -0.832 . . . . 0.0 112.173 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -46.72 -35.27 5.92 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.627 -0.67 . . . . 0.0 110.451 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -78.07 -29.52 49.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.078 -1.014 . . . . 0.0 111.204 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 399' ' ' PRO . . . 64.49 -86.19 0.07 OUTLIER Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.24 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -100.82 1.57 40.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.212 -1.169 . . . . 0.0 113.054 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 386' ' ' TYR . 37.3 m-80 -128.76 21.77 5.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.49 -1.381 . . . . 0.0 112.896 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.5 t -55.87 85.79 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 CA-C-N 119.915 1.234 . . . . 0.0 110.704 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 384' ' ' ASN . 28.9 p90 -61.02 -26.75 67.83 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.044 -1.035 . . . . 0.0 111.795 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 149.8 21.17 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.37 127.55 12.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 392' ' ' HIS . 1.5 m-20 -128.62 166.5 24.22 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.11 -33.79 11.15 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.322 1.17 . . . . 0.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.77 -23.28 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.263 -0.898 . . . . 0.0 111.5 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 389' ' ' ASN . 48.9 t60 -62.57 -36.34 82.38 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.689 -1.257 . . . . 0.0 110.229 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.1 -26.36 66.16 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.106 -0.996 . . . . 0.0 109.518 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.1 -30.48 55.37 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.142 -0.974 . . . . 0.0 110.447 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.433 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 19.5 m170 -81.79 -35.4 29.59 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 51.1 m-85 -128.68 139.38 52.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.001 -1.062 . . . . 0.0 111.255 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.13 169.14 16.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.408 -0.808 . . . . 0.0 109.38 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -144.75 153.74 54.79 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.434 -0.791 . . . . 0.0 109.369 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.404 ' CD ' ' O ' ' A' ' 382' ' ' GLY . 37.3 Cg_endo -61.14 137.46 71.46 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 N-CA-C 108.405 -1.421 . . . . 0.0 108.405 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.34 -1.16 53.83 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.748 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.92 171.69 7.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.649 1.725 . . . . 0.0 108.546 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -24.2 53.11 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.066 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -99.0 1.78 45.74 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.637 -1.289 . . . . 0.0 113.605 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -47.32 136.85 8.95 Favored 'General case' 0 N--CA 1.522 3.164 0 CA-C-N 120.362 1.437 . . . . 0.0 110.89 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -176.06 72.72 0.08 OUTLIER Glycine 0 N--CA 1.5 2.959 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.765 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.484 ' O ' ' OG ' ' A' ' 378' ' ' SER . . . -170.13 52.57 0.2 Allowed Glycine 0 N--CA 1.499 2.894 0 C-N-CA 119.333 -1.413 . . . . 0.0 112.495 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 407' ' ' VAL . 78.5 t -72.86 73.76 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 120.762 -1.434 . . . . 0.0 110.129 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.401 ' CG ' ' O ' ' A' ' 408' ' ' GLN . 0.2 OUTLIER -136.49 81.4 1.88 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.148 -0.97 . . . . 0.0 110.572 179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.519 HG23 ' CD ' ' A' ' 412' ' ' GLN . 8.3 mt -107.43 73.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.868 -1.145 . . . . 0.0 109.8 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.9 79.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 108.838 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 78.33 58.97 3.0 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.234 -1.947 . . . . 0.0 108.234 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.519 ' CD ' HG23 ' A' ' 409' ' ' ILE . 8.1 mt-30 -48.13 -65.41 0.57 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.435 -1.038 . . . . 0.0 111.074 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -150.76 35.46 0.61 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.119 -0.988 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.75 54.23 1.5 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.103 -0.998 . . . . 0.0 110.101 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 415' ' ' THR . 5.8 t -132.67 62.61 1.65 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -0.911 . . . . 0.0 110.201 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -103.18 39.38 1.58 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.192 -0.943 . . . . 0.0 109.893 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.236 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.8 117.92 5.34 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.504 1.265 . . . . 0.0 110.384 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.8 tp -138.08 45.38 2.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.157 -0.965 . . . . 0.0 110.178 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -104.59 102.9 2.16 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.41 -60.26 0.67 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.237 -1.155 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 124.65 -137.55 10.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.7 t -134.46 119.31 18.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.211 -1.17 . . . . 0.0 110.178 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.44 56.66 1.66 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 0.0 110.069 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -135.65 40.07 1.59 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -146.3 -67.11 0.28 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.16 -1.2 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.422 ' C ' HG23 ' A' ' 374' ' ' VAL . 9.8 mttp -140.46 67.38 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.151 -0.968 . . . . 0.0 110.256 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.422 HG23 ' C ' ' A' ' 373' ' ' LYS . 67.2 t -146.28 160.69 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.975 . . . . 0.0 109.925 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -87.05 91.03 8.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.29 151.58 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.372 -0.83 . . . . 0.0 110.25 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.3 t -81.13 136.7 35.93 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.784 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -51.72 149.04 4.92 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 121.155 -0.966 . . . . 0.0 109.964 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.4 t -71.13 163.42 27.64 Favored 'General case' 0 N--CA 1.512 2.627 0 O-C-N 120.944 -1.098 . . . . 0.0 110.495 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.408 ' HA ' ' CD1' ' A' ' 409' ' ' ILE . 63.7 mtm -62.91 -31.08 72.07 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.227 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -84.41 -23.48 30.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.201 -0.937 . . . . 0.0 110.45 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 70.33 -86.06 0.33 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.55 -4.26 18.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -1.136 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -111.53 16.46 20.69 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.486 -1.384 . . . . 0.0 112.874 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -47.62 141.0 5.61 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 120.086 1.312 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.2 p90 -121.72 -39.94 2.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 112.285 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.426 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -59.24 149.45 28.49 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.619 -1.301 . . . . 0.0 109.512 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.6 74.73 1.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.159 -0.963 . . . . 0.0 111.111 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.41 148.25 38.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.91 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.34 1.179 . . . . 0.0 110.764 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -42.25 -27.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 O-C-N 120.7 -1.25 . . . . 0.0 112.422 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -66.45 -35.63 80.76 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.456 -1.403 . . . . 0.0 109.238 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.97 -28.82 70.35 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -26.63 57.0 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.224 -0.922 . . . . 0.0 111.297 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 395' ' ' HIS . 18.4 m170 -92.08 -35.52 13.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.852 -1.155 . . . . 0.0 111.238 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -117.55 144.99 44.57 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.064 -1.022 . . . . 0.0 110.521 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.74 168.77 10.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.956 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -140.5 158.3 66.37 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.702 -0.624 . . . . 0.0 110.538 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.42 139.23 75.61 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 107.99 -1.581 . . . . 0.0 107.99 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.73 -3.13 60.73 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.878 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.3 138.1 46.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.627 -1.513 . . . . 0.0 108.466 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -25.67 0.94 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.201 -0.937 . . . . 0.0 113.267 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -106.06 12.96 29.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.512 -1.368 . . . . 0.0 113.192 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -50.49 135.29 22.78 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 120.457 -1.402 . . . . 0.0 109.951 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.96 -25.81 28.28 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.316 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.428 ' C ' HG23 ' A' ' 407' ' ' VAL . . . 116.34 -116.91 3.73 Favored Glycine 0 N--CA 1.473 1.1 0 N-CA-C 107.551 -2.22 . . . . 0.0 107.551 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.428 HG23 ' C ' ' A' ' 406' ' ' GLY . 59.9 t -146.01 92.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.633 -0.922 . . . . 0.0 111.743 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -155.81 88.15 1.11 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.152 -0.968 . . . . 0.0 110.297 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.477 HG23 ' CD ' ' A' ' 412' ' ' GLN . 44.6 mt -100.21 69.84 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.844 -1.16 . . . . 0.0 110.255 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 58.0 t -119.74 74.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 91.97 56.9 1.55 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.477 ' CD ' HG23 ' A' ' 409' ' ' ILE . 8.2 mt-30 -50.37 -63.62 1.06 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.346 -1.09 . . . . 0.0 110.604 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -148.33 34.7 0.8 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.216 -0.928 . . . . 0.0 110.725 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 52.05 56.29 7.99 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.809 -1.182 . . . . 0.0 110.845 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 415' ' ' THR . 7.4 t -126.56 64.42 1.26 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.192 -0.942 . . . . 0.0 110.181 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.15 39.62 1.53 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.224 -0.922 . . . . 0.0 109.942 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.24 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.71 130.66 16.13 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.456 1.24 . . . . 0.0 110.386 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 5.0 mt -140.04 83.86 1.94 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.134 -0.979 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -125.66 148.34 16.91 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.8 p -122.19 39.69 3.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.153 -1.204 . . . . 0.0 110.337 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 61.79 -146.37 48.81 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 86.6 p -118.29 122.63 43.4 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.199 -1.177 . . . . 0.0 110.254 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.86 113.39 7.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.206 -0.934 . . . . 0.0 110.126 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -156.75 43.09 0.53 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -132.16 -65.21 0.74 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.227 -1.161 . . . . 0.0 110.402 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.27 71.96 1.03 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.269 -0.895 . . . . 0.0 110.527 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.04 160.2 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.151 -0.968 . . . . 0.0 110.703 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -84.39 82.89 8.19 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.289 -0.882 . . . . 0.0 109.208 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.433 ' HA ' ' NE ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -56.56 152.35 12.02 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.186 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -72.34 137.27 46.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.41 ' HB3' ' CA ' ' A' ' 406' ' ' GLY . 2.1 p -49.29 160.2 0.25 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.6 t -83.32 157.76 22.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.201 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.7 ptp -61.59 -36.38 80.51 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.011 -1.055 . . . . 0.0 110.181 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.416 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 16.0 m-85 -77.81 -32.99 52.63 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.171 -0.956 . . . . 0.0 110.29 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.95 -89.15 0.87 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.52 -4.42 19.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -1.056 . . . . 0.0 112.244 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.77 16.65 19.5 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.353 -1.467 . . . . 0.0 112.584 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.416 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 7.3 t -45.86 140.09 3.82 Favored 'General case' 0 N--CA 1.524 3.247 0 O-C-N 120.633 -1.292 . . . . 0.0 110.988 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.8 p90 -116.93 -39.05 3.3 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.381 -0.824 . . . . 0.0 112.279 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.45 ' HD2' ' CG ' ' A' ' 392' ' ' HIS . 6.8 ptp85 -55.19 158.75 2.86 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.651 -1.281 . . . . 0.0 110.564 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -128.12 62.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.248 -0.908 . . . . 0.0 110.517 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.35 145.16 33.14 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.23 -59.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.234 1.123 . . . . 0.0 110.901 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 12.2 p -43.61 -33.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 O-C-N 121.084 -1.01 . . . . 0.0 111.708 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.45 ' CG ' ' HD2' ' A' ' 387' ' ' ARG . 34.4 t60 -66.54 -36.33 82.42 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.91 -29.68 70.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.069 -1.019 . . . . 0.0 109.257 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.432 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 1.3 mp0 -77.23 -29.22 54.0 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.233 -0.917 . . . . 0.0 110.749 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -86.09 -32.99 21.07 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.19 -0.944 . . . . 0.0 111.377 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -124.11 143.41 50.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.791 -1.193 . . . . 0.0 110.592 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 404' ' ' TYR . 0.0 OUTLIER -89.19 170.03 10.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -0.901 . . . . 0.0 111.354 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -143.02 153.06 59.94 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.04 140.57 79.52 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 N-CA-C 108.018 -1.57 . . . . 0.0 108.018 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.92 -0.16 62.43 Favored Glycine 0 CA--C 1.55 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.454 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.0 144.39 41.42 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.643 1.722 . . . . 0.0 108.071 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 61.4 m -52.09 -26.27 10.68 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.98 -1.075 . . . . 0.0 112.4 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -103.36 10.45 37.43 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.504 -1.372 . . . . 0.0 113.315 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 397' ' ' SER . 21.5 t80 -50.89 137.23 21.19 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 120.398 -1.439 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -140.05 23.06 2.76 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.662 -1.256 . . . . 0.0 112.008 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.412 ' HA2' ' NE2' ' A' ' 408' ' ' GLN . . . -77.77 -29.49 54.71 Favored Glycine 0 N--CA 1.494 2.503 0 CA-C-N 119.57 1.685 . . . . 0.0 110.041 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 407' ' ' VAL . 13.5 p -73.63 67.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.517 -0.99 . . . . 0.0 111.242 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.412 ' NE2' ' HA2' ' A' ' 406' ' ' GLY . 4.1 mp0 -92.19 60.72 3.78 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.781 -1.199 . . . . 0.0 109.322 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 409' ' ' ILE . 19.7 mt 51.62 70.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.902 -1.124 . . . . 0.0 110.4 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 410' ' ' VAL . 59.9 t -120.63 61.53 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.424 -0.797 . . . . 0.0 109.459 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 134.81 -43.15 1.28 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 53.85 44.78 29.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -1.077 . . . . 0.0 110.669 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.1 t0 53.56 38.26 27.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.371 -0.83 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -128.53 41.06 3.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.199 -0.938 . . . . 0.0 110.171 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.24 66.36 0.71 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.275 -0.891 . . . . 0.0 110.042 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.33 85.83 2.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.249 -0.907 . . . . 0.0 110.211 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.209 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.8 148.19 45.82 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.34 1.179 . . . . 0.0 110.416 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.75 170.35 16.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 110.195 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -72.22 125.66 10.95 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.6 p -129.57 -65.58 0.84 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.196 -1.179 . . . . 0.0 110.162 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -69.27 128.99 22.72 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 4.8 m -133.1 126.72 32.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.139 -1.213 . . . . 0.0 110.142 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -139.02 62.26 1.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.066 -1.021 . . . . 0.0 110.163 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -146.04 39.17 1.14 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -125.52 -58.63 1.41 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.324 -1.104 . . . . 0.0 109.61 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.81 59.54 1.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 64.8 t -144.48 147.43 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.002 -1.062 . . . . 0.0 110.117 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 66.9 9.68 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.895 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -58.29 156.43 10.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.759 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.3 t -74.91 145.75 42.4 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.654 -0.818 . . . . 0.0 108.879 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 0.8 OUTLIER -51.67 169.06 0.07 Allowed 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.323 -178.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 54.1 t -85.44 158.79 20.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.155 -0.966 . . . . 0.0 108.44 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.0 mtm -63.07 -33.59 75.78 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 120.758 -1.214 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -94.7 -20.11 19.82 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.983 -1.073 . . . . 0.0 111.168 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 58.37 -95.59 0.06 OUTLIER Glycine 0 N--CA 1.494 2.536 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -86.89 -21.16 26.5 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.246 -1.149 . . . . 0.0 111.632 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -94.23 6.81 47.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.743 -1.223 . . . . 0.0 112.558 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.3 t -43.0 134.39 3.43 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 120.655 -1.278 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 27.4 p90 -119.95 -35.66 3.44 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.334 -0.854 . . . . 0.0 112.477 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.473 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 4.0 ptm180 -48.72 163.82 0.07 Allowed 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.68 -1.262 . . . . 0.0 110.968 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.9 pttm -129.81 56.83 1.7 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.196 -0.94 . . . . 0.0 110.522 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -109.41 144.16 29.24 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.26 -0.9 . . . . 0.0 110.51 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -73.94 -73.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 O-C-N 123.318 1.167 . . . . 0.0 110.355 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 72.2 t -41.24 -27.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 O-C-N 120.797 -1.19 . . . . 0.0 112.601 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -63.65 -37.43 87.32 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.375 -1.453 . . . . 0.0 108.533 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -60.59 -31.58 70.72 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.084 -1.01 . . . . 0.0 109.527 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.21 -27.21 38.84 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.102 -0.999 . . . . 0.0 110.987 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -84.8 -29.87 25.04 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.843 -1.161 . . . . 0.0 111.803 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -124.41 137.66 54.43 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.799 -1.188 . . . . 0.0 111.183 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.77 153.77 32.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.296 -0.878 . . . . 0.0 111.516 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -134.29 157.32 77.78 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.51 136.67 64.67 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 N-CA-C 108.281 -1.469 . . . . 0.0 108.281 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.32 1.99 56.76 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.032 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.52 141.7 45.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.211 1.506 . . . . 0.0 108.71 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 58.2 m -52.78 -25.94 12.81 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.214 -0.928 . . . . 0.0 111.83 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -98.12 -3.45 37.79 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.68 -1.262 . . . . 0.0 113.051 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -45.17 141.85 2.23 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 120.202 1.365 . . . . 0.0 111.491 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -172.75 54.23 0.16 Allowed Glycine 0 N--CA 1.502 3.07 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.592 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -110.17 -65.15 0.54 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 407' ' ' VAL . 85.2 t 45.62 61.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.704 -0.88 . . . . 0.0 111.491 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -101.69 92.29 4.79 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.281 -0.887 . . . . 0.0 110.426 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.571 HG23 ' CD ' ' A' ' 412' ' ' GLN . 92.8 mt -111.28 71.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.104 -0.997 . . . . 0.0 109.768 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.6 t -115.4 77.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.321 -0.862 . . . . 0.0 108.944 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 87.59 57.55 1.95 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.571 ' CD ' HG23 ' A' ' 409' ' ' ILE . 8.3 mt-30 -49.94 -62.82 1.35 Allowed 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.275 -1.132 . . . . 0.0 110.508 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -148.28 34.43 0.8 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.331 -0.855 . . . . 0.0 110.502 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -140.01 53.98 1.66 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.122 -0.986 . . . . 0.0 110.172 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.52 66.38 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.071 -1.018 . . . . 0.0 109.93 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.84 42.78 2.25 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.251 -0.906 . . . . 0.0 110.182 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.259 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.75 140.26 32.02 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.388 1.204 . . . . 0.0 110.381 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 5.4 tp 52.77 80.58 0.1 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.053 -1.03 . . . . 0.0 110.778 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.67 142.42 13.31 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 32.1 t -142.78 46.42 1.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.17 -1.194 . . . . 0.0 110.274 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 75.68 103.47 0.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 7.8 t -122.91 84.68 2.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.233 -1.157 . . . . 0.0 110.334 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -139.58 43.98 1.97 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.243 -0.911 . . . . 0.0 110.118 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -147.51 40.48 0.98 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -128.35 -59.99 1.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -1.176 . . . . 0.0 109.956 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -133.59 48.11 2.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.227 -0.921 . . . . 0.0 110.105 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.37 161.5 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.267 -0.895 . . . . 0.0 110.326 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -91.35 94.2 9.4 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.327 -0.858 . . . . 0.0 109.452 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.45 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -70.81 174.21 6.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.606 -0.684 . . . . 0.0 110.433 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -94.68 136.04 35.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.37 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 7.9 t -58.05 122.78 13.87 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.371 -0.83 . . . . 0.0 109.744 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.3 t -42.37 148.61 0.2 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -49.98 -29.13 7.92 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.546 -0.721 . . . . 0.0 110.386 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 9.3 m-85 -84.63 -23.77 29.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.027 -1.046 . . . . 0.0 111.444 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.05 -88.58 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 O-C-N 120.375 -1.453 . . . . 0.0 110.635 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.5 3.76 40.51 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.177 -1.19 . . . . 0.0 113.259 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 386' ' ' TYR . 16.8 m-80 -130.93 26.97 4.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.424 -1.422 . . . . 0.0 112.371 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.413 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 52.9 t -57.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.625 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 384' ' ' ASN . 34.9 p90 -63.59 -27.92 69.57 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 121.135 -0.978 . . . . 0.0 112.362 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 162.63 28.95 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 120.72 -1.237 . . . . 0.0 109.086 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.94 91.77 1.14 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.073 -1.017 . . . . 0.0 111.461 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.57 166.83 10.14 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.0 110.045 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.83 -32.28 5.79 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.404 1.213 . . . . 0.0 110.79 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.52 -22.6 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.149 -0.969 . . . . 0.0 111.029 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.56 -37.01 82.24 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.803 -1.186 . . . . 0.0 109.469 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -56.38 -27.55 56.52 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.095 -1.003 . . . . 0.0 109.53 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.72 -30.49 26.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.106 -0.996 . . . . 0.0 110.562 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.0 m170 -76.2 -32.85 59.2 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.908 -1.12 . . . . 0.0 111.785 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 56.0 m-85 -132.57 138.49 47.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 111.077 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 28.2 m -78.83 165.42 23.56 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -143.04 160.87 51.14 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.249 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.26 137.52 71.29 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.09 -1.87 61.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.642 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.76 149.6 36.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.449 1.624 . . . . 0.0 108.439 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 79.2 p -56.85 -32.07 65.41 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.062 -1.024 . . . . 0.0 111.152 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -80.18 -8.08 59.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.943 -1.098 . . . . 0.0 113.589 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.457 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 8.0 t80 -40.42 113.82 0.4 Allowed 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 120.524 1.511 . . . . 0.0 111.263 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -165.2 77.89 0.14 Allowed Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.91 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.446 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -155.84 -62.47 0.01 OUTLIER Glycine 0 N--CA 1.5 2.939 0 C-N-CA 119.399 -1.382 . . . . 0.0 112.024 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 407' ' ' VAL . 12.9 p -109.26 70.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.752 1.276 . . . . 0.0 111.544 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.441 ' NE2' ' CE2' ' A' ' 404' ' ' TYR . 7.7 mt-30 -131.54 86.11 2.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 0.0 109.593 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.491 HG23 ' CG ' ' A' ' 412' ' ' GLN . 71.0 mt -106.44 67.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.238 -0.914 . . . . 0.0 110.092 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 410' ' ' VAL . 12.0 p -113.82 66.12 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.315 -0.866 . . . . 0.0 108.823 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 102.17 54.78 0.89 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.491 ' CG ' HG23 ' A' ' 409' ' ' ILE . 13.5 mm-40 -56.96 -39.14 74.01 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.277 -1.131 . . . . 0.0 110.173 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.23 37.34 2.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.237 -0.914 . . . . 0.0 110.054 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -148.93 49.41 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.108 -0.995 . . . . 0.0 110.455 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 66.46 0.65 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.227 -0.921 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -143.18 40.34 1.48 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.231 -0.918 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 25.2 t70 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.228 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.74 94.54 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.414 1.218 . . . . 0.0 110.354 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.53 93.46 3.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.224 -0.923 . . . . 0.0 110.203 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -110.41 154.38 16.62 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 67.0 m -143.28 83.13 1.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.236 -1.155 . . . . 0.0 110.331 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 110.82 99.38 2.53 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.1 t -141.85 105.5 4.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.177 -1.19 . . . . 0.0 110.204 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -141.61 -172.13 3.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 89.29 41.41 5.82 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -135.4 -64.81 0.63 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.179 -1.189 . . . . 0.0 110.054 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.07 47.71 1.81 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.124 -0.985 . . . . 0.0 109.93 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.74 161.65 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.369 -0.832 . . . . 0.0 110.059 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 87.62 7.0 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.185 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 376' ' ' ARG . 0.0 OUTLIER -61.92 151.02 35.95 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.258 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.0 t -71.66 141.85 49.9 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.503 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.27 157.51 2.68 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.05 154.41 25.64 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.816 -1.178 . . . . 0.0 110.874 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.415 ' CE ' ' CE2' ' A' ' 381' ' ' TYR . 4.0 ptt? -54.62 -28.84 49.6 Favored 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.437 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.445 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 72.0 m-85 -82.64 -29.03 30.33 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.958 -1.089 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 72.19 -93.84 0.61 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -103.41 -0.23 30.32 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -1.182 . . . . 0.0 112.474 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 386' ' ' TYR . 29.9 m-80 -121.38 24.26 10.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.347 -1.471 . . . . 0.0 112.504 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 49.2 t -59.38 81.83 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.95 0 O-C-N 120.783 -1.198 . . . . 0.0 110.589 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 384' ' ' ASN . 29.6 p90 -61.92 -25.42 67.56 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.169 -0.957 . . . . 0.0 111.738 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -87.5 157.89 19.07 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.798 -1.188 . . . . 0.0 110.134 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.73 124.04 5.32 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.217 -0.927 . . . . 0.0 110.91 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 392' ' ' HIS . 6.8 m-20 -126.06 166.93 18.57 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.284 -0.885 . . . . 0.0 109.69 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.09 -33.48 11.64 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.418 1.22 . . . . 0.0 110.263 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.26 -24.67 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.972 . . . . 0.0 111.416 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.404 ' CB ' ' HB2' ' A' ' 389' ' ' ASN . 47.9 t60 -60.48 -38.98 86.0 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.577 -1.327 . . . . 0.0 110.006 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -56.5 -28.6 60.25 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.408 ' O ' ' HD2' ' A' ' 376' ' ' ARG . 0.8 OUTLIER -79.96 -32.23 39.92 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.577 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -78.15 -35.17 49.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.219 -0.925 . . . . 0.0 111.486 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.25 144.34 51.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.952 -1.093 . . . . 0.0 110.726 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 10.0 m -91.42 171.47 9.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -143.48 159.17 55.7 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.11 139.3 83.3 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.73 -1.03 56.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.3 153.85 30.19 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.267 1.533 . . . . 0.0 107.658 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -29.06 70.41 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.135 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -85.91 -1.8 57.65 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -41.3 112.81 0.34 Allowed 'General case' 0 N--CA 1.527 3.4 0 CA-C-N 120.713 1.597 . . . . 0.0 111.102 -178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -57.31 -49.25 74.18 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.246 -0.909 . . . . 0.0 111.819 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 126.1 58.16 0.15 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.673 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 80.1 t 44.76 89.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.549 -0.971 . . . . 0.0 113.046 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.42 91.49 2.2 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.174 -0.954 . . . . 0.0 110.715 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 60.8 mt -111.21 74.25 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.944 -1.098 . . . . 0.0 109.826 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.69 74.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.221 -0.924 . . . . 0.0 109.465 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 112.39 -41.62 2.18 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 54.54 37.45 27.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.277 -1.131 . . . . 0.0 110.724 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.1 t70 51.41 38.15 21.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.11 -0.994 . . . . 0.0 110.96 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.11 42.07 3.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.124 -0.985 . . . . 0.0 110.35 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 65.25 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 110.044 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.3 t70 52.74 39.12 28.04 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.031 -1.043 . . . . 0.0 110.754 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.159 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.8 165.33 33.06 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.408 1.215 . . . . 0.0 110.396 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.2 tp -140.71 -59.94 0.51 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 125.02 129.58 3.39 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.2 p -142.7 125.95 16.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.141 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 70.5 157.41 2.11 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.24 39.14 1.59 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.236 -1.155 . . . . 0.0 110.394 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.43 -172.1 4.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.179 -0.951 . . . . 0.0 110.384 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -66.84 -86.77 0.08 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -129.29 64.23 1.48 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.211 -1.17 . . . . 0.0 110.046 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.83 66.32 1.26 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.953 -1.092 . . . . 0.0 110.371 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.14 161.56 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.239 -0.913 . . . . 0.0 110.609 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -79.87 94.49 5.84 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.455 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.6 OUTLIER -68.52 153.77 43.13 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.605 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 9.1 t -79.05 142.8 36.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.694 -0.629 . . . . 0.0 109.419 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.3 p -56.33 155.25 7.14 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.33 156.34 28.06 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.05 -1.031 . . . . 0.0 110.265 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -58.54 -35.77 72.83 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.16 -0.963 . . . . 0.0 110.635 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -71.89 -39.11 69.81 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.083 -1.01 . . . . 0.0 110.114 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.51 -86.92 1.31 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.07 -0.73 28.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.144 -1.209 . . . . 0.0 112.33 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.27 13.57 9.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.556 -1.34 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 48.8 t -49.39 152.57 1.25 Allowed 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.462 -1.398 . . . . 0.0 111.3 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 18.3 p90 -101.93 -29.62 11.71 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.446 -0.784 . . . . 0.0 111.525 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER 23.61 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.16 -2.88 25.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.983 -1.073 . . . . 0.0 111.462 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -130.35 157.57 76.94 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.582 -1.324 . . . . 0.0 109.267 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.23 -44.3 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.312 1.164 . . . . 0.0 110.061 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.4 t -47.73 -31.51 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 O-C-N 121.131 -0.981 . . . . 0.0 110.591 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -63.65 -31.97 73.3 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.003 -1.061 . . . . 0.0 109.428 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.429 ' CZ ' ' NH1' ' A' ' 387' ' ' ARG . 27.9 m-85 -63.19 -24.37 67.85 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.009 -1.057 . . . . 0.0 109.269 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.89 -28.94 32.63 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.663 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.45 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.8 m170 -83.38 -32.58 26.11 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 121.032 -1.043 . . . . 0.0 111.843 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 73.5 m-85 -130.97 143.54 50.8 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.895 -1.128 . . . . 0.0 110.705 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 68.1 m -86.46 163.65 17.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.402 -0.811 . . . . 0.0 110.993 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -139.85 159.43 64.8 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.704 -0.623 . . . . 0.0 109.868 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.07 136.44 60.82 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 N-CA-C 108.248 -1.482 . . . . 0.0 108.248 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.24 -3.39 51.11 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.27 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -113.42 141.06 47.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.56 -1.553 . . . . 0.0 108.248 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 56.0 m -51.78 -25.96 8.68 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.067 -1.021 . . . . 0.0 112.2 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -93.49 0.21 56.63 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.506 -1.371 . . . . 0.0 113.517 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -46.11 131.99 9.81 Favored 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 120.562 1.528 . . . . 0.0 111.09 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -82.8 -25.03 51.42 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.512 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 116.14 -120.04 4.75 Favored Glycine 0 C--O 1.217 -0.961 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 58.7 t -137.53 96.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.747 -0.855 . . . . 0.0 110.367 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -116.5 88.95 3.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.234 -0.916 . . . . 0.0 110.066 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.794 HG23 ' CD ' ' A' ' 412' ' ' GLN . 79.0 mt -108.5 77.15 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.09 -1.007 . . . . 0.0 110.118 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.83 78.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.327 -0.858 . . . . 0.0 108.824 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 77.53 55.51 4.23 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.794 ' CD ' HG23 ' A' ' 409' ' ' ILE . 4.4 mt-30 -47.62 -63.35 1.08 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.39 -1.065 . . . . 0.0 110.994 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -135.83 37.61 2.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -0.897 . . . . 0.0 110.364 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 52.9 54.95 9.66 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.901 -1.125 . . . . 0.0 110.864 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.41 66.46 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.211 -0.931 . . . . 0.0 109.944 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -122.15 41.19 3.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 11.3 t0 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.18 -179.963 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.79 81.13 1.66 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.435 1.229 . . . . 0.0 110.379 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 5.8 tp -137.53 141.67 41.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.172 -0.955 . . . . 0.0 110.224 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 113.06 -132.75 10.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.1 p -140.96 90.96 2.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.213 -1.169 . . . . 0.0 110.204 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -116.93 104.36 1.2 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 2.7 m -137.17 135.16 37.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.171 -1.194 . . . . 0.0 110.171 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -129.16 -174.63 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.197 -0.939 . . . . 0.0 110.286 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 98.93 48.07 1.81 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -147.78 -66.64 0.25 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.162 -1.199 . . . . 0.0 110.421 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.408 ' C ' HG23 ' A' ' 374' ' ' VAL . 10.7 mptt -129.35 47.95 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.183 -0.948 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.408 HG23 ' C ' ' A' ' 373' ' ' LYS . 66.4 t -146.16 158.41 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.88 . . . . 0.0 109.893 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -80.27 81.68 6.48 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.172 -0.955 . . . . 0.0 109.979 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.68 146.56 16.52 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.308 -0.87 . . . . 0.0 110.726 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.0 m -67.09 130.21 42.39 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.427 ' OG ' ' NE2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER -51.14 162.33 0.31 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.16 -0.962 . . . . 0.0 110.523 -178.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.48 156.73 27.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.09 -1.006 . . . . 0.0 109.839 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -62.75 -31.04 71.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 120.987 -1.071 . . . . 0.0 110.725 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -80.09 -33.07 39.08 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.021 -1.05 . . . . 0.0 110.228 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 79.46 -89.34 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.45 -3.46 18.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.323 -1.104 . . . . 0.0 112.338 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.35 17.15 18.72 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.505 -1.372 . . . . 0.0 112.653 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.7 t -45.32 137.27 4.8 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 120.664 -1.273 . . . . 0.0 110.853 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.7 p90 -117.46 -40.98 3.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.926 . . . . 0.0 111.875 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.464 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -55.99 156.66 5.13 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.731 -1.231 . . . . 0.0 110.168 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.07 68.19 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.743 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.78 143.43 28.62 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 109.628 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.03 -70.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.435 1.229 . . . . 0.0 110.594 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 9.9 p -38.18 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 O-C-N 121.221 -0.925 . . . . 0.0 112.94 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -69.19 -42.07 76.3 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.918 -1.114 . . . . 0.0 109.144 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -55.93 -36.72 68.04 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.247 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -77.47 -26.39 51.33 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.452 -0.78 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -86.66 -34.57 19.72 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.856 -1.152 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -117.85 146.97 43.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.925 -1.109 . . . . 0.0 110.449 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.11 162.87 13.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.239 -0.913 . . . . 0.0 110.961 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -135.08 157.62 76.56 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.728 -0.607 . . . . 0.0 110.507 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.2 141.48 88.28 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 N-CA-C 107.78 -1.661 . . . . 0.0 107.78 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.19 65.28 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.5 140.07 43.72 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.727 -1.455 . . . . 0.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.9 t -50.58 -24.38 3.21 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.045 -1.034 . . . . 0.0 112.858 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.45 15.63 23.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.435 -1.416 . . . . 0.0 113.467 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.406 ' CZ ' ' O ' ' A' ' 406' ' ' GLY . 20.2 t80 -47.34 123.23 5.35 Favored 'General case' 0 N--CA 1.524 3.257 0 CA-C-N 120.363 1.438 . . . . 0.0 110.767 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -61.67 -38.01 95.18 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.406 ' O ' ' CZ ' ' A' ' 404' ' ' TYR . . . 127.31 -130.93 7.0 Favored Glycine 0 C--O 1.216 -0.989 0 N-CA-C 107.671 -2.172 . . . . 0.0 107.671 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.5 93.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 121.687 -0.89 . . . . 0.0 110.324 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.427 ' NE2' ' OG ' ' A' ' 378' ' ' SER . 0.7 OUTLIER -112.95 89.85 3.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.245 -0.909 . . . . 0.0 109.986 179.504 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.407 HG23 ' CG ' ' A' ' 412' ' ' GLN . 11.1 mt -107.23 82.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.127 -0.983 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 410' ' ' VAL . 59.1 t -118.55 57.97 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.0 109.472 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 412' ' ' GLN . . . 126.81 -46.18 1.1 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.407 ' CG ' HG23 ' A' ' 409' ' ' ILE . 10.7 mt-30 65.3 -65.96 0.15 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.832 -0.804 . . . . 0.0 111.214 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.12 39.01 0.99 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.041 -1.037 . . . . 0.0 110.596 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -116.66 40.75 2.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.119 -0.988 . . . . 0.0 110.215 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.03 65.35 0.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 110.021 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.8 43.14 3.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.174 -0.954 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.1 t0 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.197 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.79 134.01 21.14 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.339 1.179 . . . . 0.0 110.407 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 7.4 tp -133.59 130.76 38.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -0.974 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 137.36 165.97 10.59 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.65 102.44 4.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.247 -1.149 . . . . 0.0 110.273 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 72.82 74.29 0.8 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.1 m -144.1 86.87 1.86 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.251 -1.147 . . . . 0.0 110.326 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -126.79 100.31 6.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.194 -0.941 . . . . 0.0 110.043 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -140.56 41.69 1.26 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -146.93 -67.63 0.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.13 -1.218 . . . . 0.0 110.522 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -156.8 74.86 0.82 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.105 -0.997 . . . . 0.0 110.582 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 74.2 t -145.23 161.01 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.141 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -86.63 93.97 9.35 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.371 -0.83 . . . . 0.0 109.437 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 155.82 10.77 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.611 -0.681 . . . . 0.0 110.467 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -83.03 138.75 33.61 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 157.79 0.73 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.13 -0.981 . . . . 0.0 110.602 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.8 t -77.98 158.01 29.46 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -62.24 -30.94 71.46 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 120.878 -1.139 . . . . 0.0 110.473 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.401 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 14.2 m-85 -81.04 -31.84 34.34 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.089 -1.007 . . . . 0.0 110.412 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 77.35 -89.05 1.01 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.49 -1.75 21.09 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.193 -1.18 . . . . 0.0 112.138 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -115.95 18.2 15.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.497 -1.377 . . . . 0.0 112.69 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.401 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.4 t -46.3 137.63 6.16 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 120.612 -1.305 . . . . 0.0 110.517 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.7 p90 -115.14 -40.44 3.47 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.295 -0.878 . . . . 0.0 112.011 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.45 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -60.94 149.8 35.36 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.778 -1.202 . . . . 0.0 109.551 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.23 69.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.271 -0.893 . . . . 0.0 110.613 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.11 151.76 42.71 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.24 -68.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.52 1.274 . . . . 0.0 111.027 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 8.2 p -40.52 -32.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 O-C-N 121.155 -0.965 . . . . 0.0 112.782 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.04 -39.07 83.14 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.959 -1.088 . . . . 0.0 109.445 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.55 -32.1 71.18 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.19 -27.01 59.45 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.391 -0.818 . . . . 0.0 111.427 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 395' ' ' HIS . 24.6 m170 -93.45 -34.51 13.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.836 -1.165 . . . . 0.0 111.162 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.23 140.19 48.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.993 -1.067 . . . . 0.0 110.807 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.8 t -91.68 165.15 13.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.391 -0.818 . . . . 0.0 110.637 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.91 157.94 72.3 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.802 -0.561 . . . . 0.0 109.764 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.53 140.55 82.21 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.28 -1.52 62.58 Favored Glycine 0 CA--C 1.552 2.38 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.935 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -110.64 142.5 42.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.442 -1.622 . . . . 0.0 108.403 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.3 t -50.88 -26.78 6.27 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.201 -0.937 . . . . 0.0 112.472 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -102.24 8.94 40.35 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.505 -1.372 . . . . 0.0 113.157 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 406' ' ' GLY . 23.3 t80 -47.07 125.37 7.57 Favored 'General case' 0 N--CA 1.52 3.07 0 CA-C-N 120.305 1.412 . . . . 0.0 110.969 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -76.65 -29.67 57.38 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.09 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 404' ' ' TYR . . . 116.04 -118.05 4.11 Favored Glycine 0 C--O 1.217 -0.944 0 N-CA-C 106.879 -2.488 . . . . 0.0 106.879 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.76 92.78 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.705 -0.88 . . . . 0.0 110.724 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -131.72 89.28 2.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.258 -0.901 . . . . 0.0 109.666 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.488 ' HA ' ' NE2' ' A' ' 412' ' ' GLN . 73.3 mt -103.65 70.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.149 -0.969 . . . . 0.0 109.932 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.59 80.06 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 108.855 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 412' ' ' GLN . . . 107.95 -67.18 0.23 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.488 ' NE2' ' HA ' ' A' ' 409' ' ' ILE . 12.3 mm-40 77.34 -60.65 0.44 Allowed 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 123.407 0.683 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -103.76 38.67 1.76 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.035 -1.041 . . . . 0.0 110.075 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -142.53 52.4 1.43 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.248 -0.908 . . . . 0.0 110.222 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 66.29 0.66 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.247 -0.908 . . . . 0.0 110.048 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.71 84.83 2.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 110.212 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.3 t0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.172 -179.944 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.76 139.42 30.63 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.455 1.239 . . . . 0.0 110.436 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.2 tp -137.88 41.55 2.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.219 -0.925 . . . . 0.0 110.185 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -131.52 51.98 0.84 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.6 t -133.28 81.83 1.96 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.257 -1.143 . . . . 0.0 110.231 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -123.7 -90.98 0.95 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 12.1 p -120.73 121.86 39.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -1.157 . . . . 0.0 110.198 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -131.91 77.46 1.76 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.153 -0.967 . . . . 0.0 110.024 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -138.53 40.73 1.43 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -145.28 -67.33 0.31 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.126 -1.22 . . . . 0.0 110.407 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.401 ' C ' HG23 ' A' ' 374' ' ' VAL . 17.6 mttt -137.91 60.71 1.62 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.083 -1.01 . . . . 0.0 110.298 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 373' ' ' LYS . 67.8 t -145.24 161.01 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.105 -0.997 . . . . 0.0 110.295 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -93.01 96.37 10.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.31 -0.869 . . . . 0.0 109.246 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.452 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 3.1 mtt85 -54.61 -179.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.422 -0.799 . . . . 0.0 111.029 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -107.15 128.64 54.58 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.464 ' HB3' ' N ' ' A' ' 406' ' ' GLY . 9.5 p -52.5 117.26 2.74 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.241 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 4.2 t -36.37 151.64 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 381' ' ' TYR . 10.8 ptp -51.12 -30.02 15.09 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.403 ' N ' ' HG3' ' A' ' 380' ' ' MET . 53.6 m-85 -84.96 -23.7 28.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.152 -0.967 . . . . 0.0 111.318 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.13 -82.95 0.12 Allowed Glycine 0 N--CA 1.492 2.419 0 O-C-N 120.361 -1.462 . . . . 0.0 109.935 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -108.01 -0.11 21.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.297 -1.119 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -119.5 19.69 12.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.398 -1.439 . . . . 0.0 113.153 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.1 t -47.66 143.25 3.95 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 120.171 1.35 . . . . 0.0 110.552 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 35.6 p90 -120.14 -39.38 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.324 -0.86 . . . . 0.0 112.222 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.44 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.7 ptp85 -67.66 145.27 54.97 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.719 -1.238 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 73.13 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.977 . . . . 0.0 111.384 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.55 150.8 40.58 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.945 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.31 -73.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.305 1.16 . . . . 0.0 110.477 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.6 t -41.84 -29.5 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 120.885 -1.134 . . . . 0.0 112.082 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.418 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 30.0 t60 -63.19 -35.09 79.16 Favored 'General case' 0 N--CA 1.514 2.767 0 O-C-N 120.604 -1.31 . . . . 0.0 109.307 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.01 -26.75 67.68 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -31.57 57.47 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.913 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -82.75 -40.48 20.47 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.872 -1.142 . . . . 0.0 110.397 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -110.02 165.36 11.79 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.294 -0.879 . . . . 0.0 109.685 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -112.38 169.16 9.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -143.35 160.21 52.46 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.035 . . . . 0.0 110.304 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.05 137.71 68.57 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 108.778 -1.278 . . . . 0.0 108.778 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.33 62.54 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.364 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.59 139.35 45.93 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.411 1.605 . . . . 0.0 108.427 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 51.1 m -49.18 -26.13 2.66 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.188 -0.945 . . . . 0.0 112.679 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -97.8 2.58 49.59 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.394 -1.441 . . . . 0.0 114.433 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 378' ' ' SER . 4.6 t80 -39.79 124.5 1.73 Allowed 'General case' 0 N--CA 1.533 3.688 0 CA-C-N 120.683 1.583 . . . . 0.0 111.029 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.99 77.4 0.11 Allowed Glycine 0 N--CA 1.5 2.961 0 C-N-CA 119.224 -1.465 . . . . 0.0 111.27 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.464 ' N ' ' HB3' ' A' ' 378' ' ' SER . . . -151.71 -58.37 0.01 OUTLIER Glycine 0 N--CA 1.497 2.759 0 C-N-CA 119.622 -1.275 . . . . 0.0 111.513 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 407' ' ' VAL . 14.5 p -118.96 69.31 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 118.65 1.225 . . . . 0.0 112.266 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.423 ' NE2' ' CD2' ' A' ' 404' ' ' TYR . 5.0 mt-30 -126.89 93.34 3.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.013 -1.054 . . . . 0.0 109.366 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.592 HG23 ' CD ' ' A' ' 412' ' ' GLN . 64.9 mt -80.77 68.67 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 121.185 -0.947 . . . . 0.0 109.778 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 63.7 t -123.13 66.89 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 95.21 51.41 1.89 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.592 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.7 mt-30 -48.39 -61.9 1.77 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.49 -1.006 . . . . 0.0 110.903 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -126.15 37.25 4.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.377 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -126.86 40.35 3.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 110.16 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.6 t -139.02 59.21 1.62 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 0.0 110.089 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -102.6 38.92 1.61 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.275 -0.89 . . . . 0.0 109.969 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.233 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.7 108.26 2.51 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.382 1.201 . . . . 0.0 110.49 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 13.8 tp -133.93 134.97 43.24 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.278 -0.888 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -99.12 142.34 16.0 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 21.8 t -142.25 128.55 19.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.14 -1.212 . . . . 0.0 110.246 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.15 108.94 0.65 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 15.6 m -127.36 103.22 7.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -1.187 . . . . 0.0 110.213 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -138.42 -172.9 3.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.907 . . . . 0.0 110.065 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -86.19 -110.98 0.81 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -126.73 73.56 1.41 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -1.137 . . . . 0.0 109.917 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 4.7 mptt 53.53 60.73 3.51 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.977 -1.077 . . . . 0.0 110.465 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.27 161.75 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.224 -0.923 . . . . 0.0 110.678 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.74 89.91 6.82 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.779 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.419 ' NE ' ' O ' ' A' ' 394' ' ' GLN . 2.5 mmt-85 -62.14 151.85 34.62 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.319 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.3 t -74.0 140.91 45.8 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.408 ' OG ' ' NE2' ' A' ' 408' ' ' GLN . 10.9 p -57.18 157.29 6.29 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.316 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -73.15 161.57 30.44 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.044 -1.035 . . . . 0.0 110.232 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -31.83 71.68 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -85.08 -21.53 29.3 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.105 -0.997 . . . . 0.0 110.564 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.4 -86.61 0.11 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.48 -8.7 18.91 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -1.174 . . . . 0.0 112.243 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -106.63 12.96 28.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.48 -1.388 . . . . 0.0 112.975 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.1 t -47.0 142.28 3.63 Favored 'General case' 0 N--CA 1.524 3.235 0 O-C-N 120.534 -1.354 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 32.4 p90 -121.13 -37.05 3.0 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.275 -0.891 . . . . 0.0 112.67 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 1.7 ptm180 -55.11 157.13 3.55 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.742 -1.224 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -129.01 64.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.0 110.749 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -111.74 148.31 38.66 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.076 -1.015 . . . . 0.0 109.93 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.66 -69.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.444 1.234 . . . . 0.0 110.493 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.8 t -43.01 -29.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.177 0 O-C-N 120.819 -1.175 . . . . 0.0 111.752 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.24 -36.26 83.6 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.507 -1.371 . . . . 0.0 108.903 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -57.89 -30.03 65.53 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.159 -0.963 . . . . 0.0 109.071 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.419 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -82.42 -28.65 31.24 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.179 -0.951 . . . . 0.0 110.444 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -75.44 -34.26 60.96 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.969 -1.082 . . . . 0.0 110.873 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -134.65 149.18 50.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.004 -1.06 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.0 t -93.85 164.91 12.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.772 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.15 159.16 70.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.35 138.94 74.35 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.54 -2.08 60.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -176.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -110.07 138.9 45.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 119.14 1.47 . . . . 0.0 107.657 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.3 -23.24 5.47 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.13 -0.981 . . . . 0.0 112.538 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -103.6 11.97 35.5 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.294 -1.504 . . . . 0.0 113.562 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -47.07 128.67 11.66 Favored 'General case' 0 N--CA 1.523 3.181 0 CA-C-N 120.546 1.521 . . . . 0.0 110.925 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -66.22 -36.83 92.32 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.697 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 125.15 -130.16 7.24 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 73.9 t -131.38 97.76 3.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.697 -0.884 . . . . 0.0 110.452 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.408 ' NE2' ' OG ' ' A' ' 378' ' ' SER . 0.1 OUTLIER -138.1 83.17 1.96 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 179.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.576 HG23 ' CD ' ' A' ' 412' ' ' GLN . 10.8 mt -103.94 75.34 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.754 -1.216 . . . . 0.0 110.245 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.92 78.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.291 -0.88 . . . . 0.0 108.678 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 80.42 58.62 2.69 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.576 ' CD ' HG23 ' A' ' 409' ' ' ILE . 7.9 mt-30 -48.51 -65.0 0.64 Allowed 'General case' 0 N--CA 1.513 2.719 0 O-C-N 121.413 -1.051 . . . . 0.0 110.951 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -153.38 37.04 0.47 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.167 -0.958 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -117.04 51.69 0.99 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.072 -1.017 . . . . 0.0 110.311 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.39 66.13 0.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.174 -0.954 . . . . 0.0 109.93 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 52.77 40.09 29.9 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.189 -0.944 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.292 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.9 123.65 9.08 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.462 1.243 . . . . 0.0 110.405 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.3 mp -132.86 -61.98 0.82 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.258 -0.902 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -114.52 68.73 0.25 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.1 m -141.2 47.27 1.71 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.233 -1.157 . . . . 0.0 110.26 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 117.86 134.89 5.23 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 52.2 m -141.93 39.55 1.64 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -1.188 . . . . 0.0 110.37 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -149.13 163.96 36.1 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.168 -0.958 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -91.4 -61.89 1.23 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -145.96 63.84 1.23 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.156 -1.203 . . . . 0.0 110.399 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 52.96 63.76 2.12 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.022 -1.049 . . . . 0.0 110.741 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.34 160.35 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.25 88.64 7.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.319 -0.863 . . . . 0.0 109.271 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.483 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 3.3 mmt-85 -61.53 152.18 30.98 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.294 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -73.38 143.64 46.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.463 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 8.5 t -57.35 168.7 0.72 Allowed 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.616 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 35.9 t -83.23 158.12 22.41 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.075 -1.016 . . . . 0.0 109.832 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 52.8 mtm -56.26 -31.23 63.38 Favored 'General case' 0 N--CA 1.513 2.691 0 O-C-N 121.007 -1.058 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.54 -21.89 35.19 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.081 -1.012 . . . . 0.0 111.052 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.36 -91.95 0.17 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.88 0.66 28.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.448 -1.031 . . . . 0.0 112.271 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -117.49 22.13 12.6 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.471 -1.393 . . . . 0.0 112.299 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 13.2 t -52.31 147.55 7.74 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 120.446 -1.409 . . . . 0.0 109.819 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 19.4 p90 -125.96 -35.63 2.45 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.328 -0.858 . . . . 0.0 112.993 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.474 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 3.0 ptp85 -61.99 162.09 9.74 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.549 -1.344 . . . . 0.0 109.819 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 66.9 1.39 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.199 -0.938 . . . . 0.0 110.649 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -107.53 145.95 32.34 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.272 -0.892 . . . . 0.0 110.078 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.58 -69.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.342 1.18 . . . . 0.0 110.38 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 91.5 t -44.76 -30.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.522 3.126 0 O-C-N 120.854 -1.154 . . . . 0.0 110.972 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.434 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 45.4 t60 -63.73 -36.0 82.43 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.863 -1.148 . . . . 0.0 109.064 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -58.83 -27.54 65.19 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.005 -1.059 . . . . 0.0 109.272 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.05 -31.25 25.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.106 -0.996 . . . . 0.0 110.176 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.421 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 25.7 m170 -73.24 -29.05 62.5 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.978 -1.076 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 59.5 m-85 -140.29 145.86 37.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 110.856 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.483 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 45.7 m -90.1 163.13 14.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.473 -0.767 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -139.14 160.89 60.57 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.692 -0.63 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.03 140.12 77.13 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 108.003 -1.576 . . . . 0.0 108.003 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.8 60.56 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.256 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.27 143.28 45.12 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.367 1.584 . . . . 0.0 107.813 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.9 m -52.81 -30.4 33.06 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.085 -1.009 . . . . 0.0 110.992 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.29 -1.65 57.69 Favored 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.467 ' CE2' ' NE2' ' A' ' 408' ' ' GLN . 8.0 t80 -40.85 116.73 0.75 Allowed 'General case' 0 N--CA 1.532 3.657 0 CA-C-N 120.861 1.664 . . . . 0.0 110.903 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -162.59 79.36 0.15 Allowed Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.437 -1.364 . . . . 0.0 111.221 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -154.35 -56.87 0.01 OUTLIER Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.487 -1.339 . . . . 0.0 111.372 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 407' ' ' VAL . 15.0 p -120.72 75.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.068 -1.254 . . . . 0.0 112.247 -178.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.467 ' NE2' ' CE2' ' A' ' 404' ' ' TYR . 14.0 mt-30 -137.68 85.15 2.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.017 -1.052 . . . . 0.0 109.791 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.525 HG23 ' CD ' ' A' ' 412' ' ' GLN . 11.5 mt -101.13 67.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.205 -0.934 . . . . 0.0 109.853 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.2 t -114.14 78.21 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.357 -0.84 . . . . 0.0 108.794 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 79.54 57.82 3.03 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.525 ' CD ' HG23 ' A' ' 409' ' ' ILE . 7.0 mt-30 -48.57 -63.75 1.0 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.384 -1.068 . . . . 0.0 110.868 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.76 36.94 0.96 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.208 -0.932 . . . . 0.0 110.429 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 53.14 40.98 32.11 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.976 -1.077 . . . . 0.0 110.686 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 415' ' ' THR . 6.1 t -132.54 61.73 1.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.31 39.1 1.63 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.156 -0.965 . . . . 0.0 109.919 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.224 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.89 110.31 3.0 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.435 1.229 . . . . 0.0 110.37 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.7 mt -117.93 150.28 39.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.186 -0.946 . . . . 0.0 110.301 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 112.69 -135.14 12.45 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.7 p -119.22 128.38 54.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.224 -1.162 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -91.66 -147.35 19.99 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.9 m -117.07 -57.12 2.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.5 -178.83 3.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.178 -0.951 . . . . 0.0 110.111 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -62.84 -68.09 1.81 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -149.04 59.42 1.04 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.207 -1.172 . . . . 0.0 110.483 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 7.5 tptt 53.27 64.89 1.69 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.897 -1.127 . . . . 0.0 110.453 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.62 159.52 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.251 -0.906 . . . . 0.0 110.307 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -68.48 82.99 0.26 Allowed 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.473 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt-85 -61.91 152.24 32.53 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.33 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.4 t -71.84 141.52 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.983 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 t -54.84 161.03 1.71 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.153 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 25.3 t -81.28 155.99 25.78 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.893 -1.129 . . . . 0.0 110.757 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 49.9 mtm -56.02 -27.53 53.42 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.24 -0.913 . . . . 0.0 110.932 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 385' ' ' CYS . 87.8 m-85 -84.52 -21.8 30.4 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.05 -1.032 . . . . 0.0 110.723 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 66.61 -93.55 0.21 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.08 0.18 23.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.291 -1.123 . . . . 0.0 112.182 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -116.65 23.41 12.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.475 -1.391 . . . . 0.0 111.837 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 381' ' ' TYR . 14.0 t -52.63 144.22 14.31 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 120.533 -1.355 . . . . 0.0 109.962 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 16.3 p90 -122.9 -36.44 2.88 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.603 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.482 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.08 161.52 26.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.592 -1.318 . . . . 0.0 109.265 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -150.41 111.16 4.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.0 111.223 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -120.06 166.87 13.83 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 109.775 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.36 -28.89 14.49 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.312 1.164 . . . . 0.0 110.395 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.79 -22.94 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.014 -1.054 . . . . 0.0 111.676 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -61.75 -38.04 86.52 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.603 -1.31 . . . . 0.0 109.644 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.83 -28.59 61.77 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.149 -0.97 . . . . 0.0 109.43 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.93 -32.43 25.09 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.404 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 15.8 m170 -71.62 -31.04 66.46 Favored 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.021 -1.049 . . . . 0.0 111.64 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 36.9 m-85 -140.71 148.53 40.9 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.802 -1.186 . . . . 0.0 110.857 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 376' ' ' ARG . 18.3 m -86.81 169.52 12.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.444 -0.785 . . . . 0.0 110.657 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -143.37 157.84 58.87 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.592 -0.693 . . . . 0.0 109.782 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 138.96 73.4 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.114 -1.533 . . . . 0.0 108.114 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.04 54.76 Favored Glycine 0 CA--C 1.553 2.435 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.042 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.14 147.62 40.02 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.733 -1.451 . . . . 0.0 107.902 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 48.0 t -58.71 -27.05 64.51 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.725 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.62 -0.56 57.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.681 -1.262 . . . . 0.0 113.918 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -45.37 125.23 5.43 Favored 'General case' 0 N--CA 1.521 3.095 0 CA-C-N 120.81 1.641 . . . . 0.0 110.789 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -71.86 -32.22 63.97 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 121.37 -127.16 6.82 Favored Glycine 0 C--O 1.218 -0.893 0 N-CA-C 106.62 -2.592 . . . . 0.0 106.62 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 64.9 t -138.27 97.95 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.663 -0.904 . . . . 0.0 110.667 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.63 85.86 1.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.179 -0.951 . . . . 0.0 110.982 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.834 HG23 ' CD ' ' A' ' 412' ' ' GLN . 5.2 mp -111.66 72.56 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.974 -1.079 . . . . 0.0 109.827 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 50.7 t -113.27 79.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 73.94 53.67 6.96 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.834 ' CD ' HG23 ' A' ' 409' ' ' ILE . 3.2 mt-30 -47.05 -57.27 5.22 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.365 -1.079 . . . . 0.0 111.192 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -143.42 39.32 1.41 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.296 -0.878 . . . . 0.0 110.335 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.11 65.02 1.13 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.13 -0.981 . . . . 0.0 110.144 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.98 65.22 0.64 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.179 -0.95 . . . . 0.0 109.918 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -115.28 41.57 2.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.317 -0.864 . . . . 0.0 110.264 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.214 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.72 79.83 1.85 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.453 1.238 . . . . 0.0 110.408 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 3.4 mt -136.8 114.96 11.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.969 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 130.97 60.58 0.09 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 t -142.74 79.71 1.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.143 -1.21 . . . . 0.0 110.248 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.18 -121.93 2.01 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 10.4 p -121.73 85.66 2.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -1.196 . . . . 0.0 110.345 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -127.36 77.43 1.74 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.929 . . . . 0.0 110.087 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.48 41.26 1.11 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -135.61 -61.16 0.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.151 -1.205 . . . . 0.0 109.943 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.81 59.54 1.69 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.04 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.6 t -145.88 161.46 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.991 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -89.53 96.02 10.52 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.251 -0.905 . . . . 0.0 109.427 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.89 150.57 39.12 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.344 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.2 t -76.58 -179.66 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.183 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 404' ' ' TYR . 0.1 OUTLIER -97.16 126.81 42.59 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.004 -1.06 . . . . 0.0 110.82 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 5.3 t -45.07 145.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.614 -0.679 . . . . 0.0 112.333 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 11.3 ptp -49.4 -28.08 4.76 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.469 -0.769 . . . . 0.0 111.031 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -86.81 -22.47 25.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.942 -1.099 . . . . 0.0 111.214 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.65 -84.87 0.04 OUTLIER Glycine 0 N--CA 1.497 2.703 0 O-C-N 120.495 -1.378 . . . . 0.0 110.784 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.11 -9.74 17.6 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.202 -1.175 . . . . 0.0 112.569 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -112.84 18.69 17.99 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.521 -1.362 . . . . 0.0 113.22 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 30.9 t -47.89 139.13 8.04 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.055 1.298 . . . . 0.0 110.239 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 37.5 p90 -116.22 -40.68 3.23 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.461 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -71.35 162.75 28.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.904 -1.122 . . . . 0.0 109.154 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -155.99 104.07 2.26 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.177 -0.952 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.49 165.3 14.7 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 -24.74 18.58 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.437 1.23 . . . . 0.0 110.588 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.22 -21.73 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.039 -1.038 . . . . 0.0 111.756 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.442 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 45.5 t60 -63.84 -38.19 90.18 Favored 'General case' 0 N--CA 1.512 2.663 0 O-C-N 120.517 -1.364 . . . . 0.0 110.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -58.1 -30.61 66.41 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -32.14 44.93 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.876 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -77.82 -37.76 47.88 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.119 -0.988 . . . . 0.0 110.589 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.9 m-85 -125.18 150.52 46.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.1 t -94.7 174.48 7.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.161 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -144.33 156.49 57.36 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.478 -0.764 . . . . 0.0 109.278 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.14 138.9 80.88 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.61 -2.54 55.95 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.791 -1.195 . . . . 0.0 110.874 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.14 146.87 39.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.699 1.75 . . . . 0.0 108.415 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.8 t -54.48 -28.45 44.82 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.124 -0.985 . . . . 0.0 111.645 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -92.12 1.44 57.21 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 0.0 113.058 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 378' ' ' SER . 23.3 t80 -48.58 132.61 17.28 Favored 'General case' 0 N--CA 1.514 2.76 0 CA-C-N 120.391 1.451 . . . . 0.0 110.253 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -126.17 16.09 6.8 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.636 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -54.55 -29.67 48.59 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-N 119.942 1.871 . . . . 0.0 111.042 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 407' ' ' VAL . 89.3 t -99.9 67.77 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.443 -1.034 . . . . 0.0 109.494 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -66.46 78.92 0.1 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.291 -0.88 . . . . 0.0 109.48 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.566 HG23 ' CD ' ' A' ' 412' ' ' GLN . 13.5 mt 51.33 67.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.07 -1.019 . . . . 0.0 110.42 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 410' ' ' VAL . 70.4 t -120.56 65.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.73 51.48 1.96 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.566 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.5 mt-30 -49.07 -61.86 1.84 Allowed 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.441 -1.035 . . . . 0.0 110.702 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -122.34 36.97 4.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.325 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -140.99 54.29 1.57 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.194 -0.941 . . . . 0.0 110.098 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 66.43 0.64 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.191 -0.943 . . . . 0.0 110.079 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -116.3 83.8 2.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.332 -0.855 . . . . 0.0 110.225 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.168 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.81 129.53 14.55 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.445 1.234 . . . . 0.0 110.372 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 12.3 tp -142.87 115.73 8.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -79.3 130.81 10.13 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.7 t -132.11 81.52 1.97 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.223 -1.163 . . . . 0.0 110.302 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 97.63 149.7 25.56 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.41 124.46 43.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -1.168 . . . . 0.0 110.147 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.87 171.05 15.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.168 -0.958 . . . . 0.0 110.417 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -95.88 -43.59 3.29 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -146.07 53.67 1.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.166 -1.196 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 10.0 mttt 52.97 61.88 2.96 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.01 -1.057 . . . . 0.0 110.754 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.7 p -138.52 161.52 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 110.831 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -83.29 99.22 9.86 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.452 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -72.64 152.99 41.45 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.803 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.1 m -73.43 141.8 46.91 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.439 ' HB2' ' N ' ' A' ' 406' ' ' GLY . 8.2 t -58.18 158.49 6.97 Favored 'General case' 0 N--CA 1.511 2.606 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.503 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.83 151.46 35.88 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.911 -1.118 . . . . 0.0 110.577 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -52.91 -28.59 24.09 Favored 'General case' 0 N--CA 1.514 2.76 0 O-C-N 121.226 -0.921 . . . . 0.0 111.118 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.412 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 8.8 m-85 -77.34 -31.95 54.84 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.977 -1.077 . . . . 0.0 110.169 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.94 -90.91 0.89 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.34 4.98 29.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.331 -1.099 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -128.34 25.78 5.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.556 -1.34 . . . . 0.0 112.191 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.412 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 34.4 t -50.66 143.77 9.05 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 120.668 -1.27 . . . . 0.0 110.165 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 13.3 p90 -116.4 -36.01 4.12 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.284 -0.885 . . . . 0.0 112.001 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -73.52 149.54 42.16 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.831 -1.168 . . . . 0.0 109.694 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.5 100.89 3.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.062 -1.024 . . . . 0.0 111.171 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.21 164.57 21.84 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 0.0 109.848 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.41 -29.93 16.05 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.324 1.171 . . . . 0.0 110.447 179.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.14 -23.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.12 -0.988 . . . . 0.0 111.304 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -61.7 -37.45 84.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.764 -1.21 . . . . 0.0 109.637 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -57.73 -26.06 61.27 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.47 -30.3 30.05 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 11.6 m170 -79.32 -34.22 42.49 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.159 -0.963 . . . . 0.0 111.336 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 65.6 m-85 -133.26 142.43 48.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.224 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.452 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 56.0 m -85.71 169.27 13.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.401 -0.812 . . . . 0.0 110.167 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -144.39 158.75 53.77 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.6 -0.687 . . . . 0.0 109.923 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.09 137.43 66.63 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 N-CA-C 108.341 -1.446 . . . . 0.0 108.341 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.12 -1.94 56.45 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.698 -178.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.24 150.75 40.89 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.651 -1.499 . . . . 0.0 107.564 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 81.3 p -60.32 -32.07 70.88 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.456 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.8 -11.44 60.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.028 -1.045 . . . . 0.0 112.634 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.431 ' CD2' ' NE2' ' A' ' 408' ' ' GLN . 8.8 t80 -45.49 113.49 0.6 Allowed 'General case' 0 N--CA 1.517 2.886 0 CA-C-N 120.288 1.404 . . . . 0.0 110.214 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -163.82 78.93 0.14 Allowed Glycine 0 N--CA 1.499 2.875 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.6 -178.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.439 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -150.95 -55.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.865 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.93 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 407' ' ' VAL . 12.5 p -111.21 61.85 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.118 -1.225 . . . . 0.0 110.509 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.431 ' NE2' ' CD2' ' A' ' 404' ' ' TYR . 12.6 mt-30 -132.17 92.13 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.425 -0.797 . . . . 0.0 109.91 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.569 HG23 ' CD ' ' A' ' 412' ' ' GLN . 68.7 mt -96.66 66.77 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.304 -0.873 . . . . 0.0 109.716 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 67.2 t -117.48 69.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 91.7 53.87 2.03 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.569 ' CD ' HG23 ' A' ' 409' ' ' ILE . 5.0 mt-30 -48.34 -62.99 1.2 Allowed 'General case' 0 N--CA 1.511 2.613 0 O-C-N 121.433 -1.039 . . . . 0.0 110.959 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -139.85 38.48 1.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.095 -1.003 . . . . 0.0 110.24 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -116.99 47.88 1.41 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.212 -0.93 . . . . 0.0 110.21 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.55 66.57 0.66 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.129 -0.982 . . . . 0.0 110.076 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -121.89 40.5 3.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.238 -0.914 . . . . 0.0 110.231 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.213 -179.952 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.78 168.14 25.36 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.419 1.22 . . . . 0.0 110.372 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 86.5 mt -133.37 177.14 7.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 104.99 58.16 0.67 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.0 t -143.24 96.08 2.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.121 -1.223 . . . . 0.0 110.386 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 96.51 125.4 4.89 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.1 m -145.67 60.31 1.27 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.201 -1.176 . . . . 0.0 110.447 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -142.62 44.1 1.61 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.045 -1.034 . . . . 0.0 110.21 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -147.33 40.11 1.01 Allowed Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -126.96 -59.11 1.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.248 -1.148 . . . . 0.0 110.079 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -137.75 50.55 1.93 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.298 -0.876 . . . . 0.0 110.258 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.28 160.22 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.055 -1.028 . . . . 0.0 110.634 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -88.37 94.53 9.88 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -67.75 150.25 48.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.456 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.7 t -78.92 172.12 14.23 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.771 -179.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.2 p -76.99 157.53 31.15 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.076 -1.015 . . . . 0.0 109.272 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.42 160.74 29.91 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.429 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 7.5 ptp -61.45 -35.31 77.26 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.901 -1.125 . . . . 0.0 109.944 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.409 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 15.4 m-85 -77.14 -33.48 56.69 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.484 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 76.13 -87.64 0.89 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -106.75 -3.19 20.74 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.261 -1.141 . . . . 0.0 112.469 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -115.44 17.33 16.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.415 -1.428 . . . . 0.0 112.809 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.409 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 8.6 t -45.14 139.69 3.19 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-N 120.059 1.3 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 33.5 p90 -117.22 -39.39 3.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.313 -0.867 . . . . 0.0 112.363 -178.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.446 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 7.4 ptp85 -57.28 156.58 7.36 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 120.632 -1.293 . . . . 0.0 110.165 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.93 65.56 1.2 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 110.871 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -109.95 144.15 29.41 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.113 -0.992 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.47 -71.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.358 1.189 . . . . 0.0 110.529 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 71.8 t -41.48 -28.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 O-C-N 120.885 -1.134 . . . . 0.0 112.318 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.435 ' CE1' ' HD2' ' A' ' 387' ' ' ARG . 27.2 t60 -65.23 -37.6 87.75 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 120.496 -1.378 . . . . 0.0 108.66 177.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -57.37 -31.04 65.38 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.068 -1.02 . . . . 0.0 109.35 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 -26.99 39.95 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.211 -0.931 . . . . 0.0 110.737 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -81.85 -37.88 26.29 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.002 -1.062 . . . . 0.0 110.185 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 54.5 m-85 -125.15 145.44 49.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 1.8 t -94.22 170.35 9.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.34 158.77 65.75 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.664 -0.647 . . . . 0.0 109.983 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.61 139.74 82.89 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 108.153 -1.518 . . . . 0.0 108.153 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.41 -1.63 60.47 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.807 -176.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -112.62 141.5 46.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.619 -1.518 . . . . 0.0 107.983 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.0 m -51.6 -28.53 14.41 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.149 -0.969 . . . . 0.0 111.752 -178.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.682 -1.261 . . . . 0.0 113.355 -178.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.426 ' CE2' ' HA2' ' A' ' 406' ' ' GLY . 26.0 t80 -43.79 126.45 4.67 Favored 'General case' 0 N--CA 1.522 3.128 0 CA-C-N 120.466 1.485 . . . . 0.0 111.121 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.6 -24.08 44.16 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.227 -178.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 404' ' ' TYR . . . 115.99 -119.98 4.74 Favored Glycine 0 C--O 1.218 -0.866 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 -179.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 64.1 t -138.7 97.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.821 -0.811 . . . . 0.0 110.526 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -157.43 87.11 0.95 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.335 -0.853 . . . . 0.0 110.444 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.535 HG23 ' CD ' ' A' ' 412' ' ' GLN . 74.9 mt -88.37 71.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.908 -1.12 . . . . 0.0 110.056 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.5 t -126.62 67.62 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 95.88 51.31 1.81 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -178.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.535 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.4 mt-30 -48.85 -56.04 9.9 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 121.379 -1.071 . . . . 0.0 110.565 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -119.57 32.69 5.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.302 -0.874 . . . . 0.0 110.564 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.97 62.65 1.07 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.071 -1.018 . . . . 0.0 109.776 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.25 65.82 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.26 -0.9 . . . . 0.0 110.067 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.55 87.02 2.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.294 -0.879 . . . . 0.0 109.996 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.226 179.959 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.79 169.82 21.1 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.428 1.225 . . . . 0.0 110.481 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 6.5 mt -131.97 103.98 6.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 110.264 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 94.25 43.63 3.71 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.6 m -131.87 -65.33 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.203 -1.175 . . . . 0.0 110.224 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.7 -119.41 5.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.41 128.66 55.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.215 -1.168 . . . . 0.0 110.025 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -127.68 69.1 1.31 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -148.02 38.81 1.03 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -126.38 -60.07 1.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.136 -1.214 . . . . 0.0 109.664 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -133.97 48.13 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.878 . . . . 0.0 109.636 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.48 160.75 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.116 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -95.49 100.51 12.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.494 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.7 OUTLIER -80.89 161.75 24.24 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.777 -0.577 . . . . 0.0 111.334 -179.219 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.4 t -76.62 174.17 10.71 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.9 t -94.7 129.99 41.37 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 120.684 -1.26 . . . . 0.0 111.78 -178.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 7.8 t -40.11 148.55 0.08 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.895 -0.503 . . . . 0.0 112.036 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 6.1 ptp -47.64 -37.83 13.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.622 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.437 ' HB3' ' N ' ' A' ' 385' ' ' CYS . 27.9 m-85 -73.58 -35.21 65.39 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.57 -86.62 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.047 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.24 7.06 43.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.26 -1.141 . . . . 0.0 112.847 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -134.87 25.09 3.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.343 -1.473 . . . . 0.0 112.577 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 381' ' ' TYR . 12.2 t -49.63 151.72 1.6 Allowed 'General case' 0 N--CA 1.521 3.076 0 O-C-N 120.514 -1.366 . . . . 0.0 111.113 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.1 p90 -126.3 -33.2 2.63 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.992 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.423 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.1 OUTLIER -55.97 173.81 0.14 Allowed 'General case' 0 N--CA 1.514 2.729 0 O-C-N 120.388 -1.445 . . . . 0.0 110.167 179.936 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -143.7 55.88 1.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 110.532 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -112.05 148.18 38.48 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 109.606 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -73.34 -66.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.396 1.208 . . . . 0.0 110.473 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.3 t -43.01 -29.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 120.888 -1.132 . . . . 0.0 111.999 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.4 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 39.0 t60 -63.87 -38.98 93.09 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.665 -1.272 . . . . 0.0 108.824 178.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -56.13 -29.27 60.48 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 178.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -29.72 45.23 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.159 -0.963 . . . . 0.0 110.501 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 17.2 m170 -75.33 -35.47 61.19 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.453 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 34.0 m-85 -134.78 138.19 44.07 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.087 -1.008 . . . . 0.0 110.304 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.494 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 1.5 m -81.58 169.48 17.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.518 -0.739 . . . . 0.0 109.23 178.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -141.6 155.22 66.92 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.61 140.07 92.0 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 N-CA-C 108.735 -1.294 . . . . 0.0 108.735 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.57 0.79 64.44 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.722 -177.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.22 143.81 44.23 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.413 1.606 . . . . 0.0 108.646 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.6 t -50.01 -30.79 11.32 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.09 -1.006 . . . . 0.0 111.839 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.83 -6.15 54.65 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.684 -1.26 . . . . 0.0 113.55 -177.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -39.47 129.55 1.84 Allowed 'General case' 0 N--CA 1.525 3.289 0 CA-C-N 120.551 1.523 . . . . 0.0 111.294 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -173.91 70.62 0.1 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.609 -178.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -137.91 -63.02 0.05 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.128 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 407' ' ' VAL . 96.1 t 41.67 63.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.695 -0.885 . . . . 0.0 111.333 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -113.86 96.54 5.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.28 -0.888 . . . . 0.0 110.518 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.642 HG23 ' CD ' ' A' ' 412' ' ' GLN . 78.7 mt -108.87 71.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.345 -0.847 . . . . 0.0 109.962 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.9 67.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.241 -0.912 . . . . 0.0 108.783 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 92.24 51.4 2.4 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 -178.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.642 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.8 mt-30 -47.81 -62.45 1.45 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 121.432 -1.04 . . . . 0.0 111.058 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.05 39.61 3.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 0.0 110.313 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -123.86 49.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.167 -0.958 . . . . 0.0 110.21 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 415' ' ' THR . 6.4 t -131.41 62.74 1.62 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.161 -0.962 . . . . 0.0 110.111 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.38 39.29 1.61 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.216 -0.928 . . . . 0.0 109.844 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.256 179.934 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.14 -43.68 0.69 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.4 1.211 . . . . 0.0 110.34 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 2.0 tt -127.9 87.88 2.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.141 -0.974 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 106.22 149.2 16.93 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 24.4 p -122.21 136.96 54.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.213 -1.169 . . . . 0.0 110.238 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 130.5 106.98 1.17 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.9 134.85 53.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.22 -1.165 . . . . 0.0 110.221 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.01 167.54 22.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.217 -0.927 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -62.51 -72.0 0.73 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -139.5 57.77 1.63 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.142 -1.211 . . . . 0.0 110.295 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 5.0 mptt 52.31 58.06 5.79 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.955 -1.091 . . . . 0.0 110.76 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.66 152.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 110.062 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -69.84 91.38 0.64 Allowed 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.487 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -58.04 158.28 6.97 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.697 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 7.5 t -75.08 145.67 42.1 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.449 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 1.3 t -56.44 163.2 1.81 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.646 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 6.1 t -78.34 162.3 26.57 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.04 -1.038 . . . . 0.0 109.8 178.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 47.9 mtm -58.4 -31.16 67.43 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.403 179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.11 -26.11 25.42 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.144 -0.972 . . . . 0.0 110.768 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.19 -89.75 0.6 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -104.61 -1.19 26.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.343 -1.092 . . . . 0.0 111.956 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -112.51 16.95 19.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.34 -1.475 . . . . 0.0 112.275 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.4 t -49.19 143.84 5.67 Favored 'General case' 0 N--CA 1.519 2.98 0 O-C-N 120.558 -1.339 . . . . 0.0 110.377 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 26.5 p90 -120.77 -33.94 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.353 -0.842 . . . . 0.0 112.536 -179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.6 OUTLIER -72.64 174.54 7.42 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.709 -1.245 . . . . 0.0 109.618 179.571 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.6 93.3 1.18 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.899 -1.126 . . . . 0.0 111.096 -179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -115.23 162.43 24.44 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.736 -1.227 . . . . 0.0 110.034 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -26.04 12.73 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 O-C-N 123.514 1.27 . . . . 0.0 110.652 178.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.76 -25.42 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.093 -1.004 . . . . 0.0 111.411 178.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -61.88 -36.02 80.02 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.662 -1.273 . . . . 0.0 109.946 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -58.13 -26.67 62.94 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -31.08 27.86 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.178 -0.951 . . . . 0.0 110.468 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 18.5 m170 -75.46 -34.3 60.93 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.808 -1.183 . . . . 0.0 111.371 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 48.3 m-85 -137.21 145.66 43.92 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.722 -1.236 . . . . 0.0 110.839 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 66.5 m -91.4 169.97 10.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.222 -0.924 . . . . 0.0 111.503 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -141.64 153.54 65.22 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.109 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.34 140.14 81.04 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 N-CA-C 107.253 -1.864 . . . . 0.0 107.253 178.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.31 1.61 60.79 Favored Glycine 0 CA--C 1.553 2.438 0 C-N-CA 119.041 -1.552 . . . . 0.0 110.825 -178.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.66 156.94 24.97 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.837 1.818 . . . . 0.0 107.778 177.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -29.11 70.24 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.207 -179.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -94.41 6.09 49.8 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 120.533 -1.355 . . . . 0.0 114.0 -177.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -48.62 134.62 15.64 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-N 120.643 1.565 . . . . 0.0 109.966 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -155.43 45.04 0.54 Allowed Glycine 0 N--CA 1.497 2.7 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.278 -178.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -109.32 -56.05 0.55 Allowed Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 407' ' ' VAL . 98.5 t 41.95 69.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.862 -0.787 . . . . 0.0 111.639 179.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -102.04 53.7 0.81 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.259 -0.9 . . . . 0.0 109.792 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.545 HG23 ' HG2' ' A' ' 412' ' ' GLN . 13.7 mt 50.01 68.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.284 -0.885 . . . . 0.0 110.807 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 410' ' ' VAL . 62.2 t -107.64 65.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 98.18 51.99 1.41 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 -178.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.545 ' HG2' HG23 ' A' ' 409' ' ' ILE . 12.5 mm-40 -59.42 -49.77 76.54 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.244 -1.151 . . . . 0.0 109.833 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.75 37.42 2.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.241 -0.912 . . . . 0.0 109.827 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -135.64 62.62 1.62 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.966 . . . . 0.0 110.231 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.0 65.1 0.66 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.014 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -130.37 83.34 2.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.303 -179.999 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.77 130.72 16.12 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.332 1.175 . . . . 0.0 110.38 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.49 -174.18 2.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.263 -0.898 . . . . 0.0 110.249 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -112.81 -58.04 0.43 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 367' ' ' SER . 9.5 t -132.95 48.62 2.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.171 -1.194 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -126.16 142.98 14.08 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.3 p -122.67 -65.77 1.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.249 -1.148 . . . . 0.0 110.055 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -143.97 75.28 1.46 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -0.97 . . . . 0.0 110.237 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -156.91 39.46 0.56 Allowed Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -126.21 -59.62 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.166 -1.197 . . . . 0.0 110.052 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -139.14 52.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.981 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.1 t -142.83 157.24 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 109.931 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 86.88 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.47 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -61.2 153.65 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.293 -179.637 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -71.07 142.46 50.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.425 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 28.8 t -53.05 165.19 0.33 Allowed 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.686 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 396' ' ' PHE . 45.2 t -87.51 156.97 19.3 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.974 -1.079 . . . . 0.0 109.682 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 4.1 ptp -55.25 -31.61 61.67 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -93.52 -20.74 19.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.974 -1.079 . . . . 0.0 111.439 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.45 -98.86 0.22 Allowed Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.521 -1.362 . . . . 0.0 110.392 178.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.58 -13.32 32.18 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.429 -1.042 . . . . 0.0 111.764 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -104.51 16.44 26.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.565 -1.335 . . . . 0.0 112.39 -179.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 16.9 t -48.92 139.78 9.71 Favored 'General case' 0 N--CA 1.52 3.065 0 O-C-N 120.517 -1.364 . . . . 0.0 111.039 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 17.9 p90 -117.03 -37.16 3.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.438 -0.789 . . . . 0.0 111.765 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.457 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.0 OUTLIER -79.69 153.66 29.15 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.644 -1.285 . . . . 0.0 109.408 179.184 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 108.29 4.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -0.98 . . . . 0.0 111.02 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -118.97 167.47 11.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 0.0 110.209 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.15 -27.67 16.58 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.432 1.227 . . . . 0.0 110.319 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.4 t -98.17 -24.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.084 -1.01 . . . . 0.0 111.92 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -61.94 -38.09 87.17 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.6 -1.313 . . . . 0.0 110.113 -179.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -56.96 -28.81 62.62 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.83 -1.169 . . . . 0.0 109.148 178.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -32.53 30.06 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.238 -0.914 . . . . 0.0 110.275 179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.433 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 22.1 m170 -71.98 -32.0 66.81 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.07 -1.019 . . . . 0.0 111.408 -179.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 42.7 m-85 -140.02 148.08 41.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.952 -1.093 . . . . 0.0 111.43 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 15.9 m -87.61 168.76 12.75 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -0.81 . . . . 0.0 110.997 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -143.7 153.33 57.91 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.15 139.08 76.33 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 177.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.4 -0.81 55.78 Favored Glycine 0 CA--C 1.553 2.446 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.757 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -116.41 158.07 24.09 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.662 1.731 . . . . 0.0 108.229 178.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 59.2 m -64.02 -28.01 69.51 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.708 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.65 2.38 56.51 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.644 -1.285 . . . . 0.0 114.061 -176.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -48.14 130.58 15.87 Favored 'General case' 0 N--CA 1.523 3.182 0 CA-C-N 120.741 1.61 . . . . 0.0 110.131 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -170.54 76.78 0.1 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.759 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -178.32 56.24 0.09 OUTLIER Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.086 -1.53 . . . . 0.0 112.55 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 99.2 t -75.21 77.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.241 -1.152 . . . . 0.0 109.498 179.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.58 94.87 2.7 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.339 -0.85 . . . . 0.0 109.975 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.673 HG23 ' CD ' ' A' ' 412' ' ' GLN . 5.3 mp -110.96 72.54 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.002 -1.061 . . . . 0.0 110.653 -179.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.07 67.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.259 -0.901 . . . . 0.0 108.677 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.21 52.76 2.81 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -178.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.673 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.9 mt-30 -47.5 -65.31 0.59 Allowed 'General case' 0 N--CA 1.513 2.69 0 O-C-N 121.539 -0.977 . . . . 0.0 111.321 -178.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -155.55 39.4 0.39 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.164 -0.96 . . . . 0.0 110.655 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -115.57 45.93 1.59 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.164 -0.96 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.83 66.5 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 0.0 110.005 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.08 42.39 3.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.219 -0.926 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.259 179.915 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_